Processing 00000000.tx.1: Increased Risk of Type 2 Diabetes in Alzheimer Disease Juliette Janson1,2, Thomas Laedtke1, Joseph E. 

Phrase: "Increased Risk of Type 2 Diabetes"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   783   C1171304:diabetes risk [Quantitative Concept]
   753   C0035647:Risk [Qualitative Concept]
   753   C0205217:Increased [Quantitative Concept]
   753   C0442805:Increased [Functional Concept]

Phrase: "in Alzheimer Disease Juliette Janson1,"

Phrase: "2,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "Thomas Laedtke1,"

Phrase: "Joseph E."
Processing 00000000.tx.2: Parisi2, Peter OBrien3, Ronald C. 

Phrase: "Parisi2,"

Phrase: "Peter OBrien3,"

Phrase: "Ronald C."
Processing 00000000.tx.3: Petersen4, and Peter C. 

Phrase: "Petersen4,"

Phrase: "and"

Phrase: "Peter C."
Processing 00000000.tx.4: Butler5 1 Endocrine Research Unit, Mayo Clinic, Rochester, Minnesota 2 Department of Pathology, Mayo Clinic, Rochester, Minnesota 3 Department of Biostatistics, Mayo Clinic, Rochester, Minnesota 4 Department of Neurology and Health Sciences Research, Mayo Clinic, Rochester, Minnesota 5 Division of Endocrinology and Diabetes, Keck School of Medicine, University of Southern California, Los Angeles, California  ABSTRACT TOP ABSTRACT RESEARCH DESIGN AND METHODS RESULTS DISCUSSION REFERENCES  Alzheimer disease and type 2 diabetes are characterized by increased prevalence with aging, a genetic predisposition, and comparable pathological features in the islet and brain (amyloid derived from amyloid  protein in the brain in Alzheimer disease and islet amyloid derived from islet amyloid polypeptide in the pancreas in type 2 diabetes). 

Phrase: "Butler5 1 Endocrine Research Unit,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   804   C0439148:Unit [Quantitative Concept]
   804   C1519795:Unit [Quantitative Concept]
   804   C1704753:Unit [Manufactured Object]
   804   C1880519:Unit [Quantitative Concept]

Phrase: "Mayo Clinic,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0002424:Clinic [Health Care Related Organization,Manufactured Object]
   861   C0442592:Clinic [Health Care Related Organization,Manufactured Object]
   789 E C0205210:Clinical [Qualitative Concept]

Phrase: "Rochester,"

Phrase: "Minnesota 2 Department of Pathology,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   797   C0587487:Pathology department [Health Care Related Organization]
   760   C1704729:Department [Organization]

Phrase: "Mayo Clinic,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0002424:Clinic [Health Care Related Organization,Manufactured Object]
   861   C0442592:Clinic [Health Care Related Organization,Manufactured Object]
   789 E C0205210:Clinical [Qualitative Concept]

Phrase: "Rochester,"

Phrase: "Minnesota 3 Department of Biostatistics,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1704729:Department [Organization]

Phrase: "Mayo Clinic,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0002424:Clinic [Health Care Related Organization,Manufactured Object]
   861   C0442592:Clinic [Health Care Related Organization,Manufactured Object]
   789 E C0205210:Clinical [Qualitative Concept]

Phrase: "Rochester,"

Phrase: "Minnesota 4 Department of Neurology"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   797   C0587475:Neurology department [Health Care Related Organization]
   760   C1704729:Department [Organization]

Phrase: "and"

Phrase: "Health Sciences"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1512352:Health Sciences [Biomedical Occupation or Discipline]
   861   C0036397:Sciences [Occupation or Discipline]

Phrase: "Research"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0035168:research [Research Activity]
  1000   C0242481:Research [Research Activity]

Phrase: ","

Phrase: "Mayo Clinic,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0002424:Clinic [Health Care Related Organization,Manufactured Object]
   861   C0442592:Clinic [Health Care Related Organization,Manufactured Object]
   789 E C0205210:Clinical [Qualitative Concept]

Phrase: "Rochester,"

Phrase: "Minnesota 5 Division of Endocrinology"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C1293097:Division [Therapeutic or Preventive Procedure]
   760   C2919030:Division [Organization]
   760   C2919031:Division [Activity]

Phrase: "and"

Phrase: "Diabetes,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0011847:Diabetes [Disease or Syndrome]
  1000   C0011849:Diabetes [Disease or Syndrome]

Phrase: "Keck School of Medicine,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0036375:School [Manufactured Object,Organization]

Phrase: "University of Southern California,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C0006754:California [Geographic Area]
   812   C0041740:University [Manufactured Object,Organization]
   812   C1710133:Southern [Spatial Concept]
   812   C3146274:California [Plant]

Phrase: "Los Angeles,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0024015:Los Angeles [Geographic Area]

Phrase: "California  ABSTRACT TOP ABSTRACT RESEARCH DESIGN"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0035171:Research Design [Research Activity]
   799   C0035168:research [Research Activity]
   799   C0242481:Research [Research Activity]
   799   C1707689:Design [Activity]
   799   C2983265:DESIGN [Intellectual Product]

Phrase: "AND"

Phrase: "METHODS RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Alzheimer disease"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "and"

Phrase: "type 2 diabetes"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0011860:Type 2 Diabetes [Disease or Syndrome]
   913   C1320657:type diabetes [Finding]
   901   C0441730:Type 2 [Classification]
   827   C0011847:Diabetes [Disease or Syndrome]
   827   C0011849:Diabetes [Disease or Syndrome]
   827   C0332307:Type [Qualitative Concept]
   827   C1547052:*Type [Quantitative Concept]

Phrase: "are"

Phrase: "characterized by increased prevalence"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0033105:Prevalence [Quantitative Concept]
   770   C0205217:Increased [Quantitative Concept]
   770   C0220900:prevalence [Quantitative Concept]
   770   C0442805:Increased [Functional Concept]
   770   C1880022:Characterized [Activity]

Phrase: "with aging,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001811:Ageing [Organism Function]

Phrase: "a genetic predisposition,"
Meta Candidates (Total=20; Excluded=15; Pruned=0; Remaining=5)
  1000   C0314657:Genetic Predisposition [Organism Attribute]
   861   C0012655:Predisposition [Clinical Attribute]
   861   C0017296:GENETIC [Therapeutic or Preventive Procedure]
   861   C0220898:Predisposition [Organism Attribute]
   861   C0314603:Genetic [Functional Concept]
   805 E C0005615:Birth [Organism Function]
   805 E C0035150:Reproduction [Organism Function]
   805 E C0079946:origin [Classification]
   805 E C0439659:Origin [Temporal Concept]
   805 E C1550512:origin [Intellectual Product]
   805 E C1550722:birth [Idea or Concept]
   805 E C3245487:birth [Intellectual Product]
   789 E C0231203:Predisposed [Functional Concept]
   777 E C0454729:Natal [Geographic Area]
   777 E C0559522:Genital [Body System]
   777 E C1546649:Genital [Intellectual Product]
   777 E C1550642:Genital [Body Substance]
   768 E C0205313:Original [Idea or Concept]
   768 E C2347409:Original [Occupational Activity]
   750 E C0598240:originality [Mental Process]

Phrase: "and"

Phrase: "comparable pathological features in the islet"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   719   C1521970:Feature [Qualitative Concept]
   719   C1706388:Feature [Conceptual Entity]
   719   C2346469:Feature [Qualitative Concept]
   719   C2348519:Feature [Qualitative Concept]

Phrase: "and"

Phrase: "brain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0006104:Brain [Body Part, Organ, or Organ Component]
  1000   C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "(amyloid"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0011560:Amyloid [Pathologic Function]
  1000   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "derived from amyloid  protein"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   833   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   770   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C0011560:Amyloid [Pathologic Function]
   770   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C1441547:Derived [Qualitative Concept]
   770   C3245521:derived [Idea or Concept]

Phrase: "in the brain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0006104:Brain [Body Part, Organ, or Organ Component]
  1000   C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "in Alzheimer disease"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "and"

Phrase: "islet amyloid"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0011560:Amyloid [Pathologic Function]
   861   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "derived from islet amyloid polypeptide"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   862   C0063684:Islet Amyloid Polypeptide [Amino Acid, Peptide, or Protein,Hormone]
   862   C1415831:ISLET AMYLOID POLYPEPTIDE [Gene or Genome]
   760   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0011560:Amyloid [Pathologic Function]
   760   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C1305923:Polypeptide [Amino Acid, Peptide, or Protein]
   760   C1441547:Derived [Qualitative Concept]
   760   C3245521:derived [Idea or Concept]

Phrase: "in the pancreas"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0030274:Pancreas [Body Part, Organ, or Organ Component]
  1000   C1278931:Pancreas [Body Part, Organ, or Organ Component]

Phrase: "in type 2 diabetes"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0011860:Type 2 Diabetes [Disease or Syndrome]
   913   C1320657:type diabetes [Finding]
   901   C0441730:Type 2 [Classification]
   827   C0011847:Diabetes [Disease or Syndrome]
   827   C0011849:Diabetes [Disease or Syndrome]
   827   C0332307:Type [Qualitative Concept]
   827   C1547052:*Type [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.5: Evidence is growing to link precursors of amyloid deposition in the brain and pancreas with the pathogenesis of Alzheimer disease and type 2 diabetes, respectively. 

Phrase: "Evidence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332120:Evidence [Functional Concept]

Phrase: "is"

Phrase: "growing"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "link"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1517892:Link [Intellectual Product]
  1000   C1704666:Link [Intellectual Product]

Phrase: "precursors of amyloid deposition"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   737   C1709634:Precursor [Idea or Concept]

Phrase: "in the brain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0006104:Brain [Body Part, Organ, or Organ Component]
  1000   C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "and"

Phrase: "pancreas with the pathogenesis of Alzheimer disease"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   805   C0030286:DISEASES OF THE PANCREAS [Disease or Syndrome]
           Disease of pancreas, NOS
           disease pancreas
   748   C0030274:Pancreas [Body Part, Organ, or Organ Component]
   748   C1278931:Pancreas [Body Part, Organ, or Organ Component]

Phrase: "and"

Phrase: "type 2 diabetes,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0011860:Type 2 Diabetes [Disease or Syndrome]
   913   C1320657:type diabetes [Finding]
   901   C0441730:Type 2 [Classification]
   827   C0011847:Diabetes [Disease or Syndrome]
   827   C0011849:Diabetes [Disease or Syndrome]
   827   C0332307:Type [Qualitative Concept]
   827   C1547052:*Type [Quantitative Concept]

Phrase: "respectively."
Processing 00000000.tx.6: Given these similarities, we questioned whether there may be a common underlying mechanism predisposing to islet and cerebral amyloid. 

Phrase: "Given"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C1442162:GIVEN [Conceptual Entity]
  1000   C1550718:given [Idea or Concept]
  1000   C3244317:given [Intellectual Product]
   966 E C1947971:Give [Functional Concept]

Phrase: "these similarities,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C2348205:Similarity [Qualitative Concept]

Phrase: "we"

Phrase: "questioned"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1522634:Question [Intellectual Product]

Phrase: "whether"

Phrase: "there"

Phrase: "may"

Phrase: "be"

Phrase: "a common underlying mechanism predisposing to islet"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0231203:predisposing [Functional Concept]

Phrase: "and"

Phrase: "cerebral amyloid."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0011560:Amyloid [Pathologic Function]
   861   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.7: To address this, we first examined the prevalence of type 2 diabetes in a community-based controlled study, the Mayo Clinic Alzheimer Disease Patient Registry (ADPR), which follows patients with Alzheimer disease versus control subjects without Alzheimer disease. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "address"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0376649:Address [Intellectual Product]
  1000   C1442065:Address [Spatial Concept]

Phrase: "this,"

Phrase: "we first"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205435:First [Quantitative Concept]
  1000   C1279901:First [Qualitative Concept]

Phrase: "examined"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332128:Examined [Finding]

Phrase: "the prevalence of type 2 diabetes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0033105:Prevalence [Quantitative Concept]
   753   C0220900:prevalence [Quantitative Concept]

Phrase: "in a community-based controlled study,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0681867:Controlled Study [Research Activity]
   812   C0557651:Study [Manufactured Object]
   812   C2603343:Study [Research Activity]

Phrase: "the Mayo Clinic Alzheimer Disease Patient Registry (ADPR),"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   839   C0920465:disease registry [Intellectual Product]
   827   C0920631:patient registry [Intellectual Product]
   799   C0034975:Registry [Intellectual Product]

Phrase: "which"

Phrase: "follows"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332283:follow [Temporal Concept]
  1000   C1719822:Follow [Intellectual Product]

Phrase: "patients with Alzheimer disease"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0030705:Patients [Patient or Disabled Group]

Phrase: "versus"

Phrase: "control subjects without Alzheimer disease."
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   797   C0920467:control disease [Therapeutic or Preventive Procedure]
   760   C0243148:control [Qualitative Concept]
   760   C1550141:Control [Substance]
   760   C1882979:Control [Conceptual Entity]
   760   C2587213:Control [Functional Concept]
   760   C3274648:Control [Qualitative Concept]
   726   C0681850:Subject [Group]
   726   C1550501:{Subject} [Idea or Concept]
   726   C1706203:Subject [Idea or Concept]
   726   C2349001:Subject [Human]
   726   C2697811:Subject [Functional Concept]
Processing 00000000.tx.8: In addition to this clinical study, we performed a pathological study of autopsy cases from this same community to determine whether there is an increased prevalence of islet amyloid in patients with Alzheimer disease and increased prevalence of cerebral amyloid in patients with type 2 diabetes. 

Phrase: "In addition to this clinical study,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0008972:Clinical Study [Research Activity]
   861   C0205210:Clinical [Qualitative Concept]
   861   C0557651:Study [Manufactured Object]
   861   C2603343:Study [Research Activity]

Phrase: "we"

Phrase: "performed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]

Phrase: "a pathological study of autopsy cases"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   767   C0085973:Case Study [Intellectual Product]
   754   C0551718:Pathology study [Clinical Attribute]
   753   C0030664:Pathological [Biomedical Occupation or Discipline]
   753   C0557651:Study [Manufactured Object]
   753   C1521733:Pathological [Functional Concept]
   753   C2603343:Study [Research Activity]

Phrase: "from this same community to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0009462:Community [Geographic Area]

Phrase: "determine"

Phrase: "whether"

Phrase: "there"

Phrase: "is"

Phrase: "an increased prevalence of islet amyloid"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0033105:Prevalence [Quantitative Concept]
   753   C0220900:prevalence [Quantitative Concept]

Phrase: "in patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030705:Patients [Patient or Disabled Group]

Phrase: "with Alzheimer disease"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "and"

Phrase: "increased prevalence of cerebral amyloid"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0033105:Prevalence [Quantitative Concept]
   760   C0220900:prevalence [Quantitative Concept]

Phrase: "in patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030705:Patients [Patient or Disabled Group]

Phrase: "with type 2 diabetes."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0011860:Type 2 Diabetes [Disease or Syndrome]
   913   C1320657:type diabetes [Finding]
   901   C0441730:Type 2 [Classification]
   827   C0011847:Diabetes [Disease or Syndrome]
   827   C0011849:Diabetes [Disease or Syndrome]
   827   C0332307:Type [Qualitative Concept]
   827   C1547052:*Type [Quantitative Concept]
Processing 00000000.tx.9: Patients who were enrolled in the ADPR (Alzheimer disease n = 100, non-Alzheimer disease control subjects n = 138) were classified according to fasting glucose concentration (FPG) as nondiabetic (FPG <110 mg/dl), impaired fasting glucose (IFG, FPG 110125 mg/dl), and type 2 diabetes (FPG >126 mg/dl). 

Phrase: "Patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030705:Patients [Patient or Disabled Group]

Phrase: "who"

Phrase: "were"

Phrase: "enrolled in the ADPR"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   800   C0597185:patient/disease registry [Intellectual Product]
   778   C0002395:Alzheimer's Disease [Disease or Syndrome]
   778   C0920631:patient registry [Intellectual Product]
   778   C1521724:Alzheimer's Disease [Pathologic Function]
   774   C0920465:disease registry [Intellectual Product]
   748   C0012634:Disease [Disease or Syndrome]
   748   C0030705:*^patient [Patient or Disabled Group]
   748   C0034975:Registry [Intellectual Product]

Phrase: "(Alzheimer disease n = 100,"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   861   C0002395:Alzheimer's Disease [Disease or Syndrome]
   861   C1521724:Alzheimer's Disease [Pathologic Function]
   812   C0012634:Disease [Disease or Syndrome]
   756 E C1836721:MALS [Finding]
   756 E C3538764:MALS [Gene or Genome]
   756 E C3540595:MAL [Gene or Genome]

Phrase: "non-Alzheimer disease control subjects n = 138"
Meta Candidates (Total=18; Excluded=3; Pruned=0; Remaining=15)
   818   C0002395:Alzheimer's Disease [Disease or Syndrome]
   818   C0920467:disease control [Therapeutic or Preventive Procedure]
   818   C1521724:Alzheimer's Disease [Pathologic Function]
   795   C0012634:Disease [Disease or Syndrome]
   795   C0243148:control [Qualitative Concept]
   795   C1518422:Non [Functional Concept]
   795   C1550141:Control [Substance]
   795   C1882979:Control [Conceptual Entity]
   795   C2587213:Control [Functional Concept]
   795   C3274648:Control [Qualitative Concept]
   762   C0681850:Subject [Group]
   762   C1550501:{Subject} [Idea or Concept]
   762   C1706203:Subject [Idea or Concept]
   762   C2349001:Subject [Human]
   762   C2697811:Subject [Functional Concept]
   740 E C1836721:MALS [Finding]
   740 E C3538764:MALS [Gene or Genome]
   740 E C3540595:MAL [Gene or Genome]

Phrase: ")"

Phrase: "were"

Phrase: "classified according to fasting glucose concentration"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   790   C0427743:Glucose concentration [Laboratory Procedure]
   790   C1287281:Glucose concentration [Laboratory or Test Result]
   753   C0008902:Classified [Classification]
   753   C0015663:Fasting [Finding]
   753   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   753   C0086045:Concentration [Mental Process]
   753   C0680240:according [Social Behavior]
   753   C1446561:Concentration [Quantitative Concept]
   753   C1550565:fasting [Intellectual Product]
   719 E C0456962:Fast [Qualitative Concept]

Phrase: "(FPG"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   901   C0202042:Plasma glucose [Laboratory Procedure]
   901   C0455280:plasma glucose [Laboratory or Test Result]
   827   C0015663:Fasting [Finding]
   827   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   827   C0032105:Plasma [Body Substance]
   827   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]
   827   C1550565:fasting [Intellectual Product]
   793 E C0456962:Fast [Qualitative Concept]

Phrase: ")"

Phrase: "as nondiabetic"

Phrase: "(FPG"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   901   C0202042:Plasma glucose [Laboratory Procedure]
   901   C0455280:plasma glucose [Laboratory or Test Result]
   827   C0015663:Fasting [Finding]
   827   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   827   C0032105:Plasma [Body Substance]
   827   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]
   827   C1550565:fasting [Intellectual Product]
   793 E C0456962:Fast [Qualitative Concept]

Phrase: "<110 mg/dl"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0439269:mg dl [Quantitative Concept]
   827   C3642216:/dL [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "impaired fasting glucose"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
  1000   C1272092:Impaired fasting glucose [Finding]
   827   C0015663:Fasting [Finding]
   827   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   827   C0221099:Impaired [Functional Concept]
   827   C0684336:Impaired [Pathologic Function]
   827   C1550565:fasting [Intellectual Product]
   793 E C0456962:Fast [Qualitative Concept]

Phrase: "(IFG,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1334085:IFG [Gene or Genome]
  1000   C1708411:IFG [Gene or Genome]

Phrase: "FPG 110125 mg/dl"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0439269:mg dl [Quantitative Concept]
   799   C3642216:/dL [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "type 2 diabetes"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0011860:Type 2 Diabetes [Disease or Syndrome]
   913   C1320657:type diabetes [Finding]
   901   C0441730:Type 2 [Classification]
   827   C0011847:Diabetes [Disease or Syndrome]
   827   C0011849:Diabetes [Disease or Syndrome]
   827   C0332307:Type [Qualitative Concept]
   827   C1547052:*Type [Quantitative Concept]

Phrase: "(FPG"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   901   C0202042:Plasma glucose [Laboratory Procedure]
   901   C0455280:plasma glucose [Laboratory or Test Result]
   827   C0015663:Fasting [Finding]
   827   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   827   C0032105:Plasma [Body Substance]
   827   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]
   827   C1550565:fasting [Intellectual Product]
   793 E C0456962:Fast [Qualitative Concept]

Phrase: ">126 mg/dl"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0439269:mg dl [Quantitative Concept]
   827   C3642216:/dL [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.10: The mean slope of FPG over 10 years in each case was also compared between Alzheimer disease and non-Alzheimer disease control subjects. 

Phrase: "The mean slope of FPG"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0807955:Slope [Quantitative Concept]

Phrase: "over 10 years"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0439234:years [Temporal Concept]
   827 E C0439508:/year [Temporal Concept]

Phrase: "in each case"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0868928:Case [Functional Concept]
  1000   C1706255:CASE [Medical Device]
  1000   C1706256:Case [Conceptual Entity]

Phrase: "was"

Phrase: "also"

Phrase: "compared between Alzheimer disease"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   833   C0002395:Alzheimer's Disease [Disease or Syndrome]
   833   C1521724:Alzheimer's Disease [Pathologic Function]
   770   C0012634:Disease [Disease or Syndrome]
   770   C1707455:Compared [Activity]
   715 E C1836721:MALS [Finding]
   715 E C3538764:MALS [Gene or Genome]
   715 E C3540595:MAL [Gene or Genome]

Phrase: "and"

Phrase: "non-Alzheimer disease control subjects."
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   840   C0920467:disease control [Therapeutic or Preventive Procedure]
   804   C0243148:control [Qualitative Concept]
   804   C1550141:Control [Substance]
   804   C1882979:Control [Conceptual Entity]
   804   C2587213:Control [Functional Concept]
   804   C3274648:Control [Qualitative Concept]
   771   C0681850:Subject [Group]
   771   C1550501:{Subject} [Idea or Concept]
   771   C1706203:Subject [Idea or Concept]
   771   C2349001:Subject [Human]
   771   C2697811:Subject [Functional Concept]
Processing 00000000.tx.11: Pancreas and brain were examined from autopsy specimens obtained from 105 humans (first, 28 cases of Alzheimer disease disease vs. 21 non-Alzheimer disease control subjects and, second, 35 subjects with type 2 diabetes vs. 21 non-type 2 diabetes control subjects) for the presence of islet and brain amyloid. 

Phrase: "Pancreas"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0030274:Pancreas [Body Part, Organ, or Organ Component]
  1000   C1278931:Pancreas [Body Part, Organ, or Organ Component]

Phrase: "and"

Phrase: "brain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0006104:Brain [Body Part, Organ, or Organ Component]
  1000   C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "were"

Phrase: "examined from autopsy specimens"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   770   C0004398:Autopsy [Diagnostic Procedure]
   770   C0332128:Examined [Finding]
   770   C0370003:specimens [Substance]
   737 E C2347026:Specimen [Conceptual Entity]

Phrase: "obtained from 105 humans"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C0086418:Humans [Human]
   770   C1301820:Obtained [Functional Concept]
   737 E C1706701:Obtain [Activity]

Phrase: "(first,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205435:First [Quantitative Concept]
  1000   C1279901:First [Qualitative Concept]

Phrase: "28 cases of Alzheimer disease disease"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   753   C0868928:Cases [Functional Concept]
   753   C1533148:Cases [Quantitative Concept]
   719 E C1706255:CASE [Medical Device]
   719 E C1706256:Case [Conceptual Entity]

Phrase: "vs. 21 non-Alzheimer disease control subjects"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   827   C0920467:disease control [Therapeutic or Preventive Procedure]
   799   C0243148:control [Qualitative Concept]
   799   C1550141:Control [Substance]
   799   C1882979:Control [Conceptual Entity]
   799   C2587213:Control [Functional Concept]
   799   C3274648:Control [Qualitative Concept]
   766   C0681850:Subject [Group]
   766   C1550501:{Subject} [Idea or Concept]
   766   C1706203:Subject [Idea or Concept]
   766   C2349001:Subject [Human]
   766   C2697811:Subject [Functional Concept]

Phrase: "and"

Phrase: ","

Phrase: "second,"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0205436:Second [Quantitative Concept]
  1000   C0457385:Second [Temporal Concept]
  1000   C0565930:/second [Quantitative Concept]
  1000   C1561503:second [Idea or Concept]
  1000   C1705190:Second [Qualitative Concept]
   928 E C0027627:secondary [Neoplastic Process]
   928 E C0175668:Secondary [Temporal Concept]

Phrase: "35 subjects with type 2 diabetes"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   719   C0681850:Subject [Group]
   719   C1550501:{Subject} [Idea or Concept]
   719   C1706203:Subject [Idea or Concept]
   719   C2349001:Subject [Human]
   719   C2697811:Subject [Functional Concept]

Phrase: "vs. 21 non-type 2 diabetes control subjects"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   795   C0243148:control [Qualitative Concept]
   795   C1550141:Control [Substance]
   795   C1882979:Control [Conceptual Entity]
   795   C2587213:Control [Functional Concept]
   795   C3274648:Control [Qualitative Concept]
   762   C0681850:Subject [Group]
   762   C1550501:{Subject} [Idea or Concept]
   762   C1706203:Subject [Idea or Concept]
   762   C2349001:Subject [Human]
   762   C2697811:Subject [Functional Concept]

Phrase: ")"

Phrase: "for the presence"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392148:Presence [Therapeutic or Preventive Procedure]
   928 E C0150312:Present [Quantitative Concept]
   928 E C0449450:Present [Idea or Concept]

Phrase: "of islet"

Phrase: "and"

Phrase: "brain amyloid."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0011560:Amyloid [Pathologic Function]
   861   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.12: Both type 2 diabetes (35% vs. 18%; P < 0.05) and IFG (46% vs. 24%; P < 0.01) were more prevalent in Alzheimer disease versus non-Alzheimer disease control subjects, so 81% of cases of Alzheimer disease had either type 2 diabetes or IFG. 

Phrase: "Both type 2 diabetes"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0011860:Type 2 Diabetes [Disease or Syndrome]
   913   C1320657:type diabetes [Finding]
   901   C0441730:Type 2 [Classification]
   827   C0011847:Diabetes [Disease or Syndrome]
   827   C0011849:Diabetes [Disease or Syndrome]
   827   C0332307:Type [Qualitative Concept]
   827   C1547052:*Type [Quantitative Concept]

Phrase: "(35%"

Phrase: "vs. 18%"

Phrase: "; P < 0.05"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: "and"

Phrase: "IFG"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1334085:IFG [Gene or Genome]
  1000   C1708411:IFG [Gene or Genome]

Phrase: "(46%"

Phrase: "vs. 24%"

Phrase: "; P < 0.01"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: "were"

Phrase: "more prevalent in Alzheimer disease"

Phrase: "versus"

Phrase: "non-Alzheimer disease control subjects,"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   840   C0920467:disease control [Therapeutic or Preventive Procedure]
   804   C0243148:control [Qualitative Concept]
   804   C1550141:Control [Substance]
   804   C1882979:Control [Conceptual Entity]
   804   C2587213:Control [Functional Concept]
   804   C3274648:Control [Qualitative Concept]
   771   C0681850:Subject [Group]
   771   C1550501:{Subject} [Idea or Concept]
   771   C1706203:Subject [Idea or Concept]
   771   C2349001:Subject [Human]
   771   C2697811:Subject [Functional Concept]

Phrase: "so"

Phrase: "81% of cases of Alzheimer disease"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   790   C0002395:Alzheimer's Disease [Disease or Syndrome]
   790   C1521724:Alzheimer's Disease [Pathologic Function]
   753   C0012634:Disease [Disease or Syndrome]
   753   C0868928:Cases [Functional Concept]
   753   C1533148:Cases [Quantitative Concept]
   719 E C1706255:CASE [Medical Device]
   719 E C1706256:Case [Conceptual Entity]

Phrase: "had"

Phrase: "either type 2 diabetes"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   923   C0011860:Type 2 Diabetes [Disease or Syndrome]
   875   C1320657:type diabetes [Finding]
   861   C0441730:Type 2 [Classification]
   812   C0011847:Diabetes [Disease or Syndrome]
   812   C0011849:Diabetes [Disease or Syndrome]
   812   C0332307:Type [Qualitative Concept]
   812   C1547052:*Type [Quantitative Concept]

Phrase: "or"

Phrase: "IFG."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1334085:IFG [Gene or Genome]
  1000   C1708411:IFG [Gene or Genome]
Processing 00000000.tx.13: The slope of increase of FPG with age over 10 years was also greater in Alzheimer disease than non-Alzheimer disease control subjects (P < 0.01). 

Phrase: "The slope of increase of FPG"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0807955:Slope [Quantitative Concept]

Phrase: "with age"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001779:Age [Organism Attribute]

Phrase: "over 10 years"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0439234:years [Temporal Concept]
   827 E C0439508:/year [Temporal Concept]

Phrase: "was"

Phrase: "also greater in Alzheimer disease"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   760   C0443228:greater [Quantitative Concept]
   760   C1704243:Greater [Quantitative Concept]
   726 E C0549177:Great [Quantitative Concept]

Phrase: "than non-Alzheimer disease control subjects"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   840   C0920467:disease control [Therapeutic or Preventive Procedure]
   804   C0243148:control [Qualitative Concept]
   804   C1550141:Control [Substance]
   804   C1882979:Control [Conceptual Entity]
   804   C2587213:Control [Functional Concept]
   804   C3274648:Control [Qualitative Concept]
   771   C0681850:Subject [Group]
   771   C1550501:{Subject} [Idea or Concept]
   771   C1706203:Subject [Idea or Concept]
   771   C2349001:Subject [Human]
   771   C2697811:Subject [Functional Concept]

Phrase: "(P < 0.01"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")."
Processing 00000000.tx.14: Islet amyloid was more frequent (P < 0.05) and extensive (P < 0.05) in patients with Alzheimer disease than in non-Alzheimer disease control subjects. 

Phrase: "Islet amyloid"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0011560:Amyloid [Pathologic Function]
   861   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "was"

Phrase: "more frequent"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
   861   C0332183:Frequent [Temporal Concept]
   789 E C0376249:frequency [Quantitative Concept]
   789 E C0439603:Frequencies [Temporal Concept]
   789 E C0871396:Frequency [Quantitative Concept]
   789 E C1561548:Frequency [Qualitative Concept]
   789 E C1705502:Frequency [Quantitative Concept]

Phrase: "(P < 0.05"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: "and"

Phrase: "extensive"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0205231:Extensive [Qualitative Concept]
   928 E C0439795:Extensiveness [Qualitative Concept]

Phrase: "(P < 0.05"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: "in patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030705:Patients [Patient or Disabled Group]

Phrase: "with Alzheimer disease"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "than"

Phrase: "in non-Alzheimer disease control subjects."
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   840   C0920467:disease control [Therapeutic or Preventive Procedure]
   804   C0243148:control [Qualitative Concept]
   804   C1550141:Control [Substance]
   804   C1882979:Control [Conceptual Entity]
   804   C2587213:Control [Functional Concept]
   804   C3274648:Control [Qualitative Concept]
   771   C0681850:Subject [Group]
   771   C1550501:{Subject} [Idea or Concept]
   771   C1706203:Subject [Idea or Concept]
   771   C2349001:Subject [Human]
   771   C2697811:Subject [Functional Concept]
Processing 00000000.tx.15: However, diffuse and neuritic plaques were not more common in type 2 diabetes than in control subjects. 

Phrase: "However,"

Phrase: "diffuse"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205219:Diffuse [Qualitative Concept]

Phrase: "and"

Phrase: "neuritic plaques"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0333463:Neuritic Plaques [Acquired Abnormality]
           plaques
   827 E C0011389:Plaque [Disease or Syndrome]
   827 E C0332461:Plaque [Finding]
   789   C0027813:Neuritides [Disease or Syndrome]

Phrase: "were"

Phrase: "not more common in type 2 diabetes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0205214:Common [Quantitative Concept]
   748   C1522138:Common [Functional Concept]
   748   C3245511:common [Intellectual Product]

Phrase: "than"

Phrase: "in control subjects."
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   861   C0243148:control [Qualitative Concept]
   861   C1550141:Control [Substance]
   861   C1882979:Control [Conceptual Entity]
   861   C2587213:Control [Functional Concept]
   861   C3274648:Control [Qualitative Concept]
   827   C0681850:Subject [Group]
   827   C1550501:{Subject} [Idea or Concept]
   827   C1706203:Subject [Idea or Concept]
   827   C2349001:Subject [Human]
   827   C2697811:Subject [Functional Concept]
Processing 00000000.tx.16: In cases of type 2 diabetes when they were present, the duration of type 2 diabetes correlated with the density of diffuse (P < 0.001) and neuritic plaques (P < 0.01). 

Phrase: "In cases"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0868928:Cases [Functional Concept]
  1000   C1533148:Cases [Quantitative Concept]
   966 E C1706255:CASE [Medical Device]
   966 E C1706256:Case [Conceptual Entity]

Phrase: "of type 2 diabetes"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0011860:Type 2 Diabetes [Disease or Syndrome]
   913   C1320657:type diabetes [Finding]
   901   C0441730:Type 2 [Classification]
   827   C0011847:Diabetes [Disease or Syndrome]
   827   C0011849:Diabetes [Disease or Syndrome]
   827   C0332307:Type [Qualitative Concept]
   827   C1547052:*Type [Quantitative Concept]

Phrase: "when"

Phrase: "they"

Phrase: "were"

Phrase: "present,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0150312:Present [Quantitative Concept]
  1000   C0449450:Present [Idea or Concept]

Phrase: "the duration of type 2 diabetes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0449238:Duration [Temporal Concept]
   753   C2926735:Duration [Pharmacologic Substance]

Phrase: "correlated with the density of diffuse"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0178587:density [Quantitative Concept]
   753   C0205219:Diffuse [Qualitative Concept]
   753   C1707520:Correlated [Qualitative Concept]

Phrase: "(P < 0.001"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: "and"

Phrase: "neuritic plaques"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0333463:Neuritic Plaques [Acquired Abnormality]
           plaques
   827 E C0011389:Plaque [Disease or Syndrome]
   827 E C0332461:Plaque [Finding]
   789   C0027813:Neuritides [Disease or Syndrome]

Phrase: "(P < 0.01"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")."
Processing 00000000.tx.17: In this community cohort from southeast Minnesota, type 2 diabetes and IFG are more common in patients with Alzheimer disease than in control subjects, as is the pathological hallmark of type 2 diabetes, islet amyloid. 

Phrase: "In this community cohort"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0599755:Cohort [Population Group]

Phrase: "from southeast Minnesota,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0026183:Minnesota [Geographic Area]

Phrase: "type 2 diabetes"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0011860:Type 2 Diabetes [Disease or Syndrome]
   913   C1320657:type diabetes [Finding]
   901   C0441730:Type 2 [Classification]
   827   C0011847:Diabetes [Disease or Syndrome]
   827   C0011849:Diabetes [Disease or Syndrome]
   827   C0332307:Type [Qualitative Concept]
   827   C1547052:*Type [Quantitative Concept]

Phrase: "and"

Phrase: "IFG"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1334085:IFG [Gene or Genome]
  1000   C1708411:IFG [Gene or Genome]

Phrase: "are"

Phrase: "more common in patients"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0205214:Common [Quantitative Concept]
   770   C1522138:Common [Functional Concept]
   770   C3245511:common [Intellectual Product]

Phrase: "with Alzheimer disease"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "than"

Phrase: "in control subjects,"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   861   C0243148:control [Qualitative Concept]
   861   C1550141:Control [Substance]
   861   C1882979:Control [Conceptual Entity]
   861   C2587213:Control [Functional Concept]
   861   C3274648:Control [Qualitative Concept]
   827   C0681850:Subject [Group]
   827   C1550501:{Subject} [Idea or Concept]
   827   C1706203:Subject [Idea or Concept]
   827   C2349001:Subject [Human]
   827   C2697811:Subject [Functional Concept]

Phrase: "as is"

Phrase: "the pathological hallmark of type 2 diabetes,"

Phrase: "islet amyloid."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0011560:Amyloid [Pathologic Function]
   861   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.18: However, there was no increase in brain plaque formation in cases of type 2 diabetes, although when it was present, it correlated in extent with duration of diabetes. 

Phrase: "However,"

Phrase: "there"

Phrase: "was"

Phrase: "no increase in brain plaque formation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0442805:Increase [Functional Concept]

Phrase: "in cases"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0868928:Cases [Functional Concept]
  1000   C1533148:Cases [Quantitative Concept]
   966 E C1706255:CASE [Medical Device]
   966 E C1706256:Case [Conceptual Entity]

Phrase: "of type 2 diabetes,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0011860:Type 2 Diabetes [Disease or Syndrome]
   913   C1320657:type diabetes [Finding]
   901   C0441730:Type 2 [Classification]
   827   C0011847:Diabetes [Disease or Syndrome]
   827   C0011849:Diabetes [Disease or Syndrome]
   827   C0332307:Type [Qualitative Concept]
   827   C1547052:*Type [Quantitative Concept]

Phrase: "although"

Phrase: "when"

Phrase: "it"

Phrase: "was"

Phrase: "present,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0150312:Present [Quantitative Concept]
  1000   C0449450:Present [Idea or Concept]

Phrase: "it"

Phrase: "correlated in extent"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0439792:Extent [Spatial Concept]
   790   C1707520:Correlated [Qualitative Concept]

Phrase: "with duration"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0449238:Duration [Temporal Concept]
  1000   C2926735:Duration [Pharmacologic Substance]

Phrase: "of diabetes."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0011847:Diabetes [Disease or Syndrome]
  1000   C0011849:Diabetes [Disease or Syndrome]
Processing 00000000.tx.19: These data support the hypothesis that patients with Alzheimer disease are more vulnerable to type 2 diabetes and the possibility of linkage between the processes responsible for loss of brain cells and -cells in these diseases. 

Phrase: "These data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "support"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0183683:Support [Medical Device]
  1000   C1521721:Support [Conceptual Entity]

Phrase: "the hypothesis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1512571:Hypothesis [Idea or Concept]

Phrase: "that patients with Alzheimer disease"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0030705:Patients [Patient or Disabled Group]

Phrase: "are"

Phrase: "more vulnerable to type 2 diabetes"

Phrase: "and"

Phrase: "the possibility of linkage"

Phrase: "between the processes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1184743:Process [Body Part, Organ, or Organ Component]
   966   C1522240:Process [Phenomenon or Process]

Phrase: "responsible for loss of brain cells"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1273518:Responsible [Finding]

Phrase: "and -"

Phrase: "cells in these diseases."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   770   C0007634:Cells [Cell]
   770   C3282337:Cells [Cell]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.20: The islet of Langerhans in type 2 diabetes is characterized by -cell loss (1,2) and islet amyloid derived from islet amyloid polypeptide (IAPP) (35), a protein coexpressed and secreted with insulin by -cells. 

Phrase: "The islet of Langerhans"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   909   C0022131:Islet of Langerhans [Body Part, Organ, or Organ Component]
           islet langerhans

Phrase: "in type 2 diabetes"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0011860:Type 2 Diabetes [Disease or Syndrome]
   913   C1320657:type diabetes [Finding]
   901   C0441730:Type 2 [Classification]
   827   C0011847:Diabetes [Disease or Syndrome]
   827   C0011849:Diabetes [Disease or Syndrome]
   827   C0332307:Type [Qualitative Concept]
   827   C1547052:*Type [Quantitative Concept]

Phrase: "is"

Phrase: "characterized by -cell loss"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0007634:Cell [Cell]
   770   C1269647:Cell [Cell]
   770   C1517945:Loss [Quantitative Concept]
   770   C1704653:Cell [Medical Device]
   770   C1880022:Characterized [Activity]
   770   C1948049:Cell [Spatial Concept]

Phrase: "(1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: ")"

Phrase: "and"

Phrase: "islet amyloid"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0011560:Amyloid [Pathologic Function]
   861   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "derived from islet amyloid polypeptide (IAPP)"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   862   C0063684:Islet Amyloid Polypeptide [Amino Acid, Peptide, or Protein,Hormone]
   862   C1415831:ISLET AMYLOID POLYPEPTIDE [Gene or Genome]
   760   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0011560:Amyloid [Pathologic Function]
   760   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C1305923:Polypeptide [Amino Acid, Peptide, or Protein]
   760   C1441547:Derived [Qualitative Concept]
   760   C3245521:derived [Idea or Concept]

Phrase: "(35"

Phrase: ")"

Phrase: ","

Phrase: "a protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "coexpressed"

Phrase: "and"

Phrase: "secreted with insulin"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   790   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   790   C1327616:Secreted [Cell Function]
   790   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   790   C1579433:Insulin [Pharmacologic Substance]
   734 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   706 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "by -cells."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.21: Brain dysfunction in Alzheimer disease is characterized by loss of neocortical neurons (6) and focal amyloid deposits, which consist of the locally expressed amyloid  protein (AP) (713). 

Phrase: "Brain dysfunction in Alzheimer disease"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   806   C0262405:brain dysfunction [Disease or Syndrome]
   760   C0031847:dysfunction [Functional Concept]
   760   C0277785:Dysfunction, NOS [Qualitative Concept]
   704 E C0231174:Malfunction [Functional Concept]
   704 E C1881681:MALFUNCTION [Phenomenon or Process]

Phrase: "is"

Phrase: "characterized by loss of neocortical neurons"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   820   C0598940:Loss of neurons [Finding]
           neuron loss
   753   C0027882:Neurons [Cell]
   753   C1517945:Loss [Quantitative Concept]
   753   C1880022:Characterized [Activity]
   742 E C1850496:Neuronal loss [Finding]

Phrase: "(6"

Phrase: ")"

Phrase: "and"

Phrase: "focal amyloid deposits,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C2936349:Amyloid Deposits [Acquired Abnormality]
   827   C0333562:Deposits [Functional Concept]
   734   C0333571:Focal amyloid [Body Substance]

Phrase: "which"

Phrase: "consist of the locally expressed amyloid  protein (AP)"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   778   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   748   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0011560:Amyloid [Pathologic Function]
   748   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0332529:CONSIST [Qualitative Concept]
   748   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C1517927:Locally [Spatial Concept]

Phrase: "(713"

Phrase: ")."
Processing 00000000.tx.22: The prevalence of both Alzheimer disease and type 2 diabetes increases with age, and both have genetic components (1419). 

Phrase: "The prevalence of both Alzheimer disease"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0033105:Prevalence [Quantitative Concept]
   753   C0220900:prevalence [Quantitative Concept]

Phrase: "and"

Phrase: "type 2 diabetes"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0011860:Type 2 Diabetes [Disease or Syndrome]
   913   C1320657:type diabetes [Finding]
   901   C0441730:Type 2 [Classification]
   827   C0011847:Diabetes [Disease or Syndrome]
   827   C0011849:Diabetes [Disease or Syndrome]
   827   C0332307:Type [Qualitative Concept]
   827   C1547052:*Type [Quantitative Concept]

Phrase: "increases with age,"
Meta Candidates (Total=9; Excluded=7; Pruned=0; Remaining=2)
   790   C0001779:Age [Organism Attribute]
   790   C0442805:Increase [Functional Concept]
   734 E C1517378:Gain [Quantitative Concept]
   706 E C0205217:Increased [Quantitative Concept]
   706 E C0439661:Acquired [Temporal Concept]
   706 E C0442808:Increasing [Functional Concept]
   706 E C1301820:Obtain [Functional Concept]
   706 E C1706701:Acquire [Activity]
   706 E C3245488:acquired [Intellectual Product]

Phrase: "and"

Phrase: "both"

Phrase: "have"

Phrase: "genetic components"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0449432:Components [Manufactured Object]
   827 E C1705248:Component [Conceptual Entity]

Phrase: "(1419"

Phrase: ")."
Processing 00000000.tx.23: AP and IAPP both spontaneously form into amyloid aggregates in an aqueous environment (7,8,20,21). 

Phrase: "AP"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   861   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "IAPP"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0063684:Islet Amyloid Polypeptide [Amino Acid, Peptide, or Protein,Hormone]
  1000   C1415831:ISLET AMYLOID POLYPEPTIDE [Gene or Genome]
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1305923:Polypeptide [Amino Acid, Peptide, or Protein]

Phrase: "both spontaneously"

Phrase: "form into amyloid"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C0011560:Amyloid [Pathologic Function]
   790   C0348078:Form [Qualitative Concept]
   790   C0376315:Form [Manufactured Object]
   790   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C1522492:Form [Functional Concept]

Phrase: "aggregates in an aqueous environment"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0014406:Environment [Spatial Concept]
   760   C0205418:Aggregate [Qualitative Concept]
   760   C0599956:Aqueous [Qualitative Concept]

Phrase: "(7,"

Phrase: "8,"

Phrase: "20,"

Phrase: "21"

Phrase: ")."
Processing 00000000.tx.24: The role of these aggregates of IAPP and AP in -cell and cortical neuronal death in type 2 diabetes and Alzheimer disease is controversial. 

Phrase: "The role of these aggregates of IAPP"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0035820:Role [Social Behavior]
   742   C1705810:Role [Conceptual Entity]

Phrase: "and"

Phrase: "AP"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   861   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "in -cell"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C0007634:Cell [Cell]
   861   C0150312:In [Quantitative Concept]
   861   C0332285:In [Spatial Concept]
   861   C1269647:Cell [Cell]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]

Phrase: "and"

Phrase: "cortical neuronal death in type 2 diabetes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0011065:Death [Organism Function]
   748   C1306577:Death, NOS [Finding]
   743   C2754100:neuron death [Cell Function]

Phrase: "and"

Phrase: "Alzheimer disease"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "is"

Phrase: "controversial."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   928   C0680243:controversies [Social Behavior]
Processing 00000000.tx.25: Small amyloid aggregates of either of these proteins are cytotoxic (2225). 

Phrase: "Small amyloid"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0011560:Amyloid [Pathologic Function]
   861   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "aggregates of either of these proteins"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0205418:Aggregate [Qualitative Concept]

Phrase: "are"

Phrase: "cytotoxic"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0677881:Cytotoxic [Therapeutic or Preventive Procedure]
  1000   C1511636:cytotoxic [Functional Concept]

Phrase: "(2225"

Phrase: ")."
Processing 00000000.tx.26: The mechanism of the cytotoxicity mediated by small protein aggregates has been hypothesized to be by induction of membrane damage (2527). 

Phrase: "The mechanism of the cytotoxicity"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0441712:Mechanism [Functional Concept]
   760   C1706376:Mechanism [Manufactured Object]

Phrase: "mediated by small protein aggregates"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0086597:mediated [Social Behavior]
   760   C0127400:Mediated [Organic Chemical,Pharmacologic Substance]
   760   C0205418:aggregates [Qualitative Concept]
   760   C0700321:Small [Quantitative Concept]

Phrase: "has"

Phrase: "been"

Phrase: "hypothesized"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be by induction of membrane damage"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   753   C0010957:Damage [Injury or Poisoning]
   753   C0025255:Membrane [Tissue]
   753   C0205263:Induction [Functional Concept]
   753   C0596901:Membrane [Cell Component]
   753   C0857127:induction [Therapeutic or Preventive Procedure]
   753   C1706182:Membrane [Manufactured Object]
   753   C1883709:Damage [Functional Concept]
   753   C2987476:Be [Conceptual Entity]

Phrase: "(2527"

Phrase: ")."
Processing 00000000.tx.27: In the case of IAPP, evidence exists to suggest that abnormal aggregation occurs initially intracellularly, and after cell death, IAPP-derived fibrils accumulate extracellularly (24,28,29). 

Phrase: "In the case"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0868928:Case [Functional Concept]
  1000   C1706255:CASE [Medical Device]
  1000   C1706256:Case [Conceptual Entity]

Phrase: "of IAPP,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0063684:Islet Amyloid Polypeptide [Amino Acid, Peptide, or Protein,Hormone]
  1000   C1415831:ISLET AMYLOID POLYPEPTIDE [Gene or Genome]
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1305923:Polypeptide [Amino Acid, Peptide, or Protein]

Phrase: "evidence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332120:Evidence [Functional Concept]

Phrase: "exists"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2987476:Exist [Conceptual Entity]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that abnormal aggregation"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0332621:Aggregation [Functional Concept]
   861   C0439168:% aggregation [Quantitative Concept]
   789 E C0205418:Aggregate [Qualitative Concept]

Phrase: "occurs"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1709305:Occur [Activity]
  1000   C2745955:OCCUR [Temporal Concept]

Phrase: "initially intracellularly,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205265:Initially [Temporal Concept]

Phrase: "and after cell death,"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   833   C0007587:Cell Death [Cell Function]
   770   C0007634:Cell [Cell]
   770   C0011065:Death [Organism Function]
   770   C1269647:Cell [Cell]
   770   C1306577:Death, NOS [Finding]
   770   C1515981:And [Idea or Concept]
   770   C1704653:Cell [Medical Device]
   770   C1948049:Cell [Spatial Concept]

Phrase: "IAPP-derived fibrils"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   875   C1449651:Amyloid Fibrils [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0225328:fibrils [Cell Component]
   771 E C1948066:Fibril [Physical Object]
   717   C0063684:Islet Amyloid Polypeptide [Amino Acid, Peptide, or Protein,Hormone]
   717   C1415831:ISLET AMYLOID POLYPEPTIDE [Gene or Genome]

Phrase: "accumulate"

Phrase: "extracellularly"

Phrase: "(24,"

Phrase: "28,"

Phrase: "29"

Phrase: ")."
Processing 00000000.tx.28: Similar mechanisms are also possible in Alzheimer disease. 

Phrase: "Similar mechanisms"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0441712:Mechanisms [Functional Concept]
   827 E C1706376:Mechanism [Manufactured Object]

Phrase: "are"

Phrase: "also possible in Alzheimer disease."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0332149:Possible [Qualitative Concept]
   760   C1705910:Possible [Qualitative Concept]
   760   C2362652:Possible [Qualitative Concept]
Processing 00000000.tx.29: In vivo, even though IAPP and AP are present in an aqueous environment, in health neither protein forms fibrils, suggesting that mechanisms exist to prevent this otherwise spontaneous process. 

Phrase: "In vivo, even"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C1515655:In Vivo [Spatial Concept]
           vivo

Phrase: "though"

Phrase: "IAPP"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0063684:Islet Amyloid Polypeptide [Amino Acid, Peptide, or Protein,Hormone]
  1000   C1415831:ISLET AMYLOID POLYPEPTIDE [Gene or Genome]
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1305923:Polypeptide [Amino Acid, Peptide, or Protein]

Phrase: "and"

Phrase: "AP"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   861   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "are"

Phrase: "present in an aqueous environment,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0150312:Present [Quantitative Concept]
   760   C0449450:Present [Idea or Concept]

Phrase: "in health"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0018684:Health [Idea or Concept]
   900 E C0031206:healthiness [Finding]

Phrase: "neither protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "forms"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0348078:Form [Qualitative Concept]
  1000   C0376315:Form [Manufactured Object]
  1000   C1522492:Form [Functional Concept]

Phrase: "fibrils,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0225328:fibrils [Cell Component]
   966 E C1948066:Fibril [Physical Object]

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that mechanisms"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0441712:Mechanisms [Functional Concept]
   966 E C1706376:Mechanism [Manufactured Object]

Phrase: "exist"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2987476:Exist [Conceptual Entity]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "prevent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0309872:PREVENT [Pharmacologic Substance]

Phrase: "this otherwise spontaneous process."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1184743:Process [Body Part, Organ, or Organ Component]
   827   C1522240:Process [Phenomenon or Process]
Processing 00000000.tx.30: These mechanisms likely include the chaperone protein pathway, a system for protein trafficking via intracellular binding proteins (chaperone proteins), which bind nascent proteins and facilitate their transport within the cell (30). 

Phrase: "These mechanisms likely"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0441712:Mechanisms [Functional Concept]
   827 E C1706376:Mechanism [Manufactured Object]

Phrase: "include"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0332257:include [Functional Concept]
  1000   C1552866:include [Idea or Concept]
  1000   C2700399:Include [Activity]

Phrase: "the chaperone protein pathway,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1704259:Pathway [Molecular Function]
   827   C1705987:Pathway [Conceptual Entity]

Phrase: "a system for protein"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0449913:System [Functional Concept]
   770   C1553451:System [Manufactured Object]
   770   C1704459:System [Medical Device]

Phrase: "trafficking via intracellular binding proteins"
Meta Candidates (Total=11; Excluded=1; Pruned=0; Remaining=10)
   806   C0242210:Binding Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   781 E C0033618:Protein Binding [Molecular Function]
   781   C0599895:Protein Trafficking [Cell Function]
   781   C1159772:Protein Trafficking [Cell Function]
   760   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0175996:intracellular [Cell Component]
   760   C0178719:Intracellular [Spatial Concept]
   760   C0243122:binding [Functional Concept]
   760   C0599896:trafficking [Cell Function]
   760   C1145667:Binding [Activity]
   760   C1167622:Binding [Molecular Function]

Phrase: "(chaperone proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: ")"

Phrase: ","

Phrase: "which"

Phrase: "bind"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1145667:Bind [Activity]
  1000   C1167622:bind [Molecular Function]

Phrase: "nascent proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "facilitate"

Phrase: "their transport within the cell"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0005528:Transport, NOS [Cell Function]
   760   C1317949:Transport [Manufactured Object]
   760   C3495449:transport [Medical Device]

Phrase: "(30"

Phrase: ")."
Processing 00000000.tx.31: We have previously hypothesized that IAPP amyloid formation in type 2 diabetes may occur under circumstances of genetic variance, which results in a relative decreased affinity of the chaperone protein pathway for trafficking of IAPP (31). 

Phrase: "We"

Phrase: "have"

Phrase: "previously"

Phrase: "hypothesized"

Phrase: "that IAPP amyloid formation in type 2 diabetes"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   799   C2247819:islet amyloid polypeptide formation [Molecular Function]
   739   C0220781:formation [Biologic Function]
   739   C0439634:formation [Spatial Concept]
   739   C1522492:Formation [Functional Concept]

Phrase: "may"

Phrase: "occur under circumstances of genetic variance,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   790   C0042333:genetic variance [Natural Phenomenon or Process]
   753   C0017296:GENETIC [Therapeutic or Preventive Procedure]
   753   C0314603:Genetic [Functional Concept]
   753   C1709305:Occur [Activity]
   753   C1711260:Variance [Qualitative Concept]
   753   C2348152:Variance [Quantitative Concept]
   753   C2745955:OCCUR [Temporal Concept]

Phrase: "which"

Phrase: "results in a relative decreased affinity of the chaperone protein pathway"
Meta Candidates (Total=16; Excluded=1; Pruned=0; Remaining=15)
   754   C0038164:Protein A [Amino Acid, Peptide, or Protein,Immunologic Factor,Indicator, Reagent, or Diagnostic Aid]
   738   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   738   C0080103:Relative [Family Group]
   738   C0205216:Decreased [Quantitative Concept]
   738   C0205345:Relative [Qualitative Concept]
   738   C0243041:Chaperone [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   738   C0392756:Decreased [Qualitative Concept]
   738   C0442797:decreased [Qualitative Concept]
   738   C1274040:Result [Functional Concept]
   738   C1510827:Affinity [Natural Phenomenon or Process]
   738   C1546471:Result [Idea or Concept]
   738   C1547039:*Relative [Quantitative Concept]
   738   C1704259:Pathway [Molecular Function]
   738   C1705987:Pathway [Conceptual Entity]
   738   C2825142:Result [Finding]
   704 E C0547047:Decrease [Quantitative Concept]

Phrase: "for"

Phrase: "trafficking of IAPP"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   862   C0063684:Islet Amyloid Polypeptide [Amino Acid, Peptide, or Protein,Hormone]
   862   C1415831:ISLET AMYLOID POLYPEPTIDE [Gene or Genome]
   760   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0011560:Amyloid [Pathologic Function]
   760   C0599896:trafficking [Cell Function]
   760   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C1305923:Polypeptide [Amino Acid, Peptide, or Protein]

Phrase: "(31"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450355:31 [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.32: It is plausible that a low affinity for binding by one or more chaperone proteins to IAPP may be shared with a similar low affinity for binding to AP. 

Phrase: "It"

Phrase: "is"

Phrase: "plausible"

Phrase: "that"

Phrase: "a low affinity for binding"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0205251:low [Qualitative Concept]
   760   C1299352:Low [Qualitative Concept]
   760   C1510827:Affinity [Natural Phenomenon or Process]
   760   C1550472:low [Idea or Concept]

Phrase: "by one"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205447:One [Quantitative Concept]

Phrase: "or"

Phrase: "more chaperone proteins to IAPP"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   774   C1456454:Amyloid Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   748   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "may"

Phrase: "be"

Phrase: "shared with a similar low affinity"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   753   C0205251:low [Qualitative Concept]
   753   C0237876:shared [Social Behavior]
   753   C1299352:Low [Qualitative Concept]
   753   C1510827:Affinity [Natural Phenomenon or Process]
   753   C1522138:Shared [Functional Concept]
   753   C1550472:low [Idea or Concept]
   753   C2348205:Similar [Qualitative Concept]

Phrase: "for binding"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0243122:binding [Functional Concept]
  1000   C1145667:Binding [Activity]
  1000   C1167622:Binding [Molecular Function]

Phrase: "to AP."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   861   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.33: In support of this hypothesis, Schwartz (32) suggested that there might be a relationship between amyloid deposits in the brain and pancreatic islets. 

Phrase: "In support"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0183683:Support [Medical Device]
  1000   C1521721:Support [Conceptual Entity]

Phrase: "of this hypothesis,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1512571:Hypothesis [Idea or Concept]

Phrase: "Schwartz"

Phrase: "(32"

Phrase: ")"

Phrase: "suggested"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that there"

Phrase: "might"

Phrase: "be"

Phrase: "a relationship between amyloid"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0439849:Relationship [Qualitative Concept]
   770   C1705630:Relationship [Idea or Concept]
   770   C1706279:Relationship [Idea or Concept]
   770   C3540605:Relationship [Intellectual Product]

Phrase: "deposits in the brain"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0006104:Brain [Body Part, Organ, or Organ Component]
   770   C0333562:Deposit [Functional Concept]
   770   C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "and"

Phrase: "pancreatic islets."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0022131:Pancreatic Islets [Body Part, Organ, or Organ Component]
   861   C0030274:Pancreatic [Body Part, Organ, or Organ Component]
Processing 00000000.tx.34: We used both clinical studies (in living patients and community-based control subjects) and pathological studies to examine the existence of a shared risk for Alzheimer disease and type 2 diabetes. 

Phrase: "We"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "both clinical studies"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0008972:Clinical Studies [Research Activity]
   861   C0205210:Clinical [Qualitative Concept]
   861   C0947630:studies [Laboratory Procedure]
   827 E C0557651:Study [Manufactured Object]
   827 E C2603343:Study [Research Activity]

Phrase: "("

Phrase: "in living patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0030705:Patients [Patient or Disabled Group]

Phrase: "and"

Phrase: "community-based control subjects"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   812   C0243148:control [Qualitative Concept]
   812   C1550141:Control [Substance]
   812   C1882979:Control [Conceptual Entity]
   812   C2587213:Control [Functional Concept]
   812   C3274648:Control [Qualitative Concept]
   779   C0681850:Subject [Group]
   779   C1550501:{Subject} [Idea or Concept]
   779   C1706203:Subject [Idea or Concept]
   779   C2349001:Subject [Human]
   779   C2697811:Subject [Functional Concept]

Phrase: ")"

Phrase: "and"

Phrase: "pathological studies to"
Meta Candidates (Total=9; Excluded=5; Pruned=0; Remaining=4)
   865   C0919386:Pathology studies [Laboratory Procedure]
   848 E C0551718:Pathology study [Clinical Attribute]
   827   C0030664:Pathological [Biomedical Occupation or Discipline]
   827   C0947630:studies [Laboratory Procedure]
   827   C1521733:Pathological [Functional Concept]
   793 E C0557651:Study [Manufactured Object]
   793 E C2603343:Study [Research Activity]
   755 E C0205469:pathology [Functional Concept]
   755 E C0677042:pathology [Pathologic Function]

Phrase: "examine"

Phrase: "the existence of a shared risk"

Phrase: "for Alzheimer disease"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "and"

Phrase: "type 2 diabetes."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0011860:Type 2 Diabetes [Disease or Syndrome]
   913   C1320657:type diabetes [Finding]
   901   C0441730:Type 2 [Classification]
   827   C0011847:Diabetes [Disease or Syndrome]
   827   C0011849:Diabetes [Disease or Syndrome]
   827   C0332307:Type [Qualitative Concept]
   827   C1547052:*Type [Quantitative Concept]
Processing 00000000.tx.35: In the clinical studies, we took advantage of a unique community-based (Olmsted County, MN) cohort of well-characterized patients with Alzheimer disease and control subjects without Alzheimer disease (33) to address the question, "Is type 2 diabetes more common in Alzheimer disease?" 

Phrase: "In the clinical studies,"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0008972:Clinical Studies [Research Activity]
   861   C0205210:Clinical [Qualitative Concept]
   861   C0947630:studies [Laboratory Procedure]
   827 E C0557651:Study [Manufactured Object]
   827 E C2603343:Study [Research Activity]

Phrase: "we"

Phrase: "took"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1515187:Take [Health Care Activity]

Phrase: "advantage of a unique community-based"

Phrase: "(Olmsted County,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0079170:County [Geographic Area]

Phrase: "MN) cohort of well-characterized patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0599755:Cohort [Population Group]

Phrase: "with Alzheimer disease"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "and"

Phrase: "control subjects without Alzheimer disease"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   797   C0920467:control disease [Therapeutic or Preventive Procedure]
   760   C0243148:control [Qualitative Concept]
   760   C1550141:Control [Substance]
   760   C1882979:Control [Conceptual Entity]
   760   C2587213:Control [Functional Concept]
   760   C3274648:Control [Qualitative Concept]
   726   C0681850:Subject [Group]
   726   C1550501:{Subject} [Idea or Concept]
   726   C1706203:Subject [Idea or Concept]
   726   C2349001:Subject [Human]
   726   C2697811:Subject [Functional Concept]

Phrase: "(33"

Phrase: ")"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "address"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0376649:Address [Intellectual Product]
  1000   C1442065:Address [Spatial Concept]

Phrase: "the question,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1522634:Question [Intellectual Product]

Phrase: """"

Phrase: "Is"

Phrase: "type 2 diabetes"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0011860:Type 2 Diabetes [Disease or Syndrome]
   913   C1320657:type diabetes [Finding]
   901   C0441730:Type 2 [Classification]
   827   C0011847:Diabetes [Disease or Syndrome]
   827   C0011849:Diabetes [Disease or Syndrome]
   827   C0332307:Type [Qualitative Concept]
   827   C1547052:*Type [Quantitative Concept]

Phrase: "more common in Alzheimer disease?"""
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0205214:Common [Quantitative Concept]
   760   C1522138:Common [Functional Concept]
   760   C3245511:common [Intellectual Product]
Processing 00000000.tx.36: In the pathology studies, we studied brain and pancreas in autopsy cases from the same community to address the hypotheses 1) that islet amyloid is more frequent in patients with Alzheimer disease than in control subjects without Alzheimer disease and 2) that amyloid deposits are more common in the brain in patients with type 2 diabetes than in nondiabetic humans.  

Phrase: "In the pathology studies,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0919386:Pathology studies [Laboratory Procedure]
   983 E C0551718:Pathology study [Clinical Attribute]
   861   C0947630:studies [Laboratory Procedure]
   827 E C0557651:Study [Manufactured Object]
   827 E C2603343:Study [Research Activity]

Phrase: "we"

Phrase: "studied"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0557651:Study [Manufactured Object]
   966   C2603343:Study [Research Activity]

Phrase: "brain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0006104:Brain [Body Part, Organ, or Organ Component]
  1000   C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "and"

Phrase: "pancreas in autopsy cases"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0030274:Pancreas [Body Part, Organ, or Organ Component]
   770   C1278931:Pancreas [Body Part, Organ, or Organ Component]

Phrase: "from the same community to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0009462:Community [Geographic Area]

Phrase: "address"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0376649:Address [Intellectual Product]
  1000   C1442065:Address [Spatial Concept]

Phrase: "the hypotheses 1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1512571:Hypothesis [Idea or Concept]

Phrase: ")"

Phrase: "that islet amyloid"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0011560:Amyloid [Pathologic Function]
   861   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "is"

Phrase: "more frequent in patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0332183:Frequent [Temporal Concept]

Phrase: "with Alzheimer disease"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "than"

Phrase: "in control subjects"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   861   C0243148:control [Qualitative Concept]
   861   C1550141:Control [Substance]
   861   C1882979:Control [Conceptual Entity]
   861   C2587213:Control [Functional Concept]
   861   C3274648:Control [Qualitative Concept]
   827   C0681850:Subject [Group]
   827   C1550501:{Subject} [Idea or Concept]
   827   C1706203:Subject [Idea or Concept]
   827   C2349001:Subject [Human]
   827   C2697811:Subject [Functional Concept]

Phrase: "without Alzheimer disease"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "and"

Phrase: "2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: ")"

Phrase: "that amyloid deposits"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2936349:Amyloid Deposits [Acquired Abnormality]
   861   C0333562:Deposits [Functional Concept]

Phrase: "are"

Phrase: "more common in the brain"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0205214:Common [Quantitative Concept]
   760   C1522138:Common [Functional Concept]
   760   C3245511:common [Intellectual Product]

Phrase: "in patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030705:Patients [Patient or Disabled Group]

Phrase: "with type 2 diabetes"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0011860:Type 2 Diabetes [Disease or Syndrome]
   913   C1320657:type diabetes [Finding]
   901   C0441730:Type 2 [Classification]
   827   C0011847:Diabetes [Disease or Syndrome]
   827   C0011849:Diabetes [Disease or Syndrome]
   827   C0332307:Type [Qualitative Concept]
   827   C1547052:*Type [Quantitative Concept]

Phrase: "than"

Phrase: "in nondiabetic humans."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0086418:Humans [Human]
Processing 00000000.tx.37: RESEARCH DESIGN AND METHODS TOP ABSTRACT RESEARCH DESIGN AND METHODS RESULTS DISCUSSION REFERENCES  Clinical studies The primary objective of the Mayo Clinic Alzheimer Disease Patient Registry (ADPR) was to acquire a cohort of patients with Alzheimer disease and matched non-Alzheimer disease control subjects for assessment of the progression of Alzheimer disease clinically with respect to imaging and other neurological studies. 

Phrase: "RESEARCH DESIGN"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0035171:Research Design [Research Activity]
   861   C0035168:research [Research Activity]
   861   C0242481:Research [Research Activity]
   861   C1707689:Design [Activity]
   861   C2983265:DESIGN [Intellectual Product]

Phrase: "AND"

Phrase: "METHODS TOP ABSTRACT RESEARCH DESIGN"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   875   C0086912:methods research [Research Activity]
   840   C0035171:Research Design [Research Activity]
   804   C0035168:research [Research Activity]
   804   C0242481:Research [Research Activity]
   804   C1707689:Design [Activity]
   804   C2983265:DESIGN [Intellectual Product]

Phrase: "AND"

Phrase: "METHODS RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Clinical studies"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0008972:Clinical Studies [Research Activity]
   861   C0205210:Clinical [Qualitative Concept]
   861   C0947630:studies [Laboratory Procedure]
   827 E C0557651:Study [Manufactured Object]
   827 E C2603343:Study [Research Activity]

Phrase: "The primary objective of the Mayo Clinic Alzheimer Disease Patient Registry"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   738   C0018017:Objective [Intellectual Product]
   738   C1571702:Objective [Qualitative Concept]

Phrase: "(ADPR"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   875   C0920465:disease registry [Intellectual Product]
   861   C0920631:patient registry [Intellectual Product]
   812   C0034975:Registry [Intellectual Product]

Phrase: ")"

Phrase: "was"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "acquire"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C1706701:Acquire [Activity]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442805:Increase [Functional Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C1301820:Obtain [Functional Concept]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "a cohort of patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0599755:Cohort [Population Group]

Phrase: "with Alzheimer disease"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "and"

Phrase: "matched non-Alzheimer disease control subjects for assessment of the progression"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   756   C0920467:disease control [Therapeutic or Preventive Procedure]
   738   C0243148:control [Qualitative Concept]
   738   C1550141:Control [Substance]
   738   C1882979:Control [Conceptual Entity]
   738   C2587213:Control [Functional Concept]
   738   C3274648:Control [Qualitative Concept]
   704   C0681850:Subject [Group]
   704   C1550501:{Subject} [Idea or Concept]
   704   C1706203:Subject [Idea or Concept]
   704   C2349001:Subject [Human]
   704   C2697811:Subject [Functional Concept]

Phrase: "of Alzheimer disease clinically"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   901   C0002395:Alzheimer's Disease [Disease or Syndrome]
   901   C1521724:Alzheimer's Disease [Pathologic Function]
   827   C0012634:Disease [Disease or Syndrome]
   771 E C1836721:MALS [Finding]
   771 E C3538764:MALS [Gene or Genome]
   771 E C3540595:MAL [Gene or Genome]

Phrase: "with respect to imaging"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0011923:Imaging [Diagnostic Procedure]
  1000   C0079595:Imaging [Diagnostic Procedure]
   966 E C1704254:Image [Intellectual Product]
   966 E C1704922:Image [Entity]
   966 E C3542466:Image [Intellectual Product]

Phrase: "and"

Phrase: "other neurological studies."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0947630:studies [Laboratory Procedure]
   827 E C0557651:Study [Manufactured Object]
   827 E C2603343:Study [Research Activity]
Processing 00000000.tx.38: Patients who were from southeastern Minnesota and had dementia were identified at the time of routine general medical examination in the Department of Community Internal Medicine at the Mayo Clinic. 

Phrase: "Patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030705:Patients [Patient or Disabled Group]

Phrase: "who"

Phrase: "were from southeastern Minnesota"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0026183:Minnesota [Geographic Area]
   770   C1711190:Southeastern [Spatial Concept]

Phrase: "and"

Phrase: "had"

Phrase: "dementia"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0011265:dementia [Mental or Behavioral Dysfunction]
  1000   C0497327:Dementia [Mental or Behavioral Dysfunction]
   900 E C0860630:dement [Mental or Behavioral Dysfunction]

Phrase: "were"

Phrase: "identified at the time of routine general medical examination"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   790   C0260860:General medical examination [Finding]
   764   C0582103:Medical Examination [Health Care Activity]
   742   C0040223:Time [Temporal Concept]
   742   C0205246:General [Spatial Concept]
   742   C0205396:Identified [Qualitative Concept]
   742   C0205476:Medical [Functional Concept]
   742   C0205547:Routine [Qualitative Concept]
   742   C1550043:Identified [Finding]
   742   C1551388:Identified [Functional Concept]
   742   C1553889:General [Idea or Concept]
   742   C3541383:Time [Temporal Concept]

Phrase: "in the Department"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1704729:Department [Organization]

Phrase: "of Community Internal Medicine"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   913   C0009473:Community Medicine [Biomedical Occupation or Discipline]
   901   C0021782:Internal Medicine [Biomedical Occupation or Discipline]
   901   C1555750:Internal Medicine [Intellectual Product]
   827   C0013227:Medicine, NOS [Pharmacologic Substance]
   827   C0025118:Medicine [Biomedical Occupation or Discipline]
   827   C0205102:Internal [Spatial Concept]
   827   C1553872:Internal [Intellectual Product]
   827   C1619620:Internal [Intellectual Product]

Phrase: "at the Mayo Clinic."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0002424:Clinic [Health Care Related Organization,Manufactured Object]
   861   C0442592:Clinic [Health Care Related Organization,Manufactured Object]
   789 E C0205210:Clinical [Qualitative Concept]
Processing 00000000.tx.39: All studies were approved by the Mayo Clinic Institutional Review Board. 

Phrase: "All studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0947630:studies [Laboratory Procedure]
   966 E C0557651:Study [Manufactured Object]
   966 E C2603343:Study [Research Activity]

Phrase: "were"

Phrase: "approved by the Mayo Clinic Institutional Review Board."
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   800   C0086911:Review Board, Institutional [Professional or Occupational Group]
   744   C0002424:Clinic [Health Care Related Organization,Manufactured Object]
   744   C0205540:Approved [Qualitative Concept]
   744   C0282443:Review [Intellectual Product]
   744   C0442592:Clinic [Health Care Related Organization,Manufactured Object]
   744   C0454788:Mayo [Geographic Area]
   744   C0972401:board [Medical Device]
   744   C1077578:mayo [Plant]
   744   C1552617:Review [Idea or Concept]
   744   C1948070:Board [Organization]
Processing 00000000.tx.40: When there was a suspicion of Alzheimer disease during a routine periodic medical examination, a neurological evaluation that included the Mini-Mental State Exam, Geriatric Depression Scale, Hachinski Ischemic Scale, Short Test of Mental Status, Record of Independent Living, and extensive neuropsychological testing was performed (33). 

Phrase: "When"

Phrase: "there"

Phrase: "was"

Phrase: "a suspicion of Alzheimer disease"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0242114:Suspicion [Mental Process]

Phrase: "during a routine periodic medical examination,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0582103:Medical Examination [Health Care Activity]

Phrase: "a neurological evaluation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0220825:Evaluation [Functional Concept]
   861   C1261322:Evaluation [Health Care Activity]

Phrase: "that"

Phrase: "included"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0332257:included [Functional Concept]
  1000   C3538986:INCLUDED [Gene or Genome]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "the Mini-Mental State Exam,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   923   C0850338:mental state exam [Therapeutic or Preventive Procedure]
   812   C0582103:Exam [Health Care Activity]

Phrase: "Geriatric Depression Scale,"
Meta Candidates (Total=16; Excluded=3; Pruned=0; Remaining=13)
  1000   C0451184:Geriatric depression scale [Intellectual Product]
   901   C0679604:depression scale [Diagnostic Procedure,Intellectual Product]
   827   C0011570:Depression [Mental or Behavioral Dysfunction]
   827   C0011581:Depression [Mental or Behavioral Dysfunction]
   827   C0175659:Scale [Medical Device]
   827   C0344315:Depression [Finding]
   827   C0349217:depression nos [Mental or Behavioral Dysfunction]
   827   C0349674:Scale [Intellectual Product]
   827   C0460137:Depression [Functional Concept]
   827   C1704440:Geriatric [Qualitative Concept]
   827   C1947916:Scale [Activity]
   827   C1999167:geriatric [Population Group]
   827   C3536777:Scale [Manufactured Object]
   755 E C0549249:DEPRESSED [Finding]
   755 E C1710017:Scalar [Qualitative Concept]
   743 E C0222045:Scales [Body Part, Organ, or Organ Component]

Phrase: "Hachinski Ischemic Scale,"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   827   C0175659:Scale [Medical Device]
   827   C0349674:Scale [Intellectual Product]
   827   C1947916:Scale [Activity]
   827   C3536777:Scale [Manufactured Object]
   755 E C1710017:Scalar [Qualitative Concept]
   743 E C0222045:Scales [Body Part, Organ, or Organ Component]

Phrase: "Short Test of Mental Status,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   797   C0025365:Test, Mental [Diagnostic Procedure]
   797   C0420636:Test status [Functional Concept]
   760   C0022885:Test [Laboratory Procedure]
   760   C0039593:Test [Functional Concept]
   760   C0392366:test [Intellectual Product]

Phrase: "Record of Independent Living,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0034869:Record [Intellectual Product]

Phrase: "and"

Phrase: "extensive neuropsychological testing"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   901   C0027902:Neuropsychological testing [Diagnostic Procedure]
   827   C0039593:Testing [Functional Concept]
   827   C0392366:testing [Intellectual Product]
   793 E C0022885:Test [Laboratory Procedure]

Phrase: "was"

Phrase: "performed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]

Phrase: "(33"

Phrase: ")."
Processing 00000000.tx.41: Age- and sex-matched control subjects were randomly identified from the same community clinics. 

Phrase: "Age-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001779:Age [Organism Attribute]

Phrase: "and"

Phrase: "sex-matched control subjects"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   779   C0681850:Subject [Group]
   779   C1550501:{Subject} [Idea or Concept]
   779   C1706203:Subject [Idea or Concept]
   779   C2349001:Subject [Human]
   779   C2697811:Subject [Functional Concept]

Phrase: "were"

Phrase: "randomly"

Phrase: "identified from the same community clinics."
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   783   C0587907:clinics community [Health Care Related Organization,Manufactured Object]
   753   C0009462:Community [Geographic Area]
   753   C0205396:Identified [Qualitative Concept]
   753   C0442592:clinics [Health Care Related Organization,Manufactured Object]
   753   C0445247:Same [Qualitative Concept]
   753   C1550043:Identified [Finding]
   753   C1551388:Identified [Functional Concept]
   719 E C0002424:Clinic [Health Care Related Organization,Manufactured Object]
Processing 00000000.tx.42: All enrolled cases had detailed evaluation to confirm or rule out (control subjects) Alzheimer disease. 

Phrase: "All enrolled cases"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0868928:Cases [Functional Concept]
   861   C1533148:Cases [Quantitative Concept]
   827 E C1706255:CASE [Medical Device]
   827 E C1706256:Case [Conceptual Entity]

Phrase: "had"

Phrase: "detailed evaluation to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0220825:Evaluation [Functional Concept]
   827   C1261322:Evaluation [Health Care Activity]

Phrase: "confirm"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0521093:confirm [Qualitative Concept]
  1000   C0750484:confirm [Idea or Concept]
  1000   C1456348:Confirm [Qualitative Concept]

Phrase: "or"

Phrase: "rule"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0805874:Rule [Idea or Concept]
  1000   C0870077:Rule [Intellectual Product]
  1000   C1446409:rule [Qualitative Concept]

Phrase: "out"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439787:Out [Spatial Concept]
  1000   C0849355:Out [Qualitative Concept]

Phrase: "(control subjects"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   861   C0243148:control [Qualitative Concept]
   861   C1550141:Control [Substance]
   861   C1882979:Control [Conceptual Entity]
   861   C2587213:Control [Functional Concept]
   861   C3274648:Control [Qualitative Concept]
   827   C0681850:Subject [Group]
   827   C1550501:{Subject} [Idea or Concept]
   827   C1706203:Subject [Idea or Concept]
   827   C2349001:Subject [Human]
   827   C2697811:Subject [Functional Concept]

Phrase: ")"

Phrase: "Alzheimer disease."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.43: Once a patient had been enrolled in the ADPR as a case of Alzheimer disease or as a control, he or she was followed annually for clinical studies that included a fasting blood glucose measurement. 

Phrase: "Once"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1720092:Once [Intellectual Product]
  1000   C1948045:Once [Temporal Concept]

Phrase: "a patient"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030705:*^patient [Patient or Disabled Group]

Phrase: "had"

Phrase: "been"

Phrase: "enrolled in the ADPR"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   800   C0597185:patient/disease registry [Intellectual Product]
   778   C0002395:Alzheimer's Disease [Disease or Syndrome]
   778   C0920631:patient registry [Intellectual Product]
   778   C1521724:Alzheimer's Disease [Pathologic Function]
   774   C0920465:disease registry [Intellectual Product]
   748   C0012634:Disease [Disease or Syndrome]
   748   C0030705:*^patient [Patient or Disabled Group]
   748   C0034975:Registry [Intellectual Product]

Phrase: "as a case"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0868928:Case [Functional Concept]
  1000   C1706255:CASE [Medical Device]
  1000   C1706256:Case [Conceptual Entity]

Phrase: "of Alzheimer disease"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "or as a control,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0243148:control [Qualitative Concept]
   770   C1550141:Control [Substance]
   770   C1882979:Control [Conceptual Entity]
   770   C2587213:Control [Functional Concept]
   770   C3274648:Control [Qualitative Concept]

Phrase: "he"

Phrase: "or"

Phrase: "she"

Phrase: "was"

Phrase: "followed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0332283:followed [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "annually for clinical studies"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   833   C0008972:Clinical Studies [Research Activity]
   770   C0205210:Clinical [Qualitative Concept]
   770   C0332181:Annually [Temporal Concept]
   770   C0947630:studies [Laboratory Procedure]
   737 E C0557651:Study [Manufactured Object]
   737 E C2603343:Study [Research Activity]

Phrase: "that"

Phrase: "included"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0332257:included [Functional Concept]
  1000   C3538986:INCLUDED [Gene or Genome]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "a fasting blood glucose measurement."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0428568:Fasting blood glucose measurement [Laboratory Procedure]
           Fasting blood glucose
   923   C0202045:Glucose measurement, fasting [Laboratory Procedure]
   923   C0392201:Blood glucose measurement [Laboratory Procedure]
   861   C0337438:Glucose measurement [Laboratory Procedure]
   812   C0242485:Measurement [Functional Concept]
   756   C1261430:fasting blood glucose [Laboratory or Test Result]
Processing 00000000.tx.44: Recruitment to the ADPR was haphazard (i.e., not deliberately biased) with respect to the presence or absence of diabetes or the blood glucose concentration. 

Phrase: "Recruitment to the ADPR"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   774   C0242800:Patient Recruitment [Research Activity]
   748   C2949735:Recruitment [Activity]

Phrase: "was"

Phrase: "haphazard"

Phrase: "(i.e.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0683454:I-E [Diagnostic Procedure,Intellectual Product]
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "not deliberately"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1518422:Not [Functional Concept]

Phrase: "biased"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0242568:Biased [Idea or Concept]
   966 E C1504315:Bias [Bird]

Phrase: ")"

Phrase: "with respect to the presence"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392148:Presence [Therapeutic or Preventive Procedure]
   928 E C0150312:Present [Quantitative Concept]
   928 E C0449450:Present [Idea or Concept]

Phrase: "or"

Phrase: "absence of diabetes"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0332197:absence [Quantitative Concept]
   790   C1689985:Absence [Anatomical Abnormality]
   718 E C2699517:ABSENT [Finding]

Phrase: "or"

Phrase: "the blood glucose concentration."
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
  1000   C2585282:Blood glucose concentration [Finding]
   913   C0427728:Blood concentration [Laboratory or Test Result]
   913   C0699870:blood concentration [Quantitative Concept]
   913   C1313904:Blood concentration [Laboratory Procedure]
   901   C0427743:Glucose concentration [Laboratory Procedure]
   901   C1287281:Glucose concentration [Laboratory or Test Result]
   827   C0086045:Concentration [Mental Process]
   827   C1446561:Concentration [Quantitative Concept]
   755 E C1880165:Concentrated [Biomedical or Dental Material]
   734   C0005802:Blood Glucose [Carbohydrate]
Processing 00000000.tx.45: Exclusion criteria were 1) chronic treatment with glucocorticoids, 2) a history of pancreatitis, or 3) type 1 diabetes. 

Phrase: "Exclusion criteria"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0680251:Exclusion Criteria [Functional Concept]
   861   C0243161:criteria [Intellectual Product]

Phrase: "were"

Phrase: "1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ")"

Phrase: "chronic treatment with glucocorticoids,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0039798:treatment [Functional Concept]
   770   C0087111:Treatment [Therapeutic or Preventive Procedure]
   770   C1522326:Treatment [Functional Concept]
   770   C1533734:Treatment [Therapeutic or Preventive Procedure]
   770   C1705169:Treatment [Conceptual Entity]
   770   C3538994:TREATMENT [Research Activity]

Phrase: "2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: ")"

Phrase: "a history of pancreatitis,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0019664:History [Occupation or Discipline]
   770   C0019665:history [Intellectual Product]
   770   C0262512:History, NOS [Organism Attribute]
   770   C0262926:History [Finding]
   770   C1705255:History [Conceptual Entity]
   770   C2004062:History [Finding]

Phrase: "or"

Phrase: "3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: ")"

Phrase: "type 1 diabetes."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0011854:Type 1 diabetes [Disease or Syndrome]
   913   C1320657:type diabetes [Finding]
   901   C0441729:Type 1 [Classification]
   827   C0011847:Diabetes [Disease or Syndrome]
   827   C0011849:Diabetes [Disease or Syndrome]
   827   C0332307:Type [Qualitative Concept]
   827   C1547052:*Type [Quantitative Concept]
Processing 00000000.tx.46: The distinction between type 1 and type 2 diabetes was made on conventional clinical criteria. 

Phrase: "The distinction between type 1"

Phrase: "and"

Phrase: "type 2 diabetes"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0011860:Type 2 Diabetes [Disease or Syndrome]
   913   C1320657:type diabetes [Finding]
   901   C0441730:Type 2 [Classification]
   827   C0011847:Diabetes [Disease or Syndrome]
   827   C0011849:Diabetes [Disease or Syndrome]
   827   C0332307:Type [Qualitative Concept]
   827   C1547052:*Type [Quantitative Concept]

Phrase: "was"

Phrase: "made on conventional clinical criteria."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0205210:Clinical [Qualitative Concept]
   760   C0243161:criteria [Intellectual Product]
   760   C0439858:Conventional [Qualitative Concept]
   726   C1881534:Make [Functional Concept]
Processing 00000000.tx.47: The features favoring type 1 diabetes included lean BMI (and further weight loss) and young age at onset, insulin requirement at onset, documented ketoacidosis, presence of other autoimmune diseases, and a family history of autoimmune disease. 

Phrase: "The features"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   966   C1521970:Feature [Qualitative Concept]
   966   C1706388:Feature [Conceptual Entity]
   966   C2346469:Feature [Qualitative Concept]
   966   C2348519:Feature [Qualitative Concept]

Phrase: "favoring"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0309049:favoring [Organic Chemical,Pharmacologic Substance,Vitamin]

Phrase: "type 1 diabetes"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0011854:Type 1 diabetes [Disease or Syndrome]
   913   C1320657:type diabetes [Finding]
   901   C0441729:Type 1 [Classification]
   827   C0011847:Diabetes [Disease or Syndrome]
   827   C0011849:Diabetes [Disease or Syndrome]
   827   C0332307:Type [Qualitative Concept]
   827   C1547052:*Type [Quantitative Concept]

Phrase: "included"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0332257:included [Functional Concept]
  1000   C3538986:INCLUDED [Gene or Genome]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "lean BMI ("

Phrase: "and"

Phrase: "further weight loss"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   901   C0043096:WEIGHTLOSS [Finding]
   901   C2911645:Weight loss [Finding]
   827   C0005910:weight [Organism Attribute]
   827   C0043100:Weight [Quantitative Concept]
   827   C1305866:weight [Diagnostic Procedure]
   827   C1517945:Loss [Quantitative Concept]
   827   C1705104:Weight [Idea or Concept]

Phrase: ")"

Phrase: "and"

Phrase: "young age at onset,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   875   C0206132:age onset [Quantitative Concept]
   812   C0001779:Age [Organism Attribute]
   812   C0332162:Onset [Qualitative Concept]

Phrase: "insulin requirement at onset,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1514873:Requirement [Functional Concept]

Phrase: "documented ketoacidosis,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0022638:Ketoacidosis [Disease or Syndrome]
   861   C0220982:KETO ACIDOSIS [Pathologic Function]

Phrase: "presence of other autoimmune diseases,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0392148:Presence [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "a family history of autoimmune disease."
Meta Candidates (Total=16; Excluded=1; Pruned=0; Remaining=15)
   864   C0850707:family history of disease [Finding]
           disease family history
   793   C0683519:History of diseases [Finding]
           disease history
   790   C0241889:Family history [Finding]
   790   C1705495:Family History [Idea or Concept]
   783   C0344339:disease family [Finding]
   753   C0015576:Family [Family Group]
   753   C0019664:History [Occupation or Discipline]
   753   C0019665:history [Intellectual Product]
   753   C0262512:History, NOS [Organism Attribute]
   753   C0262926:History [Finding]
   753   C1704727:Family [Conceptual Entity]
   753   C1705255:History [Conceptual Entity]
   753   C2004062:History [Finding]
   748 E C0277558:Familial disease [Disease or Syndrome]
Processing 00000000.tx.48: Features favoring type 2 diabetes included strong family history, prolonged insulin-independent treatment, obesity, absence of autoimmune diseases, and later age of onset. 

Phrase: "Features"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   966   C1521970:Feature [Qualitative Concept]
   966   C1706388:Feature [Conceptual Entity]
   966   C2346469:Feature [Qualitative Concept]
   966   C2348519:Feature [Qualitative Concept]

Phrase: "favoring"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0309049:favoring [Organic Chemical,Pharmacologic Substance,Vitamin]

Phrase: "type 2 diabetes"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0011860:Type 2 Diabetes [Disease or Syndrome]
   913   C1320657:type diabetes [Finding]
   901   C0441730:Type 2 [Classification]
   827   C0011847:Diabetes [Disease or Syndrome]
   827   C0011849:Diabetes [Disease or Syndrome]
   827   C0332307:Type [Qualitative Concept]
   827   C1547052:*Type [Quantitative Concept]

Phrase: "included"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0332257:included [Functional Concept]
  1000   C3538986:INCLUDED [Gene or Genome]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "strong family history,"
Meta Candidates (Total=13; Excluded=3; Pruned=0; Remaining=10)
   901   C0241889:Family history [Finding]
   901   C1705495:Family History [Idea or Concept]
   827   C0015576:Family [Family Group]
   827   C0019664:History [Occupation or Discipline]
   827   C0019665:history [Intellectual Product]
   827   C0262512:History, NOS [Organism Attribute]
   827   C0262926:History [Finding]
   827   C1704727:Family [Conceptual Entity]
   827   C1705255:History [Conceptual Entity]
   827   C2004062:History [Finding]
   755 E C0241888:Familial [Functional Concept]
   755 E C1552658:Historical [Idea or Concept]
   755 E C1552723:Historical [Idea or Concept]

Phrase: "prolonged insulin-independent treatment,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   875   C0745343:insulin treatment [Therapeutic or Preventive Procedure]
   812   C0039798:treatment [Functional Concept]
   812   C0087111:Treatment [Therapeutic or Preventive Procedure]
   812   C1522326:Treatment [Functional Concept]
   812   C1533734:Treatment [Therapeutic or Preventive Procedure]
   812   C1705169:Treatment [Conceptual Entity]
   812   C3538994:TREATMENT [Research Activity]

Phrase: "obesity,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0028754:Obesity [Disease or Syndrome]
  1000   C1963185:Obesity [Finding]

Phrase: "absence of autoimmune diseases,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0332197:absence [Quantitative Concept]
   770   C1689985:Absence [Anatomical Abnormality]

Phrase: "and"

Phrase: "later age of onset."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   909   C0206132:Age of Onset [Quantitative Concept]
           Onset Age
   770   C0001779:Age [Organism Attribute]
Processing 00000000.tx.49: It is acknowledged that the distinction between type 1 and type 2 diabetes is not without error, but in view of the large number of cases in the present studies and the high prevalence of type 2 versus type 1 diabetes, it is unlikely that the conclusions of the present studies have been influenced by erroneous inclusion of cases of type 1 diabetes (Table 1). 

Phrase: "It"

Phrase: "is"

Phrase: "acknowledged"

Phrase: "that"

Phrase: "the distinction between type 1"

Phrase: "and"

Phrase: "type 2 diabetes"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0011860:Type 2 Diabetes [Disease or Syndrome]
   913   C1320657:type diabetes [Finding]
   901   C0441730:Type 2 [Classification]
   827   C0011847:Diabetes [Disease or Syndrome]
   827   C0011849:Diabetes [Disease or Syndrome]
   827   C0332307:Type [Qualitative Concept]
   827   C1547052:*Type [Quantitative Concept]

Phrase: "is"

Phrase: "not without error,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0743559:error [Qualitative Concept]
   790   C1518422:Not [Functional Concept]
   790   C1608199:Error [Functional Concept]

Phrase: "but in view of the large number of cases"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   742   C0233535:but [Mental or Behavioral Dysfunction]
   742   C0237753:*Number [Quantitative Concept]
   742   C0449788:Number [Quantitative Concept]
   742   C0449911:View [Spatial Concept]
   742   C0549177:Large [Quantitative Concept]
   742   C0868928:Cases [Functional Concept]
   742   C1533148:Cases [Quantitative Concept]
   708 E C1706255:CASE [Medical Device]
   708 E C1706256:Case [Conceptual Entity]

Phrase: "in the present studies"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   861   C0150312:Present [Quantitative Concept]
   861   C0449450:Present [Idea or Concept]
   861   C0947630:studies [Laboratory Procedure]
   827 E C0557651:Study [Manufactured Object]
   827 E C2603343:Study [Research Activity]

Phrase: "and"

Phrase: "the high prevalence of type 2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C1512456:High Prevalence [Quantitative Concept]
   753   C0033105:Prevalence [Quantitative Concept]
   753   C0220900:prevalence [Quantitative Concept]

Phrase: "versus"

Phrase: "type 1 diabetes,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0011854:Type 1 diabetes [Disease or Syndrome]
   913   C1320657:type diabetes [Finding]
   901   C0441729:Type 1 [Classification]
   827   C0011847:Diabetes [Disease or Syndrome]
   827   C0011849:Diabetes [Disease or Syndrome]
   827   C0332307:Type [Qualitative Concept]
   827   C1547052:*Type [Quantitative Concept]

Phrase: "it"

Phrase: "is"

Phrase: "unlikely"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0750558:Unlikely [Conceptual Entity]
  1000   C1710571:Unlikely [Qualitative Concept]

Phrase: "that"

Phrase: "the conclusions of the present studies"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1707478:Conclusions [Idea or Concept]

Phrase: "have"

Phrase: "been"

Phrase: "influenced by erroneous inclusion of cases of type 1 diabetes"
Meta Candidates (Total=14; Excluded=2; Pruned=0; Remaining=12)
   782   C0011854:Type 1 diabetes [Disease or Syndrome]
   760   C0441729:Type 1 [Classification]
   757   C1320657:Diabetes type [Finding]
   739   C0011847:Diabetes [Disease or Syndrome]
   739   C0011849:Diabetes [Disease or Syndrome]
   739   C0332307:Type [Qualitative Concept]
   739   C0868928:Cases [Functional Concept]
   739   C1512693:Inclusion [Qualitative Concept]
   739   C1533148:Cases [Quantitative Concept]
   739   C1547052:*Type [Quantitative Concept]
   739   C1547323:Erroneous [Idea or Concept]
   739   C3541364:Erroneous [Intellectual Product]
   706 E C1706255:CASE [Medical Device]
   706 E C1706256:Case [Conceptual Entity]

Phrase: "(Table 1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.50: View this table: [in this window] [in a new window]  TABLE 1 Study cases: clinical studies  Protocol 1: is type 2 diabetes more common in Alzheimer disease? 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "this table"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0039224:Table [Manufactured Object]
  1000   C1706073:Table [Medical Device]
  1000   C1706074:Table [Intellectual Product]

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  TABLE 1 Study cases"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   812   C0868928:Cases [Functional Concept]
   812   C1533148:Cases [Quantitative Concept]
   779 E C1706255:CASE [Medical Device]
   779 E C1706256:Case [Conceptual Entity]

Phrase: ":"

Phrase: "clinical studies  Protocol 1"
Meta Candidates (Total=13; Excluded=2; Pruned=0; Remaining=11)
   906   C1507394:Clinical Study Protocol [Intellectual Product]
           Study Protocol
           Protocol
   875   C0008971:Protocol, Clinical [Therapeutic or Preventive Procedure]
   861   C0008972:Clinical Studies [Research Activity]
   844   C2348563:Study Protocol [Intellectual Product]
           Protocol
   812   C0205210:Clinical [Qualitative Concept]
   812   C0442711:Protocol [Intellectual Product]
   812   C0947630:studies [Laboratory Procedure]
   812   C1522729:Protocol [Intellectual Product]
   779 E C0557651:Study [Manufactured Object]
   779 E C2603343:Study [Research Activity]

Phrase: ":"

Phrase: "is"

Phrase: "type 2 diabetes"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0011860:Type 2 Diabetes [Disease or Syndrome]
   913   C1320657:type diabetes [Finding]
   901   C0441730:Type 2 [Classification]
   827   C0011847:Diabetes [Disease or Syndrome]
   827   C0011849:Diabetes [Disease or Syndrome]
   827   C0332307:Type [Qualitative Concept]
   827   C1547052:*Type [Quantitative Concept]

Phrase: "more common in Alzheimer disease?"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0205214:Common [Quantitative Concept]
   760   C1522138:Common [Functional Concept]
   760   C3245511:common [Intellectual Product]
Processing 00000000.tx.51: These recruitment criteria provided a total of 100 patients with Alzheimer disease and 138 non-Alzheimer disease control subjects. 

Phrase: "These recruitment criteria"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0243161:criteria [Intellectual Product]

Phrase: "provided"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1999230:Provided [Activity]

Phrase: "a total of 100 patients"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0439175:% total [Quantitative Concept]
   760   C0439810:Total [Qualitative Concept]

Phrase: "with Alzheimer disease"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "and"

Phrase: "138 non-Alzheimer disease control subjects."
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   827   C0920467:disease control [Therapeutic or Preventive Procedure]
   799   C0243148:control [Qualitative Concept]
   799   C1550141:Control [Substance]
   799   C1882979:Control [Conceptual Entity]
   799   C2587213:Control [Functional Concept]
   799   C3274648:Control [Qualitative Concept]
   766   C0681850:Subject [Group]
   766   C1550501:{Subject} [Idea or Concept]
   766   C1706203:Subject [Idea or Concept]
   766   C2349001:Subject [Human]
   766   C2697811:Subject [Functional Concept]
Processing 00000000.tx.52: In protocol 1, these cases and control subjects were classified according to the criteria of the American Diabetes Association into one of three groups: nondiabetic (< 110 mg/dl), impaired fasting glucose (IFG; 110125 mg/dl), and type 2 diabetes (>126 mg/dl) based on the most recent glucose concentration measurements. 

Phrase: "In protocol 1,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0442711:Protocol [Intellectual Product]
   861   C1507394:Protocol [Intellectual Product]
   861   C1522729:Protocol [Intellectual Product]
   861   C2348563:Protocol [Intellectual Product]

Phrase: "these cases"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0868928:Cases [Functional Concept]
  1000   C1533148:Cases [Quantitative Concept]
   966 E C1706255:CASE [Medical Device]
   966 E C1706256:Case [Conceptual Entity]

Phrase: "and"

Phrase: "control subjects"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   861   C0243148:control [Qualitative Concept]
   861   C1550141:Control [Substance]
   861   C1882979:Control [Conceptual Entity]
   861   C2587213:Control [Functional Concept]
   861   C3274648:Control [Qualitative Concept]
   827   C0681850:Subject [Group]
   827   C1550501:{Subject} [Idea or Concept]
   827   C1706203:Subject [Idea or Concept]
   827   C2349001:Subject [Human]
   827   C2697811:Subject [Functional Concept]

Phrase: "were"

Phrase: "classified according to the criteria of the American Diabetes Association"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   782   C1705019:American Diabetes Association [Professional Society]
   739   C0004083:Association [Mental Process]
   739   C0008902:Classified [Classification]
   739   C0011847:Diabetes [Disease or Syndrome]
   739   C0011849:Diabetes [Disease or Syndrome]
   739   C0243161:criteria [Intellectual Product]
   739   C0439849:Association [Qualitative Concept]
   739   C0596070:American [Population Group]
   739   C0596306:Association [Phenomenon or Process]
   739   C0680240:according [Social Behavior]
   739   C0699792:association [Social Behavior]

Phrase: "into one"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205447:One [Quantitative Concept]

Phrase: "of three groups"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   861   C0441833:Group [Idea or Concept]
   861   C0687744:group [Population Group]
   861   C1257890:Group [Population Group]
   861   C1552516:Group [Health Care Related Organization]
   861   C1552839:groups [Idea or Concept]
   861   C1705428:Group [Conceptual Entity]
   861   C1705429:Group [Population Group]

Phrase: ":"

Phrase: "nondiabetic"

Phrase: "("

Phrase: "< 110 mg/dl"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0439269:mg dl [Quantitative Concept]
   827   C3642216:/dL [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "impaired fasting glucose"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
  1000   C1272092:Impaired fasting glucose [Finding]
   827   C0015663:Fasting [Finding]
   827   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   827   C0221099:Impaired [Functional Concept]
   827   C0684336:Impaired [Pathologic Function]
   827   C1550565:fasting [Intellectual Product]
   793 E C0456962:Fast [Qualitative Concept]

Phrase: "(IFG"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1334085:IFG [Gene or Genome]
  1000   C1708411:IFG [Gene or Genome]

Phrase: "; 110125 mg/dl"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0439269:mg dl [Quantitative Concept]
   827   C3642216:/dL [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "type 2 diabetes"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0011860:Type 2 Diabetes [Disease or Syndrome]
   913   C1320657:type diabetes [Finding]
   901   C0441730:Type 2 [Classification]
   827   C0011847:Diabetes [Disease or Syndrome]
   827   C0011849:Diabetes [Disease or Syndrome]
   827   C0332307:Type [Qualitative Concept]
   827   C1547052:*Type [Quantitative Concept]

Phrase: "("

Phrase: ">126 mg/"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0439269:mg% [Quantitative Concept]
   861   C1960952:mg % [Quantitative Concept]
   861   C2346927:Mg++ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "dl)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642216:/dL [Quantitative Concept]

Phrase: "based on the most recent glucose concentration measurements."
Meta Candidates (Total=14; Excluded=3; Pruned=0; Remaining=11)
   770   C0427743:Glucose concentration [Laboratory Procedure]
   770   C1287281:Glucose concentration [Laboratory or Test Result]
   767   C0337438:glucose measurements [Laboratory Procedure]
   754   C1446561:Concentration measurement [Quantitative Concept]
           Concentration
   744   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   744   C0086045:Concentration [Mental Process]
   744   C0242485:measurements [Functional Concept]
   744   C0332185:Recent [Temporal Concept]
   744   C1527178:Based [Functional Concept]
   744   C1705938:Based [Idea or Concept]
   711 E C0002055:base [Inorganic Chemical]
   711 E C0178499:Base [Chemical Viewed Functionally]
   711 E C1880279:Base [Biomedical or Dental Material]
Processing 00000000.tx.53: Individuals who were taking blood glucose-lowering treatment for diabetes were classified as type 2 diabetes regardless of their most recent fasting glucose concentration. 

Phrase: "Individuals"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0027361:Individual [Population Group]
   966   C0237401:Individual [Human]

Phrase: "who"

Phrase: "were"

Phrase: "taking blood glucose-lowering treatment for diabetes"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   774   C0596197:Blood Treatment [Therapeutic or Preventive Procedure]
   748   C0039798:treatment [Functional Concept]
   748   C0087111:Treatment [Therapeutic or Preventive Procedure]
   748   C1522326:Treatment [Functional Concept]
   748   C1533734:Treatment [Therapeutic or Preventive Procedure]
   748   C1705169:Treatment [Conceptual Entity]
   748   C3538994:TREATMENT [Research Activity]

Phrase: "were"

Phrase: "classified as type 2 diabetes"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   862   C0011860:Type 2 Diabetes [Disease or Syndrome]
   806   C0441730:Type 2 [Classification]
   797   C1320657:Diabetes type [Finding]
   760   C0008902:Classified [Classification]
   760   C0011847:Diabetes [Disease or Syndrome]
   760   C0011849:Diabetes [Disease or Syndrome]
   760   C0332307:Type [Qualitative Concept]
   760   C1547052:*Type [Quantitative Concept]

Phrase: "regardless of their most recent fasting glucose concentration."
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   840   C0427743:Glucose concentration [Laboratory Procedure]
   840   C1287281:Glucose concentration [Laboratory or Test Result]
   804   C0086045:Concentration [Mental Process]
   804   C1446561:Concentration [Quantitative Concept]
   733 E C1880165:Concentrated [Biomedical or Dental Material]
Processing 00000000.tx.54: Protocol 2: is the increase in fasting plasma glucose with age greater in Alzheimer disease? 

Phrase: "Protocol 2"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0442711:Protocol [Intellectual Product]
   861   C1507394:Protocol [Intellectual Product]
   861   C1522729:Protocol [Intellectual Product]
   861   C2348563:Protocol [Intellectual Product]

Phrase: ":"

Phrase: "is"

Phrase: "the increase in fasting plasma glucose"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0442805:Increase [Functional Concept]

Phrase: "with age"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001779:Age [Organism Attribute]

Phrase: "greater in Alzheimer disease?"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C0443228:greater [Quantitative Concept]
   770   C1704243:Greater [Quantitative Concept]
   737 E C0549177:Great [Quantitative Concept]
Processing 00000000.tx.55: We also examined the changes in fasting plasma glucose (FPG) with aging in this cohort of patients. 

Phrase: "We also"

Phrase: "examined"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332128:Examined [Finding]

Phrase: "the changes in fasting plasma glucose (FPG)"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   773   C0025320:The change [Physiologic Function]
   753   C0392747:changes [Functional Concept]
   753   C0443172:changes [Quantitative Concept]
   719 E C1705241:Change [Quantitative Concept]

Phrase: "with aging"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001811:Ageing [Organism Function]

Phrase: "in this cohort"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0599755:Cohort [Population Group]

Phrase: "of patients."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030705:Patients [Patient or Disabled Group]
Processing 00000000.tx.56: For each subject, we regressed the annual median FPG value against age. 

Phrase: "For each subject,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0681850:Subject [Group]
  1000   C1550501:{Subject} [Idea or Concept]
  1000   C1706203:Subject [Idea or Concept]
  1000   C2349001:Subject [Human]
  1000   C2697811:Subject [Functional Concept]

Phrase: "we"

Phrase: "regressed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   928   C0700186:Involuted [Qualitative Concept]
   907 E C0684320:Regressing [Pathologic Function]

Phrase: "the annual median FPG value against age."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C1522609:Value [Quantitative Concept]
Processing 00000000.tx.57: This was used to obtain a predicted FPG value for each subject at each decade and also to compare the slopes of the regression lines between groups (Alzheimer disease versus control subjects), using a two-sided rank sum test. 

Phrase: "This"

Phrase: "was"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "obtain"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
  1000   C1301820:Obtain [Functional Concept]
  1000   C1706701:Obtain [Activity]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442805:Increase [Functional Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "a predicted FPG value for each subject"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C1522609:Value [Quantitative Concept]

Phrase: "at each decade"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2981279:Decade [Quantitative Concept]

Phrase: "and"

Phrase: "also to"

Phrase: "compare"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707455:Compare [Activity]

Phrase: "the slopes of the regression lines"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0807955:slopes [Quantitative Concept]

Phrase: "between groups"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0441833:Group [Idea or Concept]
  1000   C0687744:group [Population Group]
  1000   C1257890:Group [Population Group]
  1000   C1552516:Group [Health Care Related Organization]
  1000   C1552839:groups [Idea or Concept]
  1000   C1705428:Group [Conceptual Entity]
  1000   C1705429:Group [Population Group]

Phrase: "(Alzheimer disease"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "versus"

Phrase: "control subjects"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   861   C0243148:control [Qualitative Concept]
   861   C1550141:Control [Substance]
   861   C1882979:Control [Conceptual Entity]
   861   C2587213:Control [Functional Concept]
   861   C3274648:Control [Qualitative Concept]
   827   C0681850:Subject [Group]
   827   C1550501:{Subject} [Idea or Concept]
   827   C1706203:Subject [Idea or Concept]
   827   C2349001:Subject [Human]
   827   C2697811:Subject [Functional Concept]

Phrase: ")"

Phrase: ","

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a two-sided rank sum test."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   911   C1883413:2-Sided Test [Research Activity]
   884   C0242928:Test, Rank-Sum [Quantitative Concept]
   804   C0022885:Test [Laboratory Procedure]
   804   C0039593:Test [Functional Concept]
   804   C0392366:test [Intellectual Product]
   804   C0699794:Rank [Intellectual Product]
   804   C1515051:Sum [Quantitative Concept]
Processing 00000000.tx.58: To be included in this analysis, patients were required to have FPG values recorded that spanned at least 10 consecutive years from age 50 or greater and at least one value available for each calendar year. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "included in this analysis,"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   770   C0002778:Analysis [Laboratory Procedure]
   770   C0332257:included [Functional Concept]
   770   C0936012:Analysis [Research Activity]
   770   C1524024:analysis [Functional Concept]
   770   C3538986:INCLUDED [Gene or Genome]
   737 E C1552866:include [Idea or Concept]
   737 E C2700399:Include [Activity]

Phrase: "patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030705:Patients [Patient or Disabled Group]

Phrase: "were"

Phrase: "required"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1514873:Required [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "have"

Phrase: "FPG values"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C0042295:Values [Qualitative Concept]
   779 E C1522609:Value [Quantitative Concept]

Phrase: "recorded"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0034869:Record [Intellectual Product]

Phrase: "that"

Phrase: "spanned at least 10 consecutive years"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   753   C0439234:years [Temporal Concept]
   753   C1707491:Consecutive [Qualitative Concept]
   719 E C0439508:/year [Temporal Concept]
   719   C1711300:Span [Conceptual Entity]
   719   C2700613:Span [Quantitative Concept]

Phrase: "from age 50"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0001779:Age [Organism Attribute]

Phrase: "or"

Phrase: "greater"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0443228:greater [Quantitative Concept]
  1000   C1704243:Greater [Quantitative Concept]
   966 E C0549177:Great [Quantitative Concept]

Phrase: "and at least one value"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0205447:One [Quantitative Concept]
   760   C1515981:And [Idea or Concept]
   760   C1522609:Value [Quantitative Concept]

Phrase: "available for each calendar year."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0470187:Available [Functional Concept]
Processing 00000000.tx.59: Ages of 50 years only were considered. 

Phrase: "Ages of 50 years only"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   797   C1510829:Age-Years [Temporal Concept]
   760   C0001779:Age [Organism Attribute]

Phrase: "were"

Phrase: "considered."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0750591:considered [Idea or Concept]
Processing 00000000.tx.60: These criteria resulted in a study population of 52 patients with Alzheimer disease and 105 non-Alzheimer disease control subjects. 

Phrase: "These criteria"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0243161:criteria [Intellectual Product]

Phrase: "resulted in a study population of 52 patients"
Meta Candidates (Total=11; Excluded=1; Pruned=0; Remaining=10)
   770   C2348561:Study Population [Population Group]
   767 E C0681876:Population Study [Research Activity]
   750   C0683954:result study [Finding]
   744   C0030705:Patients [Patient or Disabled Group]
   744   C0032659:Population [Quantitative Concept]
   744   C0557651:Study [Manufactured Object]
   744   C1257890:Population [Population Group]
   744   C2603343:Study [Research Activity]
   711   C1274040:Result [Functional Concept]
   711   C1546471:Result [Idea or Concept]
   711   C2825142:Result [Finding]

Phrase: "with Alzheimer disease"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "and"

Phrase: "105 non-Alzheimer disease control subjects."
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   827   C0920467:disease control [Therapeutic or Preventive Procedure]
   799   C0243148:control [Qualitative Concept]
   799   C1550141:Control [Substance]
   799   C1882979:Control [Conceptual Entity]
   799   C2587213:Control [Functional Concept]
   799   C3274648:Control [Qualitative Concept]
   766   C0681850:Subject [Group]
   766   C1550501:{Subject} [Idea or Concept]
   766   C1706203:Subject [Idea or Concept]
   766   C2349001:Subject [Human]
   766   C2697811:Subject [Functional Concept]
Processing 00000000.tx.61: Pathology studies Case recruitment. 

Phrase: "Pathology"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0030664:Pathology [Biomedical Occupation or Discipline]
  1000   C0205469:pathology [Functional Concept]
  1000   C0677042:pathology [Pathologic Function]
   928 E C1521733:Pathologic [Functional Concept]

Phrase: "studies"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557651:Study [Manufactured Object]
  1000   C0947630:studies [Laboratory Procedure]
  1000   C2603343:Study [Research Activity]

Phrase: "Case recruitment."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2949735:Recruitment [Activity]
Processing 00000000.tx.62: Alzheimer disease patients (group 1) and control subjects (non-Alzheimer disease; group 2) had been enrolled in the Mayo Clinic ADPR study during life (33). 

Phrase: "Alzheimer disease patients"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0030705:Patients [Patient or Disabled Group]
   734   C0002395:Alzheimer's Disease [Disease or Syndrome]
   734   C1521724:Alzheimer's Disease [Pathologic Function]

Phrase: "(group 1"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0441861:Group 1 [Intellectual Product]
   861   C0441833:Group [Idea or Concept]
   861   C0687744:group [Population Group]
   861   C1257890:Group [Population Group]
   861   C1552516:Group [Health Care Related Organization]
   861   C1705428:Group [Conceptual Entity]
   861   C1705429:Group [Population Group]

Phrase: ")"

Phrase: "and"

Phrase: "control subjects"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   861   C0243148:control [Qualitative Concept]
   861   C1550141:Control [Substance]
   861   C1882979:Control [Conceptual Entity]
   861   C2587213:Control [Functional Concept]
   861   C3274648:Control [Qualitative Concept]
   827   C0681850:Subject [Group]
   827   C1550501:{Subject} [Idea or Concept]
   827   C1706203:Subject [Idea or Concept]
   827   C2349001:Subject [Human]
   827   C2697811:Subject [Functional Concept]

Phrase: "(non-Alzheimer disease"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   901   C0002395:Alzheimer's Disease [Disease or Syndrome]
   901   C1521724:Alzheimer's Disease [Pathologic Function]
   827   C0012634:Disease [Disease or Syndrome]
   827   C1518422:Non [Functional Concept]
   771 E C1836721:MALS [Finding]
   771 E C3538764:MALS [Gene or Genome]
   771 E C3540595:MAL [Gene or Genome]

Phrase: "; group 2"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0441865:Group 2 [Intellectual Product]
   861   C0441833:Group [Idea or Concept]
   861   C0687744:group [Population Group]
   861   C1257890:Group [Population Group]
   861   C1552516:Group [Health Care Related Organization]
   861   C1705428:Group [Conceptual Entity]
   861   C1705429:Group [Population Group]

Phrase: ")"

Phrase: "had"

Phrase: "been"

Phrase: "enrolled in the Mayo Clinic ADPR study"
Meta Candidates (Total=16; Excluded=0; Pruned=0; Remaining=16)
   775   C0597185:patient/disease registry [Intellectual Product]
   760   C0002395:Alzheimer's Disease [Disease or Syndrome]
   760   C0920631:patient registry [Intellectual Product]
   760   C1521724:Alzheimer's Disease [Pathologic Function]
   757   C0920465:disease registry [Intellectual Product]
   757   C2985664:Study Registry [Organization]
   739   C0002424:Clinic [Health Care Related Organization,Manufactured Object]
   739   C0012634:Disease [Disease or Syndrome]
   739   C0030705:*^patient [Patient or Disabled Group]
   739   C0034975:Registry [Intellectual Product]
   739   C0442592:Clinic [Health Care Related Organization,Manufactured Object]
   739   C0454788:Mayo [Geographic Area]
   739   C0557651:Study [Manufactured Object]
   739   C1077578:mayo [Plant]
   739   C2603343:Study [Research Activity]
   722   C0008972:Clinical Study [Research Activity]

Phrase: "during life"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0376558:Life [Idea or Concept]
   916 E C0595998:lives [Finding]

Phrase: "(33"

Phrase: ")."
Processing 00000000.tx.63: At death, non-Alzheimer disease and Alzheimer disease cases had an autopsy examination of the brain and the diagnosis of Alzheimer disease (or its absence) was confirmed using CERAD (Consortium to Establish a Registry for Alzheimer Disease) criteria (34). 

Phrase: "At death,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0011065:Death [Organism Function]
  1000   C1306577:Death, NOS [Finding]

Phrase: "non-Alzheimer disease"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   901   C0002395:Alzheimer's Disease [Disease or Syndrome]
   901   C1521724:Alzheimer's Disease [Pathologic Function]
   827   C0012634:Disease [Disease or Syndrome]
   827   C1518422:Non [Functional Concept]
   771 E C1836721:MALS [Finding]
   771 E C3538764:MALS [Gene or Genome]
   771 E C3540595:MAL [Gene or Genome]

Phrase: "and"

Phrase: "Alzheimer disease cases"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   827   C0868928:Cases [Functional Concept]
   827   C1533148:Cases [Quantitative Concept]
   793 E C1706255:CASE [Medical Device]
   793 E C1706256:Case [Conceptual Entity]
   734   C0002395:Alzheimer's Disease [Disease or Syndrome]
   734   C1521724:Alzheimer's Disease [Pathologic Function]

Phrase: "had"

Phrase: "an autopsy examination of the brain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0004398:Autopsy examination [Diagnostic Procedure]
   783   C0555351:Brain examination [Diagnostic Procedure]

Phrase: "and"

Phrase: "the diagnosis of Alzheimer disease"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0011900:Diagnosis [Finding]
   760   C1704338:diagnosis [Qualitative Concept]
   760   C1704656:DIAGNOSIS [Research Activity]

Phrase: "("

Phrase: "or"

Phrase: "its absence"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0332197:absence [Quantitative Concept]
  1000   C1689985:Absence [Anatomical Abnormality]
   928 E C2699517:ABSENT [Finding]

Phrase: ")"

Phrase: "was"

Phrase: "confirmed"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0521093:confirmed [Qualitative Concept]
  1000   C0750484:Confirmed [Idea or Concept]
   966 E C1456348:Confirm [Qualitative Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "CERAD"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   812   C0002395:Alzheimer's Disease [Disease or Syndrome]
   812   C1521724:Alzheimer's Disease [Pathologic Function]
   793   C0012634:Disease [Disease or Syndrome]
   793   C0034975:Registry [Intellectual Product]
   793   C0443211:establish [Qualitative Concept]
   793   C1513822:Consortium [Professional or Occupational Group]
   793   C1880171:Consortium [Professional or Occupational Group]
   737 E C1836721:MALS [Finding]
   737 E C3538764:MALS [Gene or Genome]
   737 E C3540595:MAL [Gene or Genome]

Phrase: "(Consortium to Establish a Registry for Alzheimer Disease) criteria"
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
   807   C0002395:Alzheimer's Disease [Disease or Syndrome]
   807   C1521724:Alzheimer's Disease [Pathologic Function]
   791   C0012634:Disease [Disease or Syndrome]
   791   C0034975:Registry [Intellectual Product]
   791   C0243161:criteria [Intellectual Product]
   791   C0443211:establish [Qualitative Concept]
   791   C1513822:Consortium [Professional or Occupational Group]
   791   C1880171:Consortium [Professional or Occupational Group]
   735 E C1836721:MALS [Finding]
   735 E C3538764:MALS [Gene or Genome]
   735 E C3540595:MAL [Gene or Genome]

Phrase: "(34"

Phrase: ")."
Processing 00000000.tx.64: In the pathology study, we include 1) only cases with clinically and pathologically confirmed Alzheimer disease or non-Alzheimer disease, 2) cases with an autopsy including both brain and pancreas, and 3) cases with FPG documented at the Mayo Clinic within 2 years (Alzheimer disease 100%, non-Alzheimer disease 100%) and in most cases 1 year (non-Alzheimer disease 100%, Alzheimer disease 89% of complete autopsies) of death. 

Phrase: "In the pathology study,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0551718:Pathology study [Clinical Attribute]
   861   C0557651:Study [Manufactured Object]
   861   C2603343:Study [Research Activity]

Phrase: "we"

Phrase: "include"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0332257:include [Functional Concept]
  1000   C1552866:include [Idea or Concept]
  1000   C2700399:Include [Activity]

Phrase: "1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ")"

Phrase: "only cases with clinically"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   770   C0868928:Cases [Functional Concept]
   770   C1533148:Cases [Quantitative Concept]
   737 E C1706255:CASE [Medical Device]
   737 E C1706256:Case [Conceptual Entity]

Phrase: "and"

Phrase: "pathologically confirmed Alzheimer disease"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   861   C0002395:Alzheimer's Disease [Disease or Syndrome]
   861   C1521724:Alzheimer's Disease [Pathologic Function]
   812   C0012634:Disease [Disease or Syndrome]
   756 E C1836721:MALS [Finding]
   756 E C3538764:MALS [Gene or Genome]
   756 E C3540595:MAL [Gene or Genome]

Phrase: "or"

Phrase: "non-Alzheimer disease, 2"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   923   C1863051:ALZHEIMER DISEASE 2 [Disease or Syndrome]
   861   C0002395:Alzheimer's Disease [Disease or Syndrome]
   861   C1521724:Alzheimer's Disease [Pathologic Function]
   833   C1425076:MALS-2 [Gene or Genome]
   812   C0012634:Disease [Disease or Syndrome]
   812   C1518422:Non [Functional Concept]
   756 E C1836721:MALS [Finding]
   756 E C3538764:MALS [Gene or Genome]
   756 E C3540595:MAL [Gene or Genome]

Phrase: ")"

Phrase: "cases with an autopsy"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   770   C0868928:Cases [Functional Concept]
   770   C1533148:Cases [Quantitative Concept]
   737 E C1706255:CASE [Medical Device]
   737 E C1706256:Case [Conceptual Entity]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "both brain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0006104:Brain [Body Part, Organ, or Organ Component]
  1000   C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "and"

Phrase: "pancreas,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0030274:Pancreas [Body Part, Organ, or Organ Component]
  1000   C1278931:Pancreas [Body Part, Organ, or Organ Component]

Phrase: "and"

Phrase: "3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: ")"

Phrase: "cases with FPG"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   760   C0868928:Cases [Functional Concept]
   760   C1533148:Cases [Quantitative Concept]
   726 E C1706255:CASE [Medical Device]
   726 E C1706256:Case [Conceptual Entity]

Phrase: "documented at the Mayo Clinic"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   760   C0002424:Clinic [Health Care Related Organization,Manufactured Object]
   760   C0442592:Clinic [Health Care Related Organization,Manufactured Object]
   760   C0454788:Mayo [Geographic Area]
   760   C1077578:mayo [Plant]
   760   C1301725:Documented [Health Care Activity]
   760   C1609436:documented [Idea or Concept]
   745   C1828480:Clinical document [Intellectual Product]
   726 E C1301746:document [Intellectual Product]
   726 E C1547673:Document [Intellectual Product]

Phrase: "within 2 years"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0439234:years [Temporal Concept]
   827 E C0439508:/year [Temporal Concept]

Phrase: "(Alzheimer disease 100%,"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   901   C0002395:Alzheimer's Disease [Disease or Syndrome]
   901   C1521724:Alzheimer's Disease [Pathologic Function]
   827   C0012634:Disease [Disease or Syndrome]
   771 E C1836721:MALS [Finding]
   771 E C3538764:MALS [Gene or Genome]
   771 E C3540595:MAL [Gene or Genome]

Phrase: "non-Alzheimer disease 100%"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   861   C0002395:Alzheimer's Disease [Disease or Syndrome]
   861   C1521724:Alzheimer's Disease [Pathologic Function]
   812   C0012634:Disease [Disease or Syndrome]
   812   C1518422:Non [Functional Concept]
   756 E C1836721:MALS [Finding]
   756 E C3538764:MALS [Gene or Genome]
   756 E C3540595:MAL [Gene or Genome]

Phrase: ")"

Phrase: "and in most cases 1 year"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   753   C0439234:year [Temporal Concept]
   753   C0439508:/year [Temporal Concept]
   753   C0868928:Cases [Functional Concept]
   753   C1515981:And [Idea or Concept]
   753   C1533148:Cases [Quantitative Concept]
   719 E C1706255:CASE [Medical Device]
   719 E C1706256:Case [Conceptual Entity]

Phrase: "(non-Alzheimer disease 100%,"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   861   C0002395:Alzheimer's Disease [Disease or Syndrome]
   861   C1521724:Alzheimer's Disease [Pathologic Function]
   812   C0012634:Disease [Disease or Syndrome]
   812   C1518422:Non [Functional Concept]
   756 E C1836721:MALS [Finding]
   756 E C3538764:MALS [Gene or Genome]
   756 E C3540595:MAL [Gene or Genome]

Phrase: "Alzheimer disease 89% of complete autopsies"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0002395:Alzheimer's Disease [Disease or Syndrome]
   790   C1521724:Alzheimer's Disease [Pathologic Function]
   753   C0004398:Autopsies [Diagnostic Procedure]
   753   C0012634:Disease [Disease or Syndrome]
   753   C0205197:Complete [Qualitative Concept]
   753   C0725685:COMPLEAT [Food]

Phrase: ")"

Phrase: "of death."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0011065:Death [Organism Function]
  1000   C1306577:Death, NOS [Finding]
Processing 00000000.tx.65: A mean FPG value for each subject was the mean of at least two independent measurements. 

Phrase: "A mean FPG value for each subject"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   781   C0552468:Glucose mean value [Laboratory Procedure]
   742   C1522609:Value [Quantitative Concept]

Phrase: "was"

Phrase: "the mean of"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0444504:Mean [Quantitative Concept]
   790   C2347634:Mean [Quantitative Concept]
   790   C2348143:Mean [Quantitative Concept]

Phrase: "at least two independent measurements."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0242485:measurements [Functional Concept]
Processing 00000000.tx.66: Alzheimer disease patients were sex- and age-matched with control subjects during life as per the Mayo Clinic ADPR study and were still matched for age at death (84  8 vs. 85  4 years, Alzheimer disease vs. non-Alzheimer disease; P = 0.7). 

Phrase: "Alzheimer disease patients"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0030705:Patients [Patient or Disabled Group]
   734   C0002395:Alzheimer's Disease [Disease or Syndrome]
   734   C1521724:Alzheimer's Disease [Pathologic Function]

Phrase: "were"

Phrase: "sex-"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0009253:Sex [Organism Function]
  1000   C0036864:Sex [Behavior]
  1000   C0079399:sex [Organism Attribute]
  1000   C1314687:Sex [Finding]
  1000   C1522384:sex [Organism Attribute]

Phrase: "and"

Phrase: "age-matched with control subjects"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   781   C2348575:Subject Age [Organism Attribute]
   760   C0001779:Age [Organism Attribute]
   760   C0150103:matched [Research Activity]
   760   C1708943:Matched [Qualitative Concept]

Phrase: "during life"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0376558:Life [Idea or Concept]
   916 E C0595998:lives [Finding]

Phrase: "as"

Phrase: "per the Mayo Clinic ADPR study"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   841   C0008972:Clinical Study [Research Activity]
   795   C0557651:Study [Manufactured Object]
   795   C2603343:Study [Research Activity]

Phrase: "and"

Phrase: "were"

Phrase: "still"

Phrase: "matched for age"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0001779:Age [Organism Attribute]
   790   C0150103:matched [Research Activity]
   790   C1708943:Matched [Qualitative Concept]

Phrase: "at death"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0011065:Death [Organism Function]
  1000   C1306577:Death, NOS [Finding]

Phrase: "(84  8"

Phrase: "vs. 85  4 years,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0439234:years [Temporal Concept]
   793 E C0439508:/year [Temporal Concept]

Phrase: "Alzheimer disease"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "vs. non-Alzheimer disease"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   901   C0002395:Alzheimer's Disease [Disease or Syndrome]
   901   C1521724:Alzheimer's Disease [Pathologic Function]
   827   C0012634:Disease [Disease or Syndrome]
   827   C1518422:Non [Functional Concept]
   771 E C1836721:MALS [Finding]
   771 E C3538764:MALS [Gene or Genome]
   771 E C3540595:MAL [Gene or Genome]

Phrase: "; P = 0.7"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")."
Processing 00000000.tx.67: Alzheimer disease was diagnosed 5.5  2.4 (range 1.39.9) years before death. 

Phrase: "Alzheimer disease"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "was"

Phrase: "diagnosed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0011900:Diagnosed [Finding]

Phrase: "5.5  2.4"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0450380:5/5 [Quantitative Concept]
   812   C0439084:>5 [Quantitative Concept]
   812   C0728893:+5 [Quantitative Concept]

Phrase: "(range 1.39.9"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C1514721:Range [Quantitative Concept]
   812   C2348147:Range [Quantitative Concept]
   812   C3542016:Range [Intellectual Product]

Phrase: ")"

Phrase: "years before death."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C0439234:years [Temporal Concept]
   756 E C0439508:/year [Temporal Concept]
Processing 00000000.tx.68: Type 2 diabetes cases (group 3; FPG >126 mg/dl) were identified via Mayo Clinic autopsy records. 

Phrase: "Type 2 diabetes cases"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   812   C0868928:Cases [Functional Concept]
   812   C1533148:Cases [Quantitative Concept]
   779 E C1706255:CASE [Medical Device]
   779 E C1706256:Case [Conceptual Entity]
   756   C0011860:Type 2 Diabetes [Disease or Syndrome]
   708   C1320657:type diabetes [Finding]

Phrase: "(group 3"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0441869:Group 3 [Intellectual Product]
   861   C0441833:Group [Idea or Concept]
   861   C0687744:group [Population Group]
   861   C1257890:Group [Population Group]
   861   C1552516:Group [Health Care Related Organization]
   861   C1705428:Group [Conceptual Entity]
   861   C1705429:Group [Population Group]

Phrase: "; FPG"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   901   C0202042:Plasma glucose [Laboratory Procedure]
   901   C0455280:plasma glucose [Laboratory or Test Result]
   827   C0015663:Fasting [Finding]
   827   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   827   C0032105:Plasma [Body Substance]
   827   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]
   827   C1550565:fasting [Intellectual Product]
   793 E C0456962:Fast [Qualitative Concept]

Phrase: ">126 mg/"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0439269:mg% [Quantitative Concept]
   861   C1960952:mg % [Quantitative Concept]
   861   C2346927:Mg++ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "dl)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642216:/dL [Quantitative Concept]

Phrase: "were"

Phrase: "identified via Mayo Clinic autopsy records."
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   753   C0002424:Clinic [Health Care Related Organization,Manufactured Object]
   753   C0004398:Autopsy [Diagnostic Procedure]
   753   C0034869:Records [Intellectual Product]
   753   C0205396:Identified [Qualitative Concept]
   753   C0442592:Clinic [Health Care Related Organization,Manufactured Object]
   753   C0454788:Mayo [Geographic Area]
   753   C1077578:mayo [Plant]
   753   C1548330:Records [Idea or Concept]
   753   C1550043:Identified [Finding]
   753   C1551388:Identified [Functional Concept]
   753   C1553414:Records [Qualitative Concept]
Processing 00000000.tx.69: For inclusion they 1) had died in the 6 years preceding this study, 2) were also from Olmsted County, 3) had an autopsy including both brain and pancreas, and 4) had had a general medical examination performed including an FPG at Mayo Clinic during the year before death. 

Phrase: "For inclusion"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1512693:Inclusion [Qualitative Concept]

Phrase: "they 1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ")"

Phrase: "had"

Phrase: "died in the 6 years"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   760   C0011065:Died [Organism Function]
   760   C0439234:years [Temporal Concept]
   760   C1546956:Died [Finding]
   726 E C0439508:/year [Temporal Concept]

Phrase: "preceding"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332152:Preceding [Temporal Concept]

Phrase: "this study,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]

Phrase: "2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: ")"

Phrase: "were"

Phrase: "also from Olmsted County,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0079170:County [Geographic Area]

Phrase: "3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: ")"

Phrase: "had"

Phrase: "an autopsy"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0004398:Autopsy [Diagnostic Procedure]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "both brain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0006104:Brain [Body Part, Organ, or Organ Component]
  1000   C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "and"

Phrase: "pancreas,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0030274:Pancreas [Body Part, Organ, or Organ Component]
  1000   C1278931:Pancreas [Body Part, Organ, or Organ Component]

Phrase: "and"

Phrase: "4"

Phrase: ")"

Phrase: "had"

Phrase: "had"

Phrase: "a general medical examination"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0260860:General medical examination [Finding]
   901   C0582103:Medical Examination [Health Care Activity]

Phrase: "performed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "an FPG at Mayo Clinic"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   778   C0202042:Plasma glucose [Laboratory Procedure]
   778   C0455280:plasma glucose [Laboratory or Test Result]
   748   C0015663:Fasting [Finding]
   748   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   748   C0032105:Plasma [Body Substance]
   748   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]
   748   C1550565:fasting [Intellectual Product]
   714 E C0456962:Fast [Qualitative Concept]

Phrase: "during the year"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439234:year [Temporal Concept]
  1000   C0439508:/year [Temporal Concept]

Phrase: "before death."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0011065:Death [Organism Function]
  1000   C1306577:Death, NOS [Finding]
Processing 00000000.tx.70: Exclusion criteria included inadequate preservation of pancreatic tissue for anatomic study, type 1 diabetes, or secondary causes of diabetes. 

Phrase: "Exclusion criteria"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0680251:Exclusion Criteria [Functional Concept]
   861   C0243161:criteria [Intellectual Product]

Phrase: "included"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0332257:included [Functional Concept]
  1000   C3538986:INCLUDED [Gene or Genome]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "inadequate preservation of pancreatic tissue"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   797   C0040295:Tissue Preservation [Therapeutic or Preventive Procedure]
   760   C0033085:Preservation [Laboratory Procedure]
   760   C1514402:Preservation [Laboratory Procedure]

Phrase: "for anatomic study,"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   861   C0220784:anatomic [Qualitative Concept]
   861   C0557651:Study [Manufactured Object]
   861   C2603343:Study [Research Activity]
   789 E C0002808:Anatomies [Biomedical Occupation or Discipline]
   789 E C0700276:anatomy [Anatomical Structure]
   789 E C1384516:anatomy [Qualitative Concept]

Phrase: "type 1 diabetes,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0011854:Type 1 diabetes [Disease or Syndrome]
   913   C1320657:type diabetes [Finding]
   901   C0441729:Type 1 [Classification]
   827   C0011847:Diabetes [Disease or Syndrome]
   827   C0011849:Diabetes [Disease or Syndrome]
   827   C0332307:Type [Qualitative Concept]
   827   C1547052:*Type [Quantitative Concept]

Phrase: "or"

Phrase: "secondary causes of diabetes."
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   770   C0015127:causes [Functional Concept]
   770   C0027627:secondary [Neoplastic Process]
   770   C0175668:Secondary [Temporal Concept]
   770   C0205436:Secondary [Quantitative Concept]
   770   C1314792:Causes [Functional Concept]
   737 E C1524003:Cause [Conceptual Entity]
Processing 00000000.tx.71: Diagnosis of diabetes in this cohort was 12  9 years before death. 

Phrase: "Diagnosis of diabetes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0011900:Diagnosis [Finding]
   790   C1704338:diagnosis [Qualitative Concept]
   790   C1704656:DIAGNOSIS [Research Activity]

Phrase: "in this cohort"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0599755:Cohort [Population Group]

Phrase: "was"

Phrase: "12  9 years before death."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C0439234:years [Temporal Concept]
   726 E C0439508:/year [Temporal Concept]
Processing 00000000.tx.72: These selection criteria yielded 35 cases, but the mean age at death was younger in type 2 diabetes than the in Alzheimer disease cases (73  8 vs. 84  8 years; P < 0.001). 

Phrase: "These selection criteria"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0242801:Selection Criteria [Qualitative Concept]
   861   C0243161:criteria [Intellectual Product]

Phrase: "yielded"

Phrase: "35 cases,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0868928:Cases [Functional Concept]
   861   C1533148:Cases [Quantitative Concept]
   827 E C1706255:CASE [Medical Device]
   827 E C1706256:Case [Conceptual Entity]

Phrase: "but"

Phrase: "the mean age at death"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   862   C1543138:Age at death [Clinical Attribute]
   862   C1546180:Age at death [Clinical Attribute]
   797   C0742983:age death [Finding]
   760   C0001779:Age [Organism Attribute]

Phrase: "was"

Phrase: "younger in type 2 diabetes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   726   C0332239:Young [Temporal Concept]

Phrase: "than the in Alzheimer disease cases"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   812   C0868928:Cases [Functional Concept]
   812   C1533148:Cases [Quantitative Concept]
   779 E C1706255:CASE [Medical Device]
   779 E C1706256:Case [Conceptual Entity]

Phrase: "(73  8"

Phrase: "vs. 84  8 years"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0439234:years [Temporal Concept]
   793 E C0439508:/year [Temporal Concept]

Phrase: "; P < 0.001"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")."
Processing 00000000.tx.73: Therefore, identified from the Mayo Clinic autopsy records was an additional control group consisting of 21 cases (group 4) who were age, BMI, and sex matched with type 2 diabetic patients, had a normal FPG documented within 1 year before death, and were also meeting criteria 14 as for group 3. 

Phrase: "Therefore,"

Phrase: "identified from the Mayo Clinic autopsy records"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   748   C0002424:Clinic [Health Care Related Organization,Manufactured Object]
   748   C0004398:Autopsy [Diagnostic Procedure]
   748   C0034869:Records [Intellectual Product]
   748   C0205396:Identified [Qualitative Concept]
   748   C0442592:Clinic [Health Care Related Organization,Manufactured Object]
   748   C0454788:Mayo [Geographic Area]
   748   C1077578:mayo [Plant]
   748   C1548330:Records [Idea or Concept]
   748   C1550043:Identified [Finding]
   748   C1551388:Identified [Functional Concept]
   748   C1553414:Records [Qualitative Concept]

Phrase: "was"

Phrase: "an additional control group"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   901   C0009932:Control Group [Group]
   827   C0243148:control [Qualitative Concept]
   827   C0441833:Group [Idea or Concept]
   827   C0687744:group [Population Group]
   827   C1257890:Group [Population Group]
   827   C1550141:Control [Substance]
   827   C1552516:Group [Health Care Related Organization]
   827   C1705428:Group [Conceptual Entity]
   827   C1705429:Group [Population Group]
   827   C1882979:Control [Conceptual Entity]
   827   C2587213:Control [Functional Concept]
   827   C3274648:Control [Qualitative Concept]

Phrase: "consisting of 21 cases"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   770   C0868928:Cases [Functional Concept]
   770   C1533148:Cases [Quantitative Concept]
   737   C0332529:CONSIST [Qualitative Concept]
   737 E C1706255:CASE [Medical Device]
   737 E C1706256:Case [Conceptual Entity]

Phrase: "(group 4"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0441876:Group 4 [Intellectual Product]
   861   C0441833:Group [Idea or Concept]
   861   C0687744:group [Population Group]
   861   C1257890:Group [Population Group]
   861   C1552516:Group [Health Care Related Organization]
   861   C1705428:Group [Conceptual Entity]
   861   C1705429:Group [Population Group]

Phrase: ")"

Phrase: "who"

Phrase: "were"

Phrase: "age,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001779:Age [Organism Attribute]

Phrase: "BMI,"

Phrase: "and"

Phrase: "sex matched with type 2 diabetic patients,"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   774   C0150831:patients sex [Organism Attribute]
   748   C0009253:Sex [Organism Function]
   748   C0036864:Sex [Behavior]
   748   C0079399:sex [Organism Attribute]
   748   C0150103:matched [Research Activity]
   748   C1314687:Sex [Finding]
   748   C1522384:sex [Organism Attribute]
   748   C1708943:Matched [Qualitative Concept]

Phrase: "had"

Phrase: "a normal FPG"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   902   C0860800:normal glucose [Finding]
   875   C0440742:Normal plasma [Body Substance]
   861   C0202042:Plasma glucose [Laboratory Procedure]
   861   C0455280:plasma glucose [Laboratory or Test Result]
   812   C0015663:Fasting [Finding]
   812   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   812   C0032105:Plasma [Body Substance]
   812   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]
   812   C1550565:fasting [Intellectual Product]
   779 E C0456962:Fast [Qualitative Concept]

Phrase: "documented within 1 year"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   770   C0439234:year [Temporal Concept]
   770   C0439508:/year [Temporal Concept]
   770   C1301725:Documented [Health Care Activity]
   770   C1609436:documented [Idea or Concept]
   737 E C1301746:document [Intellectual Product]
   737 E C1547673:Document [Intellectual Product]

Phrase: "before death,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0011065:Death [Organism Function]
  1000   C1306577:Death, NOS [Finding]

Phrase: "and"

Phrase: "were"

Phrase: "also meeting criteria 14 as for group 3."
Meta Candidates (Total=11; Excluded=1; Pruned=0; Remaining=10)
   770   C0441869:Group 3 [Intellectual Product]
   767   C0018261:Meeting, Group [Social Behavior]
   744   C0243161:criteria [Intellectual Product]
   744   C0441833:Group [Idea or Concept]
   744   C0556656:Meeting [Health Care Activity]
   744   C0687744:group [Population Group]
   744   C1257890:Group [Population Group]
   744   C1552516:Group [Health Care Related Organization]
   744   C1705428:Group [Conceptual Entity]
   744   C1705429:Group [Population Group]
   711 E C1550543:Meet [Idea or Concept]
Processing 00000000.tx.74: Groups 3 and 4 were included haphazardly (i.e., not consciously biased) with respect to the presence or absence of Alzheimer disease. 

Phrase: "Groups"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0441833:Group [Idea or Concept]
  1000   C0687744:group [Population Group]
  1000   C1257890:Group [Population Group]
  1000   C1552516:Group [Health Care Related Organization]
  1000   C1552839:groups [Idea or Concept]
  1000   C1705428:Group [Conceptual Entity]
  1000   C1705429:Group [Population Group]

Phrase: "3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "and"

Phrase: "4"

Phrase: "were"

Phrase: "included"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0332257:included [Functional Concept]
  1000   C3538986:INCLUDED [Gene or Genome]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "haphazardly"

Phrase: "(i.e.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0683454:I-E [Diagnostic Procedure,Intellectual Product]
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "not consciously"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1518422:Not [Functional Concept]

Phrase: "biased"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0242568:Biased [Idea or Concept]
   966 E C1504315:Bias [Bird]

Phrase: ")"

Phrase: "with respect to the presence"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392148:Presence [Therapeutic or Preventive Procedure]
   928 E C0150312:Present [Quantitative Concept]
   928 E C0449450:Present [Idea or Concept]

Phrase: "or"

Phrase: "absence of Alzheimer disease."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0332197:absence [Quantitative Concept]
   770   C1689985:Absence [Anatomical Abnormality]
Processing 00000000.tx.75: The characteristics of each of these four study groups are summarized in Table 2. 

Phrase: "The characteristics of each of these four study groups"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   762   C1568011:Study Characteristics [Intellectual Product]
   742   C1521970:Characteristics [Qualitative Concept]

Phrase: "are"

Phrase: "summarized in Table 2."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0039224:Table [Manufactured Object]
   770   C1706073:Table [Medical Device]
   770   C1706074:Table [Intellectual Product]
Processing 00000000.tx.76: View this table: [in this window] [in a new window]  TABLE 2 Study cases: pathology  Protocol 3: is islet amyloid increased in patients with Alzheimer disease? 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "this table"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0039224:Table [Manufactured Object]
  1000   C1706073:Table [Medical Device]
  1000   C1706074:Table [Intellectual Product]

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  TABLE 2 Study cases"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   812   C0868928:Cases [Functional Concept]
   812   C1533148:Cases [Quantitative Concept]
   779 E C1706255:CASE [Medical Device]
   779 E C1706256:Case [Conceptual Entity]

Phrase: ":"

Phrase: "pathology  Protocol 3"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   827   C0030664:Pathology [Biomedical Occupation or Discipline]
   827   C0205469:pathology [Functional Concept]
   827   C0442711:Protocol [Intellectual Product]
   827   C0677042:pathology [Pathologic Function]
   827   C1507394:Protocol [Intellectual Product]
   827   C1522729:Protocol [Intellectual Product]
   827   C2348563:Protocol [Intellectual Product]
   755 E C1521733:Pathologic [Functional Concept]

Phrase: ":"

Phrase: "is"

Phrase: "islet amyloid"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0011560:Amyloid [Pathologic Function]
   861   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "increased in patients"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C0030705:Patients [Patient or Disabled Group]
   790   C0205217:Increased [Quantitative Concept]
   790   C0442805:Increased [Functional Concept]
   718 E C1517378:Gain [Quantitative Concept]

Phrase: "with Alzheimer disease?"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.77: To address this question, we studied pancreas samples obtained at autopsy in 28 cases with Alzheimer disease and 21 without Alzheimer disease (groups 1 and 2 in Table 2). 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "address"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0376649:Address [Intellectual Product]
  1000   C1442065:Address [Spatial Concept]

Phrase: "this question,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1522634:Question [Intellectual Product]

Phrase: "we"

Phrase: "studied"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0557651:Study [Manufactured Object]
   966   C2603343:Study [Research Activity]

Phrase: "pancreas samples"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0370003:Sample [Substance]
   827   C2347026:Sample [Conceptual Entity]

Phrase: "obtained at autopsy"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   790   C0004398:Autopsy [Diagnostic Procedure]
   790   C1301820:Obtained [Functional Concept]
   756 E C1706701:Obtain [Activity]
   718 E C1517378:Gain [Quantitative Concept]

Phrase: "in 28 cases"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0868928:Cases [Functional Concept]
   861   C1533148:Cases [Quantitative Concept]
   827 E C1706255:CASE [Medical Device]
   827 E C1706256:Case [Conceptual Entity]

Phrase: "with Alzheimer disease"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "and"

Phrase: "21 without Alzheimer disease"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   833   C0002395:Alzheimer's Disease [Disease or Syndrome]
   833   C1521724:Alzheimer's Disease [Pathologic Function]
   770   C0012634:Disease [Disease or Syndrome]
   715 E C1836721:MALS [Finding]
   715 E C3538764:MALS [Gene or Genome]
   715 E C3540595:MAL [Gene or Genome]

Phrase: "(groups 1"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
  1000   C0441861:Group 1 [Intellectual Product]
   861   C0441833:Group [Idea or Concept]
   861   C0687744:group [Population Group]
   861   C1257890:Group [Population Group]
   861   C1552516:Group [Health Care Related Organization]
   861   C1552839:groups [Idea or Concept]
   861   C1705428:Group [Conceptual Entity]
   861   C1705429:Group [Population Group]

Phrase: "and"

Phrase: "2 in Table 2"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0039224:Table [Manufactured Object]
   770   C0740116:+2 [Quantitative Concept]
   770   C1706073:Table [Medical Device]
   770   C1706074:Table [Intellectual Product]
   770   C2827735:2+ [Quantitative Concept]
   770   C2981700:2+ [Classification]

Phrase: ")."
Processing 00000000.tx.78: In addition, 35 cases with type 2 diabetes and 21 without type 2 diabetes were studied as a point of reference. 

Phrase: "In addition,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "35 cases with type 2 diabetes"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   753   C0868928:Cases [Functional Concept]
   753   C1533148:Cases [Quantitative Concept]
   719 E C1706255:CASE [Medical Device]
   719 E C1706256:Case [Conceptual Entity]

Phrase: "and"

Phrase: "21 without type 2 diabetes"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   862   C0011860:Type 2 Diabetes [Disease or Syndrome]
   806   C0441730:Type 2 [Classification]
   797   C1320657:Diabetes type [Finding]
   760   C0011847:Diabetes [Disease or Syndrome]
   760   C0011849:Diabetes [Disease or Syndrome]
   760   C0332307:Type [Qualitative Concept]
   760   C1547052:*Type [Quantitative Concept]

Phrase: "were"

Phrase: "studied as a point of reference."
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   783   C1709878:Reference Point [Spatial Concept]
   783   C2924612:Point A [Body Location or Region]
   767   C2985663:Study Reference [Intellectual Product]
   753   C1514811:Reference [Idea or Concept]
   753   C1552961:Point [Quantitative Concept]
   753   C1706462:Reference [Conceptual Entity]
   753   C2347617:point [Quantitative Concept]
   719   C0557651:Study [Manufactured Object]
   719   C2603343:Study [Research Activity]
Processing 00000000.tx.79: Protocol 3 included a total of 105 cases. 

Phrase: "Protocol 3"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0442711:Protocol [Intellectual Product]
   861   C1507394:Protocol [Intellectual Product]
   861   C1522729:Protocol [Intellectual Product]
   861   C2348563:Protocol [Intellectual Product]

Phrase: "included"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0332257:included [Functional Concept]
  1000   C3538986:INCLUDED [Gene or Genome]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "a total of 105 cases."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0439175:% total [Quantitative Concept]
   760   C0439810:Total [Qualitative Concept]
Processing 00000000.tx.80: Protocol 4: is brain amyloid more common in patients with type 2 diabetes? 

Phrase: "Protocol 4"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0442711:Protocol [Intellectual Product]
   861   C1507394:Protocol [Intellectual Product]
   861   C1522729:Protocol [Intellectual Product]
   861   C2348563:Protocol [Intellectual Product]

Phrase: ":"

Phrase: "is"

Phrase: "brain amyloid"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0011560:Amyloid [Pathologic Function]
   861   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "more common in patients"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0205214:Common [Quantitative Concept]
   770   C1522138:Common [Functional Concept]
   770   C3245511:common [Intellectual Product]

Phrase: "with type 2 diabetes?"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0011860:Type 2 Diabetes [Disease or Syndrome]
   913   C1320657:type diabetes [Finding]
   901   C0441730:Type 2 [Classification]
   827   C0011847:Diabetes [Disease or Syndrome]
   827   C0011849:Diabetes [Disease or Syndrome]
   827   C0332307:Type [Qualitative Concept]
   827   C1547052:*Type [Quantitative Concept]
Processing 00000000.tx.81: To address this question, we studied brain samples in 28 cases with and 19 without type 2 diabetes (groups 3 and 4 in Table 2). 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "address"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0376649:Address [Intellectual Product]
  1000   C1442065:Address [Spatial Concept]

Phrase: "this question,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1522634:Question [Intellectual Product]

Phrase: "we"

Phrase: "studied"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0557651:Study [Manufactured Object]
   966   C2603343:Study [Research Activity]

Phrase: "brain samples in 28 cases"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   726   C0370003:Sample [Substance]
   726   C2347026:Sample [Conceptual Entity]

Phrase: "with"

Phrase: "and"

Phrase: "19 without type 2 diabetes"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   862   C0011860:Type 2 Diabetes [Disease or Syndrome]
   806   C0441730:Type 2 [Classification]
   797   C1320657:Diabetes type [Finding]
   760   C0011847:Diabetes [Disease or Syndrome]
   760   C0011849:Diabetes [Disease or Syndrome]
   760   C0332307:Type [Qualitative Concept]
   760   C1547052:*Type [Quantitative Concept]

Phrase: "(groups 3"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
  1000   C0441869:Group 3 [Intellectual Product]
   861   C0441833:Group [Idea or Concept]
   861   C0687744:group [Population Group]
   861   C1257890:Group [Population Group]
   861   C1552516:Group [Health Care Related Organization]
   861   C1552839:groups [Idea or Concept]
   861   C1705428:Group [Conceptual Entity]
   861   C1705429:Group [Population Group]

Phrase: "and"

Phrase: "4 in Table 2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0039224:Table [Manufactured Object]
   770   C1706073:Table [Medical Device]
   770   C1706074:Table [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.82: As a reference, 26 cases with Alzheimer disease and 19 without Alzheimer disease were studied. 

Phrase: "As a reference,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "26 cases with Alzheimer disease"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   760   C0868928:Cases [Functional Concept]
   760   C1533148:Cases [Quantitative Concept]
   726 E C1706255:CASE [Medical Device]
   726 E C1706256:Case [Conceptual Entity]

Phrase: "and"

Phrase: "19 without Alzheimer disease"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   833   C0002395:Alzheimer's Disease [Disease or Syndrome]
   833   C1521724:Alzheimer's Disease [Pathologic Function]
   770   C0012634:Disease [Disease or Syndrome]
   715 E C1836721:MALS [Finding]
   715 E C3538764:MALS [Gene or Genome]
   715 E C3540595:MAL [Gene or Genome]

Phrase: "were"

Phrase: "studied."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0557651:Study [Manufactured Object]
   966   C2603343:Study [Research Activity]
Processing 00000000.tx.83: Some paraffin blocks of the superior/midfrontal gyrus were not available, resulting in 92 cases entering protocol 4. 

Phrase: "Some paraffin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030415:Paraffin [Biomedical or Dental Material,Lipid]

Phrase: "blocks of the superior/midfrontal gyrus"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   753   C0028778:Block [Pathologic Function]
   753   C0332206:Block [Functional Concept]
   753   C1282910:Superior [Spatial Concept]
   753   C1533157:Block [Substance]
   753   C1706084:Block [Geographic Area]
   753   C2828370:Block [Quantitative Concept]

Phrase: "were"

Phrase: "not available,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1548671:Not available [Idea or Concept]
   861   C0470187:Available [Functional Concept]

Phrase: "resulting in 92 cases"
Meta Candidates (Total=9; Excluded=5; Pruned=0; Remaining=4)
   833   C0332294:Resulting in [Functional Concept]
   770   C0678226:resulting [Functional Concept]
   770   C0868928:Cases [Functional Concept]
   770   C1533148:Cases [Quantitative Concept]
   737 E C1274040:Result [Functional Concept]
   737 E C1546471:Result [Idea or Concept]
   737 E C1706255:CASE [Medical Device]
   737 E C1706256:Case [Conceptual Entity]
   737 E C2825142:Result [Finding]

Phrase: "entering"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1522196:ENTER [Functional Concept]

Phrase: "protocol 4."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0442711:Protocol [Intellectual Product]
   861   C1507394:Protocol [Intellectual Product]
   861   C1522729:Protocol [Intellectual Product]
   861   C2348563:Protocol [Intellectual Product]
Processing 00000000.tx.84: Light microscopy. 

Phrase: "Light microscopy."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0430389:Light microscopy [Laboratory Procedure]
   861   C0026018:Microscopy [Laboratory Procedure]
   789 E C0205288:Microscopic [Qualitative Concept]
Processing 00000000.tx.85: Pancreas and brain samples were obtained at autopsy from the four groups described above. 

Phrase: "Pancreas"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0030274:Pancreas [Body Part, Organ, or Organ Component]
  1000   C1278931:Pancreas [Body Part, Organ, or Organ Component]

Phrase: "and"

Phrase: "brain samples"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0370003:Sample [Substance]
   827   C2347026:Sample [Conceptual Entity]

Phrase: "were"

Phrase: "obtained at autopsy"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   790   C0004398:Autopsy [Diagnostic Procedure]
   790   C1301820:Obtained [Functional Concept]
   756 E C1706701:Obtain [Activity]
   718 E C1517378:Gain [Quantitative Concept]

Phrase: "from the four"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205450:Four [Quantitative Concept]

Phrase: "groups"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0441833:Group [Idea or Concept]
  1000   C0687744:group [Population Group]
  1000   C1257890:Group [Population Group]
  1000   C1552516:Group [Health Care Related Organization]
  1000   C1552839:groups [Idea or Concept]
  1000   C1705428:Group [Conceptual Entity]
  1000   C1705429:Group [Population Group]

Phrase: "described above."
Processing 00000000.tx.86: Slides were examined blinded to the identity of the case by light microscopy. 

Phrase: "Slides"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0444330:slides [Research Device]
   966 E C1705201:Slide [Manufactured Object]

Phrase: "were"

Phrase: "examined"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332128:Examined [Finding]

Phrase: "blinded to the identity of the case"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   748   C0150108:Blinded [Research Activity]
   748   C0424215:Identity [Mental Process]
   748   C0868928:Case [Functional Concept]
   748   C1706255:CASE [Medical Device]
   748   C1706256:Case [Conceptual Entity]
   748   C2003939:Identity [Finding]
   714 E C0456909:Blind [Disease or Syndrome]
   714 E C0525065:blind [Patient or Disabled Group]

Phrase: "by light microscopy."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0430389:Light microscopy [Laboratory Procedure]
   861   C0026018:Microscopy [Laboratory Procedure]
   789 E C0205288:Microscopic [Qualitative Concept]
Processing 00000000.tx.87: Pancreas. 

Phrase: "Pancreas."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0030274:Pancreas [Body Part, Organ, or Organ Component]
  1000   C1278931:Pancreas [Body Part, Organ, or Organ Component]
Processing 00000000.tx.88: Sequential sections obtained from paraffin-embedded pancreas tail samples were stained with hematoxylin/eosin and Congo red and by immunostaining for insulin (29). 

Phrase: "Sequential sections"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0205155:Section [Spatial Concept]
   827   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   827   C1522472:Section [Substance]
   827   C1552923:Section [Quantitative Concept]
   827   C1705191:Section [Physical Object]

Phrase: "obtained from paraffin-embedded pancreas tail samples"
Meta Candidates (Total=12; Excluded=1; Pruned=0; Remaining=11)
   778   C0227590:Pancreas Tail [Body Part, Organ, or Organ Component]
   774   C0085185:embedded paraffin [Laboratory Procedure]
   757   C1277697:Sample obtained [Finding]
   748   C0030274:Pancreas [Body Part, Organ, or Organ Component]
   748   C0030415:Paraffin [Biomedical or Dental Material,Lipid]
   748   C0039259:Tail [Body Part, Organ, or Organ Component]
   748   C1278931:Pancreas [Body Part, Organ, or Organ Component]
   748   C1301820:Obtained [Functional Concept]
   748   C1707903:Embedded [Laboratory Procedure]
   714   C0370003:Sample [Substance]
   714 E C1706701:Obtain [Activity]
   714   C2347026:Sample [Conceptual Entity]

Phrase: "were"

Phrase: "stained with hematoxylin/eosin"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   802   C0018964:Haematoxylin stain [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
           Haematoxylin
   770   C0014448:Eosin [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   770   C0885297:eosin [Organic Chemical,Pharmacologic Substance]
   770   C2986582:Stained [Qualitative Concept]
   737 E C0038128:Stain [Indicator, Reagent, or Diagnostic Aid]

Phrase: "and"

Phrase: "Congo red"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0009742:Congo Red [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   861   C0009738:Congo [Geographic Area]
   861   C0332575:Red [Finding]
   861   C1260956:Red [Qualitative Concept]

Phrase: "and by immunostaining"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1515981:And [Idea or Concept]

Phrase: "for insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "(29"

Phrase: ")."
Processing 00000000.tx.89: The nature of pink amyloid deposits in Congo red-stained slides was confirmed by green/orange birefringence under polarized light. 

Phrase: "The nature of pink amyloid"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0349590:Nature [Idea or Concept]
   760   C1262865:Nature [Functional Concept]

Phrase: "deposits in Congo red-stained slides"
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
   816   C0009742:Congo red stain [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
           Congo Red
   753   C0009738:Congo [Geographic Area]
   753   C0332575:Red [Finding]
   753   C0333562:Deposit [Functional Concept]
   753   C0444330:slides [Research Device]
   753   C1260956:Red [Qualitative Concept]
   753   C2986582:Stained [Qualitative Concept]
   719 E C0038128:Stain [Indicator, Reagent, or Diagnostic Aid]
   719 E C1705201:Slide [Manufactured Object]

Phrase: "was"

Phrase: "confirmed by green/orange birefringence"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   806   C0521093:Confirmed by [Qualitative Concept]
           confirmed
   760   C0005597:Birefringence [Natural Phenomenon or Process]
   760   C0332583:Green [Qualitative Concept]
   760   C0440277:Orange [Food]
   760   C0475654:orange [Food]
   760   C0750484:Confirmed [Idea or Concept]
   760   C1313858:Orange [Qualitative Concept]
   726 E C1456348:Confirm [Qualitative Concept]

Phrase: "under polarized light."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0599025:polarized light [Human-caused Phenomenon or Process]
   861   C0023693:Light [Natural Phenomenon or Process]
   861   C1306462:Light [Functional Concept]
   861   C1881376:Light [Qualitative Concept]
Processing 00000000.tx.90: At least 25 islets per specimen were scored for presence and extent of islet amyloid. 

Phrase: "At least 25 islets"

Phrase: "per specimen"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0370003:Specimen [Substance]
  1000   C2347026:Specimen [Conceptual Entity]

Phrase: "were"

Phrase: "scored for presence"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   790   C0392148:Presence [Therapeutic or Preventive Procedure]
   790   C0449820:scored [Quantitative Concept]
   718 E C0150312:Present [Quantitative Concept]
   718 E C0449450:Present [Idea or Concept]

Phrase: "and"

Phrase: "extent of islet amyloid."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0439792:Extent [Spatial Concept]
Processing 00000000.tx.91: The extent of amyloid deposition was classified per islet on a scale from 0 to 4, with 0 = no deposits, 1 = one deposit, 2 = a few small deposits, 3 = major deposition, and 4 = just a few endocrine cells left between confluent deposits. 

Phrase: "The extent of amyloid deposition"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0439792:Extent [Spatial Concept]

Phrase: "was"

Phrase: "classified per islet"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0008902:Classified [Classification]

Phrase: "on a scale"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
  1000   C0175659:Scale [Medical Device]
  1000   C0349674:Scale [Intellectual Product]
  1000   C1947916:Scale [Activity]
  1000   C3536777:Scale [Manufactured Object]
   928 E C1710017:Scalar [Qualitative Concept]
   916 E C0222045:Scales [Body Part, Organ, or Organ Component]

Phrase: "from 0"

Phrase: "to 4,"

Phrase: "with 0"

Phrase: "="

Phrase: "no deposits,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0333562:Deposits [Functional Concept]

Phrase: "1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "= one deposit,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0333562:Deposit [Functional Concept]

Phrase: "2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "="

Phrase: "a few small deposits,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0333562:Deposits [Functional Concept]

Phrase: "3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "= major deposition,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0333562:Deposition [Functional Concept]

Phrase: "and"

Phrase: "4"

Phrase: "= just"

Phrase: "a few endocrine cells"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   901   C0229525:Endocrine Cells [Cell]
   827   C0007634:Cells [Cell]
   827   C0014136:Endocrine [Body System]
   827   C0521425:Endocrine [Functional Concept]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "left between confluent deposits."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0205091:Left [Spatial Concept]
   770   C0205200:Confluent [Qualitative Concept]
   770   C0333562:Deposits [Functional Concept]
   770   C1552822:left [Functional Concept]
Processing 00000000.tx.92: Brain. 

Phrase: "Brain."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0006104:Brain [Body Part, Organ, or Organ Component]
  1000   C1269537:Brain [Body Part, Organ, or Organ Component]
Processing 00000000.tx.93: Samples of the superior/midfrontal gyrus were collected, and the density of neuritic and diffuse plaques and neurofibrillary tangle (NFT) was determined. 

Phrase: "Samples of the superior/midfrontal gyrus"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   719   C0370003:Sample [Substance]
   719   C2347026:Sample [Conceptual Entity]

Phrase: "were"

Phrase: "collected"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1516695:Collected [Idea or Concept]
  1000   C1516698:Collected [Functional Concept]

Phrase: ","

Phrase: "and"

Phrase: "the density of neuritic"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0178587:density [Quantitative Concept]

Phrase: "and"

Phrase: "diffuse plaques"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0333463:plaques [Acquired Abnormality]
   827 E C0011389:Plaque [Disease or Syndrome]
   827 E C0332461:Plaque [Finding]

Phrase: "and"

Phrase: "neurofibrillary tangle (NFT)"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0085400:Neurofibrillary tangle [Acquired Abnormality]
  1000   C3543859:neurofibrillary tangle [Cell Component]

Phrase: "was"

Phrase: "determined."
Processing 00000000.tx.94: For visualizing neurofilaments, paraffin sections of the superior/midfrontal gyrus were stained with a modified Bielschowskys technique. 

Phrase: "For visualizing neurofilaments,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0027834:neurofilaments [Cell Component]

Phrase: "paraffin sections of the superior/midfrontal gyrus"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   748   C0030415:Paraffin [Biomedical or Dental Material,Lipid]
   714   C0205155:Section [Spatial Concept]
   714   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   714   C1522472:Section [Substance]
   714   C1552923:Section [Quantitative Concept]
   714   C1705191:Section [Physical Object]

Phrase: "were"

Phrase: "stained with a modified Bielschowskys technique."
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   753   C0392747:Modified [Functional Concept]
   753   C0449851:Technique [Functional Concept]
   753   C2986582:Stained [Qualitative Concept]
   750   C1293957:Bielschowsky's stain [Laboratory Procedure]
   719 E C0038128:Stain [Indicator, Reagent, or Diagnostic Aid]
Processing 00000000.tx.95: Per sample, the number of neuritic plaques, diffuse plagues, and NFT was determined in five microscope fields of 2 mm2 each. 

Phrase: "Per sample,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0370003:Sample [Substance]
  1000   C2347026:Sample [Conceptual Entity]

Phrase: "the number of neuritic plaques,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   844   C0449793:Number of plaques [Quantitative Concept]
   760   C0237753:*Number [Quantitative Concept]
   760   C0449788:Number [Quantitative Concept]

Phrase: "diffuse plagues,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0032064:plagues [Disease or Syndrome]

Phrase: "and"

Phrase: "NFT"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0085400:Neurofibrillary tangle [Acquired Abnormality]
  1000   C3543859:neurofibrillary tangle [Cell Component]

Phrase: "was"

Phrase: "determined in five microscope fields of 2 mm2"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   744   C0181839:Microscope [Medical Device]
   744   C0205451:Five [Quantitative Concept]
   744   C0456786:mm2 [Quantitative Concept]
   744   C1706379:Microscope [Medical Device]
   711   C0440042:Field's [Indicator, Reagent, or Diagnostic Aid]
   711   C1521738:Field [Conceptual Entity]
   711   C2346620:Field [Conceptual Entity]
   711   C2349184:Field [Conceptual Entity]
   711   C3539073:FIELD [Spatial Concept]

Phrase: "each."
Processing 00000000.tx.96: Statistical analysis Protocols 1 and 2. 

Phrase: "Statistical analysis Protocols 1"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   861   C0871424:statistical analysis [Research Activity]
   812   C0002778:Analysis [Laboratory Procedure]
   812   C0038215:Statistical [Occupation or Discipline]
   812   C0442711:Protocols [Intellectual Product]
   812   C0936012:Analysis [Research Activity]
   812   C1524024:analysis [Functional Concept]
   779 E C1507394:Protocol [Intellectual Product]
   779 E C1522729:Protocol [Intellectual Product]
   779 E C2348563:Protocol [Intellectual Product]

Phrase: "and"

Phrase: "2."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]
Processing 00000000.tx.97: A rank sum test was used to compare age, and 2 tests were used to compare number in groups according to classification for sex and diabetic, nondiabetic, or IFG status. 

Phrase: "A rank sum test"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   923   C0242928:Test, Rank-Sum [Quantitative Concept]
   812   C0022885:Test [Laboratory Procedure]
   812   C0039593:Test [Functional Concept]
   812   C0392366:test [Intellectual Product]
   812   C0699794:Rank [Intellectual Product]
   812   C1515051:Sum [Quantitative Concept]

Phrase: "was"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "compare"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707455:Compare [Activity]

Phrase: "age,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001779:Age [Organism Attribute]

Phrase: "and"

Phrase: "2 tests"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0022885:Tests [Laboratory Procedure]
   861   C0392366:Tests [Intellectual Product]
   827 E C0039593:Test [Functional Concept]

Phrase: "were"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "compare"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707455:Compare [Activity]

Phrase: "number in groups"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   858   C2985777:Group Number [Quantitative Concept]
   790   C0237753:*Number [Quantitative Concept]
   790   C0449788:Number [Quantitative Concept]

Phrase: "according to classification"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0008902:Classification [Classification]
  1000   C0008903:classification [Functional Concept]
  1000   C0678229:classification [Occupational Activity]

Phrase: "for sex"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0009253:Sex [Organism Function]
  1000   C0036864:Sex [Behavior]
  1000   C0079399:sex [Organism Attribute]
  1000   C1314687:Sex [Finding]
  1000   C1522384:sex [Organism Attribute]

Phrase: "and"

Phrase: "diabetic, nondiabetic,"

Phrase: "or"

Phrase: "IFG status."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0449438:Status [Qualitative Concept]
Processing 00000000.tx.98: A two-sided rank sum test was used to compare slope of fasting glucose versus age. 

Phrase: "A two-sided rank sum test"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   885   C1883413:2-Sided Test [Research Activity]
   861   C0242928:Test, Rank-Sum [Quantitative Concept]
   799   C0022885:Test [Laboratory Procedure]
   799   C0039593:Test [Functional Concept]
   799   C0392366:test [Intellectual Product]
   799   C0699794:Rank [Intellectual Product]
   799   C1515051:Sum [Quantitative Concept]

Phrase: "was"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "compare"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707455:Compare [Activity]

Phrase: "slope of fasting glucose"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0807955:Slope [Quantitative Concept]

Phrase: "versus"

Phrase: "age."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001779:Age [Organism Attribute]
Processing 00000000.tx.99: Protocols 3 and 4. 

Phrase: "Protocols 3"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0442711:Protocols [Intellectual Product]
   827 E C1507394:Protocol [Intellectual Product]
   827 E C1522729:Protocol [Intellectual Product]
   827 E C2348563:Protocol [Intellectual Product]

Phrase: "and"

Phrase: "4."
Processing 00000000.tx.100: An unpaired two-tailed Students t test was used to compare age and BMI between groups. 

Phrase: "An unpaired two-tailed Students t test"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   904   C1710574:Unpaired t-Test [Intellectual Product]
   799   C0022885:Test [Laboratory Procedure]
   799   C0038492:Students [Professional or Occupational Group]
   799   C0039593:Test [Functional Concept]
   799   C0392366:test [Intellectual Product]
   766 E C1551041:student [Idea or Concept]
   766 E C1552573:student [Intellectual Product]

Phrase: "was"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "compare"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707455:Compare [Activity]

Phrase: "age"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001779:Age [Organism Attribute]

Phrase: "and"

Phrase: "BMI between groups."
Processing 00000000.tx.101: The nonparametric Mann-Whitney test was used to compare the frequency and extent of islet amyloid; 

Phrase: "The nonparametric Mann-Whitney test"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   923   C1708930:Mann-Whitney Test [Intellectual Product]
   902   C1709255:Non-Parametric Test [Intellectual Product]
   812   C0022885:Test [Laboratory Procedure]
   812   C0039593:Test [Functional Concept]
   812   C0392366:test [Intellectual Product]

Phrase: "was"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "compare"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707455:Compare [Activity]

Phrase: "the frequency"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
  1000   C0376249:frequency [Quantitative Concept]
  1000   C0439603:Frequency [Temporal Concept]
  1000   C0871396:Frequency [Quantitative Concept]
  1000   C1561548:Frequency [Qualitative Concept]
  1000   C1705502:Frequency [Quantitative Concept]
   928 E C0332183:Frequent [Temporal Concept]

Phrase: "and"

Phrase: "extent of islet amyloid"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0439792:Extent [Spatial Concept]

Phrase: ";"
Processing 00000000.tx.102: FPG; 

Phrase: "FPG"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   901   C0202042:Plasma glucose [Laboratory Procedure]
   901   C0455280:plasma glucose [Laboratory or Test Result]
   827   C0015663:Fasting [Finding]
   827   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   827   C0032105:Plasma [Body Substance]
   827   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]
   827   C1550565:fasting [Intellectual Product]
   793 E C0456962:Fast [Qualitative Concept]

Phrase: ";"
Processing 00000000.tx.103: and density of neuritic plaques, diffuse plagues, and NFT among groups. 

Phrase: "and"

Phrase: "density of neuritic plaques,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0178587:density [Quantitative Concept]
   767   C1817256:dense plaque [Cell Component]

Phrase: "diffuse plagues,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0032064:plagues [Disease or Syndrome]

Phrase: "and"

Phrase: "NFT among groups."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C0085400:Neurofibrillary tangle [Acquired Abnormality]
   833   C3543859:neurofibrillary tangle [Cell Component]
Processing 00000000.tx.104: The 2 test was used to compare the number of Alzheimer disease and non-Alzheimer disease subjects with type 2 diabetes. 

Phrase: "The 2 test"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0022885:Test [Laboratory Procedure]
   861   C0039593:Test [Functional Concept]
   861   C0392366:test [Intellectual Product]

Phrase: "was"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "compare"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707455:Compare [Activity]

Phrase: "the number of Alzheimer disease"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0237753:*Number [Quantitative Concept]
   760   C0449788:Number [Quantitative Concept]

Phrase: "and"

Phrase: "non-Alzheimer disease"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   901   C0002395:Alzheimer's Disease [Disease or Syndrome]
   901   C1521724:Alzheimer's Disease [Pathologic Function]
   827   C0012634:Disease [Disease or Syndrome]
   827   C1518422:Non [Functional Concept]
   771 E C1836721:MALS [Finding]
   771 E C3538764:MALS [Gene or Genome]
   771 E C3540595:MAL [Gene or Genome]

Phrase: "subjects with type 2 diabetes."
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   862   C0011860:Type 2 Diabetes [Disease or Syndrome]
   806   C0441730:Type 2 [Classification]
   797   C1320657:Diabetes type [Finding]
   760   C0011847:Diabetes [Disease or Syndrome]
   760   C0011849:Diabetes [Disease or Syndrome]
   760   C0332307:Type [Qualitative Concept]
   760   C0681850:Subject [Group]
   760   C1547052:*Type [Quantitative Concept]
   760   C1550501:{Subject} [Idea or Concept]
   760   C1706203:Subject [Idea or Concept]
   760   C2349001:Subject [Human]
   760   C2697811:Subject [Functional Concept]
Processing 00000000.tx.105: Spearman rank correlations were used to examine relationships among diffuse plagues, neuritic plaques, and NFT density versus duration of diabetes before death and age at death in type 2 diabetes.  

Phrase: "Spearman rank correlations"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   896   C1710141:Spearman Correlation [Intellectual Product]
   793   C1707520:Correlation [Qualitative Concept]

Phrase: "were"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "examine"

Phrase: "relationships among diffuse plagues,"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   770   C0439849:Relationships [Qualitative Concept]
   737 E C1705630:Relationship [Idea or Concept]
   737 E C1706279:Relationship [Idea or Concept]
   737 E C3540605:Relationship [Intellectual Product]

Phrase: "neuritic plaques,"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0333463:Neuritic Plaques [Acquired Abnormality]
           plaques
   827 E C0011389:Plaque [Disease or Syndrome]
   827 E C0332461:Plaque [Finding]
   789   C0027813:Neuritides [Disease or Syndrome]

Phrase: "and"

Phrase: "NFT density"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   827   C0178587:density [Quantitative Concept]
   755 E C0439794:Dense [Qualitative Concept]
   734   C0085400:Neurofibrillary tangle [Acquired Abnormality]
   734   C3543859:neurofibrillary tangle [Cell Component]

Phrase: "versus"

Phrase: "duration of diabetes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0449238:Duration [Temporal Concept]
   790   C2926735:Duration [Pharmacologic Substance]

Phrase: "before death"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0011065:Death [Organism Function]
  1000   C1306577:Death, NOS [Finding]

Phrase: "and"

Phrase: "age at death"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1543138:Age at death [Clinical Attribute]
  1000   C1546180:Age at death [Clinical Attribute]
   858   C0742983:age death [Finding]
   790   C0001779:Age [Organism Attribute]

Phrase: "in type 2 diabetes."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0011860:Type 2 Diabetes [Disease or Syndrome]
   913   C1320657:type diabetes [Finding]
   901   C0441730:Type 2 [Classification]
   827   C0011847:Diabetes [Disease or Syndrome]
   827   C0011849:Diabetes [Disease or Syndrome]
   827   C0332307:Type [Qualitative Concept]
   827   C1547052:*Type [Quantitative Concept]
Processing 00000000.tx.106: RESULTS TOP ABSTRACT RESEARCH DESIGN AND METHODS RESULTS DISCUSSION REFERENCES  Clinical studies: prevalence of type 2 diabetes and IFG in the living cohort of Alzheimer disease versus non-Alzheimer disease control subjects and trend of FPG with aging Protocol 1. 

Phrase: "RESULTS TOP ABSTRACT RESEARCH DESIGN"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   840   C0035171:Research Design [Research Activity]
   804   C0035168:research [Research Activity]
   804   C0242481:Research [Research Activity]
   804   C1707689:Design [Activity]
   804   C2983265:DESIGN [Intellectual Product]

Phrase: "AND"

Phrase: "METHODS RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Clinical studies"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0008972:Clinical Studies [Research Activity]
   861   C0205210:Clinical [Qualitative Concept]
   861   C0947630:studies [Laboratory Procedure]
   827 E C0557651:Study [Manufactured Object]
   827 E C2603343:Study [Research Activity]

Phrase: ":"

Phrase: "prevalence of type 2 diabetes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0033105:Prevalence [Quantitative Concept]
   760   C0220900:prevalence [Quantitative Concept]

Phrase: "and"

Phrase: "IFG in the living cohort of Alzheimer disease"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C1334085:IFG [Gene or Genome]
   744   C1708411:IFG [Gene or Genome]

Phrase: "versus"

Phrase: "non-Alzheimer disease control subjects"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   840   C0920467:disease control [Therapeutic or Preventive Procedure]
   804   C0243148:control [Qualitative Concept]
   804   C1550141:Control [Substance]
   804   C1882979:Control [Conceptual Entity]
   804   C2587213:Control [Functional Concept]
   804   C3274648:Control [Qualitative Concept]
   771   C0681850:Subject [Group]
   771   C1550501:{Subject} [Idea or Concept]
   771   C1706203:Subject [Idea or Concept]
   771   C2349001:Subject [Human]
   771   C2697811:Subject [Functional Concept]

Phrase: "and"

Phrase: "trend of FPG"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1521798:trend [Temporal Concept]

Phrase: "with aging Protocol 1."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0001811:Ageing [Organism Function]
   827   C0442711:Protocol [Intellectual Product]
   827   C1507394:Protocol [Intellectual Product]
   827   C1522729:Protocol [Intellectual Product]
   827   C2348563:Protocol [Intellectual Product]
Processing 00000000.tx.107: There was no difference in age or sex distribution between the Alzheimer disease and non-Alzheimer disease control group (Table 1). 

Phrase: "There"

Phrase: "was"

Phrase: "no difference in age"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   819   C0699810:age difference [Age Group]
   770   C1705241:*Difference [Quantitative Concept]
   770   C1705242:Difference [Qualitative Concept]

Phrase: "or"

Phrase: "sex distribution between the Alzheimer disease"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0036878:Sex Distribution [Quantitative Concept]
   753   C0520511:distribution [Idea or Concept]
   753   C1704711:Distribution [Functional Concept]

Phrase: "and"

Phrase: "non-Alzheimer disease control group"
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
   840   C0009932:Control Group [Group]
   840   C0920467:disease control [Therapeutic or Preventive Procedure]
   804   C0243148:control [Qualitative Concept]
   804   C0441833:Group [Idea or Concept]
   804   C0687744:group [Population Group]
   804   C1257890:Group [Population Group]
   804   C1550141:Control [Substance]
   804   C1552516:Group [Health Care Related Organization]
   804   C1705428:Group [Conceptual Entity]
   804   C1705429:Group [Population Group]
   804   C1882979:Control [Conceptual Entity]
   804   C2587213:Control [Functional Concept]
   804   C3274648:Control [Qualitative Concept]

Phrase: "(Table 1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.108: BMI was slightly but not significantly higher in control subjects versus Alzheimer disease. 

Phrase: "BMI"

Phrase: "was"

Phrase: "slightly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0750482:Slightly [Idea or Concept]

Phrase: "but"

Phrase: "not significantly higher in control subjects"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   719   C0205250:High [Qualitative Concept]
   719   C1299351:High [Qualitative Concept]
   719   C2700149:HIGH [Intellectual Product]

Phrase: "versus"

Phrase: "Alzheimer disease."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.109: The prevalence of both type 2 diabetes (34.6 vs. 18.1%; P < 0.05) and IFG (46.2 vs. 23.8%; P < 0.01) was greater in the Alzheimer disease versus the non-Alzheimer disease control group (Fig. 1); 

Phrase: "The prevalence of both type 2 diabetes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0033105:Prevalence [Quantitative Concept]
   748   C0220900:prevalence [Quantitative Concept]

Phrase: "(34.6"

Phrase: "vs. 18.1%"

Phrase: "; P < 0.05"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: "and"

Phrase: "IFG"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1334085:IFG [Gene or Genome]
  1000   C1708411:IFG [Gene or Genome]

Phrase: "(46.2"

Phrase: "vs. 23.8%"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450348:23 [Quantitative Concept]

Phrase: "; P < 0.01"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: "was"

Phrase: "greater in the Alzheimer disease"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   760   C0443228:greater [Quantitative Concept]
   760   C1704243:Greater [Quantitative Concept]
   726 E C0549177:Great [Quantitative Concept]

Phrase: "versus"

Phrase: "the non-Alzheimer disease control group"
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
   840   C0009932:Control Group [Group]
   840   C0920467:disease control [Therapeutic or Preventive Procedure]
   804   C0243148:control [Qualitative Concept]
   804   C0441833:Group [Idea or Concept]
   804   C0687744:group [Population Group]
   804   C1257890:Group [Population Group]
   804   C1550141:Control [Substance]
   804   C1552516:Group [Health Care Related Organization]
   804   C1705428:Group [Conceptual Entity]
   804   C1705429:Group [Population Group]
   804   C1882979:Control [Conceptual Entity]
   804   C2587213:Control [Functional Concept]
   804   C3274648:Control [Qualitative Concept]

Phrase: "(Fig. 1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")"

Phrase: ";"
Processing 00000000.tx.110: 81% of the Alzheimer disease cases therefore had either type 2 diabetes or IFG. 

Phrase: "81% of the Alzheimer disease cases therefore"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   778   C0002395:Alzheimer's Disease [Disease or Syndrome]
   778   C1521724:Alzheimer's Disease [Pathologic Function]
   748   C0012634:Disease [Disease or Syndrome]
   748   C0868928:Cases [Functional Concept]
   748   C1533148:Cases [Quantitative Concept]
   714 E C1706255:CASE [Medical Device]
   714 E C1706256:Case [Conceptual Entity]

Phrase: "had"

Phrase: "either type 2 diabetes"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   923   C0011860:Type 2 Diabetes [Disease or Syndrome]
   875   C1320657:type diabetes [Finding]
   861   C0441730:Type 2 [Classification]
   812   C0011847:Diabetes [Disease or Syndrome]
   812   C0011849:Diabetes [Disease or Syndrome]
   812   C0332307:Type [Qualitative Concept]
   812   C1547052:*Type [Quantitative Concept]

Phrase: "or"

Phrase: "IFG."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1334085:IFG [Gene or Genome]
  1000   C1708411:IFG [Gene or Genome]
Processing 00000000.tx.111: View larger version (16K): [in this window] [in a new window]  FIG. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(16K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  FIG."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.112: 1. 

Phrase: "1."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]
Processing 00000000.tx.113: Protocol 1: the prevalence of diabetes and IFG in the Olmsted County community-based cohort of cases of Alzheimer disease (AD) and control subjects (non-Alzheimer disease [non-AD]; top). 

Phrase: "Protocol 1"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0442711:Protocol [Intellectual Product]
   861   C1507394:Protocol [Intellectual Product]
   861   C1522729:Protocol [Intellectual Product]
   861   C2348563:Protocol [Intellectual Product]

Phrase: ":"

Phrase: "the prevalence of diabetes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0033105:Prevalence [Quantitative Concept]
   770   C0220900:prevalence [Quantitative Concept]

Phrase: "and"

Phrase: "IFG in the Olmsted County community-based cohort of cases of Alzheimer disease (AD)"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   735   C1334085:IFG [Gene or Genome]
   735   C1708411:IFG [Gene or Genome]

Phrase: "and"

Phrase: "control subjects"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   861   C0243148:control [Qualitative Concept]
   861   C1550141:Control [Substance]
   861   C1882979:Control [Conceptual Entity]
   861   C2587213:Control [Functional Concept]
   861   C3274648:Control [Qualitative Concept]
   827   C0681850:Subject [Group]
   827   C1550501:{Subject} [Idea or Concept]
   827   C1706203:Subject [Idea or Concept]
   827   C2349001:Subject [Human]
   827   C2697811:Subject [Functional Concept]

Phrase: "(non-Alzheimer disease [non-AD]"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   901   C0002395:Alzheimer's Disease [Disease or Syndrome]
   901   C1521724:Alzheimer's Disease [Pathologic Function]
   827   C0012634:Disease [Disease or Syndrome]
   827   C1518422:Non [Functional Concept]
   771 E C1836721:MALS [Finding]
   771 E C3538764:MALS [Gene or Genome]
   771 E C3540595:MAL [Gene or Genome]

Phrase: "; top)."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1704458:Top [Spatial Concept]
Processing 00000000.tx.114: Protocol 2: the slope of FPG concentration versus age in the same cohort (bottom). 

Phrase: "Protocol 2"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0442711:Protocol [Intellectual Product]
   861   C1507394:Protocol [Intellectual Product]
   861   C1522729:Protocol [Intellectual Product]
   861   C2348563:Protocol [Intellectual Product]

Phrase: ":"

Phrase: "the slope of FPG concentration"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0807955:Slope [Quantitative Concept]

Phrase: "versus"

Phrase: "age in the same cohort"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   797   C2348001:Age Cohort [Population Group]
   760   C0001779:Age [Organism Attribute]

Phrase: "(bottom"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511276:Bottom [Spatial Concept]
  1000   C1552825:bottom [Idea or Concept]

Phrase: ")."
Processing 00000000.tx.115: TTDM, type 2 diabetes.  

Phrase: "TTDM,"

Phrase: "type 2 diabetes."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0011860:Type 2 Diabetes [Disease or Syndrome]
   913   C1320657:type diabetes [Finding]
   901   C0441730:Type 2 [Classification]
   827   C0011847:Diabetes [Disease or Syndrome]
   827   C0011849:Diabetes [Disease or Syndrome]
   827   C0332307:Type [Qualitative Concept]
   827   C1547052:*Type [Quantitative Concept]
Processing 00000000.tx.116: Protocol 2. 

Phrase: "Protocol 2."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0442711:Protocol [Intellectual Product]
   861   C1507394:Protocol [Intellectual Product]
   861   C1522729:Protocol [Intellectual Product]
   861   C2348563:Protocol [Intellectual Product]
Processing 00000000.tx.117: When the trend of FPG with aging was examined, there was a gradual increase with aging in both groups (P < 0.01 vs. no change). 

Phrase: "When"

Phrase: "the trend of FPG"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1521798:trend [Temporal Concept]

Phrase: "with aging"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001811:Ageing [Organism Function]

Phrase: "was"

Phrase: "examined"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332128:Examined [Finding]

Phrase: ","

Phrase: "there"

Phrase: "was"

Phrase: "a gradual increase with aging"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0442805:Increase [Functional Concept]

Phrase: "in both groups"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0441833:Group [Idea or Concept]
  1000   C0687744:group [Population Group]
  1000   C1257890:Group [Population Group]
  1000   C1552516:Group [Health Care Related Organization]
  1000   C1552839:groups [Idea or Concept]
  1000   C1705428:Group [Conceptual Entity]
  1000   C1705429:Group [Population Group]

Phrase: "(P < 0.01"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: "vs."

Phrase: "no change"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0392747:Change [Functional Concept]
  1000   C0443172:change [Quantitative Concept]
  1000   C1705241:Change [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.118: However, the Alzheimer disease group had a greater increase per year compared with non-Alzheimer disease control subjects (0.83 vs. 0.57 mg  dl-1  y-1; P < 0.01; Fig. 1). 

Phrase: "However,"

Phrase: "the Alzheimer disease group"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   827   C0441833:Group [Idea or Concept]
   827   C0687744:group [Population Group]
   827   C1257890:Group [Population Group]
   827   C1552516:Group [Health Care Related Organization]
   827   C1705428:Group [Conceptual Entity]
   827   C1705429:Group [Population Group]
   734   C0002395:Alzheimer's Disease [Disease or Syndrome]
   734   C1521724:Alzheimer's Disease [Pathologic Function]

Phrase: "had"

Phrase: "a greater increase per year"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0442805:Increase [Functional Concept]

Phrase: "compared with non-Alzheimer disease control subjects"
Meta Candidates (Total=16; Excluded=0; Pruned=0; Remaining=16)
   778   C0002395:Alzheimer's Disease [Disease or Syndrome]
   778   C0920467:disease control [Therapeutic or Preventive Procedure]
   778   C1521724:Alzheimer's Disease [Pathologic Function]
   748   C0012634:Disease [Disease or Syndrome]
   748   C0243148:control [Qualitative Concept]
   748   C1518422:Non [Functional Concept]
   748   C1550141:Control [Substance]
   748   C1707455:Compared [Activity]
   748   C1882979:Control [Conceptual Entity]
   748   C2587213:Control [Functional Concept]
   748   C3274648:Control [Qualitative Concept]
   714   C0681850:Subject [Group]
   714   C1550501:{Subject} [Idea or Concept]
   714   C1706203:Subject [Idea or Concept]
   714   C2349001:Subject [Human]
   714   C2697811:Subject [Functional Concept]

Phrase: "(0.83"

Phrase: "vs. 0.57 mg  dl-1  y-1"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   818   C0439269:mg dl [Quantitative Concept]
           mg%
   795   C1960952:mg % [Quantitative Concept]
   795   C2346927:Mg++ [Element, Ion, or Isotope,Pharmacologic Substance]
   795   C3642216:/dL [Quantitative Concept]

Phrase: "; P < 0.01"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: "; Fig. 1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.119: This greater rate of increase of blood glucose was preserved in Alzheimer disease when cases with diabetes were excluded from the analysis. 

Phrase: "This greater rate of increase of blood glucose"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0871208:Rate [Activity]
   744   C1521828:Rate [Quantitative Concept]

Phrase: "was"

Phrase: "preserved in Alzheimer disease"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   833   C0002395:Alzheimer's Disease [Disease or Syndrome]
   833   C1521724:Alzheimer's Disease [Pathologic Function]
   770   C0012634:Disease [Disease or Syndrome]
   770   C0033085:Preserved [Laboratory Procedure]
   715 E C1836721:MALS [Finding]
   715 E C3538764:MALS [Gene or Genome]
   715 E C3540595:MAL [Gene or Genome]

Phrase: "when"

Phrase: "cases with diabetes"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   790   C0868928:Cases [Functional Concept]
   790   C1533148:Cases [Quantitative Concept]
   756 E C1706255:CASE [Medical Device]
   756 E C1706256:Case [Conceptual Entity]

Phrase: "were"

Phrase: "excluded from the analysis."
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   770   C0002778:Analysis [Laboratory Procedure]
   770   C0936012:Analysis [Research Activity]
   770   C1524024:analysis [Functional Concept]
   770   C1554077:Excluded [Idea or Concept]
   770   C2828389:Excluded [Activity]
   737 E C0332196:Exclude [Functional Concept]
Processing 00000000.tx.120: Pathology studies: islet amyloid in Alzheimer disease (protocol 3) and brain amyloid in type 2 diabetes (protocol 4) Protocol 3: islet amyloid in Alzheimer disease. 

Phrase: "Pathology studies"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0919386:Pathology studies [Laboratory Procedure]
   983 E C0551718:Pathology study [Clinical Attribute]
   861   C0947630:studies [Laboratory Procedure]
   827 E C0557651:Study [Manufactured Object]
   827 E C2603343:Study [Research Activity]

Phrase: ":"

Phrase: "islet amyloid in Alzheimer disease"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   797   C0002726:amyloid disease [Disease or Syndrome]
   760   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0011560:Amyloid [Pathologic Function]
   760   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(protocol 3"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0442711:Protocol [Intellectual Product]
   861   C1507394:Protocol [Intellectual Product]
   861   C1522729:Protocol [Intellectual Product]
   861   C2348563:Protocol [Intellectual Product]

Phrase: ")"

Phrase: "and"

Phrase: "brain amyloid in type 2 diabetes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0011560:Amyloid [Pathologic Function]
   753   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(protocol 4"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0442711:Protocol [Intellectual Product]
   861   C1507394:Protocol [Intellectual Product]
   861   C1522729:Protocol [Intellectual Product]
   861   C2348563:Protocol [Intellectual Product]

Phrase: ")"

Phrase: "Protocol 3"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0442711:Protocol [Intellectual Product]
   861   C1507394:Protocol [Intellectual Product]
   861   C1522729:Protocol [Intellectual Product]
   861   C2348563:Protocol [Intellectual Product]

Phrase: ":"

Phrase: "islet amyloid in Alzheimer disease."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   797   C0002726:amyloid disease [Disease or Syndrome]
   760   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0011560:Amyloid [Pathologic Function]
   760   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.121: Both the frequency and the extent of islet amyloid were higher in the Alzheimer disease group versus the non-Alzheimer disease group (both P < 0.05; Fig. 2) despite a trend toward a lower BMI in Alzheimer disease (24.3  3.4 vs. 27.1  6.7 kg/m2 Alzheimer disease vs. non-Alzheimer disease; P = 0.06). 

Phrase: "Both"

Phrase: "the frequency"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
  1000   C0376249:frequency [Quantitative Concept]
  1000   C0439603:Frequency [Temporal Concept]
  1000   C0871396:Frequency [Quantitative Concept]
  1000   C1561548:Frequency [Qualitative Concept]
  1000   C1705502:Frequency [Quantitative Concept]
   928 E C0332183:Frequent [Temporal Concept]

Phrase: "and"

Phrase: "the extent of islet amyloid"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0439792:Extent [Spatial Concept]

Phrase: "were"

Phrase: "higher in the Alzheimer disease group"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   719   C0205250:High [Qualitative Concept]
   719   C1299351:High [Qualitative Concept]
   719   C2700149:HIGH [Intellectual Product]

Phrase: "versus"

Phrase: "the non-Alzheimer disease group"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   812   C0441833:Group [Idea or Concept]
   812   C0687744:group [Population Group]
   812   C1257890:Group [Population Group]
   812   C1552516:Group [Health Care Related Organization]
   812   C1705428:Group [Conceptual Entity]
   812   C1705429:Group [Population Group]

Phrase: "("

Phrase: "both P < 0.05"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: "; Fig. 2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")"

Phrase: "despite a trend"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1521798:trend [Temporal Concept]

Phrase: "toward a lower BMI"

Phrase: "in Alzheimer disease"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "(24.3  3.4"

Phrase: "vs. 27.1  6.7 kg/m2 Alzheimer disease"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   812   C0002395:Alzheimer's Disease [Disease or Syndrome]
   812   C1521724:Alzheimer's Disease [Pathologic Function]
   793   C0012634:Disease [Disease or Syndrome]
   737 E C1836721:MALS [Finding]
   737 E C3538764:MALS [Gene or Genome]
   737 E C3540595:MAL [Gene or Genome]

Phrase: "vs. non-Alzheimer disease"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   901   C0002395:Alzheimer's Disease [Disease or Syndrome]
   901   C1521724:Alzheimer's Disease [Pathologic Function]
   827   C0012634:Disease [Disease or Syndrome]
   827   C1518422:Non [Functional Concept]
   771 E C1836721:MALS [Finding]
   771 E C3538764:MALS [Gene or Genome]
   771 E C3540595:MAL [Gene or Genome]

Phrase: "; P = 0.06"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")."
Processing 00000000.tx.122: As expected, the frequency and the extent of islet amyloid was greater in type 2 diabetes (group 3) versus non-type 2 diabetes (group 4; P < 0.001; Fig. 2). 

Phrase: "As"

Phrase: "expected"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1517001:Expected [Idea or Concept]

Phrase: ","

Phrase: "the frequency"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
  1000   C0376249:frequency [Quantitative Concept]
  1000   C0439603:Frequency [Temporal Concept]
  1000   C0871396:Frequency [Quantitative Concept]
  1000   C1561548:Frequency [Qualitative Concept]
  1000   C1705502:Frequency [Quantitative Concept]
   928 E C0332183:Frequent [Temporal Concept]

Phrase: "and"

Phrase: "the extent of islet amyloid"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0439792:Extent [Spatial Concept]

Phrase: "was"

Phrase: "greater in type 2 diabetes"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   760   C0443228:greater [Quantitative Concept]
   760   C1704243:Greater [Quantitative Concept]
   726 E C0549177:Great [Quantitative Concept]

Phrase: "(group 3"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0441869:Group 3 [Intellectual Product]
   861   C0441833:Group [Idea or Concept]
   861   C0687744:group [Population Group]
   861   C1257890:Group [Population Group]
   861   C1552516:Group [Health Care Related Organization]
   861   C1705428:Group [Conceptual Entity]
   861   C1705429:Group [Population Group]

Phrase: ")"

Phrase: "versus"

Phrase: "non-type 2 diabetes"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   923   C0011860:Type 2 Diabetes [Disease or Syndrome]
   875   C1320657:type diabetes [Finding]
   861   C0441730:Type 2 [Classification]
   812   C0011847:Diabetes [Disease or Syndrome]
   812   C0011849:Diabetes [Disease or Syndrome]
   812   C0332307:Type [Qualitative Concept]
   812   C1547052:*Type [Quantitative Concept]

Phrase: "(group 4"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0441876:Group 4 [Intellectual Product]
   861   C0441833:Group [Idea or Concept]
   861   C0687744:group [Population Group]
   861   C1257890:Group [Population Group]
   861   C1552516:Group [Health Care Related Organization]
   861   C1705428:Group [Conceptual Entity]
   861   C1705429:Group [Population Group]

Phrase: "; P < 0.001"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: "; Fig. 2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.123: View larger version (14K): [in this window] [in a new window]  FIG. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(14K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  FIG."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.124: 2. 

Phrase: "2."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]
Processing 00000000.tx.125: Protocol 3: frequency of islet amyloid (top) and extent of islet amyloid (bottom) in patients with Alzheimer disease (AD) and control subjects (non-Alzheimer disease [non-AD]) and in patients with type 2 diabetes (TTDM) and their control group (non-TTDM). 

Phrase: "Protocol 3"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0442711:Protocol [Intellectual Product]
   861   C1507394:Protocol [Intellectual Product]
   861   C1522729:Protocol [Intellectual Product]
   861   C2348563:Protocol [Intellectual Product]

Phrase: ":"

Phrase: "frequency of islet amyloid"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0376249:frequency [Quantitative Concept]
   770   C0439603:Frequency [Temporal Concept]
   770   C0871396:Frequency [Quantitative Concept]
   770   C1561548:Frequency [Qualitative Concept]
   770   C1705502:Frequency [Quantitative Concept]

Phrase: "(top)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1704458:Top [Spatial Concept]

Phrase: "and"

Phrase: "extent of islet amyloid"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0439792:Extent [Spatial Concept]

Phrase: "(bottom"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511276:Bottom [Spatial Concept]
  1000   C1552825:bottom [Idea or Concept]

Phrase: ")"

Phrase: "in patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030705:Patients [Patient or Disabled Group]

Phrase: "with Alzheimer disease"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "(AD"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: ")"

Phrase: "and"

Phrase: "control subjects"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   861   C0243148:control [Qualitative Concept]
   861   C1550141:Control [Substance]
   861   C1882979:Control [Conceptual Entity]
   861   C2587213:Control [Functional Concept]
   861   C3274648:Control [Qualitative Concept]
   827   C0681850:Subject [Group]
   827   C1550501:{Subject} [Idea or Concept]
   827   C1706203:Subject [Idea or Concept]
   827   C2349001:Subject [Human]
   827   C2697811:Subject [Functional Concept]

Phrase: "(non-Alzheimer disease"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   901   C0002395:Alzheimer's Disease [Disease or Syndrome]
   901   C1521724:Alzheimer's Disease [Pathologic Function]
   827   C0012634:Disease [Disease or Syndrome]
   827   C1518422:Non [Functional Concept]
   771 E C1836721:MALS [Finding]
   771 E C3538764:MALS [Gene or Genome]
   771 E C3540595:MAL [Gene or Genome]

Phrase: "[non-AD"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   901   C0002395:Alzheimer's Disease [Disease or Syndrome]
   901   C1521724:Alzheimer's Disease [Pathologic Function]
   827   C0012634:Disease [Disease or Syndrome]
   827   C1518422:Non [Functional Concept]
   771 E C1836721:MALS [Finding]
   771 E C3538764:MALS [Gene or Genome]
   771 E C3540595:MAL [Gene or Genome]

Phrase: "]"

Phrase: ")"

Phrase: "and in patients"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0030705:Patients [Patient or Disabled Group]
   790   C1515981:And [Idea or Concept]

Phrase: "with type 2 diabetes"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0011860:Type 2 Diabetes [Disease or Syndrome]
   913   C1320657:type diabetes [Finding]
   901   C0441730:Type 2 [Classification]
   827   C0011847:Diabetes [Disease or Syndrome]
   827   C0011849:Diabetes [Disease or Syndrome]
   827   C0332307:Type [Qualitative Concept]
   827   C1547052:*Type [Quantitative Concept]

Phrase: "(TTDM"

Phrase: ")"

Phrase: "and"

Phrase: "their control group"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
  1000   C0009932:Control Group [Group]
   861   C0243148:control [Qualitative Concept]
   861   C0441833:Group [Idea or Concept]
   861   C0687744:group [Population Group]
   861   C1257890:Group [Population Group]
   861   C1550141:Control [Substance]
   861   C1552516:Group [Health Care Related Organization]
   861   C1705428:Group [Conceptual Entity]
   861   C1705429:Group [Population Group]
   861   C1882979:Control [Conceptual Entity]
   861   C2587213:Control [Functional Concept]
   861   C3274648:Control [Qualitative Concept]

Phrase: "(non-TTDM"

Phrase: ")."
Processing 00000000.tx.126: Individual values () and medians (line).  

Phrase: "Individual values"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0042295:Values [Qualitative Concept]
   827 E C1522609:Value [Quantitative Concept]

Phrase: "("

Phrase: ")"

Phrase: "and"

Phrase: "medians"
Meta Candidates (Total=5; Excluded=4; Pruned=0; Remaining=1)
  1000   C0549183:medians [Spatial Concept]
   966 E C0876920:Median [Quantitative Concept]
   966 E C2347635:Median [Quantitative Concept]
   966 E C2348144:Median [Quantitative Concept]
   966 E C2939193:Median [Spatial Concept]

Phrase: "(line"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205132:Line [Spatial Concept]
  1000   C1550648:Line [Substance]
  1000   C1552960:Line [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.127: Inclusion of cases in this autopsy protocol was blinded with respect to the presence or absence of diabetes but with the requirement that FPG be documented. 

Phrase: "Inclusion of cases"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1512693:Inclusion [Qualitative Concept]

Phrase: "in this autopsy protocol"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0442711:Protocol [Intellectual Product]
   861   C1507394:Protocol [Intellectual Product]
   861   C1522729:Protocol [Intellectual Product]
   861   C2348563:Protocol [Intellectual Product]

Phrase: "was"

Phrase: "blinded with respect to the presence"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   753   C0150108:Blinded [Research Activity]
   753   C0392148:Presence [Therapeutic or Preventive Procedure]
   753   C0679133:respect [Social Behavior]
   719 E C0456909:Blind [Disease or Syndrome]
   719 E C0525065:blind [Patient or Disabled Group]

Phrase: "or"

Phrase: "absence of diabetes"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0332197:absence [Quantitative Concept]
   790   C1689985:Absence [Anatomical Abnormality]
   718 E C2699517:ABSENT [Finding]

Phrase: "but with the requirement"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0233535:but [Mental or Behavioral Dysfunction]
   770   C1514873:Requirement [Functional Concept]

Phrase: "that FPG"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   901   C0202042:Plasma glucose [Laboratory Procedure]
   901   C0455280:plasma glucose [Laboratory or Test Result]
   827   C0015663:Fasting [Finding]
   827   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   827   C0032105:Plasma [Body Substance]
   827   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]
   827   C1550565:fasting [Intellectual Product]
   793 E C0456962:Fast [Qualitative Concept]

Phrase: "be"

Phrase: "documented."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C1301725:Documented [Health Care Activity]
  1000   C1609436:documented [Idea or Concept]
   966 E C1301746:document [Intellectual Product]
   966 E C1547673:Document [Intellectual Product]
Processing 00000000.tx.128: Subsequent analysis of the FPG concentrations revealed that the prevalence of type 2 diabetes (FPG >126 mg/dl) in the Alzheimer disease group was 32% and in non-Alzheimer disease cases was 14% (P = 0.15). 

Phrase: "Subsequent analysis of the FPG concentrations"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   744   C0002778:Analysis [Laboratory Procedure]
   744   C0936012:Analysis [Research Activity]
   744   C1524024:analysis [Functional Concept]

Phrase: "revealed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443289:Revealed [Qualitative Concept]

Phrase: "that"

Phrase: "the prevalence of type 2 diabetes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0033105:Prevalence [Quantitative Concept]
   753   C0220900:prevalence [Quantitative Concept]

Phrase: "(FPG"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   901   C0202042:Plasma glucose [Laboratory Procedure]
   901   C0455280:plasma glucose [Laboratory or Test Result]
   827   C0015663:Fasting [Finding]
   827   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   827   C0032105:Plasma [Body Substance]
   827   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]
   827   C1550565:fasting [Intellectual Product]
   793 E C0456962:Fast [Qualitative Concept]

Phrase: ">126 mg/"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0439269:mg% [Quantitative Concept]
   861   C1960952:mg % [Quantitative Concept]
   861   C2346927:Mg++ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "dl) in the Alzheimer disease group"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C3642216:/dL [Quantitative Concept]

Phrase: "was"

Phrase: "32%"

Phrase: "and in non-Alzheimer disease cases"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   790   C0002395:Alzheimer's Disease [Disease or Syndrome]
   790   C1521724:Alzheimer's Disease [Pathologic Function]
   753   C0012634:Disease [Disease or Syndrome]
   753   C0868928:Cases [Functional Concept]
   753   C1515981:And [Idea or Concept]
   753   C1518422:Non [Functional Concept]
   753   C1533148:Cases [Quantitative Concept]
   719 E C1706255:CASE [Medical Device]
   719 E C1706256:Case [Conceptual Entity]

Phrase: "was"

Phrase: "14%"

Phrase: "(P = 0.15"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")."
Processing 00000000.tx.129: The mean FPG in Alzheimer disease was not higher than in control subjects (126  8 vs. 110  6 mg/dl; P = 0.09). 

Phrase: "The mean FPG in Alzheimer disease"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   770   C0202042:Plasma glucose [Laboratory Procedure]
   770   C0455280:plasma glucose [Laboratory or Test Result]
   744   C0015663:Fasting [Finding]
   744   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   744   C0032105:Plasma [Body Substance]
   744   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]
   744   C1550565:fasting [Intellectual Product]
   711 E C0456962:Fast [Qualitative Concept]

Phrase: "was"

Phrase: "not higher than"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   756   C0205250:High [Qualitative Concept]
   756   C1299351:High [Qualitative Concept]
   756   C2700149:HIGH [Intellectual Product]
   706 E C0489786:Height [Organism Attribute]

Phrase: "in control subjects"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   861   C0243148:control [Qualitative Concept]
   861   C1550141:Control [Substance]
   861   C1882979:Control [Conceptual Entity]
   861   C2587213:Control [Functional Concept]
   861   C3274648:Control [Qualitative Concept]
   827   C0681850:Subject [Group]
   827   C1550501:{Subject} [Idea or Concept]
   827   C1706203:Subject [Idea or Concept]
   827   C2349001:Subject [Human]
   827   C2697811:Subject [Functional Concept]

Phrase: "(126  8"

Phrase: "vs. 110  6 mg/dl"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0439269:mg dl [Quantitative Concept]
   812   C3642216:/dL [Quantitative Concept]

Phrase: "; P = 0.09"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")."
Processing 00000000.tx.130: Protocol 4: brain amyloid in type 2 diabetes. 

Phrase: "Protocol 4"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0442711:Protocol [Intellectual Product]
   861   C1507394:Protocol [Intellectual Product]
   861   C1522729:Protocol [Intellectual Product]
   861   C2348563:Protocol [Intellectual Product]

Phrase: ":"

Phrase: "brain amyloid in type 2 diabetes."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0011560:Amyloid [Pathologic Function]
   753   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.131: The density of diffuse or neuritic plaques or NFT was not different between patients with type 2 diabetes versus nondiabetic control subjects (P = 0.07, P = 0.3, and P = 0.4, respectively; Table 3). 

Phrase: "The density of diffuse"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0178587:density [Quantitative Concept]

Phrase: "or"

Phrase: "neuritic plaques"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0333463:Neuritic Plaques [Acquired Abnormality]
           plaques
   827 E C0011389:Plaque [Disease or Syndrome]
   827 E C0332461:Plaque [Finding]
   789   C0027813:Neuritides [Disease or Syndrome]

Phrase: "or"

Phrase: "NFT"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0085400:Neurofibrillary tangle [Acquired Abnormality]
  1000   C3543859:neurofibrillary tangle [Cell Component]

Phrase: "was"

Phrase: "not different between patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1705242:Different [Qualitative Concept]

Phrase: "with type 2 diabetes"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0011860:Type 2 Diabetes [Disease or Syndrome]
   913   C1320657:type diabetes [Finding]
   901   C0441730:Type 2 [Classification]
   827   C0011847:Diabetes [Disease or Syndrome]
   827   C0011849:Diabetes [Disease or Syndrome]
   827   C0332307:Type [Qualitative Concept]
   827   C1547052:*Type [Quantitative Concept]

Phrase: "versus"

Phrase: "nondiabetic control subjects"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   793   C0681850:Subject [Group]
   793   C1550501:{Subject} [Idea or Concept]
   793   C1706203:Subject [Idea or Concept]
   793   C2349001:Subject [Human]
   793   C2697811:Subject [Functional Concept]

Phrase: "(P = 0.07,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: "P = 0.3,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: "and"

Phrase: "P = 0.4,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: "respectively"

Phrase: "; Table 3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.132: As expected, the density of neuritic plaques, diffuse plaques, and NFT was greater (P < 0.05) in Alzheimer disease cases (group 1) versus non-Alzheimer disease (group 2). 

Phrase: "As"

Phrase: "expected"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1517001:Expected [Idea or Concept]

Phrase: ","

Phrase: "the density of neuritic plaques,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0178587:density [Quantitative Concept]
   745   C1817256:dense plaque [Cell Component]

Phrase: "diffuse plaques,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0333463:plaques [Acquired Abnormality]
   827 E C0011389:Plaque [Disease or Syndrome]
   827 E C0332461:Plaque [Finding]

Phrase: "and"

Phrase: "NFT"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0085400:Neurofibrillary tangle [Acquired Abnormality]
  1000   C3543859:neurofibrillary tangle [Cell Component]

Phrase: "was"

Phrase: "greater"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0443228:greater [Quantitative Concept]
  1000   C1704243:Greater [Quantitative Concept]
   966 E C0549177:Great [Quantitative Concept]

Phrase: "(P < 0.05"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: "in Alzheimer disease cases"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   827   C0868928:Cases [Functional Concept]
   827   C1533148:Cases [Quantitative Concept]
   793 E C1706255:CASE [Medical Device]
   793 E C1706256:Case [Conceptual Entity]
   734   C0002395:Alzheimer's Disease [Disease or Syndrome]
   734   C1521724:Alzheimer's Disease [Pathologic Function]

Phrase: "(group 1"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0441861:Group 1 [Intellectual Product]
   861   C0441833:Group [Idea or Concept]
   861   C0687744:group [Population Group]
   861   C1257890:Group [Population Group]
   861   C1552516:Group [Health Care Related Organization]
   861   C1705428:Group [Conceptual Entity]
   861   C1705429:Group [Population Group]

Phrase: ")"

Phrase: "versus"

Phrase: "non-Alzheimer disease"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   901   C0002395:Alzheimer's Disease [Disease or Syndrome]
   901   C1521724:Alzheimer's Disease [Pathologic Function]
   827   C0012634:Disease [Disease or Syndrome]
   827   C1518422:Non [Functional Concept]
   771 E C1836721:MALS [Finding]
   771 E C3538764:MALS [Gene or Genome]
   771 E C3540595:MAL [Gene or Genome]

Phrase: "(group 2"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0441865:Group 2 [Intellectual Product]
   861   C0441833:Group [Idea or Concept]
   861   C0687744:group [Population Group]
   861   C1257890:Group [Population Group]
   861   C1552516:Group [Health Care Related Organization]
   861   C1705428:Group [Conceptual Entity]
   861   C1705429:Group [Population Group]

Phrase: ")."
Processing 00000000.tx.133: View this table: [in this window] [in a new window]  TABLE 3 Brain pathology  In 22 of 28 type 2 diabetes cases, the year of diagnosis of diabetes was documented. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "this table"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0039224:Table [Manufactured Object]
  1000   C1706073:Table [Medical Device]
  1000   C1706074:Table [Intellectual Product]

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  TABLE 3 Brain pathology  In 22 of 28 type 2 diabetes cases,"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   753   C0006119:Brain Pathology [Pathologic Function]
   751   C1310510:Brain-2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   736   C0006104:Brain [Body Part, Organ, or Organ Component]
   736   C0030664:Pathology [Biomedical Occupation or Discipline]
   736   C0205469:pathology [Functional Concept]
   736   C0677042:pathology [Pathologic Function]
   736   C1269537:Brain [Body Part, Organ, or Organ Component]
   734   C0230041:brain case [Body Space or Junction]

Phrase: "the year of diagnosis of diabetes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0439234:year [Temporal Concept]
   753   C0439508:/year [Temporal Concept]

Phrase: "was"

Phrase: "documented."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C1301725:Documented [Health Care Activity]
  1000   C1609436:documented [Idea or Concept]
   966 E C1301746:document [Intellectual Product]
   966 E C1547673:Document [Intellectual Product]
Processing 00000000.tx.134: Diffuse plaques were detected in 12 and neuritic plaques in 7 of these 22 cases of type 2 diabetes with a documented age of onset of diabetes. 

Phrase: "Diffuse plaques"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0333463:plaques [Acquired Abnormality]
   827 E C0011389:Plaque [Disease or Syndrome]
   827 E C0332461:Plaque [Finding]

Phrase: "were"

Phrase: "detected in 12"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0442726:Detected [Finding]
   790   C1511790:Detected [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "neuritic plaques in 7 of these 22 cases of type 2 diabetes"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   753   C0333463:Neuritic Plaques [Acquired Abnormality]
           plaques
   703 E C0011389:Plaque [Disease or Syndrome]
   703 E C0332461:Plaque [Finding]

Phrase: "with a documented age"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0001779:Age [Organism Attribute]

Phrase: "of onset"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332162:Onset [Qualitative Concept]

Phrase: "of diabetes."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0011847:Diabetes [Disease or Syndrome]
  1000   C0011849:Diabetes [Disease or Syndrome]
Processing 00000000.tx.135: There was a positive relationship between duration of known diabetes and the extent of diffuse plaques (rs = 0.8, P < 0.001) or neuritic plaques (rs = 0.9, P < 0.01) in these cases (Fig. 3). 

Phrase: "There"

Phrase: "was"

Phrase: "a positive relationship between duration of known diabetes"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   744   C0439849:Relationship [Qualitative Concept]
   744   C1705630:Relationship [Idea or Concept]
   744   C1706279:Relationship [Idea or Concept]
   744   C3540605:Relationship [Intellectual Product]

Phrase: "and"

Phrase: "the extent of diffuse plaques"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0439792:Extent [Spatial Concept]

Phrase: "(rs = 0.8,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C3539879:RS [Idea or Concept]

Phrase: "P < 0.001"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: "or"

Phrase: "neuritic plaques"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0333463:Neuritic Plaques [Acquired Abnormality]
           plaques
   827 E C0011389:Plaque [Disease or Syndrome]
   827 E C0332461:Plaque [Finding]
   789   C0027813:Neuritides [Disease or Syndrome]

Phrase: "(rs = 0.9,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C3539879:RS [Idea or Concept]

Phrase: "P < 0.01"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: "in these cases"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0868928:Cases [Functional Concept]
  1000   C1533148:Cases [Quantitative Concept]
   966 E C1706255:CASE [Medical Device]
   966 E C1706256:Case [Conceptual Entity]

Phrase: "(Fig. 3"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.136: In contrast, in neither type 2 diabetes nor non-type 2 diabetes was there a correlation with the density of either of these plaques and the age at death. 

Phrase: "In contrast,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1979874:Contrast [Qualitative Concept]

Phrase: "in neither type 2 diabetes"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0011860:Type 2 Diabetes [Disease or Syndrome]
   913   C1320657:type diabetes [Finding]
   901   C0441730:Type 2 [Classification]
   827   C0011847:Diabetes [Disease or Syndrome]
   827   C0011849:Diabetes [Disease or Syndrome]
   827   C0332307:Type [Qualitative Concept]
   827   C1547052:*Type [Quantitative Concept]

Phrase: "nor"

Phrase: "non-type 2 diabetes"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   923   C0011860:Type 2 Diabetes [Disease or Syndrome]
   875   C1320657:type diabetes [Finding]
   861   C0441730:Type 2 [Classification]
   812   C0011847:Diabetes [Disease or Syndrome]
   812   C0011849:Diabetes [Disease or Syndrome]
   812   C0332307:Type [Qualitative Concept]
   812   C1547052:*Type [Quantitative Concept]

Phrase: "was"

Phrase: "there"

Phrase: "a correlation with the density of either of these plaques"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   739   C1707520:Correlation [Qualitative Concept]

Phrase: "and"

Phrase: "the age at death."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   909   C1543138:Age at death [Clinical Attribute]
   909   C1546180:Age at death [Clinical Attribute]
   819   C0742983:age death [Finding]
   770   C0001779:Age [Organism Attribute]
Processing 00000000.tx.137: View larger version (12K): [in this window] [in a new window]  FIG. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(12K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  FIG."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.138: 3. 

Phrase: "3."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]
Processing 00000000.tx.139: Protocol 4: relationship between the density of diffuse plaques (rs = 0.8, P < 0.001; top) or neuritic plaques (rs = 0.9, P < 0.01; bottom) versus the duration of diabetes in patients with type 2 diabetes. 

Phrase: "Protocol 4"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0442711:Protocol [Intellectual Product]
   861   C1507394:Protocol [Intellectual Product]
   861   C1522729:Protocol [Intellectual Product]
   861   C2348563:Protocol [Intellectual Product]

Phrase: ":"

Phrase: "relationship between the density of diffuse plaques"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0439849:Relationship [Qualitative Concept]
   748   C1705630:Relationship [Idea or Concept]
   748   C1706279:Relationship [Idea or Concept]
   748   C3540605:Relationship [Intellectual Product]

Phrase: "(rs = 0.8,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C3539879:RS [Idea or Concept]

Phrase: "P < 0.001"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: "; top)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1704458:Top [Spatial Concept]

Phrase: "or"

Phrase: "neuritic plaques"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0333463:Neuritic Plaques [Acquired Abnormality]
           plaques
   827 E C0011389:Plaque [Disease or Syndrome]
   827 E C0332461:Plaque [Finding]
   789   C0027813:Neuritides [Disease or Syndrome]

Phrase: "(rs = 0.9,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C3539879:RS [Idea or Concept]

Phrase: "P < 0.01"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: "; bottom"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511276:Bottom [Spatial Concept]
  1000   C1552825:bottom [Idea or Concept]

Phrase: ")"

Phrase: "versus"

Phrase: "the duration of diabetes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0449238:Duration [Temporal Concept]
   770   C2926735:Duration [Pharmacologic Substance]

Phrase: "in patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030705:Patients [Patient or Disabled Group]

Phrase: "with type 2 diabetes."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0011860:Type 2 Diabetes [Disease or Syndrome]
   913   C1320657:type diabetes [Finding]
   901   C0441730:Type 2 [Classification]
   827   C0011847:Diabetes [Disease or Syndrome]
   827   C0011849:Diabetes [Disease or Syndrome]
   827   C0332307:Type [Qualitative Concept]
   827   C1547052:*Type [Quantitative Concept]
Processing 00000000.tx.140: Cases were included only when the duration of diabetes was documented and the respective plaque type was detected (y did not equal zero).   

Phrase: "Cases"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0868928:Cases [Functional Concept]
  1000   C1533148:Cases [Quantitative Concept]
   966 E C1706255:CASE [Medical Device]
   966 E C1706256:Case [Conceptual Entity]

Phrase: "were"

Phrase: "included"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0332257:included [Functional Concept]
  1000   C3538986:INCLUDED [Gene or Genome]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "only"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205171:Only [Quantitative Concept]
  1000   C1720467:Only [Intellectual Product]

Phrase: "when"

Phrase: "the duration of diabetes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0449238:Duration [Temporal Concept]
   770   C2926735:Duration [Pharmacologic Substance]

Phrase: "was"

Phrase: "documented"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C1301725:Documented [Health Care Activity]
  1000   C1609436:documented [Idea or Concept]
   966 E C1301746:document [Intellectual Product]
   966 E C1547673:Document [Intellectual Product]

Phrase: "and"

Phrase: "the respective plaque type"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0332307:Type [Qualitative Concept]
   827   C1547052:*Type [Quantitative Concept]

Phrase: "was"

Phrase: "detected"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0442726:Detected [Finding]
  1000   C1511790:Detected [Therapeutic or Preventive Procedure]

Phrase: "(y"

Phrase: "did"

Phrase: "not equal zero"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0919414:Zero [Quantitative Concept]
   734   C0242503:Not Equal [Qualitative Concept]

Phrase: ")."
Processing 00000000.tx.141: DISCUSSION TOP ABSTRACT RESEARCH DESIGN AND METHODS RESULTS DISCUSSION REFERENCES  We report that the prevalence of both type 2 diabetes and IFG are increased in a well-characterized community cohort of patients with Alzheimer disease from southeast Minnesota. 

Phrase: "DISCUSSION TOP ABSTRACT RESEARCH DESIGN"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   840   C0035171:Research Design [Research Activity]
   804   C0035168:research [Research Activity]
   804   C0242481:Research [Research Activity]
   804   C1707689:Design [Activity]
   804   C2983265:DESIGN [Intellectual Product]

Phrase: "AND"

Phrase: "METHODS RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "We"

Phrase: "report"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0684224:Report [Intellectual Product]
  1000   C0700287:Report [Health Care Activity]
  1000   C3273238:Report [Intellectual Product]

Phrase: "that"

Phrase: "the prevalence of both type 2 diabetes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0033105:Prevalence [Quantitative Concept]
   748   C0220900:prevalence [Quantitative Concept]

Phrase: "and"

Phrase: "IFG"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1334085:IFG [Gene or Genome]
  1000   C1708411:IFG [Gene or Genome]

Phrase: "are"

Phrase: "increased in a well-characterized community cohort of patients"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   742   C0009462:Community [Geographic Area]
   742   C0030705:Patients [Patient or Disabled Group]
   742   C0205170:Well [Qualitative Concept]
   742   C0205217:Increased [Quantitative Concept]
   742   C0442805:Increased [Functional Concept]
   742   C0599755:Cohort [Population Group]
   742   C1880022:Characterized [Activity]
   742   C3146287:Well [Manufactured Object]
   715   C0456394:Community acquired [Qualitative Concept]

Phrase: "with Alzheimer disease"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "from southeast Minnesota."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0026183:Minnesota [Geographic Area]
Processing 00000000.tx.142: In the related pathology studies, we also report an increased frequency of islet amyloid in patients with Alzheimer disease. 

Phrase: "In the related pathology studies,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   901   C0919386:Pathology studies [Laboratory Procedure]
   884 E C0551718:Pathology study [Clinical Attribute]
   827   C0947630:studies [Laboratory Procedure]
   793 E C0557651:Study [Manufactured Object]
   793 E C2603343:Study [Research Activity]

Phrase: "we also"

Phrase: "report"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0684224:Report [Intellectual Product]
  1000   C0700287:Report [Health Care Activity]
  1000   C3273238:Report [Intellectual Product]

Phrase: "an increased frequency of islet amyloid"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0376249:frequency [Quantitative Concept]
   753   C0439603:Frequency [Temporal Concept]
   753   C0871396:Frequency [Quantitative Concept]
   753   C1561548:Frequency [Qualitative Concept]
   753   C1705502:Frequency [Quantitative Concept]

Phrase: "in patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030705:Patients [Patient or Disabled Group]

Phrase: "with Alzheimer disease."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.143: However, brain amyloid was not increased in patients with type 2 diabetes versus non-type 2 diabetes, but the density of diffuse and neuritic plaques, when present, was associated with the duration of diabetes. 

Phrase: "However,"

Phrase: "brain amyloid"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0011560:Amyloid [Pathologic Function]
   861   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "was"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "increased in patients"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C0030705:Patients [Patient or Disabled Group]
   790   C0205217:Increased [Quantitative Concept]
   790   C0442805:Increased [Functional Concept]
   718 E C1517378:Gain [Quantitative Concept]

Phrase: "with type 2 diabetes"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0011860:Type 2 Diabetes [Disease or Syndrome]
   913   C1320657:type diabetes [Finding]
   901   C0441730:Type 2 [Classification]
   827   C0011847:Diabetes [Disease or Syndrome]
   827   C0011849:Diabetes [Disease or Syndrome]
   827   C0332307:Type [Qualitative Concept]
   827   C1547052:*Type [Quantitative Concept]

Phrase: "versus"

Phrase: "non-type 2 diabetes,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   923   C0011860:Type 2 Diabetes [Disease or Syndrome]
   875   C1320657:type diabetes [Finding]
   861   C0441730:Type 2 [Classification]
   812   C0011847:Diabetes [Disease or Syndrome]
   812   C0011849:Diabetes [Disease or Syndrome]
   812   C0332307:Type [Qualitative Concept]
   812   C1547052:*Type [Quantitative Concept]

Phrase: "but"

Phrase: "the density of diffuse"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0178587:density [Quantitative Concept]

Phrase: "and"

Phrase: "neuritic plaques,"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0333463:Neuritic Plaques [Acquired Abnormality]
           plaques
   827 E C0011389:Plaque [Disease or Syndrome]
   827 E C0332461:Plaque [Finding]
   789   C0027813:Neuritides [Disease or Syndrome]

Phrase: "when"

Phrase: "present,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0150312:Present [Quantitative Concept]
  1000   C0449450:Present [Idea or Concept]

Phrase: "was"

Phrase: "associated with the duration of diabetes."
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   790   C0332281:Associated with [Qualitative Concept]
           Associated
   753   C0011847:Diabetes [Disease or Syndrome]
   753   C0011849:Diabetes [Disease or Syndrome]
   753   C0449238:Duration [Temporal Concept]
   753   C2926735:Duration [Pharmacologic Substance]
   719 E C0750490:Associate [Idea or Concept]
   719 E C1706221:Associate [Professional or Occupational Group]
Processing 00000000.tx.144: The studies were initially undertaken to test the hypothesis that there may be a shared predisposition for development of islet amyloid and brain amyloid in patients with Alzheimer disease and type 2 diabetes, respectively. 

Phrase: "The studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0947630:studies [Laboratory Procedure]
   966 E C0557651:Study [Manufactured Object]
   966 E C2603343:Study [Research Activity]

Phrase: "were"

Phrase: "initially"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205265:Initially [Temporal Concept]

Phrase: "undertaken"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "test"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0022885:Test [Laboratory Procedure]
  1000   C0039593:Test [Functional Concept]
  1000   C0392366:test [Intellectual Product]

Phrase: "the hypothesis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1512571:Hypothesis [Idea or Concept]

Phrase: "that there"

Phrase: "may"

Phrase: "be"

Phrase: "a shared predisposition for development of islet amyloid"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0012655:Predisposition [Clinical Attribute]
   744   C0220898:Predisposition [Organism Attribute]

Phrase: "and"

Phrase: "brain amyloid in patients"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C0011560:Amyloid [Pathologic Function]
   770   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "with Alzheimer disease"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "and"

Phrase: "type 2 diabetes,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0011860:Type 2 Diabetes [Disease or Syndrome]
   913   C1320657:type diabetes [Finding]
   901   C0441730:Type 2 [Classification]
   827   C0011847:Diabetes [Disease or Syndrome]
   827   C0011849:Diabetes [Disease or Syndrome]
   827   C0332307:Type [Qualitative Concept]
   827   C1547052:*Type [Quantitative Concept]

Phrase: "respectively."
Processing 00000000.tx.145: This postulate arose from the close resemblance in pathology in the brain in Alzheimer disease and islets in type 2 diabetes. 

Phrase: "This"

Phrase: "postulate"

Phrase: "arose from the close resemblance"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0587267:Close [Functional Concept]

Phrase: "in pathology"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0030664:Pathology [Biomedical Occupation or Discipline]
  1000   C0205469:pathology [Functional Concept]
  1000   C0677042:pathology [Pathologic Function]
   928 E C1521733:Pathologic [Functional Concept]

Phrase: "in the brain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0006104:Brain [Body Part, Organ, or Organ Component]
  1000   C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "in Alzheimer disease"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "and"

Phrase: "islets in type 2 diabetes."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   781   C1425576:ISLET 2 [Gene or Genome]
Processing 00000000.tx.146: In both diseases, a locally expressed protein (AP in Alzheimer disease and IAPP in type 2 diabetes) is deposited in amyloid deposits with a gradual decline in the number of cells of the respective proteins. 

Phrase: "In both diseases,"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0012634:Diseases [Disease or Syndrome]
   928 E C1836721:MALS [Finding]
   928 E C3538764:MALS [Gene or Genome]
   928 E C3540595:MAL [Gene or Genome]

Phrase: "a locally expressed protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(AP in Alzheimer disease"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   891   C0611285:Alzheimer's Disease Amyloid Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   806   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   760   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "IAPP in type 2 diabetes"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   814   C0063684:Islet Amyloid Polypeptide [Amino Acid, Peptide, or Protein,Hormone]
   814   C1415831:ISLET AMYLOID POLYPEPTIDE [Gene or Genome]
   774   C1425576:ISLET 2 [Gene or Genome]
   748   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0011560:Amyloid [Pathologic Function]
   748   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C1305923:Polypeptide [Amino Acid, Peptide, or Protein]

Phrase: ")"

Phrase: "is"

Phrase: "deposited in amyloid"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   841   C2936349:Deposit, Amyloid [Acquired Abnormality]
   790   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C0011560:Amyloid [Pathologic Function]
   790   C0333562:deposited [Functional Concept]
   790   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "deposits with a gradual decline"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0333562:Deposit [Functional Concept]
   760   C0439833:Gradual [Qualitative Concept]

Phrase: "in the number"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0237753:*Number [Quantitative Concept]
  1000   C0449788:Number [Quantitative Concept]

Phrase: "of cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "of the respective proteins."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.147: Amyloid deposits of both AP and IAPP (or more likely their oligomeric precursors) are cytotoxic (22,23,3540) by a mechanism that may relate to membrane disruption (2527). 

Phrase: "Amyloid"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0011560:Amyloid [Pathologic Function]
  1000   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "deposits of both AP"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   806   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   797   C2936349:Amyloid Deposits [Acquired Abnormality]
   760   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0011560:Amyloid [Pathologic Function]
   760   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0333562:Deposit [Functional Concept]
   760   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "IAPP"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0063684:Islet Amyloid Polypeptide [Amino Acid, Peptide, or Protein,Hormone]
  1000   C1415831:ISLET AMYLOID POLYPEPTIDE [Gene or Genome]
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1305923:Polypeptide [Amino Acid, Peptide, or Protein]

Phrase: "("

Phrase: "or"

Phrase: "more likely"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205172:More [Functional Concept]
   861   C0332148:Likely [Qualitative Concept]
   861   C0750492:Likely [Idea or Concept]

Phrase: "their oligomeric precursors"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1709634:Precursor [Idea or Concept]

Phrase: ")"

Phrase: "are"

Phrase: "cytotoxic"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0677881:Cytotoxic [Therapeutic or Preventive Procedure]
  1000   C1511636:cytotoxic [Functional Concept]

Phrase: "(22,"

Phrase: "23,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450348:23 [Quantitative Concept]

Phrase: "3540"

Phrase: ")"

Phrase: "by a mechanism"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0441712:Mechanism [Functional Concept]
  1000   C1706376:Mechanism [Manufactured Object]

Phrase: "that"

Phrase: "may"

Phrase: "relate to membrane disruption"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0025255:Membrane [Tissue]
   770   C0163712:Relate [Organic Chemical]
   770   C0332453:Disruption [Functional Concept]
   770   C0596901:Membrane [Cell Component]
   770   C1706182:Membrane [Manufactured Object]

Phrase: "(2527"

Phrase: ")."
Processing 00000000.tx.148: However, as yet, there is still no clear explanation for why these amyloidogenic proteins form amyloid fibrils in those who develop type 2 diabetes and Alzheimer disease. 

Phrase: "However,"

Phrase: "as yet,"

Phrase: "there"

Phrase: "is"

Phrase: "still"

Phrase: "no clear explanation for why"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0681841:Explanation [Intellectual Product]

Phrase: "these amyloidogenic proteins"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1456454:Amyloidogenic Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   861   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "form"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0348078:Form [Qualitative Concept]
  1000   C0376315:Form [Manufactured Object]
  1000   C1522492:Form [Functional Concept]

Phrase: "amyloid fibrils in those"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   833   C1449651:Amyloid Fibrils [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C0225328:fibrils [Cell Component]
   737 E C1948066:Fibril [Physical Object]

Phrase: "who"

Phrase: "develop"

Phrase: "type 2 diabetes"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0011860:Type 2 Diabetes [Disease or Syndrome]
   913   C1320657:type diabetes [Finding]
   901   C0441730:Type 2 [Classification]
   827   C0011847:Diabetes [Disease or Syndrome]
   827   C0011849:Diabetes [Disease or Syndrome]
   827   C0332307:Type [Qualitative Concept]
   827   C1547052:*Type [Quantitative Concept]

Phrase: "and"

Phrase: "Alzheimer disease."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.149: Because both of these proteins spontaneously form amyloid fibrils in vitro in the aqueous environment present in the cell, mechanisms must exist in health to prevent this aggregation, which presumably include the chaperone protein pathway (30). 

Phrase: "Because"

Phrase: "both of these proteins spontaneously"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0238767:Both [Spatial Concept]
   760   C1706086:Both [Qualitative Concept]

Phrase: "form"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0348078:Form [Qualitative Concept]
  1000   C0376315:Form [Manufactured Object]
  1000   C1522492:Form [Functional Concept]

Phrase: "amyloid fibrils"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C1449651:Amyloid Fibrils [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0225328:fibrils [Cell Component]
   827 E C1948066:Fibril [Physical Object]

Phrase: "in vitro in the aqueous environment present"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   778   C0021135:In Vitro [Intellectual Product]
   778   C1533691:in vitro [Qualitative Concept]
           vitro
   778   C2827718:In Vitro [Functional Concept]

Phrase: "in the cell,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0007634:Cell [Cell]
  1000   C1269647:Cell [Cell]
  1000   C1704653:Cell [Medical Device]
  1000   C1948049:Cell [Spatial Concept]

Phrase: "mechanisms"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0441712:Mechanisms [Functional Concept]
   966 E C1706376:Mechanism [Manufactured Object]

Phrase: "must"

Phrase: "exist in health to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0018684:Health [Idea or Concept]
   770   C2987476:Exist [Conceptual Entity]

Phrase: "prevent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0309872:PREVENT [Pharmacologic Substance]

Phrase: "this aggregation,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0332621:Aggregation [Functional Concept]
  1000   C0439168:% aggregation [Quantitative Concept]
   928 E C0205418:Aggregate [Qualitative Concept]

Phrase: "which presumably"

Phrase: "include"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0332257:include [Functional Concept]
  1000   C1552866:include [Idea or Concept]
  1000   C2700399:Include [Activity]

Phrase: "the chaperone protein pathway"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1704259:Pathway [Molecular Function]
   827   C1705987:Pathway [Conceptual Entity]

Phrase: "(30"

Phrase: ")."
Processing 00000000.tx.150: All newly synthesized proteins are bound by a chaperone protein that has the function of preventing insoluble proteins (e.g., IAPP and AP) from aggregating in cells and trafficking the protein to its appropriate subcellular location. 

Phrase: "All newly synthesized proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "are"

Phrase: "bound by a chaperone protein"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   797   C0038164:Protein A [Amino Acid, Peptide, or Protein,Immunologic Factor,Indicator, Reagent, or Diagnostic Aid]
   797   C0522527:Protein bound [Qualitative Concept]
   760   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0243041:Chaperone [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0332297:bound [Spatial Concept]
   760   C1145667:Bound [Activity]
   760   C1167622:Bound [Molecular Function]
   760   C1689898:% bound [Quantitative Concept]
   760   C2349209:Bound [Conceptual Entity]

Phrase: "that"

Phrase: "has"

Phrase: "the function of preventing insoluble proteins"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   783   C0815043:function proteins [Amino Acid, Peptide, or Protein]
   767 E C1527118:Protein Function [Molecular Function]
   753   C0031843:function [Physiologic Function]
   753   C0542341:Function [Functional Concept]
   753   C0700205:FUNCTION [Classification]
   753   C1705273:Function [Intellectual Product]

Phrase: "("

Phrase: "e.g."

Phrase: ","

Phrase: "IAPP"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0063684:Islet Amyloid Polypeptide [Amino Acid, Peptide, or Protein,Hormone]
  1000   C1415831:ISLET AMYLOID POLYPEPTIDE [Gene or Genome]
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1305923:Polypeptide [Amino Acid, Peptide, or Protein]

Phrase: "and"

Phrase: "AP"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   861   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: ")"

Phrase: "from aggregating"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205418:aggregating [Qualitative Concept]

Phrase: "in cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "and"

Phrase: "trafficking"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0599896:trafficking [Cell Function]

Phrase: "the protein to its appropriate subcellular location."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   774   C1325816:protein location [Cell Component]
   748   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.151: Chaperon proteins have been described as promiscuous because each chaperone protein binds and traffics numerous different proteins with structurally similar properties (30). 

Phrase: "Chaperon proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "have"

Phrase: "been"

Phrase: "described as promiscuous"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C1552738:described [Idea or Concept]
   718   C0562558:Promiscuity, NOS [Social Behavior]
   718   C2919102:Promiscuity [Finding]

Phrase: "because"

Phrase: "each chaperone protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "binds"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1145667:Bind [Activity]
  1000   C1167622:bind [Molecular Function]

Phrase: "and"

Phrase: "traffics"

Phrase: "numerous different proteins with structurally similar properties"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(30"

Phrase: ")."
Processing 00000000.tx.152: As individual chaperone proteins traffic structurally similar peptides, it is possible that IAPP and AP share one or more chaperone proteins. 

Phrase: "As individual chaperone proteins traffic structurally similar peptides,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   795   C0030956:Peptides [Amino Acid, Peptide, or Protein]

Phrase: "it"

Phrase: "is"

Phrase: "possible"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0332149:Possible [Qualitative Concept]
  1000   C1705910:Possible [Qualitative Concept]
  1000   C2362652:Possible [Qualitative Concept]

Phrase: "that IAPP"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0063684:Islet Amyloid Polypeptide [Amino Acid, Peptide, or Protein,Hormone]
  1000   C1415831:ISLET AMYLOID POLYPEPTIDE [Gene or Genome]
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1305923:Polypeptide [Amino Acid, Peptide, or Protein]

Phrase: "and"

Phrase: "AP share one"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0205447:One [Quantitative Concept]

Phrase: "or"

Phrase: "more chaperone proteins."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.153: In Fig. 

Phrase: "In Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.154: 4, the amino acid sequence and structural properties of each amino acid of IAPP137 and AP142 are shown. 

Phrase: "4,"

Phrase: "the amino acid sequence"
Meta Candidates (Total=11; Excluded=2; Pruned=0; Remaining=9)
  1000   C0002518:Amino Acid Sequence [Amino Acid Sequence]
   901   C0002520:Amino acid [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   901   C2917660:Amino Acid [Pharmacologic Substance]
   827   C0001128:Acid [Chemical]
   827   C0004793:Sequence [Nucleotide Sequence]
   827   C0162326:Sequence [Nucleotide Sequence]
   827   C0162327:Sequence [Nucleotide Sequence]
   827   C0202406:Acid [Laboratory Procedure]
   827   C1519249:Sequence [Functional Concept]
   755 E C1548958:Sequential [Idea or Concept]
   755 E C1705294:Sequential [Qualitative Concept]

Phrase: "and"

Phrase: "structural properties of each amino acid of IAPP137"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   744   C0871161:properties [Qualitative Concept]
   744   C1292721:properties [Functional Concept]
   711 E C1882134:Property [Conceptual Entity]
   711 E C2347695:Property [Entity]

Phrase: "and"

Phrase: "AP142"

Phrase: "are"

Phrase: "shown."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]
Processing 00000000.tx.155: They have been aligned to reveal the major overlap (90%) in structural properties of IAPP2028 and AP2533, areas that are hydrophobic and therefore likely to be a target for binding by chaperone proteins. 

Phrase: "They"

Phrase: "have"

Phrase: "been"

Phrase: "aligned"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1706765:Aligned [Quantitative Concept]
   966 E C2369992:Align [Pharmacologic Substance]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "reveal"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443289:reveal [Qualitative Concept]

Phrase: "the major overlap"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0185027:overlap [Therapeutic or Preventive Procedure]
   861   C1948020:Overlap [Conceptual Entity]

Phrase: "(90%"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439083:>90 [Quantitative Concept]
  1000   C0439087:<90 [Quantitative Concept]

Phrase: ")"

Phrase: "in structural properties"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0871161:properties [Qualitative Concept]
   861   C1292721:properties [Functional Concept]
   827 E C1882134:Property [Conceptual Entity]
   827 E C2347695:Property [Entity]

Phrase: "of IAPP2028"

Phrase: "and"

Phrase: "AP2533,"

Phrase: "areas"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0205146:areas [Spatial Concept]
   966 E C0017446:Area [Geographic Area]

Phrase: "that"

Phrase: "are"

Phrase: "hydrophobic"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0598629:Hydrophobic [Qualitative Concept]

Phrase: "and"

Phrase: "therefore likely to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0332148:Likely [Qualitative Concept]
   827   C0750492:Likely [Idea or Concept]

Phrase: "be"

Phrase: "a target for binding"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1521840:Target [Functional Concept]
   770   C2986546:TARGET [Diagnostic Procedure]

Phrase: "by chaperone proteins."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.156: Furthermore, this region of IAPP is well-established as the amyloidogenic sequence (36) and AP2535 is neurotoxic (41). 

Phrase: "Furthermore,"

Phrase: "this region of IAPP"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0017446:Region [Geographic Area]
   753   C0205147:Region [Spatial Concept]

Phrase: "is"

Phrase: "well-established as the amyloidogenic sequence"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0205170:Well [Qualitative Concept]
   753   C0443211:Established [Qualitative Concept]
   753   C1272684:Established [Qualitative Concept]
   753   C3146287:Well [Manufactured Object]

Phrase: "(36"

Phrase: ")"

Phrase: "and"

Phrase: "AP2535"

Phrase: "is"

Phrase: "neurotoxic"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   928   C0235032:Neurotoxicity [Injury or Poisoning]

Phrase: "(41"

Phrase: ")."
Processing 00000000.tx.157: Recently it has been suggested that the toxic intermediate form of IAPP and AP oligomers are recognized by the same antibody, suggesting a strong structural relationship (42). 

Phrase: "Recently"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332185:Recently [Temporal Concept]

Phrase: "it"

Phrase: "has"

Phrase: "been"

Phrase: "suggested"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "the toxic intermediate form of IAPP"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   744   C0348078:Form [Qualitative Concept]
   744   C0376315:Form [Manufactured Object]
   744   C1522492:Form [Functional Concept]

Phrase: "and"

Phrase: "AP oligomers"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "are"

Phrase: "recognized by the same antibody,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   760   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   760   C0445247:Same [Qualitative Concept]

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "a strong structural relationship"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C0923800:Structural relationship [Conceptual Entity]
   827   C0439849:Relationship [Qualitative Concept]
   827   C1705630:Relationship [Idea or Concept]
   827   C1706279:Relationship [Idea or Concept]
   827   C3540605:Relationship [Intellectual Product]

Phrase: "(42"

Phrase: ")."
Processing 00000000.tx.158: View larger version (13K): [in this window] [in a new window]  FIG. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(13K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  FIG."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.159: 4. 

Phrase: "4."
Processing 00000000.tx.160: The structural overlap between IAPP and AP. 

Phrase: "The structural overlap between IAPP"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0185027:overlap [Therapeutic or Preventive Procedure]
   748   C1948020:Overlap [Conceptual Entity]

Phrase: "and"

Phrase: "AP."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   861   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.161: There is a major overlap (90%) in the structural properties of IAPP2028 and AP2533 when the amino acids are classified as acidic (A), basic (B), nonpolar (NP), and polar uncharged (Pu). 

Phrase: "There"

Phrase: "is"

Phrase: "a major overlap"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0185027:overlap [Therapeutic or Preventive Procedure]
   861   C1948020:Overlap [Conceptual Entity]

Phrase: "(90%"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439083:>90 [Quantitative Concept]
  1000   C0439087:<90 [Quantitative Concept]

Phrase: ")"

Phrase: "in the structural properties"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0871161:properties [Qualitative Concept]
   861   C1292721:properties [Functional Concept]
   827 E C1882134:Property [Conceptual Entity]
   827 E C2347695:Property [Entity]

Phrase: "of IAPP2028"

Phrase: "and"

Phrase: "AP2533"

Phrase: "when"

Phrase: "the amino acids"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0002520:Amino Acids [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   966 E C2917660:Amino Acid [Pharmacologic Substance]
   861   C0001128:Acids [Chemical]
   827 E C0202406:Acid [Laboratory Procedure]

Phrase: "are"

Phrase: "classified as acidic (A), basic (B), nonpolar (NP),"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0001128:Acidic [Chemical]
   760   C0008902:Classified [Classification]
   760   C0813984:nonpolar [Quantitative Concept]
   760   C1527178:Basic [Functional Concept]

Phrase: "and"

Phrase: "polar uncharged (Pu)."
Processing 00000000.tx.162: Gray boxed and hatched areas are identical amino acids; 

Phrase: "Gray boxed"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0179400:Box [Manufactured Object]
   827   C1533124:Box [Medical Device]

Phrase: "and"

Phrase: "hatched areas"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0205146:areas [Spatial Concept]
   827 E C0017446:Area [Geographic Area]

Phrase: "are"

Phrase: "identical amino acids"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   901   C0002520:Amino Acids [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   867 E C2917660:Amino Acid [Pharmacologic Substance]
   827   C0001128:Acids [Chemical]
   793 E C0202406:Acid [Laboratory Procedure]

Phrase: ";"
Processing 00000000.tx.163: gray boxed areas are amino acids with similar structural properties.  

Phrase: "gray boxed areas"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0205146:areas [Spatial Concept]
   793 E C0017446:Area [Geographic Area]

Phrase: "are"

Phrase: "amino acids with similar structural properties."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   790   C0002520:Amino Acids [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   756 E C2917660:Amino Acid [Pharmacologic Substance]
   753   C0001128:Acids [Chemical]
   719 E C0202406:Acid [Laboratory Procedure]
Processing 00000000.tx.164: If the chaperone protein pathway for trafficking AP or IAPP is shared, then any decreased capacity for trafficking of either might also be shared. 

Phrase: "If"

Phrase: "the chaperone protein pathway for"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1704259:Pathway [Molecular Function]
   760   C1705987:Pathway [Conceptual Entity]

Phrase: "trafficking"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0599896:trafficking [Cell Function]

Phrase: "AP"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   861   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "or"

Phrase: "IAPP"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0063684:Islet Amyloid Polypeptide [Amino Acid, Peptide, or Protein,Hormone]
  1000   C1415831:ISLET AMYLOID POLYPEPTIDE [Gene or Genome]
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1305923:Polypeptide [Amino Acid, Peptide, or Protein]

Phrase: "is"

Phrase: "shared"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0237876:shared [Social Behavior]
  1000   C1522138:Shared [Functional Concept]

Phrase: ","

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "any decreased capacity for"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1516240:Capacity [Quantitative Concept]

Phrase: "trafficking of either"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0599896:trafficking [Cell Function]

Phrase: "might"

Phrase: "also"

Phrase: "be"

Phrase: "shared."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0237876:shared [Social Behavior]
  1000   C1522138:Shared [Functional Concept]
Processing 00000000.tx.165: Under these circumstances, aggregation of either or both proteins might occur, resulting in the development of the relevant phenotype for Alzheimer disease and/or type 2 diabetes. 

Phrase: "Under these circumstances,"

Phrase: "aggregation of either"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0332621:Aggregation [Functional Concept]
   790   C0439168:% aggregation [Quantitative Concept]
   718 E C0205418:Aggregate [Qualitative Concept]

Phrase: "or"

Phrase: "both proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "might"

Phrase: "occur"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1709305:Occur [Activity]
  1000   C2745955:OCCUR [Temporal Concept]

Phrase: ","

Phrase: "resulting in the development of the relevant phenotype"
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
   770   C0332294:Resulting in [Functional Concept]
   744   C0031437:Phenotype [Organism Attribute]
   744   C0243107:development [Physiologic Function]
   744   C0678226:resulting [Functional Concept]
   744   C0678723:Development [Organism Function]
   744   C1285572:Phenotype [Laboratory Procedure]
   744   C1527148:Development [Functional Concept]
   744   C2347946:Relevant [Qualitative Concept]
   711 E C1274040:Result [Functional Concept]
   711 E C1546471:Result [Idea or Concept]
   711 E C2825142:Result [Finding]

Phrase: "for Alzheimer disease"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "and/or"

Phrase: "type 2 diabetes."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0011860:Type 2 Diabetes [Disease or Syndrome]
   913   C1320657:type diabetes [Finding]
   901   C0441730:Type 2 [Classification]
   827   C0011847:Diabetes [Disease or Syndrome]
   827   C0011849:Diabetes [Disease or Syndrome]
   827   C0332307:Type [Qualitative Concept]
   827   C1547052:*Type [Quantitative Concept]
Processing 00000000.tx.166: In addition, type 2 diabetes and Alzheimer disease increase in prevalence with aging, and cell chaperone protein capacity declines with aging (43), which would be expected to reveal any partial deficiency in chaperone capacity with aging. 

Phrase: "In addition,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "type 2 diabetes"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0011860:Type 2 Diabetes [Disease or Syndrome]
   913   C1320657:type diabetes [Finding]
   901   C0441730:Type 2 [Classification]
   827   C0011847:Diabetes [Disease or Syndrome]
   827   C0011849:Diabetes [Disease or Syndrome]
   827   C0332307:Type [Qualitative Concept]
   827   C1547052:*Type [Quantitative Concept]

Phrase: "and"

Phrase: "Alzheimer disease increase in prevalence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0442805:Increase [Functional Concept]

Phrase: "with aging,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001811:Ageing [Organism Function]

Phrase: "and"

Phrase: "cell chaperone protein capacity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1516240:Capacity [Quantitative Concept]

Phrase: "declines with aging"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0001811:Ageing [Organism Function]

Phrase: "(43"

Phrase: ")"

Phrase: ","

Phrase: "which"

Phrase: "would"

Phrase: "be"

Phrase: "expected"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1517001:Expected [Idea or Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "reveal"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443289:reveal [Qualitative Concept]

Phrase: "any partial deficiency in chaperone capacity"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0011155:Deficiency [Functional Concept]
   753   C0162429:Deficiency [Disease or Syndrome]
   753   C1623416:deficiency [Qualitative Concept]

Phrase: "with aging."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001811:Ageing [Organism Function]
Processing 00000000.tx.167: Therefore, one potential explanation for the reported shared risk for Alzheimer disease and type 2 diabetes and similar pathology is that IAPP and AP share one or more chaperone proteins and that a functional defect in this shared pathway (decreased chaperone protein binding, decreased chaperone protein availability) results in a shared vulnerability for AP to aggregate in -pleated sheets in cortical cells and IAPP to aggregate in -cells. 

Phrase: "Therefore,"

Phrase: "one potential explanation for the reported shared risk"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0681841:Explanation [Intellectual Product]

Phrase: "for Alzheimer disease"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "and"

Phrase: "type 2 diabetes"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0011860:Type 2 Diabetes [Disease or Syndrome]
   913   C1320657:type diabetes [Finding]
   901   C0441730:Type 2 [Classification]
   827   C0011847:Diabetes [Disease or Syndrome]
   827   C0011849:Diabetes [Disease or Syndrome]
   827   C0332307:Type [Qualitative Concept]
   827   C1547052:*Type [Quantitative Concept]

Phrase: "and"

Phrase: "similar pathology"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0030664:Pathology [Biomedical Occupation or Discipline]
   861   C0205469:pathology [Functional Concept]
   861   C0677042:pathology [Pathologic Function]
   789 E C1521733:Pathologic [Functional Concept]

Phrase: "is"

Phrase: "that IAPP"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0063684:Islet Amyloid Polypeptide [Amino Acid, Peptide, or Protein,Hormone]
  1000   C1415831:ISLET AMYLOID POLYPEPTIDE [Gene or Genome]
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1305923:Polypeptide [Amino Acid, Peptide, or Protein]

Phrase: "and"

Phrase: "AP share one"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0205447:One [Quantitative Concept]

Phrase: "or"

Phrase: "more chaperone proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "that"

Phrase: "a functional defect in this shared pathway"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C1457869:Defect [Functional Concept]
   748   C1861101:DEFECT [Disease or Syndrome]

Phrase: "(decreased chaperone protein binding,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   923   C1523111:chaperone protein binding [Molecular Function]
           chaperone binding
   861   C0033618:Protein Binding [Molecular Function]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0243122:binding [Functional Concept]
   812   C1145667:Binding [Activity]
   812   C1167622:Binding [Molecular Function]

Phrase: "decreased chaperone protein availability"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0470187:Availability [Functional Concept]

Phrase: ")"

Phrase: "results in a shared vulnerability"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0237876:shared [Social Behavior]
   760   C1274040:Result [Functional Concept]
   760   C1522138:Shared [Functional Concept]
   760   C1546471:Result [Idea or Concept]
   760   C2825142:Result [Finding]

Phrase: "for AP to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "aggregate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205418:Aggregate [Qualitative Concept]

Phrase: "in -pleated sheets in cortical cells"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   753   C0439643:Sheets [Spatial Concept]
   719 E C2349187:Sheet [Quantitative Concept]

Phrase: "and"

Phrase: "IAPP to"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   923   C0063684:Islet Amyloid Polypeptide [Amino Acid, Peptide, or Protein,Hormone]
   923   C1415831:ISLET AMYLOID POLYPEPTIDE [Gene or Genome]
   812   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0011560:Amyloid [Pathologic Function]
   812   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C1305923:Polypeptide [Amino Acid, Peptide, or Protein]

Phrase: "aggregate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205418:Aggregate [Qualitative Concept]

Phrase: "in -cells."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.168: An alternative hypothesis to account for the reported overlap between islet amyloid and brain amyloid is that subtle hyperglycemia causes Alzheimer disease. 

Phrase: "An alternative hypothesis to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1512571:Hypothesis [Idea or Concept]
   827   C1523987:Alternative [Conceptual Entity]

Phrase: "account for the reported overlap"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   760   C0185027:overlap [Therapeutic or Preventive Procedure]
   760   C0684224:Reported [Intellectual Product]
   760   C0700287:Reported [Health Care Activity]
   760   C1551359:account [Idea or Concept]
   760   C1948020:Overlap [Conceptual Entity]
   760   C2741673:Account # [Clinical Attribute]
   760   C2981730:Account [Classification]
   760   C3496591:Reported [Clinical Attribute]
   726 E C3273238:Report [Intellectual Product]

Phrase: "between islet amyloid"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0011560:Amyloid [Pathologic Function]
   861   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "brain amyloid"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0011560:Amyloid [Pathologic Function]
   861   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "is"

Phrase: "that subtle hyperglycemia"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0020456:Hyperglycaemia [Disease or Syndrome]

Phrase: "causes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0015127:cause [Functional Concept]
  1000   C1314792:Causes [Functional Concept]
  1000   C1524003:Cause [Conceptual Entity]

Phrase: "Alzheimer disease."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.169: This possibility has been reviewed by Finch and Cohen (44). 

Phrase: "This possibility"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   928   C0332149:Possible [Qualitative Concept]
   928   C1705910:Possible [Qualitative Concept]
   928   C2362652:Possible [Qualitative Concept]

Phrase: "has"

Phrase: "been"

Phrase: "reviewed by Finch"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C0282443:reviewed [Intellectual Product]
   790   C0326915:Finch [Bird]
   790   C1709940:Reviewed [Qualitative Concept]
   756 E C1552617:Review [Idea or Concept]

Phrase: "and"

Phrase: "Cohen"

Phrase: "(44"

Phrase: ")."
Processing 00000000.tx.170: Finch and Cohen proposed that the progressive increase in plasma glucose concentration that occurs with aging in the general population may be important in the pathogenesis of Alzheimer disease. 

Phrase: "Finch"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0326915:Finch [Bird]

Phrase: "and"

Phrase: "Cohen"

Phrase: "proposed"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1441414:PROPOSED [Idea or Concept]
  1000   C1553874:Proposed [Qualitative Concept]
  1000   C1578820:Proposed [Idea or Concept]

Phrase: "that"

Phrase: "the progressive increase in plasma glucose concentration"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0442805:Increase [Functional Concept]

Phrase: "that"

Phrase: "occurs with aging"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0001811:Ageing [Organism Function]
   790   C1709305:Occur [Activity]
   790   C2745955:OCCUR [Temporal Concept]

Phrase: "in the general population"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0683971:General Population [Population Group]
   861   C0032659:Population [Quantitative Concept]
   861   C1257890:Population [Population Group]

Phrase: "may"

Phrase: "be"

Phrase: "important in the pathogenesis of Alzheimer disease."
Processing 00000000.tx.171: They proposed that this may be mediated by induction of oxidative stress or by glycosylation of key regulatory proteins (45,46). 

Phrase: "They"

Phrase: "proposed"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1441414:PROPOSED [Idea or Concept]
  1000   C1553874:Proposed [Qualitative Concept]
  1000   C1578820:Proposed [Idea or Concept]

Phrase: "that"

Phrase: "this"

Phrase: "may"

Phrase: "be"

Phrase: "mediated by induction of oxidative stress"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   820   C1518761:Oxidative Stress Induction [Cell or Molecular Dysfunction]
   790   C0242606:Oxidative Stress [Cell or Molecular Dysfunction]
   753   C0038435:Stress [Finding]
   753   C0086597:mediated [Social Behavior]
   753   C0127400:Mediated [Organic Chemical,Pharmacologic Substance]
   753   C0205263:Induction [Functional Concept]
   753   C0311404:Oxidative [Functional Concept]
   753   C0857127:induction [Therapeutic or Preventive Procedure]

Phrase: "or by glycosylation of key regulatory proteins"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   778   C0815047:regulatory proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   774   C0376322:glycosylation proteins [Molecular Function]
           Glycosylation
   748   C0017982:glycosylation [Natural Phenomenon or Process]
   748   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0220905:regulatory [Regulation or Law]
   748   C1704735:Regulatory [Conceptual Entity]

Phrase: "(45,"

Phrase: "46"

Phrase: ")."
Processing 00000000.tx.172: The current study was at least partly supportive of this interesting hypothesis. 

Phrase: "The current study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0557651:Study [Manufactured Object]
   861   C2603343:Study [Research Activity]

Phrase: "was at least partly supportive of this interesting hypothesis."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   742   C0043194:WAS [Disease or Syndrome]
   742   C0258432:WAS [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0543488:interesting [Mental Process]
   742   C1421478:WAS [Gene or Genome]
   742   C1512571:Hypothesis [Idea or Concept]
   742   C1521721:Supportive [Conceptual Entity]
Processing 00000000.tx.173: When present, the density of diffuse and neuritic plaques in brain increased with the duration of diabetes but not with age. 

Phrase: "When"

Phrase: "present,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0150312:Present [Quantitative Concept]
  1000   C0449450:Present [Idea or Concept]

Phrase: "the density of diffuse"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0178587:density [Quantitative Concept]

Phrase: "and"

Phrase: "neuritic plaques in brain"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   833   C0333463:Neuritic Plaques [Acquired Abnormality]
           plaques
   737 E C0011389:Plaque [Disease or Syndrome]
   737 E C0332461:Plaque [Finding]

Phrase: "increased with the duration of diabetes"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   753   C0011847:Diabetes [Disease or Syndrome]
   753   C0011849:Diabetes [Disease or Syndrome]
   753   C0205217:Increased [Quantitative Concept]
   753   C0442805:Increased [Functional Concept]
   753   C0449238:Duration [Temporal Concept]
   753   C2926735:Duration [Pharmacologic Substance]

Phrase: "but"

Phrase: "not with age."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0001779:Age [Organism Attribute]
   790   C1518422:Not [Functional Concept]
Processing 00000000.tx.174: Prolonged exposure to hyperglycemia thus might trigger brain plaque formation in those at risk. 

Phrase: "Prolonged exposure to hyperglycemia thus"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   806   C0332157:Exposure to [Clinical Attribute]
           Exposure
   760   C0274281:Exposure, NOS [Injury or Poisoning]
   760   C0439590:Prolonged [Temporal Concept]

Phrase: "might"

Phrase: "trigger"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032930:Trigger [Clinical Attribute]
  1000   C1444748:Trigger [Qualitative Concept]

Phrase: "brain plaque formation in those at risk."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0220781:formation [Biologic Function]
   748   C0439634:formation [Spatial Concept]
   748   C1522492:Formation [Functional Concept]
Processing 00000000.tx.175: However, against this hypothesis, there was not an overall increase in the pathological features of Alzheimer disease in cases of type 2 diabetes compared with control subjects, consistent with a previous pathological report (47). 

Phrase: "However,"

Phrase: "against this hypothesis,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1512571:Hypothesis [Idea or Concept]

Phrase: "there"

Phrase: "was"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "an overall increase in the pathological features of Alzheimer disease"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   739   C0442805:Increase [Functional Concept]

Phrase: "in cases"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0868928:Cases [Functional Concept]
  1000   C1533148:Cases [Quantitative Concept]
   966 E C1706255:CASE [Medical Device]
   966 E C1706256:Case [Conceptual Entity]

Phrase: "of type 2 diabetes"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0011860:Type 2 Diabetes [Disease or Syndrome]
   913   C1320657:type diabetes [Finding]
   901   C0441730:Type 2 [Classification]
   827   C0011847:Diabetes [Disease or Syndrome]
   827   C0011849:Diabetes [Disease or Syndrome]
   827   C0332307:Type [Qualitative Concept]
   827   C1547052:*Type [Quantitative Concept]

Phrase: "compared with control subjects,"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   770   C0243148:control [Qualitative Concept]
   770   C1550141:Control [Substance]
   770   C1707455:Compared [Activity]
   770   C1882979:Control [Conceptual Entity]
   770   C2587213:Control [Functional Concept]
   770   C3274648:Control [Qualitative Concept]
   737   C0681850:Subject [Group]
   737   C1550501:{Subject} [Idea or Concept]
   737   C1706203:Subject [Idea or Concept]
   737   C2349001:Subject [Human]
   737   C2697811:Subject [Functional Concept]

Phrase: "consistent with a previous pathological report"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0332290:Consistent with [Idea or Concept]
           Consistent

Phrase: "(47"

Phrase: ")."
Processing 00000000.tx.176: The high risk of underlying vascular disease in diabetes has been reported to increase rates of vascular dementia in diabetes (48,49). 

Phrase: "The high risk of underlying vascular disease"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   814   C0332167:High risk of [Qualitative Concept]
           High Risk
   778   C3272283:High Risk [Finding]
   774   C1281905:disease risk [Finding]
   748   C0035647:Risk [Qualitative Concept]
   748   C0205250:High [Qualitative Concept]
   748   C1299351:High [Qualitative Concept]
   748   C2700149:HIGH [Intellectual Product]

Phrase: "in diabetes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0011847:Diabetes [Disease or Syndrome]
  1000   C0011849:Diabetes [Disease or Syndrome]

Phrase: "has"

Phrase: "been"

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "increase"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C1301820:Obtain [Functional Concept]
   916 E C1706701:Acquire [Activity]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "rates of vascular dementia"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   737   C0871208:Rate [Activity]
   737   C1521828:Rate [Quantitative Concept]

Phrase: "in diabetes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0011847:Diabetes [Disease or Syndrome]
  1000   C0011849:Diabetes [Disease or Syndrome]

Phrase: "(48,"

Phrase: "49"

Phrase: ")."
Processing 00000000.tx.177: Furthermore, hypertension and hyperlipidemia, both strongly associated with diabetes (50), both are risk factors for vascular dementia (5154). 

Phrase: "Furthermore,"

Phrase: "hypertension"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0020538:Hypertension [Disease or Syndrome]
  1000   C1963138:Hypertension [Finding]

Phrase: "and"

Phrase: "hyperlipidemia,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0020473:Hyperlipidaemia [Disease or Syndrome]

Phrase: "both strongly"

Phrase: "associated with diabetes"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   882   C0332281:Associated with [Qualitative Concept]
           Associated
   790   C0011847:Diabetes [Disease or Syndrome]
   790   C0011849:Diabetes [Disease or Syndrome]
   756 E C0750490:Associate [Idea or Concept]
   756 E C1706221:Associate [Professional or Occupational Group]

Phrase: "(50"

Phrase: ")"

Phrase: ","

Phrase: "both"

Phrase: "are"

Phrase: "risk factors for vascular dementia"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   806   C0035648:risk factors [Quantitative Concept]
   806   C1553898:risk factors [Idea or Concept]
   781   C0078057:vascular factor [Amino Acid, Peptide, or Protein]
   760   C0035647:Risk [Qualitative Concept]
   726   C1521761:Factor [Functional Concept]
   726   C2827422:Factor [Conceptual Entity]

Phrase: "(5154"

Phrase: ")."
Processing 00000000.tx.178: Another potential mechanism for decreased cognitive function in long-standing diabetes is recurrent hypoglycemia (5557). 

Phrase: "Another potential mechanism for decreased cognitive function"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0441712:Mechanism [Functional Concept]
   748   C1706376:Mechanism [Manufactured Object]

Phrase: "in long-standing diabetes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0011847:Diabetes [Disease or Syndrome]
   827   C0011849:Diabetes [Disease or Syndrome]

Phrase: "is"

Phrase: "recurrent hypoglycemia"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0020615:Hypoglycaemia [Disease or Syndrome]
   789 E C0020616:Hypoglycaemic [Pharmacologic Substance]

Phrase: "(5557"

Phrase: ")."
Processing 00000000.tx.179: However, in the present studies, we included only cases with type 2 diabetes in which recurrent hypoglycemia is rare in comparison with type 1 diabetes. 

Phrase: "However,"

Phrase: "in the present studies,"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   861   C0150312:Present [Quantitative Concept]
   861   C0449450:Present [Idea or Concept]
   861   C0947630:studies [Laboratory Procedure]
   827 E C0557651:Study [Manufactured Object]
   827 E C2603343:Study [Research Activity]

Phrase: "we"

Phrase: "included"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0332257:included [Functional Concept]
  1000   C3538986:INCLUDED [Gene or Genome]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "only cases with type 2 diabetes"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   753   C0868928:Cases [Functional Concept]
   753   C1533148:Cases [Quantitative Concept]
   719 E C1706255:CASE [Medical Device]
   719 E C1706256:Case [Conceptual Entity]

Phrase: "in which recurrent hypoglycemia"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0020615:Hypoglycaemia [Disease or Syndrome]
   789 E C0020616:Hypoglycaemic [Pharmacologic Substance]

Phrase: "is"

Phrase: "rare in comparison"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0521114:Rare [Temporal Concept]
   790   C0522498:Rare [Qualitative Concept]
   790   C1514917:RARE [Gene or Genome]

Phrase: "with type 1 diabetes."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0011854:Type 1 diabetes [Disease or Syndrome]
   913   C1320657:type diabetes [Finding]
   901   C0441729:Type 1 [Classification]
   827   C0011847:Diabetes [Disease or Syndrome]
   827   C0011849:Diabetes [Disease or Syndrome]
   827   C0332307:Type [Qualitative Concept]
   827   C1547052:*Type [Quantitative Concept]
Processing 00000000.tx.180: These multiple factors that might influence a relationship between dementia and type 2 diabetes as well as differences in populations and inclusion criteria likely contribute to the conflicting epidemiological data in this field. 

Phrase: "These multiple factors"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0439064:Multiple [Quantitative Concept]
   827   C1521761:Factor [Functional Concept]
   827   C2827422:Factor [Conceptual Entity]

Phrase: "that"

Phrase: "might"

Phrase: "influence"

Phrase: "a relationship between dementia"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0439849:Relationship [Qualitative Concept]
   770   C1705630:Relationship [Idea or Concept]
   770   C1706279:Relationship [Idea or Concept]
   770   C3540605:Relationship [Intellectual Product]

Phrase: "and"

Phrase: "type 2 diabetes"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0011860:Type 2 Diabetes [Disease or Syndrome]
   913   C1320657:type diabetes [Finding]
   901   C0441730:Type 2 [Classification]
   827   C0011847:Diabetes [Disease or Syndrome]
   827   C0011849:Diabetes [Disease or Syndrome]
   827   C0332307:Type [Qualitative Concept]
   827   C1547052:*Type [Quantitative Concept]

Phrase: "as well as"

Phrase: "differences in populations"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   756   C1705241:*Difference [Quantitative Concept]
   756   C1705242:Difference [Qualitative Concept]
   706 E C0443199:Differential [Qualitative Concept]

Phrase: "and"

Phrase: "inclusion criteria likely"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C1512693:Inclusion Criteria [Qualitative Concept]
   827   C0243161:criteria [Intellectual Product]

Phrase: "contribute to the conflicting epidemiological data"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   753   C0009671:conflicting [Individual Behavior]
   753   C0014507:Epidemiological [Biomedical Occupation or Discipline]
   753   C1511726:Data [Idea or Concept]
   753   C1880177:Contribute [Activity]
   753   C3245479:data [Medical Device]
   719 E C1705242:Conflict [Qualitative Concept]

Phrase: "in this field."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0440042:Field's [Indicator, Reagent, or Diagnostic Aid]
  1000   C1521738:Field [Conceptual Entity]
  1000   C2346620:Field [Conceptual Entity]
  1000   C2349184:Field [Conceptual Entity]
  1000   C3539073:FIELD [Spatial Concept]
Processing 00000000.tx.181: Some studies suggest that the prevalence of Alzheimer disease is increased in type 2 diabetes (5860), whereas in others, it has been reported as decreased (6166) or comparable (48,49,6771). 

Phrase: "Some studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0947630:studies [Laboratory Procedure]
   966 E C0557651:Study [Manufactured Object]
   966 E C2603343:Study [Research Activity]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "the prevalence of Alzheimer disease"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0033105:Prevalence [Quantitative Concept]
   760   C0220900:prevalence [Quantitative Concept]

Phrase: "is"

Phrase: "increased in type 2 diabetes"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   862   C0011860:Type 2 Diabetes [Disease or Syndrome]
   806   C0441730:Type 2 [Classification]
   797   C1320657:Diabetes type [Finding]
   760   C0011847:Diabetes [Disease or Syndrome]
   760   C0011849:Diabetes [Disease or Syndrome]
   760   C0205217:Increased [Quantitative Concept]
   760   C0332307:Type [Qualitative Concept]
   760   C0442805:Increased [Functional Concept]
   760   C1547052:*Type [Quantitative Concept]

Phrase: "(5860"

Phrase: ")"

Phrase: ","

Phrase: "whereas in others,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1955473:Others [Finding]

Phrase: "it"

Phrase: "has"

Phrase: "been"

Phrase: "reported as decreased"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   790   C0205216:Decreased [Quantitative Concept]
   790   C0392756:Decreased [Qualitative Concept]
   790   C0442797:decreased [Qualitative Concept]
   790   C0684224:Reported [Intellectual Product]
   790   C0700287:Reported [Health Care Activity]
   790   C3496591:Reported [Clinical Attribute]
   756 E C0547047:Decrease [Quantitative Concept]
   756 E C3273238:Report [Intellectual Product]

Phrase: "(6166"

Phrase: ")"

Phrase: "or"

Phrase: "comparable"

Phrase: "(48,"

Phrase: "49,"

Phrase: "6771"

Phrase: ")."
Processing 00000000.tx.182: A confounding factor in these studies (including the current one) is that Alzheimer disease is often accompanied by a decreased BMI presumed to be a result of decreased food intake. 

Phrase: "A confounding factor in these studies"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1521761:Factor [Functional Concept]
   753   C2827422:Factor [Conceptual Entity]

Phrase: "("

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "the current one)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205447:One [Quantitative Concept]

Phrase: "is"

Phrase: "that Alzheimer disease"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "is"

Phrase: "often"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332183:Often [Temporal Concept]

Phrase: "accompanied by a decreased BMI"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   760   C0205216:Decreased [Quantitative Concept]
   760   C0392756:Decreased [Qualitative Concept]
   760   C0442797:decreased [Qualitative Concept]
   726 E C0547047:Decrease [Quantitative Concept]

Phrase: "presumed"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "a result of decreased food intake."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C1274040:Result [Functional Concept]
   753   C1546471:Result [Idea or Concept]
   753   C2825142:Result [Finding]
Processing 00000000.tx.183: Because the most potent risk factor for development of type 2 diabetes is an increased BMI, it is possible that an association between these conditions has been obscured by the relative protective effect of a decreased BMI in Alzheimer disease. 

Phrase: "Because"

Phrase: "the most potent risk factor for development of type 2 diabetes"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   756   C0035648:Risk factor [Quantitative Concept]
   754   C1171304:diabetes risk [Quantitative Concept]
   738   C0035647:Risk [Qualitative Concept]
   738   C1521761:Factor [Functional Concept]
   738   C2827422:Factor [Conceptual Entity]

Phrase: "is"

Phrase: "an increased BMI,"

Phrase: "it"

Phrase: "is"

Phrase: "possible"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0332149:Possible [Qualitative Concept]
  1000   C1705910:Possible [Qualitative Concept]
  1000   C2362652:Possible [Qualitative Concept]

Phrase: "that"

Phrase: "an association between these conditions"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0004083:Association [Mental Process]
   760   C0439849:Association [Qualitative Concept]
   760   C0596306:Association [Phenomenon or Process]
   760   C0699792:association [Social Behavior]

Phrase: "has"

Phrase: "been"

Phrase: "obscured by the relative protective effect of a decreased BMI"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   739   C0080103:Relative [Family Group]
   739   C0205216:Decreased [Quantitative Concept]
   739   C0205345:Relative [Qualitative Concept]
   739   C0392756:Decreased [Qualitative Concept]
   739   C0442797:decreased [Qualitative Concept]
   739   C1280500:Effect [Qualitative Concept]
   739   C1547039:*Relative [Quantitative Concept]
   739   C2348382:Effect [Qualitative Concept]
   706 E C0547047:Decrease [Quantitative Concept]

Phrase: "in Alzheimer disease."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.184: Alternatively, it is possible that people with Alzheimer disease exercise less and therefore have decreased insulin sensitivity and increased risk for type 2 diabetes. 

Phrase: "Alternatively,"

Phrase: "it"

Phrase: "is"

Phrase: "possible"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0332149:Possible [Qualitative Concept]
  1000   C1705910:Possible [Qualitative Concept]
  1000   C2362652:Possible [Qualitative Concept]

Phrase: "that people with Alzheimer disease"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0027361:People [Population Group]

Phrase: "exercise"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0015259:Exercise [Daily or Recreational Activity]
  1000   C1522704:Exercise [Therapeutic or Preventive Procedure]

Phrase: "less"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439092:less [Intellectual Product]
  1000   C0547044:Less [Qualitative Concept]

Phrase: "and"

Phrase: "therefore"

Phrase: "have"

Phrase: "decreased insulin sensitivity"
Meta Candidates (Total=18; Excluded=4; Pruned=0; Remaining=14)
   913   C0020580:Decreased Sensitivity [Finding]
   913   C1880261:DECREASED SENSITIVITY [Phenomenon or Process]
   913   C2348085:DECREASED SENSITIVITY [Phenomenon or Process]
   901   C0920563:Insulin Sensitivity [Pathologic Function]
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C0036667:Sensitivity [Quantitative Concept]
   827   C0312418:Sensitivity [Mental Process]
   827   C0427965:Sensitivity [Finding]
   827   C1511883:Sensitivity [Quantitative Concept]
   827   C1522640:Sensitivity [Qualitative Concept]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   827   C2346484:SENSITIVITY [Phenomenon or Process]
   827   C2349185:Sensitivity [Qualitative Concept]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   755 E C0332324:Sensitive [Functional Concept]
   755 E C1550474:sensitive [Idea or Concept]
   743 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "and"

Phrase: "increased risk for type 2 diabetes."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   783   C1171304:diabetes risk [Quantitative Concept]
   753   C0035647:Risk [Qualitative Concept]
   753   C0205217:Increased [Quantitative Concept]
   753   C0442805:Increased [Functional Concept]
Processing 00000000.tx.185: As type 2 diabetes tends to develop at a younger age than Alzheimer disease and is associated with a decreased life expectancy, early death from complications of diabetes might obscure subsequent development of Alzheimer disease. 

Phrase: "As type 2 diabetes"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0011860:Type 2 Diabetes [Disease or Syndrome]
   913   C1320657:type diabetes [Finding]
   901   C0441730:Type 2 [Classification]
   827   C0011847:Diabetes [Disease or Syndrome]
   827   C0011849:Diabetes [Disease or Syndrome]
   827   C0332307:Type [Qualitative Concept]
   827   C1547052:*Type [Quantitative Concept]

Phrase: "tends"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "develop at a younger age"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0001779:Age [Organism Attribute]
   726   C0332239:Young [Temporal Concept]

Phrase: "than Alzheimer disease"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "and"

Phrase: "is"

Phrase: "associated with a decreased life expectancy,"
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
   790   C0023671:Life Expectancy [Group Attribute]
   790   C0332281:Associated with [Qualitative Concept]
           Associated
   753   C0205216:Decreased [Quantitative Concept]
   753   C0376558:Life [Idea or Concept]
   753   C0392756:Decreased [Qualitative Concept]
   753   C0442797:decreased [Qualitative Concept]
   753   C0679138:Expectancy [Idea or Concept]
   719 E C0547047:Decrease [Quantitative Concept]
   719 E C0750490:Associate [Idea or Concept]
   719 E C1706221:Associate [Professional or Occupational Group]

Phrase: "early death from complications of diabetes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C1836407:Early death [Finding]
   753   C0011065:Death [Organism Function]
   753   C1306577:Death, NOS [Finding]

Phrase: "might"

Phrase: "obscure"

Phrase: "subsequent development of Alzheimer disease."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0243107:development [Physiologic Function]
   760   C0678723:Development [Organism Function]
   760   C1527148:Development [Functional Concept]
Processing 00000000.tx.186: The current pathology studies are unique inasmuch as the Alzheimer disease and non-Alzheimer disease groups were fully characterized both in life and by autopsy, and so although the numbers are small, it is provocative that there is a distinct increase in risk of islet amyloid in patients with Alzheimer disease despite a lower BMI. 

Phrase: "The current pathology studies"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   901   C0919386:Pathology studies [Laboratory Procedure]
   884 E C0551718:Pathology study [Clinical Attribute]
   827   C0947630:studies [Laboratory Procedure]
   793 E C0557651:Study [Manufactured Object]
   793 E C2603343:Study [Research Activity]

Phrase: "are"

Phrase: "unique"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1710548:Unique [Qualitative Concept]

Phrase: "inasmuch as"

Phrase: "the Alzheimer disease"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "and"

Phrase: "non-Alzheimer disease groups"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   812   C0441833:Group [Idea or Concept]
   812   C0687744:group [Population Group]
   812   C1257890:Group [Population Group]
   812   C1552516:Group [Health Care Related Organization]
   812   C1552839:groups [Idea or Concept]
   812   C1705428:Group [Conceptual Entity]
   812   C1705429:Group [Population Group]

Phrase: "were"

Phrase: "fully"

Phrase: "characterized"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1880022:Characterized [Activity]

Phrase: "both in life"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0150312:In [Quantitative Concept]
   861   C0332285:In [Spatial Concept]
   861   C0376558:Life [Idea or Concept]
   777 E C0595998:lives [Finding]

Phrase: "and by autopsy,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0004398:Autopsy [Diagnostic Procedure]
   790   C1515981:And [Idea or Concept]

Phrase: "and"

Phrase: "so"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0037640:SO [Geographic Area]

Phrase: "although"

Phrase: "the numbers"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0237753:*Number [Quantitative Concept]
  1000   C0449788:Number [Quantitative Concept]

Phrase: "are"

Phrase: "small,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0700321:Small [Quantitative Concept]

Phrase: "it"

Phrase: "is"

Phrase: "provocative"

Phrase: "that there"

Phrase: "is"

Phrase: "a distinct increase in risk of islet amyloid"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0442805:Increase [Functional Concept]

Phrase: "in patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030705:Patients [Patient or Disabled Group]

Phrase: "with Alzheimer disease"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "despite a lower BMI."
Processing 00000000.tx.187: The clinical data (protocols 1 and 2) are also community-based cases that have been defined extensively with respect to the presence or absence of dementia and followed over a relatively long term (33). 

Phrase: "The clinical data"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1516606:Clinical Data [Intellectual Product]
   861   C1511726:Data [Idea or Concept]
   861   C3245479:data [Medical Device]

Phrase: "(protocols 1"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0442711:Protocols [Intellectual Product]
   827 E C1507394:Protocol [Intellectual Product]
   827 E C1522729:Protocol [Intellectual Product]
   827 E C2348563:Protocol [Intellectual Product]

Phrase: "and"

Phrase: "2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: ")"

Phrase: "are"

Phrase: "also community-based cases"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   812   C0868928:Cases [Functional Concept]
   812   C1533148:Cases [Quantitative Concept]
   779 E C1706255:CASE [Medical Device]
   779 E C1706256:Case [Conceptual Entity]

Phrase: "that"

Phrase: "have"

Phrase: "been"

Phrase: "defined"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1704788:Defined [Conceptual Entity]
  1000   C3539106:Defined [Intellectual Product]

Phrase: "extensively with respect to the presence"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0392148:Presence [Therapeutic or Preventive Procedure]
   753   C0679133:respect [Social Behavior]

Phrase: "or"

Phrase: "absence of dementia"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0332197:absence [Quantitative Concept]
   790   C1689985:Absence [Anatomical Abnormality]
   718 E C2699517:ABSENT [Finding]

Phrase: "and"

Phrase: "followed over a relatively long term"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   790   C0443252:Long-term [Temporal Concept]
   753   C0205166:Long [Qualitative Concept]
   753   C0332283:followed [Temporal Concept]
   753   C1515273:Term [Temporal Concept]
   753   C1705313:Term [Idea or Concept]
   753   C1706317:Long [Qualitative Concept]
   753   C2826302:TERM [Intellectual Product]
   719 E C1719822:Follow [Intellectual Product]

Phrase: "(33"

Phrase: ")."
Processing 00000000.tx.188: It is of interest that a population-based study from the same region showed an association between type 2 diabetes and Alzheimer disease (59). 

Phrase: "It"

Phrase: "is of"

Phrase: "interest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0543488:Interest [Mental Process]

Phrase: "that"

Phrase: "a population-based study from the same region"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   800   C1709599:Population Based Study [Research Activity]
   767   C0681876:Population Study [Research Activity]
   767   C2348561:Study Population [Population Group]
   744   C0557651:Study [Manufactured Object]
   744   C2603343:Study [Research Activity]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "an association between type 2 diabetes"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   783   C3645563:Association type [Intellectual Product]
   753   C0004083:Association [Mental Process]
   753   C0439849:Association [Qualitative Concept]
   753   C0596306:Association [Phenomenon or Process]
   753   C0699792:association [Social Behavior]

Phrase: "and"

Phrase: "Alzheimer disease"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "(59"

Phrase: ")."
Processing 00000000.tx.189: Whereas the former study examined records of all known cases of type 2 diabetes in the Rochester area at the time of the study for a diagnosis of dementia and Alzheimer disease (1,455 cases), the present study was focused on a much smaller cohort of patients with Alzheimer disease (100 cases) and control subjects (138 cases) enrolled in the ADPR (33), wherein the diagnosis of Alzheimer disease was rigorously established, and then the same patients were followed annually in the study thereafter and when deceased were included in the autopsy studies. 

Phrase: "Whereas"

Phrase: "the former study examined records of all known cases of type 2 diabetes"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   751   C0585753:Type of record [Intellectual Product]
           Record type
   735   C0034869:Records [Intellectual Product]
   735   C1548330:Records [Idea or Concept]
   735   C1553414:Records [Qualitative Concept]

Phrase: "in the Rochester area"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0017446:Area [Geographic Area]
   861   C0205146:Area [Spatial Concept]

Phrase: "at the time"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0040223:Time [Temporal Concept]
  1000   C3541383:Time [Temporal Concept]
   944 E C0442043:Temporal [Spatial Concept]
   944 E C2362314:Temporal [Temporal Concept]
   916 E C1632851:Times [Quantitative Concept]

Phrase: "of the study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]

Phrase: "for a diagnosis"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0011900:Diagnosis [Finding]
  1000   C1704338:diagnosis [Qualitative Concept]
  1000   C1704656:DIAGNOSIS [Research Activity]

Phrase: "of dementia"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0011265:dementia [Mental or Behavioral Dysfunction]
  1000   C0497327:Dementia [Mental or Behavioral Dysfunction]
   900 E C0860630:dement [Mental or Behavioral Dysfunction]

Phrase: "and"

Phrase: "Alzheimer disease"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "(1,455 cases"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   827   C0868928:Cases [Functional Concept]
   827   C1533148:Cases [Quantitative Concept]
   793 E C1706255:CASE [Medical Device]
   793 E C1706256:Case [Conceptual Entity]

Phrase: ")"

Phrase: ","

Phrase: "the present study"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0150312:Present [Quantitative Concept]
   861   C0449450:Present [Idea or Concept]
   861   C0557651:Study [Manufactured Object]
   861   C2603343:Study [Research Activity]

Phrase: "was"

Phrase: "focused on a much smaller cohort of patients"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   744   C0030705:Patients [Patient or Disabled Group]
   744   C0205234:Focused [Spatial Concept]
   744   C0547044:Smaller [Qualitative Concept]
   744   C0599755:Cohort [Population Group]
   744   C0700321:Smaller [Quantitative Concept]
   744   C1285542:focused [Functional Concept]

Phrase: "with Alzheimer disease"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "(100 cases"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0868928:Cases [Functional Concept]
   861   C1533148:Cases [Quantitative Concept]
   827 E C1706255:CASE [Medical Device]
   827 E C1706256:Case [Conceptual Entity]

Phrase: ")"

Phrase: "and"

Phrase: "control subjects"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   861   C0243148:control [Qualitative Concept]
   861   C1550141:Control [Substance]
   861   C1882979:Control [Conceptual Entity]
   861   C2587213:Control [Functional Concept]
   861   C3274648:Control [Qualitative Concept]
   827   C0681850:Subject [Group]
   827   C1550501:{Subject} [Idea or Concept]
   827   C1706203:Subject [Idea or Concept]
   827   C2349001:Subject [Human]
   827   C2697811:Subject [Functional Concept]

Phrase: "(138 cases"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0868928:Cases [Functional Concept]
   861   C1533148:Cases [Quantitative Concept]
   827 E C1706255:CASE [Medical Device]
   827 E C1706256:Case [Conceptual Entity]

Phrase: ")"

Phrase: "enrolled in the ADPR"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   800   C0597185:patient/disease registry [Intellectual Product]
   778   C0002395:Alzheimer's Disease [Disease or Syndrome]
   778   C0920631:patient registry [Intellectual Product]
   778   C1521724:Alzheimer's Disease [Pathologic Function]
   774   C0920465:disease registry [Intellectual Product]
   748   C0012634:Disease [Disease or Syndrome]
   748   C0030705:*^patient [Patient or Disabled Group]
   748   C0034975:Registry [Intellectual Product]

Phrase: "(33"

Phrase: ")"

Phrase: ","

Phrase: "wherein"

Phrase: "the diagnosis of Alzheimer disease"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0011900:Diagnosis [Finding]
   760   C1704338:diagnosis [Qualitative Concept]
   760   C1704656:DIAGNOSIS [Research Activity]

Phrase: "was"

Phrase: "rigorously"

Phrase: "established"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0443211:Established [Qualitative Concept]
  1000   C1272684:Established [Qualitative Concept]

Phrase: ","

Phrase: "and"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "the same patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0030705:Patients [Patient or Disabled Group]

Phrase: "were"

Phrase: "followed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0332283:followed [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "annually in the study thereafter"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0332181:Annually [Temporal Concept]
   760   C0557651:Study [Manufactured Object]
   760   C2603343:Study [Research Activity]

Phrase: "and"

Phrase: "when"

Phrase: "deceased"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0011065:deceased [Organism Function]

Phrase: "were"

Phrase: "included in the autopsy studies."
Meta Candidates (Total=8; Excluded=4; Pruned=0; Remaining=4)
   760   C0004398:Autopsy [Diagnostic Procedure]
   760   C0332257:included [Functional Concept]
   760   C0947630:studies [Laboratory Procedure]
   760   C3538986:INCLUDED [Gene or Genome]
   726 E C0557651:Study [Manufactured Object]
   726 E C1552866:include [Idea or Concept]
   726 E C2603343:Study [Research Activity]
   726 E C2700399:Include [Activity]
Processing 00000000.tx.190: One other factor that might have caused discrepancies between reported studies is the changing definition of diabetes. 

Phrase: "One"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205447:One [Quantitative Concept]

Phrase: "other factor"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1521761:Factor [Functional Concept]
  1000   C2827422:Factor [Conceptual Entity]

Phrase: "that"

Phrase: "might"

Phrase: "have"

Phrase: "caused discrepancies between reported studies"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1290905:discrepancies [Finding]

Phrase: "is"

Phrase: "the changing definition of diabetes."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C1550452:definition [Idea or Concept]
   760   C1704788:Definition [Conceptual Entity]
   760   C3539107:Definition [Intellectual Product]
Processing 00000000.tx.191: The present study uses the criteria adopted for FPG concentrations in 1997 by an expert committee convened by the American Diabetes Association (72). 

Phrase: "The present study"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0150312:Present [Quantitative Concept]
   861   C0449450:Present [Idea or Concept]
   861   C0557651:Study [Manufactured Object]
   861   C2603343:Study [Research Activity]

Phrase: "uses"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0042153:use [Functional Concept]
  1000   C0457083:Use [Functional Concept]
  1000   C1947944:Use [Intellectual Product]

Phrase: "the criteria"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0243161:criteria [Intellectual Product]

Phrase: "adopted for FPG concentrations"
Meta Candidates (Total=15; Excluded=2; Pruned=0; Remaining=13)
   816   C2584434:Plasma glucose concentration [Finding]
   790   C0202042:Plasma glucose [Laboratory Procedure]
   790   C0455280:plasma glucose [Laboratory or Test Result]
   783   C0427743:concentrations glucose [Laboratory Procedure]
   783   C0683150:concentrations plasma [Quantitative Concept]
   783   C1287281:concentrations glucose [Laboratory or Test Result]
   753   C0015663:Fasting [Finding]
   753   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   753   C0032105:Plasma [Body Substance]
   753   C0086045:Concentrations [Mental Process]
   753   C0425382:Adopted [Finding]
   753   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]
   753   C1550565:fasting [Intellectual Product]
   719 E C0456962:Fast [Qualitative Concept]
   719 E C1446561:Concentration [Quantitative Concept]

Phrase: "in 1997"

Phrase: "by an expert committee"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2699414:Committee [Group]

Phrase: "convened by the American Diabetes Association"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   833   C1705019:American Diabetes Association [Professional Society]
   753   C0004083:Association [Mental Process]
   753   C0011847:Diabetes [Disease or Syndrome]
   753   C0011849:Diabetes [Disease or Syndrome]
   753   C0439849:Association [Qualitative Concept]
   753   C0596070:American [Population Group]
   753   C0596306:Association [Phenomenon or Process]
   753   C0699792:association [Social Behavior]

Phrase: "(72"

Phrase: ")."
Processing 00000000.tx.192: As a consequence of this report, the plasma glucose concentration required to establish the diagnosis of diabetes was decreased from 140 mg/dl to 126 mg/dl. 

Phrase: "As a consequence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0686907:Consequence [Functional Concept]

Phrase: "of this report,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0684224:Report [Intellectual Product]
  1000   C0700287:Report [Health Care Activity]
  1000   C3273238:Report [Intellectual Product]

Phrase: "the plasma glucose concentration"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
  1000   C2584434:Plasma glucose concentration [Finding]
   913   C0683150:plasma concentration [Quantitative Concept]
   901   C0427743:Glucose concentration [Laboratory Procedure]
   901   C1287281:Glucose concentration [Laboratory or Test Result]
   827   C0086045:Concentration [Mental Process]
   827   C1446561:Concentration [Quantitative Concept]
   755 E C1880165:Concentrated [Biomedical or Dental Material]
   734   C0202042:Plasma glucose [Laboratory Procedure]
   734   C0455280:plasma glucose [Laboratory or Test Result]

Phrase: "required"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1514873:Required [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "establish"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443211:establish [Qualitative Concept]

Phrase: "the diagnosis of diabetes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0011900:Diagnosis [Finding]
   770   C1704338:diagnosis [Qualitative Concept]
   770   C1704656:DIAGNOSIS [Research Activity]

Phrase: "was"

Phrase: "decreased from 140 mg/dl"
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
   806   C0439269:mg dl [Quantitative Concept]
           mg%
   797 E C3463848:dl mg [Quantitative Concept]
   760   C0205216:Decreased [Quantitative Concept]
   760   C0392756:Decreased [Qualitative Concept]
   760   C0442797:decreased [Qualitative Concept]
   760   C1960952:mg % [Quantitative Concept]
   760   C2346927:Mg++ [Element, Ion, or Isotope,Pharmacologic Substance]
   760   C3642216:/dL [Quantitative Concept]
   726 E C0547047:Decrease [Quantitative Concept]

Phrase: "to 126 mg/dl."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0439269:mg dl [Quantitative Concept]
   827   C3642216:/dL [Quantitative Concept]
Processing 00000000.tx.193: Furthermore, a high-risk group was established for the subsequent development of diabetes with an FPG concentration of 110125 mg/dl. 

Phrase: "Furthermore,"

Phrase: "a high-risk group"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0684030:high-risk group [Population Group]
   827   C0441833:Group [Idea or Concept]
   827   C0687744:group [Population Group]
   827   C1257890:Group [Population Group]
   827   C1552516:Group [Health Care Related Organization]
   827   C1705428:Group [Conceptual Entity]
   827   C1705429:Group [Population Group]
   734   C0332167:High Risk [Qualitative Concept]
   734   C3272283:High Risk [Finding]

Phrase: "was"

Phrase: "established for the subsequent development of diabetes"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   748   C0011847:Diabetes [Disease or Syndrome]
   748   C0011849:Diabetes [Disease or Syndrome]
   748   C0243107:development [Physiologic Function]
   748   C0332282:Subsequent [Temporal Concept]
   748   C0443211:Established [Qualitative Concept]
   748   C0678723:Development [Organism Function]
   748   C1272684:Established [Qualitative Concept]
   748   C1527148:Development [Functional Concept]

Phrase: "with an FPG concentration"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   923   C2584434:Plasma glucose concentration [Finding]
   875   C0683150:plasma concentration [Quantitative Concept]
   861   C0427743:Glucose concentration [Laboratory Procedure]
   861   C1287281:Glucose concentration [Laboratory or Test Result]
   812   C0086045:Concentration [Mental Process]
   812   C1446561:Concentration [Quantitative Concept]
   741 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "of 110125 mg/dl."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0439269:mg dl [Quantitative Concept]
   827   C3642216:/dL [Quantitative Concept]
Processing 00000000.tx.194: Studies that used the higher values for diagnosis of diabetes would report lower prevalence rates in both Alzheimer disease and control subjects and possibly not observe differences between groups that might be evident with the criteria used here. 

Phrase: "Studies"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557651:Study [Manufactured Object]
  1000   C0947630:studies [Laboratory Procedure]
  1000   C2603343:Study [Research Activity]

Phrase: "that"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the higher values for diagnosis of diabetes"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   748   C0042295:Values [Qualitative Concept]
   714 E C1522609:Value [Quantitative Concept]

Phrase: "would"

Phrase: "report"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0684224:Report [Intellectual Product]
  1000   C0700287:Report [Health Care Activity]
  1000   C3273238:Report [Intellectual Product]

Phrase: "lower prevalence rates in both Alzheimer disease"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   774   C0026538:disease rates [Quantitative Concept]
   748   C0033105:Prevalence [Quantitative Concept]
   748   C0220900:prevalence [Quantitative Concept]
   714   C0871208:Rate [Activity]
   714   C1521828:Rate [Quantitative Concept]

Phrase: "and"

Phrase: "control subjects"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   861   C0243148:control [Qualitative Concept]
   861   C1550141:Control [Substance]
   861   C1882979:Control [Conceptual Entity]
   861   C2587213:Control [Functional Concept]
   861   C3274648:Control [Qualitative Concept]
   827   C0681850:Subject [Group]
   827   C1550501:{Subject} [Idea or Concept]
   827   C1706203:Subject [Idea or Concept]
   827   C2349001:Subject [Human]
   827   C2697811:Subject [Functional Concept]

Phrase: "and"

Phrase: "possibly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2362652:Possibly [Qualitative Concept]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "observe"

Phrase: "differences between groups"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   756   C1705241:*Difference [Quantitative Concept]
   756   C1705242:Difference [Qualitative Concept]
   706 E C0443199:Differential [Qualitative Concept]

Phrase: "that"

Phrase: "might"

Phrase: "be"

Phrase: "evident with the criteria"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "here."
Processing 00000000.tx.195: Another potential confounding factor in previous as well as the present studies is recruitment bias. 

Phrase: "Another potential confounding factor in previous"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1521761:Factor [Functional Concept]
   753   C2827422:Factor [Conceptual Entity]

Phrase: "as well as"

Phrase: "the present studies"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   861   C0150312:Present [Quantitative Concept]
   861   C0449450:Present [Idea or Concept]
   861   C0947630:studies [Laboratory Procedure]
   827 E C0557651:Study [Manufactured Object]
   827 E C2603343:Study [Research Activity]

Phrase: "is"

Phrase: "recruitment bias."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0242568:Bias [Idea or Concept]
   861   C1504315:Bias [Bird]
   827 E C1061346:Bia [Eukaryote]
   827 E C1704746:BIA [Diagnostic Procedure]
Processing 00000000.tx.196: All studies performed at major tertiary referral centers such as the Mayo Clinic are subject to such bias. 

Phrase: "All studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0947630:studies [Laboratory Procedure]
   966 E C0557651:Study [Manufactured Object]
   966 E C2603343:Study [Research Activity]

Phrase: "performed at major tertiary referral centers"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   833   C0587437:Tertiary Referral Centers [Health Care Related Organization,Manufactured Object]
   753   C0034927:Referral [Health Care Activity]
   753   C0205099:centers [Spatial Concept]
   753   C0205164:Major [Qualitative Concept]
   753   C0205372:Tertiary [Quantitative Concept]
   753   C0884358:Performed [Functional Concept]
   719 E C2947996:Perform [Pharmacologic Substance]

Phrase: "such as the Mayo Clinic"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0002424:Clinic [Health Care Related Organization,Manufactured Object]
   861   C0442592:Clinic [Health Care Related Organization,Manufactured Object]
   789 E C0205210:Clinical [Qualitative Concept]

Phrase: "are subject to such bias."
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
   760   C0242568:Bias [Idea or Concept]
   760   C0681850:Subject [Group]
   760   C1504315:Bias [Bird]
   760   C1550501:{Subject} [Idea or Concept]
   760   C1551058:Are [Quantitative Concept]
   760   C1706203:Subject [Idea or Concept]
   760   C2349001:Subject [Human]
   760   C2697811:Subject [Functional Concept]
   726 E C1061346:Bia [Eukaryote]
   726 E C1704746:BIA [Diagnostic Procedure]
Processing 00000000.tx.197: Efforts were made to minimize this in the present clinical studies by recruitment of patients from the local community from the community clinics of the Mayo Medical Center. 

Phrase: "Efforts"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0015264:Effort [Organism Function]

Phrase: "were"

Phrase: "made"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1881534:Make [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "minimize"

Phrase: "this in the present clinical studies"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   790   C0008972:Clinical Studies [Research Activity]
   753   C0150312:Present [Quantitative Concept]
   753   C0205210:Clinical [Qualitative Concept]
   753   C0449450:Present [Idea or Concept]
   753   C0947630:studies [Laboratory Procedure]
   753   C1080058:This [Eukaryote]
   719 E C0557651:Study [Manufactured Object]
   719 E C2603343:Study [Research Activity]

Phrase: "by recruitment"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2949735:Recruitment [Activity]

Phrase: "of patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030705:Patients [Patient or Disabled Group]

Phrase: "from the local community"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0009462:Community [Geographic Area]

Phrase: "from the community clinics"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   983   C0587907:Community clinic [Health Care Related Organization,Manufactured Object]
   861   C0442592:clinics [Health Care Related Organization,Manufactured Object]
   827 E C0002424:Clinic [Health Care Related Organization,Manufactured Object]
   777 E C0205210:Clinical [Qualitative Concept]

Phrase: "of the Mayo Medical Center."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   901   C0565990:Medical center [Health Care Related Organization,Manufactured Object]
   901   C1552471:Medical Center [Health Care Related Organization,Manufactured Object]
   827   C0205099:Center [Spatial Concept]
   827   C0205476:Medical [Functional Concept]
   827   C0454788:Mayo [Geographic Area]
   827   C1077578:mayo [Plant]
Processing 00000000.tx.198: Patients were therefore attending the Mayo Clinic community clinics for primary care when they were recruited for either the Alzheimer disease or control groups of the clinical studies. 

Phrase: "Patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030705:Patients [Patient or Disabled Group]

Phrase: "were"

Phrase: "therefore"

Phrase: "attending"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1547429:Attending [Professional or Occupational Group]
  1000   C1999232:attending [Functional Concept]

Phrase: "the Mayo Clinic community clinics for primary care"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   767   C0587907:clinics community [Health Care Related Organization,Manufactured Object]
   744   C0442592:clinics [Health Care Related Organization,Manufactured Object]

Phrase: "when"

Phrase: "they"

Phrase: "were"

Phrase: "recruited for either"

Phrase: "the Alzheimer disease"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "or"

Phrase: "control groups of the clinical studies."
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
   790   C0009932:Control Groups [Group]
   753   C0243148:control [Qualitative Concept]
   753   C0441833:Group [Idea or Concept]
   753   C0687744:group [Population Group]
   753   C1257890:Group [Population Group]
   753   C1550141:Control [Substance]
   753   C1552516:Group [Health Care Related Organization]
   753   C1552839:groups [Idea or Concept]
   753   C1705428:Group [Conceptual Entity]
   753   C1705429:Group [Population Group]
   753   C1882979:Control [Conceptual Entity]
   753   C2587213:Control [Functional Concept]
   753   C3274648:Control [Qualitative Concept]
Processing 00000000.tx.199: Nonetheless, other recruitment bias may be introduced in a study such as ours by the failure of affected patients to seek medical care and therefore be unavailable for consideration. 

Phrase: "Nonetheless,"

Phrase: "other recruitment bias"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0242568:Bias [Idea or Concept]
   861   C1504315:Bias [Bird]
   827 E C1061346:Bia [Eukaryote]
   827 E C1704746:BIA [Diagnostic Procedure]

Phrase: "may"

Phrase: "be"

Phrase: "introduced in a study"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0557651:Study [Manufactured Object]
   770   C2603343:Study [Research Activity]
   737   C1292748:introduce [Functional Concept]

Phrase: "such as ours"

Phrase: "by the failure"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0231174:Failure [Functional Concept]
  1000   C0680095:failure [Individual Behavior]

Phrase: "of affected patients to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0522476:affected patients [Qualitative Concept]
   827   C0030705:Patients [Patient or Disabled Group]

Phrase: "seek"

Phrase: "medical care"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0496675:medical care [Finding]
   861   C1947933:Care [Activity]

Phrase: "and"

Phrase: "therefore"

Phrase: "be"

Phrase: "unavailable for consideration."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0686905:Unavailable [Functional Concept]
Processing 00000000.tx.200: In the present study, there is a greater proportion of women than men in the clinical studies, which might be in part a reflection of recruitment bias but also potentially be due to the shorter life span of men than women once Alzheimer disease is diagnosed. 

Phrase: "In the present study,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0150312:Present [Quantitative Concept]
   861   C0449450:Present [Idea or Concept]
   861   C0557651:Study [Manufactured Object]
   861   C2603343:Study [Research Activity]

Phrase: "there"

Phrase: "is"

Phrase: "a greater proportion of women"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1709707:Proportion [Quantitative Concept]

Phrase: "than men"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0025266:Men [Population Group]
   966 E C0024554:MAN [Finding]
   966 E C0086418:Man [Human]

Phrase: "in the clinical studies,"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0008972:Clinical Studies [Research Activity]
   861   C0205210:Clinical [Qualitative Concept]
   861   C0947630:studies [Laboratory Procedure]
   827 E C0557651:Study [Manufactured Object]
   827 E C2603343:Study [Research Activity]

Phrase: "which"

Phrase: "might"

Phrase: "be in part"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0449719:Part [Spatial Concept]
   790   C1709471:Part [Quantitative Concept]
   790   C2987476:Be [Conceptual Entity]

Phrase: "a reflection of recruitment bias"

Phrase: "but"

Phrase: "also potentially"

Phrase: "be due to the shorter life span of men"
Meta Candidates (Total=15; Excluded=2; Pruned=0; Remaining=13)
   773   C1011825:life of man [Plant]
   764   C0678226:Due to [Functional Concept]
           due
   764   C0870809:life span [Group Attribute]
   742   C0025266:Men [Population Group]
   742   C0376558:Life [Idea or Concept]
   742   C1711300:Span [Conceptual Entity]
   742   C2700613:Span [Quantitative Concept]
   742   C2987476:Be [Conceptual Entity]
   742   C3146286:Due [Idea or Concept]
   708 E C0024554:MAN [Finding]
   708 E C0086418:Man [Human]
   708   C1282927:short [Qualitative Concept]
   708   C1806781:Short [Quantitative Concept]
   708   C2350002:Short [Quantitative Concept]

Phrase: "than women once Alzheimer disease"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   861   C0002395:Alzheimer's Disease [Disease or Syndrome]
   861   C1521724:Alzheimer's Disease [Pathologic Function]
   812   C0012634:Disease [Disease or Syndrome]
   756 E C1836721:MALS [Finding]
   756 E C3538764:MALS [Gene or Genome]
   756 E C3540595:MAL [Gene or Genome]

Phrase: "is"

Phrase: "diagnosed."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0011900:Diagnosed [Finding]
Processing 00000000.tx.201: Autopsy studies of Alzheimer disease cases and control subjects (for islet amyloid) would be subject to the same ascertainment bias as the ADPR since the cases were in the ADPR until death. 

Phrase: "Autopsy"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0004398:Autopsy [Diagnostic Procedure]

Phrase: "studies of Alzheimer disease cases"
Meta Candidates (Total=14; Excluded=5; Pruned=0; Remaining=9)
   806   C0002395:Alzheimer's Disease [Disease or Syndrome]
   806   C1521724:Alzheimer's Disease [Pathologic Function]
   781   C0085973:Case Studies [Intellectual Product]
   760   C0012634:Disease [Disease or Syndrome]
   760   C0557651:Study [Manufactured Object]
   760   C0868928:Cases [Functional Concept]
   760   C0947630:studies [Laboratory Procedure]
   760   C1533148:Cases [Quantitative Concept]
   760   C2603343:Study [Research Activity]
   726 E C1706255:CASE [Medical Device]
   726 E C1706256:Case [Conceptual Entity]
   704 E C1836721:MALS [Finding]
   704 E C3538764:MALS [Gene or Genome]
   704 E C3540595:MAL [Gene or Genome]

Phrase: "and"

Phrase: "control subjects"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   861   C0243148:control [Qualitative Concept]
   861   C1550141:Control [Substance]
   861   C1882979:Control [Conceptual Entity]
   861   C2587213:Control [Functional Concept]
   861   C3274648:Control [Qualitative Concept]
   827   C0681850:Subject [Group]
   827   C1550501:{Subject} [Idea or Concept]
   827   C1706203:Subject [Idea or Concept]
   827   C2349001:Subject [Human]
   827   C2697811:Subject [Functional Concept]

Phrase: "("

Phrase: "for islet amyloid"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0011560:Amyloid [Pathologic Function]
   861   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: ")"

Phrase: "would"

Phrase: "be subject to the same ascertainment bias"
Meta Candidates (Total=11; Excluded=2; Pruned=0; Remaining=9)
   748   C0242568:Bias [Idea or Concept]
   748   C0445247:Same [Qualitative Concept]
   748   C0681850:Subject [Group]
   748   C1504315:Bias [Bird]
   748   C1550501:{Subject} [Idea or Concept]
   748   C1706203:Subject [Idea or Concept]
   748   C2349001:Subject [Human]
   748   C2697811:Subject [Functional Concept]
   748   C2987476:Be [Conceptual Entity]
   714 E C1061346:Bia [Eukaryote]
   714 E C1704746:BIA [Diagnostic Procedure]

Phrase: "as the ADPR"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   875   C0920465:disease registry [Intellectual Product]
   861   C0920631:patient registry [Intellectual Product]
   812   C0034975:Registry [Intellectual Product]

Phrase: "since"

Phrase: "the cases"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0868928:Cases [Functional Concept]
  1000   C1533148:Cases [Quantitative Concept]
   966 E C1706255:CASE [Medical Device]
   966 E C1706256:Case [Conceptual Entity]

Phrase: "were in the ADPR"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   800   C0597185:patient/disease registry [Intellectual Product]
   778   C0002395:Alzheimer's Disease [Disease or Syndrome]
   778   C0920631:patient registry [Intellectual Product]
   778   C1521724:Alzheimer's Disease [Pathologic Function]
   774   C0920465:disease registry [Intellectual Product]
   748   C0012634:Disease [Disease or Syndrome]
   748   C0030705:*^patient [Patient or Disabled Group]
   748   C0034975:Registry [Intellectual Product]

Phrase: "until death."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0011065:Death [Organism Function]
  1000   C1306577:Death, NOS [Finding]
Processing 00000000.tx.202: In autopsy studies of type 2 diabetes cases versus control subjects for brain amyloid, we sought to minimize deliberate bias by including most recent autopsies in reverse sequence from cases that were appropriate for inclusion for these criteria. 

Phrase: "In autopsy"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0004398:Autopsy [Diagnostic Procedure]

Phrase: "studies of type 2 diabetes cases"
Meta Candidates (Total=17; Excluded=2; Pruned=0; Remaining=15)
   833   C0011860:Type 2 Diabetes [Disease or Syndrome]
   790   C0441730:Type 2 [Classification]
   783   C0035171:Study Type [Research Activity]
   783   C1320657:Diabetes type [Finding]
   783   C2985227:Study Type [Research Activity]
   767   C0085973:Case Studies [Intellectual Product]
   753   C0011847:Diabetes [Disease or Syndrome]
   753   C0011849:Diabetes [Disease or Syndrome]
   753   C0332307:Type [Qualitative Concept]
   753   C0557651:Study [Manufactured Object]
   753   C0868928:Cases [Functional Concept]
   753   C0947630:studies [Laboratory Procedure]
   753   C1533148:Cases [Quantitative Concept]
   753   C1547052:*Type [Quantitative Concept]
   753   C2603343:Study [Research Activity]
   719 E C1706255:CASE [Medical Device]
   719 E C1706256:Case [Conceptual Entity]

Phrase: "versus"

Phrase: "control subjects for brain amyloid,"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   797   C0596948:brain control [Mental Process]
   760   C0243148:control [Qualitative Concept]
   760   C1550141:Control [Substance]
   760   C1882979:Control [Conceptual Entity]
   760   C2587213:Control [Functional Concept]
   760   C3274648:Control [Qualitative Concept]
   726   C0681850:Subject [Group]
   726   C1550501:{Subject} [Idea or Concept]
   726   C1706203:Subject [Idea or Concept]
   726   C2349001:Subject [Human]
   726   C2697811:Subject [Functional Concept]

Phrase: "we"

Phrase: "sought"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "minimize"

Phrase: "deliberate bias by"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   790   C0242568:Bias [Idea or Concept]
   790   C1504315:Bias [Bird]
   756 E C1061346:Bia [Eukaryote]
   756 E C1704746:BIA [Diagnostic Procedure]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "most recent autopsies in reverse sequence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0004398:Autopsies [Diagnostic Procedure]

Phrase: "from cases"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0868928:Cases [Functional Concept]
  1000   C1533148:Cases [Quantitative Concept]
   966 E C1706255:CASE [Medical Device]
   966 E C1706256:Case [Conceptual Entity]

Phrase: "that"

Phrase: "were"

Phrase: "appropriate for inclusion"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C1548787:Appropriate [Qualitative Concept]
   718 E C0814634:appropriateness [Qualitative Concept]

Phrase: "for these criteria."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0243161:criteria [Intellectual Product]
Processing 00000000.tx.203: People who have an autopsy are of course in themselves a subgroup of the general population, so bias has to be considered. 

Phrase: "People"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0027361:People [Population Group]

Phrase: "who"

Phrase: "have"

Phrase: "an autopsy"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0004398:Autopsy [Diagnostic Procedure]

Phrase: "are of course"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0750729:Course [Temporal Concept]
   790   C1551058:Are [Quantitative Concept]

Phrase: "in themselves"

Phrase: "a subgroup of the general population,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1079230:subgroup [Virus]
   753   C1515021:Subgroup [Classification]

Phrase: "so"

Phrase: "bias"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0242568:Bias [Idea or Concept]
  1000   C1504315:Bias [Bird]
   966 E C1061346:Bia [Eukaryote]
   966 E C1704746:BIA [Diagnostic Procedure]

Phrase: "has"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "considered."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0750591:considered [Idea or Concept]
Processing 00000000.tx.204: Notwithstanding these limitations, we do have the opportunity of presenting autopsy data from cases that were well characterized in life compared with most autopsy studies. 

Phrase: "Notwithstanding these limitations,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449295:limitations [Functional Concept]

Phrase: "we"

Phrase: "do"

Phrase: "have"

Phrase: "the opportunity of presenting autopsy data"

Phrase: "from cases"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0868928:Cases [Functional Concept]
  1000   C1533148:Cases [Quantitative Concept]
   966 E C1706255:CASE [Medical Device]
   966 E C1706256:Case [Conceptual Entity]

Phrase: "that"

Phrase: "were"

Phrase: "well characterized in life"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C0376558:Life [Idea or Concept]
   729 E C0595998:lives [Finding]

Phrase: "compared with most autopsy studies."
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   760   C0004398:Autopsy [Diagnostic Procedure]
   760   C0947630:studies [Laboratory Procedure]
   760   C1707455:Compared [Activity]
   726 E C0557651:Study [Manufactured Object]
   726 E C2603343:Study [Research Activity]
Processing 00000000.tx.205: In conclusion, we report that there is an increased prevalence of both type 2 diabetes and IFG in a community cohort of patients with Alzheimer disease followed in Olmsted County, Rochester, Minnesota. 

Phrase: "In conclusion,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707478:Conclusion [Idea or Concept]

Phrase: "we"

Phrase: "report"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0684224:Report [Intellectual Product]
  1000   C0700287:Report [Health Care Activity]
  1000   C3273238:Report [Intellectual Product]

Phrase: "that there"

Phrase: "is"

Phrase: "an increased prevalence of both type 2 diabetes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0033105:Prevalence [Quantitative Concept]
   744   C0220900:prevalence [Quantitative Concept]

Phrase: "and"

Phrase: "IFG in a community cohort of patients"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C1334085:IFG [Gene or Genome]
   748   C1708411:IFG [Gene or Genome]

Phrase: "with Alzheimer disease"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "followed in Olmsted County,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C0079170:County [Geographic Area]
   770   C0332283:followed [Temporal Concept]
   737 E C1719822:Follow [Intellectual Product]

Phrase: "Rochester,"

Phrase: "Minnesota."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0026183:Minnesota [Geographic Area]
Processing 00000000.tx.206: We also report increased islet amyloid in patients with Alzheimer disease compared with control subjects. 

Phrase: "We also"

Phrase: "report"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0684224:Report [Intellectual Product]
  1000   C0700287:Report [Health Care Activity]
  1000   C3273238:Report [Intellectual Product]

Phrase: "increased islet amyloid in patients"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0011560:Amyloid [Pathologic Function]
   760   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "with Alzheimer disease"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "compared with control subjects."
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   770   C0243148:control [Qualitative Concept]
   770   C1550141:Control [Substance]
   770   C1707455:Compared [Activity]
   770   C1882979:Control [Conceptual Entity]
   770   C2587213:Control [Functional Concept]
   770   C3274648:Control [Qualitative Concept]
   737   C0681850:Subject [Group]
   737   C1550501:{Subject} [Idea or Concept]
   737   C1706203:Subject [Idea or Concept]
   737   C2349001:Subject [Human]
   737   C2697811:Subject [Functional Concept]
Processing 00000000.tx.207: However, we did not observe an increased frequency of brain amyloid in cases of type 2 diabetes, although in cases of type 2 diabetes that did have brain amyloid, the extent of this amyloid increased with longer duration of diabetes, a correlate that did not extend to the age of patients with type 2 diabetes. 

Phrase: "However,"

Phrase: "we"

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "observe"

Phrase: "an increased frequency of brain amyloid"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0376249:frequency [Quantitative Concept]
   753   C0439603:Frequency [Temporal Concept]
   753   C0871396:Frequency [Quantitative Concept]
   753   C1561548:Frequency [Qualitative Concept]
   753   C1705502:Frequency [Quantitative Concept]

Phrase: "in cases"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0868928:Cases [Functional Concept]
  1000   C1533148:Cases [Quantitative Concept]
   966 E C1706255:CASE [Medical Device]
   966 E C1706256:Case [Conceptual Entity]

Phrase: "of type 2 diabetes,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0011860:Type 2 Diabetes [Disease or Syndrome]
   913   C1320657:type diabetes [Finding]
   901   C0441730:Type 2 [Classification]
   827   C0011847:Diabetes [Disease or Syndrome]
   827   C0011849:Diabetes [Disease or Syndrome]
   827   C0332307:Type [Qualitative Concept]
   827   C1547052:*Type [Quantitative Concept]

Phrase: "although in cases of type 2 diabetes"
Meta Candidates (Total=11; Excluded=2; Pruned=0; Remaining=9)
   814   C0011860:Type 2 Diabetes [Disease or Syndrome]
   778   C0441730:Type 2 [Classification]
   774   C1320657:Diabetes type [Finding]
   748   C0011847:Diabetes [Disease or Syndrome]
   748   C0011849:Diabetes [Disease or Syndrome]
   748   C0332307:Type [Qualitative Concept]
   748   C0868928:Cases [Functional Concept]
   748   C1533148:Cases [Quantitative Concept]
   748   C1547052:*Type [Quantitative Concept]
   714 E C1706255:CASE [Medical Device]
   714 E C1706256:Case [Conceptual Entity]

Phrase: "that"

Phrase: "did"

Phrase: "have"

Phrase: "brain amyloid,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0011560:Amyloid [Pathologic Function]
   861   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "the extent of this amyloid"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0439792:Extent [Spatial Concept]

Phrase: "increased with longer duration of diabetes,"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   773   C0439591:Long duration [Qualitative Concept]
   753   C0011847:Diabetes [Disease or Syndrome]
   753   C0011849:Diabetes [Disease or Syndrome]
   753   C0205217:Increased [Quantitative Concept]
   753   C0442805:Increased [Functional Concept]
   753   C0449238:Duration [Temporal Concept]
   753   C2926735:Duration [Pharmacologic Substance]
   719   C0205166:Long [Qualitative Concept]
   719   C1706317:Long [Qualitative Concept]

Phrase: "a"

Phrase: "correlate"

Phrase: "that"

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "extend to the age of patients"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0001779:Age [Organism Attribute]
   753   C0030705:Patients [Patient or Disabled Group]
   753   C0231448:Extend [Functional Concept]
   753   C0439792:extend [Spatial Concept]

Phrase: "with type 2 diabetes."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0011860:Type 2 Diabetes [Disease or Syndrome]
   913   C1320657:type diabetes [Finding]
   901   C0441730:Type 2 [Classification]
   827   C0011847:Diabetes [Disease or Syndrome]
   827   C0011849:Diabetes [Disease or Syndrome]
   827   C0332307:Type [Qualitative Concept]
   827   C1547052:*Type [Quantitative Concept]
Processing 00000000.tx.208: Taken together, these clinical and pathological studies support a possible link between the neurodegenerative processes that lead to loss of cortical brain cells in Alzheimer disease and the loss of -cells in type 2 diabetes.  

Phrase: "Taken"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883727:Taken [Conceptual Entity]
   966 E C1515187:Take [Health Care Activity]

Phrase: "together,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883357:Together [Qualitative Concept]

Phrase: "these clinical"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205210:Clinical [Qualitative Concept]

Phrase: "and"

Phrase: "pathological studies"
Meta Candidates (Total=9; Excluded=5; Pruned=0; Remaining=4)
   964   C0919386:Pathology studies [Laboratory Procedure]
   947 E C0551718:Pathology study [Clinical Attribute]
   861   C0030664:Pathological [Biomedical Occupation or Discipline]
   861   C0947630:studies [Laboratory Procedure]
   861   C1521733:Pathological [Functional Concept]
   827 E C0557651:Study [Manufactured Object]
   827 E C2603343:Study [Research Activity]
   789 E C0205469:pathology [Functional Concept]
   789 E C0677042:pathology [Pathologic Function]

Phrase: "support"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0183683:Support [Medical Device]
  1000   C1521721:Support [Conceptual Entity]

Phrase: "a possible link between the neurodegenerative processes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C1517892:Link [Intellectual Product]
   748   C1704666:Link [Intellectual Product]

Phrase: "that"

Phrase: "lead to loss of cortical brain cells"
Meta Candidates (Total=17; Excluded=3; Pruned=0; Remaining=14)
   778   C0596208:brain cells [Cell]
   748   C0001613:Cortical [Body Part, Organ, or Organ Component]
   748   C0006104:Brain [Body Part, Organ, or Organ Component]
   748   C0007634:Cells [Cell]
   748   C0007776:Cortical [Body Part, Organ, or Organ Component]
   748   C0022655:Cortical [Body Part, Organ, or Organ Component]
   748   C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   748   C1269537:Brain [Body Part, Organ, or Organ Component]
   748   C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   748   C1517945:Loss [Quantitative Concept]
   748   C1522538:Lead [Functional Concept]
   748   C2348269:Lead [Element, Ion, or Isotope]
   748   C3275067:LEAD [Therapeutic or Preventive Procedure]
   748   C3282337:Cells [Cell]
   714 E C1269647:Cell [Cell]
   714 E C1704653:Cell [Medical Device]
   714 E C1948049:Cell [Spatial Concept]

Phrase: "in Alzheimer disease"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "and"

Phrase: "the loss of -cells in type 2 diabetes."
Meta Candidates (Total=9; Excluded=4; Pruned=0; Remaining=5)
   782   C0449475:Type of cell [Intellectual Product]
           cells type
   750 E C0007634:Cell Type [Cell]
           THE CELL
           Cells
   744   C3282337:Cells [Cell]
   711 E C1269647:Cell [Cell]
   711 E C1704653:Cell [Medical Device]
   711 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.209: ACKNOWLEDGMENTS  This study was funded by grants from the National Institute on Aging, the Mayo ADPR (AG 06786), the Mayo Alzheimer Disease Research Center (AG 16574 to J.E.P. and R.C.P. and DK59579 to P.C.B.), and the Larry Hillblom Foundation (to P.C.B.). 

Phrase: "ACKNOWLEDGMENTS"

Phrase: "This study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]

Phrase: "was"

Phrase: "funded by grants"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0016820:funded [Quantitative Concept]
   790   C0018173:Grants [Quantitative Concept]
   756 E C1548284:Grant [Idea or Concept]

Phrase: "from the National Institute on Aging,"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
  1000   C1955974:National Institute on Aging [Health Care Related Organization]
   812   C0001811:Ageing [Organism Function]
   812   C0021622:institute [Organization]
   812   C1272753:Institute [Idea or Concept]
   812   C3245503:national [Intellectual Product]
   779 E C0001779:Age [Organism Attribute]

Phrase: "the Mayo ADPR"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   853   C0920465:disease registry [Intellectual Product]
   840   C0920631:patient registry [Intellectual Product]
   804   C0034975:Registry [Intellectual Product]

Phrase: "(AG 06786"

Phrase: ")"

Phrase: ","

Phrase: "the Mayo Alzheimer Disease Research Center"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   840   C0002395:Alzheimer's Disease [Disease or Syndrome]
   840   C0683939:research center [Manufactured Object,Organization]
   840   C1521724:Alzheimer's Disease [Pathologic Function]
   804   C0012634:Disease [Disease or Syndrome]
   804   C0035168:research [Research Activity]
   804   C0205099:Center [Spatial Concept]
   804   C0242481:Research [Research Activity]
   748 E C1836721:MALS [Finding]
   748 E C3538764:MALS [Gene or Genome]
   748 E C3540595:MAL [Gene or Genome]

Phrase: "(AG 16574 to J.E.P."

Phrase: "and"

Phrase: "R.C.P."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0722969:R & C [Organic Chemical,Pharmacologic Substance]
   827   C0205090:R- [Spatial Concept]
   827   C0684010:R. [Professional or Occupational Group]
   827   C2603358:R' [Clinical Attribute]

Phrase: "and"

Phrase: "DK59579 to P.C.B."

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "the Larry Hillblom Foundation"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
   827   C0016617:Foundation [Organization]
   743 E C0002055:base [Inorganic Chemical]
   743 E C0178499:Base [Chemical Viewed Functionally]
   743 E C1626935:Bases [Quantitative Concept]
   743 E C1880279:Base [Biomedical or Dental Material]
   721 E C0205112:Basal [Spatial Concept]

Phrase: "("

Phrase: "to P.C.B."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C1527178:Basic [Functional Concept]
   755 E C0920750:basicity [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.210: We acknowledge the excellent technical assistance of Jane Kahl and Karen Laakso, the staff of the Mayo Alzheimer Disease Research Center, and the excellent editorial assistance of Kim Denkers. 

Phrase: "We"

Phrase: "acknowledge"

Phrase: "the excellent technical assistance of Jane Kahl"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0018896:Assistance [Social Behavior]
   748   C0449851:Technical [Functional Concept]

Phrase: "and"

Phrase: "Karen Laakso,"

Phrase: "the staff of the Mayo Alzheimer Disease Research Center,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0851286:Staff [Professional or Occupational Group]
   742   C1947908:Staff [Professional or Occupational Group]

Phrase: "and"

Phrase: "the excellent editorial assistance of Kim Denkers."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0018896:Assistance [Social Behavior]
Processing 00000000.tx.211: We thank Robert Rizza for suggestions and support.  

Phrase: "We"

Phrase: "thank"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2986676:THANK [Gene or Genome]

Phrase: "Robert Rizza for suggestions"

Phrase: "and"

Phrase: "support."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0183683:Support [Medical Device]
  1000   C1521721:Support [Conceptual Entity]
Processing 00000000.tx.212: FOOTNOTES  R.C.P. is on an advisory panel for Elam Pharmaceuticals; 

Phrase: "FOOTNOTES  R.C.P."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0722969:R & C [Organic Chemical,Pharmacologic Substance]
   812   C0205090:R- [Spatial Concept]
   812   C0684010:R. [Professional or Occupational Group]
   812   C2603358:R' [Clinical Attribute]

Phrase: "is on an advisory panel"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0441833:Panel [Idea or Concept]
   760   C1999270:Panel [Intellectual Product]
   760   C3537156:Panel [Manufactured Object]

Phrase: "for Elam Pharmaceuticals"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C1135440:Pharmaceuticals [Therapeutic or Preventive Procedure]
   861   C1254351:Pharmaceuticals [Pharmacologic Substance]
   827 E C0031336:Pharmaceutical [Biomedical Occupation or Discipline]

Phrase: ";"
Processing 00000000.tx.213: has received honoraria from Pfizer, Eisai, Novartis, and Janssen; 

Phrase: "has"

Phrase: "received honoraria from Pfizer,"

Phrase: "Eisai,"

Phrase: "Novartis,"

Phrase: "and"

Phrase: "Janssen"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0331842:Janssen [Health Care Related Organization]

Phrase: ";"
Processing 00000000.tx.214: and has received grant/research support from the National Institute on Aging, Pfizer, and Eisai. 

Phrase: "and"

Phrase: "has"

Phrase: "received grant/research support from the National Institute on Aging,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0035176:Research Support [Quantitative Concept]
   739   C0183683:Support [Medical Device]
   739   C1521721:Support [Conceptual Entity]

Phrase: "Pfizer,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0331888:Pfizer [Health Care Related Organization]

Phrase: "and"

Phrase: "Eisai."
Processing 00000000.tx.215: Address correspondence and reprint requests to Dr. 

Phrase: "Address correspondence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0282413:Correspondence [Intellectual Product]

Phrase: "and"

Phrase: "reprint"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3273171:Reprint [Intellectual Product]

Phrase: "requests to Dr."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   790   C0031831:DR [Professional or Occupational Group]
   790   C0686900:request [Functional Concept]
   790   C1272683:Request [Functional Concept]
   790   C1522634:Request [Intellectual Product]
   790   C1707664:DR [Biomedical or Dental Material]
   790   C2348314:Dr. [Conceptual Entity]
   790   C3540849:DR [Idea or Concept]
Processing 00000000.tx.216: Peter C. 

Phrase: "Peter C."
Processing 00000000.tx.217: Butler, Division of Endocrinology and Diabetes, Keck School of Medicine, University of Southern California, 1333 San Pablo Street, BMT-B11, Los Angeles, CA 90033. 

Phrase: "Butler,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0402644:Butler [Professional or Occupational Group]

Phrase: "Division of Endocrinology"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C1293097:Division [Therapeutic or Preventive Procedure]
   790   C2919030:Division [Organization]
   790   C2919031:Division [Activity]

Phrase: "and"

Phrase: "Diabetes,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0011847:Diabetes [Disease or Syndrome]
  1000   C0011849:Diabetes [Disease or Syndrome]

Phrase: "Keck School of Medicine,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0036375:School [Manufactured Object,Organization]

Phrase: "University of Southern California,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C0006754:California [Geographic Area]
   812   C0041740:University [Manufactured Object,Organization]
   812   C1710133:Southern [Spatial Concept]
   812   C3146274:California [Plant]

Phrase: "1333 San Pablo Street,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0442658:Street [Manufactured Object]
   812   C1301826:Street [Finding]

Phrase: "BMT-B11,"

Phrase: "Los Angeles,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0024015:Los Angeles [Geographic Area]

Phrase: "CA 90033."
Processing 00000000.tx.218: E-mail: pbutler{at}usc.edu Received for publication August 13, 2003 and accepted in revised form October 27, 2003 AP, amyloid  protein; 

Phrase: "E-mail"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0013849:E-Mail [Intellectual Product]
  1000   C1705961:E-mail [Intellectual Product]
   861   C0024492:Mail [Manufactured Object]
   861   C1538057:MAIL [Gene or Genome]
   861   C1547565:Mail [Idea or Concept]

Phrase: ":"

Phrase: "pbutler{at}usc.edu"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0059804:EDU [Organic Chemical,Pharmacologic Substance]

Phrase: "Received for publication August 13,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0034036:Publication [Intellectual Product,Manufactured Object]
   760   C0034037:Publication [Occupational Activity]
   760   C1514756:Received [Qualitative Concept]
   760   C1704324:Publication [Intellectual Product]

Phrase: "2003"

Phrase: "and"

Phrase: "accepted in revised form October 27,"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   753   C0348078:Form [Qualitative Concept]
   753   C0376315:Form [Manufactured Object]
   753   C1272684:Accepted [Qualitative Concept]
   753   C1522492:Form [Functional Concept]
   753   C1527075:Revised [Therapeutic or Preventive Procedure]
   753   C1548435:Accepted [Idea or Concept]
   719 E C1548601:Accept [Idea or Concept]

Phrase: "2003 AP,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "amyloid  protein"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   861   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: ";"
Processing 00000000.tx.219: ADPR, Alzheimer Disease Patient Registry; 

Phrase: "ADPR,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   875   C0920465:disease registry [Intellectual Product]
   861   C0920631:patient registry [Intellectual Product]
   812   C0034975:Registry [Intellectual Product]

Phrase: "Alzheimer Disease Patient Registry"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   875   C0920465:disease registry [Intellectual Product]
   861   C0920631:patient registry [Intellectual Product]
   812   C0034975:Registry [Intellectual Product]

Phrase: ";"
Processing 00000000.tx.220: FPG, fasting plasma glucose; 

Phrase: "FPG,"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   901   C0202042:Plasma glucose [Laboratory Procedure]
   901   C0455280:plasma glucose [Laboratory or Test Result]
   827   C0015663:Fasting [Finding]
   827   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   827   C0032105:Plasma [Body Substance]
   827   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]
   827   C1550565:fasting [Intellectual Product]
   793 E C0456962:Fast [Qualitative Concept]

Phrase: "fasting plasma glucose"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   901   C0202042:Plasma glucose [Laboratory Procedure]
   901   C0455280:plasma glucose [Laboratory or Test Result]
   827   C0015663:Fasting [Finding]
   827   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   827   C0032105:Plasma [Body Substance]
   827   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]
   827   C1550565:fasting [Intellectual Product]
   793 E C0456962:Fast [Qualitative Concept]

Phrase: ";"
Processing 00000000.tx.221: IAPP, islet amyloid polypeptide; 

Phrase: "IAPP,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0063684:Islet Amyloid Polypeptide [Amino Acid, Peptide, or Protein,Hormone]
  1000   C1415831:ISLET AMYLOID POLYPEPTIDE [Gene or Genome]
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1305923:Polypeptide [Amino Acid, Peptide, or Protein]

Phrase: "islet amyloid polypeptide"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0063684:Islet Amyloid Polypeptide [Amino Acid, Peptide, or Protein,Hormone]
  1000   C1415831:ISLET AMYLOID POLYPEPTIDE [Gene or Genome]
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1305923:Polypeptide [Amino Acid, Peptide, or Protein]

Phrase: ";"
Processing 00000000.tx.222: IFG, impaired fasting glucose; 

Phrase: "IFG,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1334085:IFG [Gene or Genome]
  1000   C1708411:IFG [Gene or Genome]

Phrase: "impaired fasting glucose"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
  1000   C1272092:Impaired fasting glucose [Finding]
   827   C0015663:Fasting [Finding]
   827   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   827   C0221099:Impaired [Functional Concept]
   827   C0684336:Impaired [Pathologic Function]
   827   C1550565:fasting [Intellectual Product]
   793 E C0456962:Fast [Qualitative Concept]

Phrase: ";"
Processing 00000000.tx.223: NFT, neurofibrillary tangle  REFERENCES TOP ABSTRACT RESEARCH DESIGN AND METHODS RESULTS DISCUSSION REFERENCES  Westermark P, Wilander E: The influence of amyloid deposits on the islet volume in maturity onset diabetes mellitus. 

Phrase: "NFT,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0085400:Neurofibrillary tangle [Acquired Abnormality]
  1000   C3543859:neurofibrillary tangle [Cell Component]

Phrase: "neurofibrillary tangle"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0085400:Neurofibrillary tangle [Acquired Abnormality]
  1000   C3543859:neurofibrillary tangle [Cell Component]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "TOP ABSTRACT RESEARCH DESIGN"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0035171:Research Design [Research Activity]
   812   C0035168:research [Research Activity]
   812   C0242481:Research [Research Activity]
   812   C1707689:Design [Activity]
   812   C2983265:DESIGN [Intellectual Product]

Phrase: "AND"

Phrase: "METHODS RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Westermark P,"

Phrase: "Wilander E"

Phrase: ":"

Phrase: "The influence of amyloid"

Phrase: "deposits on the islet volume"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0333562:Deposit [Functional Concept]
   760   C0449468:*Volume [Quantitative Concept]
   760   C1690016:% volume [Qualitative Concept]
   760   C1705102:Volume [Intellectual Product]
   760   C2700258:Volume [Laboratory Procedure]

Phrase: "in maturity onset diabetes mellitus."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0011860:Maturity-Onset Diabetes Mellitus [Disease or Syndrome]
           Maturity-Onset Diabetes
   861   C0011849:Diabetes Mellitus [Disease or Syndrome]
Processing 00000000.tx.224: Diabetologia15 :417 421,1978[Medline] Clark A, Wells CA, Buley ID, Cruickshank JK, Vanhegan RI, Matthews DR, Cooper GJ, Holman RR, Turner RC: Islet amyloid, increased A-cells, reduced B-cells and exocrine fibrosis: quantitative changes in the pancreas in type 2 diabetes. 

Phrase: "Diabetologia15"

Phrase: ":"

Phrase: "417 421,"

Phrase: "1978"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Clark A, Wells CA,"

Phrase: "Buley ID,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0600091:ID [Intellectual Product]

Phrase: "Cruickshank JK,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1420098:JK [Gene or Genome]

Phrase: "Vanhegan RI,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0035487:RI [Geographic Area]

Phrase: "Matthews DR,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0031831:DR [Professional or Occupational Group]
   861   C1707664:DR [Biomedical or Dental Material]
   861   C2348314:Dr. [Conceptual Entity]
   861   C3540849:DR [Idea or Concept]

Phrase: "Cooper GJ,"

Phrase: "Holman RR,"

Phrase: "Turner RC"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1419366:RC [Gene or Genome]

Phrase: ":"

Phrase: "Islet amyloid,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0011560:Amyloid [Pathologic Function]
   861   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "increased"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
  1000   C0205217:Increased [Quantitative Concept]
  1000   C0442805:Increased [Functional Concept]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C1706701:Acquire [Activity]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "A-cells,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "reduced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392756:Reduced [Qualitative Concept]

Phrase: "B-cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "and"

Phrase: "exocrine fibrosis"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0016059:Fibrosis [Pathologic Function]
   789 E C0334129:Fibrotic [Functional Concept]

Phrase: ":"

Phrase: "quantitative changes in the pancreas"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   760   C0392747:changes [Functional Concept]
   760   C0443172:changes [Quantitative Concept]
   726 E C1705241:Change [Quantitative Concept]

Phrase: "in type 2 diabetes."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0011860:Type 2 Diabetes [Disease or Syndrome]
   913   C1320657:type diabetes [Finding]
   901   C0441730:Type 2 [Classification]
   827   C0011847:Diabetes [Disease or Syndrome]
   827   C0011849:Diabetes [Disease or Syndrome]
   827   C0332307:Type [Qualitative Concept]
   827   C1547052:*Type [Quantitative Concept]
Processing 00000000.tx.225: Diabetes Res9 :151 159,1988[Medline] Cooper GJ, Willis AC, Clark A, Turner RC, Sim RB, Reid KB: Purification and characterization of a peptide from amyloid-rich pancreases of type 2 diabetic patients. 

Phrase: "Diabetes Res9"

Phrase: ":"

Phrase: "151 159,"

Phrase: "1988"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Cooper GJ,"

Phrase: "Willis AC,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1412573:AC [Gene or Genome]
   861   C2350443:AC [Amino Acid, Peptide, or Protein,Enzyme]
   861   C3539770:AC [Gene or Genome]

Phrase: "Clark A, Turner RC,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1419366:RC [Gene or Genome]

Phrase: "Sim RB,"

Phrase: "Reid KB"

Phrase: ":"

Phrase: "Purification"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0243114:purification [Functional Concept]
  1000   C1998793:Purification [Functional Concept]

Phrase: "and"

Phrase: "characterization of a peptide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1880022:Characterization [Activity]

Phrase: "from amyloid-rich pancreases"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   793   C0030274:Pancreas [Body Part, Organ, or Organ Component]
   793   C1278931:Pancreas [Body Part, Organ, or Organ Component]

Phrase: "of type 2 diabetic patients."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0030705:Patients [Patient or Disabled Group]
Processing 00000000.tx.226: Proc Natl Acad Sci U S A84 :8628 8632,1987[Abstract] Westermark P, Wernstedt C, Wilander E, Hayden DW, OBrien TD, Johnson KH: Amyloid fibrils in human insulinoma and islets of Langerhans of the diabetic cat are derived from a neuropeptide-like protein also present in normal islet cells. 

Phrase: "Proc Natl Acad Sci U S A84"

Phrase: ":"

Phrase: "8628 8632,"

Phrase: "1987"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Westermark P,"

Phrase: "Wernstedt C,"

Phrase: "Wilander E,"

Phrase: "Hayden DW,"

Phrase: "OBrien TD,"

Phrase: "Johnson KH"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0006797:KH [Geographic Area]

Phrase: ":"

Phrase: "Amyloid fibrils in human insulinoma"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   806   C1449651:Amyloid Fibrils [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0225328:fibrils [Cell Component]
   726 E C1948066:Fibril [Physical Object]

Phrase: "and"

Phrase: "islets of Langerhans of the diabetic cat"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   814   C0022131:Islets of Langerhans [Body Part, Organ, or Organ Component]
           Langerhans Islets

Phrase: "are"

Phrase: "derived from a neuropeptide-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0027895:Neuropeptide [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   770   C1441547:Derived [Qualitative Concept]
   770   C3245521:derived [Idea or Concept]

Phrase: "like protein also"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "present in normal islet cells."
Meta Candidates (Total=14; Excluded=4; Pruned=0; Remaining=10)
   806   C0022131:Islet Cells [Body Part, Organ, or Organ Component]
   781   C0007634:Normal cell [Cell]
           Cells
   781   C1268443:Normal cell [Cell]
   773 E C1522529:Islet Cell [Cell]
   760   C0150312:Present [Quantitative Concept]
   760   C0205307:Normal [Qualitative Concept]
   760   C0439166:% normal [Quantitative Concept]
   760   C0449450:Present [Idea or Concept]
   760   C2347086:% Normal [Quantitative Concept]
   760   C3282337:Cells [Cell]
   726 E C1269647:Cell [Cell]
   726 E C1704653:Cell [Medical Device]
   726 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.227: Proc Natl Acad Sci U S A84 :3881 3885,1987[Abstract] Johnson KH, OBrien TD, Hayden DW, Jordan K, Ghobrial HK, Mahoney WC, Westermark P: Immunolocalization of islet amyloid polypeptide (IAPP) in pancreatic beta cells by means of peroxidase-antiperoxidase (PAP) and protein A-gold techniques. 

Phrase: "Proc Natl Acad Sci U S A84"

Phrase: ":"

Phrase: "3881 3885,"

Phrase: "1987"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Johnson KH,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0006797:KH [Geographic Area]

Phrase: "OBrien TD,"

Phrase: "Hayden DW,"

Phrase: "Jordan K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Ghobrial HK,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0019907:HK [Geographic Area]
   861   C2681927:HK [Gene or Genome]
   861   C2987742:HK [Fish]

Phrase: "Mahoney WC,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0013123:WC [Organism Function]
   861   C2825512:WC [Quantitative Concept]

Phrase: "Westermark P"

Phrase: ":"

Phrase: "Immunolocalization of islet amyloid polypeptide"

Phrase: "(IAPP"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0063684:Islet Amyloid Polypeptide [Amino Acid, Peptide, or Protein,Hormone]
  1000   C1415831:ISLET AMYLOID POLYPEPTIDE [Gene or Genome]
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1305923:Polypeptide [Amino Acid, Peptide, or Protein]

Phrase: ")"

Phrase: "in pancreatic beta cells"
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
  1000   C0030281:Pancreatic beta Cells [Cell]
           Beta cell
   827   C0007634:Cells [Cell]
   827   C0030274:Pancreatic [Body Part, Organ, or Organ Component]
   827   C0330390:Beta [Plant]
   827   C0439096:Beta [Intellectual Product]
   827   C2004068:Beta [Qualitative Concept]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "by means of peroxidase-antiperoxidase (PAP)"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0027021:Peroxidase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0031179:Peroxidase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C1318719:Peroxidase [Indicator, Reagent, or Diagnostic Aid]

Phrase: "and"

Phrase: "protein A-gold techniques."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0025664:techniques [Intellectual Product]
   812   C0449851:Techniques [Functional Concept]
Processing 00000000.tx.228: Am J Pathol130 :1 8,1988[Abstract] Braak H, Braak E: The human entorhinal cortex: normal morphology and lamina-specific pathology in various diseases. 

Phrase: "Am"

Phrase: "J Pathol130"

Phrase: ":"

Phrase: "1 8,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: "1988"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Braak H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Braak E"

Phrase: ":"

Phrase: "The human entorhinal cortex"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C0175196:Entorhinal Cortex [Body Part, Organ, or Organ Component]
   901   C1289526:Entorhinal cortex [Body Part, Organ, or Organ Component]
   827   C0007776:Cortex [Body Part, Organ, or Organ Component]
   827   C1176472:Cortex [Body Part, Organ, or Organ Component]
   827   C2700441:Cortex [Plant]

Phrase: ":"

Phrase: "normal morphology"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0332437:Morphology [Qualitative Concept]
   861   C0543482:morphology [Spatial Concept]
   861   C0700329:Morphology, NOS [Finding]
   861   C0700619:Morphology [Biomedical Occupation or Discipline]

Phrase: "and"

Phrase: "lamina-specific pathology in various diseases."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0030664:Pathology [Biomedical Occupation or Discipline]
   753   C0205469:pathology [Functional Concept]
   753   C0677042:pathology [Pathologic Function]
Processing 00000000.tx.229: Neurosci Res15 :6 31,1992[Medline] Glenner GG, Wong CW: Alzheimer disease: initial report of the purification and characterization of a novel cerebrovascular amyloid protein. 

Phrase: "Neurosci Res15"

Phrase: ":"

Phrase: "6 31,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450355:31 [Intellectual Product]

Phrase: "1992"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Glenner GG,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0018370:GG [Geographic Area]

Phrase: "Wong CW"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0454665:CW [Geographic Area]

Phrase: ":"

Phrase: "Alzheimer disease"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: ":"

Phrase: "initial report of the purification"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0684224:Report [Intellectual Product]
   760   C0700287:Report [Health Care Activity]
   760   C3273238:Report [Intellectual Product]

Phrase: "and"

Phrase: "characterization of a novel cerebrovascular amyloid protein."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1880022:Characterization [Activity]
Processing 00000000.tx.230: Biochem Biophys Res Commun120 :885 890,1984[Medline] Masters CL, Simms G, Weinman NA, Multhaup G, McDonald BL, Beyreuther K: Amyloid plaque core protein in Alzheimer disease and Down syndrome. 

Phrase: "Biochem Biophys Res Commun120"

Phrase: ":"

Phrase: "885 890,"

Phrase: "1984"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Masters CL,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0596019:Cl - [Element, Ion, or Isotope]

Phrase: "Simms G,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "Weinman NA,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597484:Na+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1272460:{NA} [Qualitative Concept]

Phrase: "Multhaup G,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "McDonald BL,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0006413:BL [Neoplastic Process]
   861   C1552663:BL [Idea or Concept]
   861   C2827109:BL [Geographic Area]

Phrase: "Beyreuther K"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: ":"

Phrase: "Amyloid plaque core protein in Alzheimer disease"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   831   C0611285:Alzheimer's Disease Amyloid Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   774   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   748   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0444669:Core [Spatial Concept]
   748   C1167518:core [Cell Component]
   748   C1706352:Core [Medical Device]
   748   C1882467:Core [Manufactured Object]
   748   C3274653:Core [Body Substance]

Phrase: "and"

Phrase: "Down syndrome."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0013080:Down Syndrome [Congenital Abnormality,Disease or Syndrome]
   861   C0039082:Syndrome [Disease or Syndrome]
   805   C0423866:Lanugo [Body Part, Organ, or Organ Component]
   805   C2626739:Lanugo [Eukaryote]
Processing 00000000.tx.231: Proc Natl Acad Sci U S A82 :4245 4249,1985[Abstract] Masters CL, Multhaup G, Simms G, Pottgiesser J, Martins RN, Beyreuther K: Neuronal origin of a cerebral amyloid: neurofibrillary tangles of Alzheimer disease contain the same protein as the amyloid of plaque cores and blood vessels. 

Phrase: "Proc Natl Acad Sci U S A82"

Phrase: ":"

Phrase: "4245 4249,"

Phrase: "1985"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Masters CL,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0596019:Cl - [Element, Ion, or Isotope]

Phrase: "Multhaup G,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "Simms G,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "Pottgiesser J,"

Phrase: "Martins RN,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3540639:RN [Gene or Genome]

Phrase: "Beyreuther K"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: ":"

Phrase: "Neuronal origin of a cerebral amyloid"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0079946:origin [Classification]
   753   C0439659:Origin [Temporal Concept]
   753   C1550512:origin [Intellectual Product]

Phrase: ":"

Phrase: "neurofibrillary tangles of Alzheimer disease"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   806   C0085400:Neurofibrillary Tangles [Acquired Abnormality]
   773 E C3543859:neurofibrillary tangle [Cell Component]

Phrase: "contain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contain [Functional Concept]
  1000   C2700400:Contain [Activity]

Phrase: "the same protein as the amyloid of plaque cores"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   762   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   742   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "blood vessels."
Meta Candidates (Total=13; Excluded=11; Pruned=0; Remaining=2)
  1000   C0005847:Blood Vessels [Body Part, Organ, or Organ Component]
           Vessels
   966 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   966 E C1511228:VESSEL, BLOOD [Tissue]
       E   Vessel
   928 E C1558950:VASCULAR [Finding]
   928 E C1801960:Vascular [Qualitative Concept]
   907 E C0005767:Blood [Tissue]
   907 E C0005768:blood [Body Substance]
   907 E C0229664:Blood [Body Substance]
   907 E C0392895:Bloods [Population Group]
   888 E C0333275:Bloody [Qualitative Concept]
   789 E C0702235:Vasal [Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.232: EMBO J4 :2757 2763,1985[Abstract] Bahmanyar S, Higgins GA, Goldgaber D, Lewis DA, Morrison JH, Wilson MC, Shankar SK, Gajdusek DC: Localization of amyloid beta protein messenger RNA in brains from patients with Alzheimer disease. 

Phrase: "EMBO J4"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0442779:J4 [Finding]

Phrase: ":"

Phrase: "2757 2763,"

Phrase: "1985"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Bahmanyar S,"

Phrase: "Higgins GA,"

Phrase: "Goldgaber D,"

Phrase: "Lewis DA,"

Phrase: "Morrison JH,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0268060:JH [Disease or Syndrome]
   861   C1415529:JH [Gene or Genome]

Phrase: "Wilson MC,"

Phrase: "Shankar SK,"

Phrase: "Gajdusek DC"

Phrase: ":"

Phrase: "Localization of amyloid beta protein messenger RNA"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   774   C0597704:protein localisation [Cell Function]
   774   C1158693:RNA localisation [Cell Function]
   774   C1159772:Protein Localization [Cell Function]
   748   C0475264:Localisation [Functional Concept]
   748   C1744691:localisation [Biologic Function]

Phrase: "in brains"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0006104:Brains [Body Part, Organ, or Organ Component]
   966 E C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "from patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030705:Patients [Patient or Disabled Group]

Phrase: "with Alzheimer disease."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.233: Science237 :77 80,1987[Medline] Goedert M: Neuronal localization of amyloid beta protein precursor mRNA in normal human brain and in Alzheimer disease. 

Phrase: "Science237"

Phrase: ":"

Phrase: "77 80,"

Phrase: "1987"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Goedert M"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: ":"

Phrase: "Neuronal localization of amyloid beta protein precursor mRNA"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   767   C0597704:protein localisation [Cell Function]
   767   C1159772:Protein Localization [Cell Function]
   744   C0475264:Localisation [Functional Concept]
   744   C1744691:localisation [Biologic Function]

Phrase: "in normal human brain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0006104:Brain [Body Part, Organ, or Organ Component]
   827   C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "and in Alzheimer disease."
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   833   C0002395:Alzheimer's Disease [Disease or Syndrome]
   833   C1521724:Alzheimer's Disease [Pathologic Function]
   770   C0012634:Disease [Disease or Syndrome]
   770   C1515981:And [Idea or Concept]
   715 E C1836721:MALS [Finding]
   715 E C3538764:MALS [Gene or Genome]
   715 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.234: EMBO J6 :3627 3632,1987[Abstract] Card JP, Meade RP, Davis LG: Immunocytochemical localization of the precursor protein for beta-amyloid in the rat central nervous system. 

Phrase: "EMBO J6"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0442780:J6 [Finding]

Phrase: ":"

Phrase: "3627 3632,"

Phrase: "1987"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Card JP,"

Phrase: "Meade RP,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1538326:RP [Gene or Genome]
   861   C3541325:RP [Idea or Concept]

Phrase: "Davis LG"

Phrase: ":"

Phrase: "Immunocytochemical localization of the precursor protein"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   783   C0597704:protein localisation [Cell Function]
   783   C1159772:Protein Localization [Cell Function]
   753   C0475264:Localisation [Functional Concept]
   753   C1744691:localisation [Biologic Function]

Phrase: "for beta-amyloid"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C2825879:Amyloid, Beta [Laboratory Procedure]
   861   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0011560:Amyloid [Pathologic Function]
   861   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "in the rat central nervous system."
Meta Candidates (Total=17; Excluded=4; Pruned=0; Remaining=13)
   923   C0927232:Central Nervous System [Body System]
   923   C1269563:Central nervous system [Body System]
   923   C1882791:Rat Nervous System [Body Part, Organ, or Organ Component]
   861   C0027763:Nervous System [Body System]
   861   C0422837:NERVOUS SYSTEM [Finding]
   861   C1269560:Nervous system [Body System]
   812   C0027769:Nervous [Sign or Symptom]
   812   C0205099:Central [Spatial Concept]
   812   C0449913:System [Functional Concept]
   812   C0599851:Nervous [Functional Concept]
   812   C1553451:System [Manufactured Object]
   812   C1704459:System [Medical Device]
   812   C1879652:Central - [Laboratory Procedure]
   805 E C0205494:Neurologic [Qualitative Concept]
   768 E C0027855:Neurology [Biomedical Occupation or Discipline]
   750 E C2707261:Neurological [Clinical Attribute]
   741 E C0205373:Systemic [Functional Concept]
Processing 00000000.tx.235: Neuron1 :835 846,1988[Medline] Shivers BD, Hilbich C, Multhaup G, Salbaum M, Beyreuther K, Seeburg PH: Alzheimer disease amyloidogenic glycoprotein: expression pattern in rat brain suggests a role in cell contact. 

Phrase: "Neuron1"

Phrase: ":"

Phrase: "835 846,"

Phrase: "1988"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Shivers BD,"

Phrase: "Hilbich C,"

Phrase: "Multhaup G,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "Salbaum M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Beyreuther K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Seeburg PH"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0020283:[pH] [Quantitative Concept]
   861   C0450407:ph+ [Finding]
   861   C0450408:ph++ [Finding]
   861   C0450409:ph+++ [Finding]

Phrase: ":"

Phrase: "Alzheimer disease amyloidogenic glycoprotein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0017968:Glycoprotein [Amino Acid, Peptide, or Protein,Carbohydrate]

Phrase: ":"

Phrase: "expression pattern in rat brain"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0449774:Pattern [Spatial Concept]

Phrase: "suggests"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "a role in cell contact."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0332158:contact [Functional Concept]
   812   C0337611:Contact [Population Group]
   812   C1705415:Contact [Idea or Concept]
Processing 00000000.tx.236: EMBO J7 :1365 1370,1988[Abstract] Van Broeckhoven C, Genthe AM, Vandenberghe A, Horsthemke B, Backhovens H, Raeymaekers P, Van Hul W, Wehnert A, Gheuens J, Cras P, et al: Failure of familial Alzheimer disease to segregate with the A4-amyloid gene in several European families. 

Phrase: "EMBO J7"

Phrase: ":"

Phrase: "1365 1370,"

Phrase: "1988"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Van Broeckhoven C,"

Phrase: "Genthe"

Phrase: "AM"

Phrase: ","

Phrase: "Vandenberghe A, Horsthemke B, Backhovens H,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   840   C1121424:acids h [Organic Chemical]
   799   C0033727:H+ [Element, Ion, or Isotope]
   799   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   799   C0441932:H+ [Classification]
   799   C0564385:/h [Quantitative Concept]

Phrase: "Raeymaekers P,"

Phrase: "Van Hul W,"

Phrase: "Wehnert A, Gheuens J,"

Phrase: "Cras P,"

Phrase: "et al"

Phrase: ":"

Phrase: "Failure of familial Alzheimer disease to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0231174:Failure [Functional Concept]
   753   C0680095:failure [Individual Behavior]

Phrase: "segregate with the A4-amyloid gene"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0011560:Amyloid [Pathologic Function]
   753   C0017337:Gene [Gene or Genome]
   753   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "in several European families."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0015576:Families [Family Group]
   827   C1704727:Family [Conceptual Entity]
   743 E C0241888:Familial [Functional Concept]
Processing 00000000.tx.237: Nature329 :153 155,1987[Medline] Tanzi RE, St George-Hyslop PH, Haines JL, Polinsky RJ, Nee L, Foncin JF, Neve RL, McClatchey AI, Conneally PM, Gusella JF: The genetic defect in familial Alzheimer disease is not tightly linked to the amyloid beta-protein gene. 

Phrase: "Nature329"

Phrase: ":"

Phrase: "153 155,"

Phrase: "1987"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Tanzi RE,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2986904:RE [Idea or Concept]

Phrase: "St George-Hyslop PH,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C0020283:[pH] [Quantitative Concept]
   812   C0450407:ph+ [Finding]
   812   C0450408:ph++ [Finding]
   812   C0450409:ph+++ [Finding]

Phrase: "Haines JL,"

Phrase: "Polinsky RJ,"

Phrase: "Nee L,"

Phrase: "Foncin JF,"

Phrase: "Neve RL,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1419337:RL [Gene or Genome]
   861   C3539667:RL [Gene or Genome]

Phrase: "McClatchey AI,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0003353:AI [Geographic Area]
   861   C0003504:ai [Disease or Syndrome]

Phrase: "Conneally PM, Gusella JF"

Phrase: ":"

Phrase: "The genetic defect in familial Alzheimer disease"
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
   774   C0019247:Genetic disease [Disease or Syndrome]
   751   C0000768:Birth Defect [Congenital Abnormality]
   751   C1737329:Birth defect [Congenital Abnormality]
   748   C0017296:GENETIC [Therapeutic or Preventive Procedure]
   748   C0314603:Genetic [Functional Concept]
   748   C1457869:Defect [Functional Concept]
   748   C1861101:DEFECT [Disease or Syndrome]
   732 E C2316203:Genetic diseases [Finding]
   732 E C2924406:Genetic diseases [Laboratory Procedure]
   710   C0870545:family origins [Family Group]

Phrase: "is"

Phrase: "not tightly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1518422:Not [Functional Concept]

Phrase: "linked to the amyloid beta-protein gene."
Meta Candidates (Total=19; Excluded=1; Pruned=0; Remaining=18)
   814   C0078939:Amyloid beta-Protein [Amino Acid, Peptide, or Protein]
   778   C0751455:protein gene [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   778   C1750295:beta protein [Genetic Function]
   778   C2362547:Beta protein [Amino Acid, Peptide, or Protein]
   778   C3484390:Amyloid beta [Amino Acid, Peptide, or Protein]
   774   C0065011:linked protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   774   C0314613:Linked gene [Genetic Function]
   774   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   774 E C2825879:Amyloid, Beta [Laboratory Procedure]
   748   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0011560:Amyloid [Pathologic Function]
   748   C0017337:Gene [Gene or Genome]
   748   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0330390:Beta [Plant]
   748   C0439096:Beta [Intellectual Product]
   748   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C2004068:Beta [Qualitative Concept]
   714   C1517892:Link [Intellectual Product]
   714   C1704666:Link [Intellectual Product]
Processing 00000000.tx.238: Nature329 :156 157,1987[Medline] St George-Hyslop PH, Haines JL, Farrer LA, Polinsky R, Van Broeckhoven C, Goate A, McLachlan DR, Orr H, Bruni AC, Sorbi S, et al: Genetic linkage studies suggest that Alzheimer disease is not a single homogeneous disorder: FAD Collaborative Study Group. 

Phrase: "Nature329"

Phrase: ":"

Phrase: "156 157,"

Phrase: "1987"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] St George-Hyslop PH,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C0020283:[pH] [Quantitative Concept]
   812   C0450407:ph+ [Finding]
   812   C0450408:ph++ [Finding]
   812   C0450409:ph+++ [Finding]

Phrase: "Haines JL,"

Phrase: "Farrer LA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0023031:La [Element, Ion, or Isotope]

Phrase: "Polinsky R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Van Broeckhoven C,"

Phrase: "Goate A, McLachlan DR,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C0031831:DR [Professional or Occupational Group]
   812   C1707664:DR [Biomedical or Dental Material]
   812   C2348314:Dr. [Conceptual Entity]
   812   C3540849:DR [Idea or Concept]

Phrase: "Orr H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Bruni AC,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1412573:AC [Gene or Genome]
   861   C2350443:AC [Amino Acid, Peptide, or Protein,Enzyme]
   861   C3539770:AC [Gene or Genome]

Phrase: "Sorbi S,"

Phrase: "et al"

Phrase: ":"

Phrase: "Genetic linkage studies"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   896   C2827447:Genetic Study [Research Activity]
   827   C0947630:studies [Laboratory Procedure]
   793 E C0557651:Study [Manufactured Object]
   793 E C2603343:Study [Research Activity]
   734   C0023745:genetic linkage [Molecular Function]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that Alzheimer disease"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "is"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "a single homogeneous disorder"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0012634:Disorder [Disease or Syndrome]

Phrase: ":"

Phrase: "FAD Collaborative Study Group."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   812   C0441833:Group [Idea or Concept]
   812   C0687744:group [Population Group]
   812   C1257890:Group [Population Group]
   812   C1552516:Group [Health Care Related Organization]
   812   C1705428:Group [Conceptual Entity]
   812   C1705429:Group [Population Group]
Processing 00000000.tx.239: Nature347 :194 197,1990[Medline] Wilson PW, Anderson KM, Kannel WB: Epidemiology of diabetes mellitus in the elderly: the Framingham Study. 

Phrase: "Nature347"

Phrase: ":"

Phrase: "194 197,"

Phrase: "1990"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Wilson PW,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0242397:PW [Geographic Area]

Phrase: "Anderson KM,"

Phrase: "Kannel WB"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0582525:Wb [Quantitative Concept]

Phrase: ":"

Phrase: "Epidemiology of diabetes mellitus"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0014507:Epidemiology [Biomedical Occupation or Discipline]
   770   C0014508:epidemiology [Functional Concept]
   770   C0699910:epidemiology [Health Care Activity]

Phrase: "in the elderly"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0001792:Elderly [Population Group]
  1000   C1999167:elderly [Population Group]

Phrase: ":"

Phrase: "the Framingham Study."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0557651:Study [Manufactured Object]
   861   C2603343:Study [Research Activity]
Processing 00000000.tx.240: Am J Med80(5A) :3 9,1986 Barnett AH, Eff C, Leslie RD, Pyke DA: Diabetes in identical twins: a study of 200 pairs. 

Phrase: "Am"

Phrase: "J Med80"

Phrase: "(5A"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553637:5a [Medical Device]

Phrase: ")"

Phrase: ":"

Phrase: "3 9,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0442760:3/9 [Finding]
   861   C0439086:<3 [Quantitative Concept]
   861   C2827736:3+ [Quantitative Concept]
   861   C2981702:3+ [Classification]

Phrase: "1986 Barnett AH,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1836672:AH [Disease or Syndrome]

Phrase: "Eff"

Phrase: "C,"

Phrase: "Leslie RD,"

Phrase: "Pyke DA"

Phrase: ":"

Phrase: "Diabetes in identical twins"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0011847:Diabetes [Disease or Syndrome]
   770   C0011849:Diabetes [Disease or Syndrome]

Phrase: ":"

Phrase: "a study of 200 pairs."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0557651:Study [Manufactured Object]
   760   C2603343:Study [Research Activity]
Processing 00000000.tx.241: Diabetologia20 :87 93,1981[Medline] Newman B, Selby JV, King MC, Slemenda C, Fabsitz R, Friedman GD: Concordance for type 2 (non-insulin-dependent) diabetes mellitus in male twins. 

Phrase: "Diabetologia20"

Phrase: ":"

Phrase: "87 93,"

Phrase: "1981"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Newman B, Selby JV,"

Phrase: "King"

Phrase: "MC,"

Phrase: "Slemenda C,"

Phrase: "Fabsitz R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Friedman GD"

Phrase: ":"

Phrase: "Concordance for type 2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0680240:concordance [Social Behavior]

Phrase: "(non-insulin-dependent) diabetes mellitus in male twins."
Meta Candidates (Total=15; Excluded=0; Pruned=0; Remaining=15)
   869   C0011860:Diabetes Mellitus, Non-Insulin-Dependent [Disease or Syndrome]
           Non-Insulin Dependent Diabetes
   869   C2697407:DIABETES MELLITUS, NONINSULIN-DEPENDENT [Gene or Genome]
   833   C0011854:Diabetes Mellitus, Insulin-Dependent [Disease or Syndrome]
           Insulin Dependent Diabetes
   770   C0011849:Diabetes Mellitus [Disease or Syndrome]
           Diabetes
   744   C0011847:Diabetes [Disease or Syndrome]
   744   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   744   C0851827:Dependent [Qualitative Concept]
   744   C1518422:Non [Functional Concept]
   744   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   744   C1579433:Insulin [Pharmacologic Substance]
   744   C1701901:Dependent [Qualitative Concept]
   744   C3244310:dependent [Functional Concept]
Processing 00000000.tx.242: Diabetologia30 :763 768,1987[Medline] Hilbich C, Kisters-Woike B, Reed J, Masters CL, Beyreuther K: Aggregation and secondary structure of synthetic amyloid beta A4 peptides of Alzheimer disease. 

Phrase: "Diabetologia30"

Phrase: ":"

Phrase: "763 768,"

Phrase: "1987"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Hilbich C,"

Phrase: "Kisters-Woike B, Reed J,"

Phrase: "Masters CL,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0596019:Cl - [Element, Ion, or Isotope]

Phrase: "Beyreuther K"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: ":"

Phrase: "Aggregation"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0332621:Aggregation [Functional Concept]
  1000   C0439168:% aggregation [Quantitative Concept]
   928 E C0205418:Aggregate [Qualitative Concept]

Phrase: "and"

Phrase: "secondary structure of synthetic amyloid beta A4 peptides of Alzheimer disease."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   756   C0162807:Secondary Structure [Spatial Concept]
   754   C0277555:Secondary disease [Disease or Syndrome]
   738   C0027627:secondary [Neoplastic Process]
   738   C0175668:Secondary [Temporal Concept]
   738   C0205436:Secondary [Quantitative Concept]
   738   C0678594:Structure [Spatial Concept]
   737   C0597196:peptide structure [Spatial Concept]
Processing 00000000.tx.243: J Mol Biol218 :149 163,1991[Medline] Glenner GG, Eanes ED, Wiley CA: Amyloid fibrils formed from a segment of the pancreatic islet amyloid protein. 

Phrase: "J Mol Biol218"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C2346604:J/mol [Quantitative Concept]

Phrase: ":"

Phrase: "149 163,"

Phrase: "1991"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Glenner GG,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0018370:GG [Geographic Area]

Phrase: "Eanes ED,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3538926:ED [Idea or Concept]

Phrase: "Wiley CA"

Phrase: ":"

Phrase: "Amyloid fibrils"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C1449651:Amyloid Fibrils [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0225328:fibrils [Cell Component]
   827 E C1948066:Fibril [Physical Object]

Phrase: "formed from a segment of the pancreatic islet amyloid protein."
Meta Candidates (Total=15; Excluded=3; Pruned=0; Remaining=12)
   775   C0002722:Amyloid A Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0022131:Pancreatic islet [Body Part, Organ, or Organ Component]
   760   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   757   C0002723:Amyloid A [Amino Acid, Peptide, or Protein,Immunologic Factor]
   757   C0038164:Protein A [Amino Acid, Peptide, or Protein,Immunologic Factor,Indicator, Reagent, or Diagnostic Aid]
   739   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   739   C0011560:Amyloid [Pathologic Function]
   739   C0030274:Pancreatic [Body Part, Organ, or Organ Component]
   739   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   739   C0205431:Formed [Functional Concept]
   739   C0441635:Segment [Spatial Concept]
   739   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   706 E C0348078:Form [Qualitative Concept]
   706 E C0376315:Form [Manufactured Object]
   706 E C1522492:Form [Functional Concept]
Processing 00000000.tx.244: Biochem Biophys Res Commun155 :608 614,1988[Medline] Lorenzo A, Razzaboni B, Weir GC, Yankner BA: Pancreatic islet cell toxicity of amylin associated with type-2 diabetes mellitus. 

Phrase: "Biochem Biophys Res Commun155"

Phrase: ":"

Phrase: "608 614,"

Phrase: "1988"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Lorenzo A, Razzaboni B, Weir GC,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C3537453:GC [Gene or Genome]

Phrase: "Yankner BA"

Phrase: ":"

Phrase: "Pancreatic islet cell toxicity of amylin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0040539:toxicity [Qualitative Concept]
   753   C0600688:Toxicity [Injury or Poisoning]

Phrase: "associated with type-2 diabetes mellitus."
Meta Candidates (Total=14; Excluded=2; Pruned=0; Remaining=12)
   882   C0011860:Diabetes Mellitus, Type 2 [Disease or Syndrome]
           Type 2 Diabetes
   882   C2984301:Type II diabetes mellitus [Functional Concept]
   790   C0011849:Diabetes Mellitus [Disease or Syndrome]
           Diabetes
   790   C0332281:Associated with [Qualitative Concept]
           Associated
   790   C0441730:Type 2 [Classification]
   783   C1320657:Diabetes type [Finding]
   753   C0011847:Diabetes [Disease or Syndrome]
   753   C0332307:Type [Qualitative Concept]
   753   C1547052:*Type [Quantitative Concept]
   719 E C0750490:Associate [Idea or Concept]
   719 E C1706221:Associate [Professional or Occupational Group]
Processing 00000000.tx.245: Nature368 :756 760,1994[Medline] Schubert D, Behl C, Lesley R, Brack A, Dargusch R, Sagara Y, Kimura H: Amyloid peptides are toxic via a common oxidative mechanism. 

Phrase: "Nature368"

Phrase: ":"

Phrase: "756 760,"

Phrase: "1994"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Schubert D,"

Phrase: "Behl C,"

Phrase: "Lesley R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Brack A, Dargusch R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0205090:R- [Spatial Concept]
   812   C0684010:R. [Professional or Occupational Group]
   812   C2603358:R' [Clinical Attribute]

Phrase: "Sagara Y,"

Phrase: "Kimura H"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: ":"

Phrase: "Amyloid peptides"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0011560:Amyloid [Pathologic Function]
   861   C0030956:Peptides [Amino Acid, Peptide, or Protein]
   861   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "are"

Phrase: "toxic via a common oxidative mechanism."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0600688:toxic [Injury or Poisoning]
   753   C1407029:Toxic [Qualitative Concept]
Processing 00000000.tx.246: Proc Natl Acad Sci U S A92 :1989 1993,1995[Abstract] OBrien TD, Butler PC, Kreutter DK, Kane LA, Eberhardt NL: Human islet amyloid polypeptide expression in COS-1 cells: a model of intracellular amyloidogenesis. 

Phrase: "Proc Natl Acad Sci U S A92"

Phrase: ":"

Phrase: "1989 1993,"

Phrase: "1995"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] OBrien TD,"

Phrase: "Butler PC,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3540812:PC [Gene or Genome]

Phrase: "Kreutter DK,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0011318:DK [Geographic Area]

Phrase: "Kane LA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0023031:La [Element, Ion, or Isotope]

Phrase: "Eberhardt NL"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0027778:NL [Geographic Area]
   861   C0560008:nL [Quantitative Concept]

Phrase: ":"

Phrase: "Human islet amyloid polypeptide expression in COS-1 cells"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: ":"

Phrase: "a model of intracellular amyloidogenesis."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C3161035:Model [Intellectual Product]
Processing 00000000.tx.247: Am J Pathol147 :609 616,1995[Abstract] Janson J, Ashley RH, Harrison D, McIntyre S, Butler PC: The mechanism of islet amyloid polypeptide toxicity is membrane disruption by intermediate-sized toxic amyloid particles. 

Phrase: "Am"

Phrase: "J Pathol147"

Phrase: ":"

Phrase: "609 616,"

Phrase: "1995"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Janson J,"

Phrase: "Ashley RH,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0035493:Rh [Element, Ion, or Isotope]
   861   C2699077:Rh- [Classification]
   861   C2699078:Rh+ [Classification]

Phrase: "Harrison D,"

Phrase: "McIntyre S,"

Phrase: "Butler PC"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3540812:PC [Gene or Genome]

Phrase: ":"

Phrase: "The mechanism of islet amyloid polypeptide toxicity"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0441712:Mechanism [Functional Concept]
   748   C1706376:Mechanism [Manufactured Object]

Phrase: "is"

Phrase: "membrane disruption by intermediate-sized toxic amyloid particles."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0332453:Disruption [Functional Concept]
Processing 00000000.tx.248: Diabetes48 :491 498,1999[Abstract] Mirzabekov TA, Lin MC, Kagan BL: Pore formation by the cytotoxic islet amyloid peptide amylin. 

Phrase: "Diabetes48"

Phrase: ":"

Phrase: "491 498,"

Phrase: "1999"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Mirzabekov TA,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1506978:Ta [Immunologic Factor]
   861   C1705538:TA [Idea or Concept]

Phrase: "Lin MC,"

Phrase: "Kagan BL"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0006413:BL [Neoplastic Process]
   861   C1552663:BL [Idea or Concept]
   861   C2827109:BL [Geographic Area]

Phrase: ":"

Phrase: "Pore formation by the cytotoxic islet amyloid peptide amylin."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   810   C2247818:islet amyloid peptide formation [Molecular Function]
   764   C1326292:pore formation [Cell Function]
   762   C1327133:peptide formation [Molecular Function]
   742   C0220781:formation [Biologic Function]
   742   C0439634:formation [Spatial Concept]
   742   C1522492:Formation [Functional Concept]
Processing 00000000.tx.249: J Biol Chem271 :1988 1992,1996[Abstract/Free FullText] Lashuel HA, Hartley D, Petre BM, Waltz T, Lansbury PT: Neurodegenerative disease: amyloid pores from pathogenic mutations. 

Phrase: "J Biol Chem271"

Phrase: ":"

Phrase: "1988 1992,"

Phrase: "1996"

Phrase: "[Abstract/Free FullText"

Phrase: "] Lashuel HA,"

Phrase: "Hartley D,"

Phrase: "Petre BM,"

Phrase: "Waltz T,"

Phrase: "Lansbury PT"

Phrase: ":"

Phrase: "Neurodegenerative disease"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0524851:Neurodegenerative Disease [Disease or Syndrome]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: ":"

Phrase: "amyloid pores from pathogenic mutations."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   726   C1325742:Pore [Cell Component]
Processing 00000000.tx.250: Nature418 :291 ,2002 Couce M, Kane LA, OBrien TD, Charlesworth J, Soeller W, McNeish J, Kreutter D, Roche P, Butler PC: Treatment with growth hormone and dexamethasone in mice transgenic for human islet amyloid polypeptide causes islet amyloidosis and -cell dysfunction. 

Phrase: "Nature418"

Phrase: ":"

Phrase: "291 ,"

Phrase: "2002 Couce M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0441923:M+ [Intellectual Product]

Phrase: "Kane LA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0023031:La [Element, Ion, or Isotope]

Phrase: "OBrien TD,"

Phrase: "Charlesworth J,"

Phrase: "Soeller W,"

Phrase: "McNeish J,"

Phrase: "Kreutter D,"

Phrase: "Roche P,"

Phrase: "Butler PC"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3540812:PC [Gene or Genome]

Phrase: ":"

Phrase: "Treatment with growth hormone"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   881   C0744483:growth hormone treatment [Disease or Syndrome]
   819   C0279025:hormone treatment [Therapeutic or Preventive Procedure]
   819   C2966671:Hormone treatment [Clinical Attribute]
   770   C0039798:treatment [Functional Concept]
   770   C0087111:Treatment [Therapeutic or Preventive Procedure]
   770   C1522326:Treatment [Functional Concept]
   770   C1533734:Treatment [Therapeutic or Preventive Procedure]
   770   C1705169:Treatment [Conceptual Entity]
   770   C3538994:TREATMENT [Research Activity]

Phrase: "and"

Phrase: "dexamethasone in mice"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   790   C0011777:Dexamethasone [Pharmacologic Substance,Steroid]
   734 E C0701252:Hexadrol [Pharmacologic Substance,Steroid]
   734 E C0701261:Decaderm [Pharmacologic Substance,Steroid]
   734 E C0740057:Decadron [Pharmacologic Substance,Steroid]

Phrase: "transgenic for human islet amyloid polypeptide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0003069:Transgenic [Animal]

Phrase: "causes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0015127:cause [Functional Concept]
  1000   C1314792:Causes [Functional Concept]
  1000   C1524003:Cause [Conceptual Entity]

Phrase: "islet amyloidosis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0002726:Amyloidosis [Disease or Syndrome]

Phrase: "and -"

Phrase: "cell dysfunction."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0031847:dysfunction [Functional Concept]
   861   C0277785:Dysfunction, NOS [Qualitative Concept]
   805 E C0231174:Malfunction [Functional Concept]
   805 E C1881681:MALFUNCTION [Phenomenon or Process]
Processing 00000000.tx.251: Diabetes45 :1094 1101,1996[Abstract] OBrien TD, Butler AE, Roche PC, Johnson KH, Butler PC: Islet amyloid polypeptide in human insulinomas: evidence for intracellular amyloidogenesis. 

Phrase: "Diabetes45"

Phrase: ":"

Phrase: "1094 1101,"

Phrase: "1996"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] OBrien TD,"

Phrase: "Butler AE,"

Phrase: "Roche PC,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3540812:PC [Gene or Genome]

Phrase: "Johnson KH,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0006797:KH [Geographic Area]

Phrase: "Butler PC"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3540812:PC [Gene or Genome]

Phrase: ":"

Phrase: "Islet amyloid polypeptide in human insulinomas"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   833   C0063684:Islet Amyloid Polypeptide [Amino Acid, Peptide, or Protein,Hormone]
           Insulinoma Amyloid Polypeptide
   833   C1415831:ISLET AMYLOID POLYPEPTIDE [Gene or Genome]
   753   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0011560:Amyloid [Pathologic Function]
   753   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C1305923:Polypeptide [Amino Acid, Peptide, or Protein]

Phrase: ":"

Phrase: "evidence for intracellular amyloidogenesis."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0332120:Evidence [Functional Concept]
Processing 00000000.tx.252: Diabetes43 :329 336,1994[Abstract] Craig EA, Weissman JS, Horwich AL: Heat shock proteins and molecular chaperones: mediators of protein conformation and turnover in the cell. 

Phrase: "Diabetes43"

Phrase: ":"

Phrase: "329 336,"

Phrase: "1994"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Craig EA,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0014963:EA [Organic Chemical,Pharmacologic Substance]
   861   C1457900:EA [Quantitative Concept]

Phrase: "Weissman JS,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1552154:Js [Body Part, Organ, or Organ Component]

Phrase: "Horwich AL"

Phrase: ":"

Phrase: "Heat shock proteins"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0018850:Heat shock proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   901   C0282498:Heat Shock [Physiologic Function]
   827   C0018837:Heat [Natural Phenomenon or Process]
   827   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0036974:Shock [Pathologic Function]

Phrase: "and"

Phrase: "molecular chaperones"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0243041:Molecular Chaperones [Amino Acid, Peptide, or Protein,Biologically Active Substance]
           Chaperone

Phrase: ":"

Phrase: "mediators of protein conformation"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C0127400:mediators [Organic Chemical,Pharmacologic Substance]
   737 E C1363844:Mediator [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "turnover in the cell."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0031227:turnover [Quantitative Concept]
   770   C0243127:turnover [Functional Concept]
   770   C0443331:Turnover [Health Care Activity]
Processing 00000000.tx.253: Cell78 :365 372,1994[Medline] Butler PC, Eberhardt NL, OBrien TD. 

Phrase: "Cell78"

Phrase: ":"

Phrase: "365 372,"

Phrase: "1994"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Butler PC,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3540812:PC [Gene or Genome]

Phrase: "Eberhardt NL,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0027778:NL [Geographic Area]
   861   C0560008:nL [Quantitative Concept]

Phrase: "OBrien TD."
Processing 00000000.tx.254: Islet amyloid polypeptide (IAPP) and insulin secretion. 

Phrase: "Islet amyloid polypeptide"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0063684:Islet Amyloid Polypeptide [Amino Acid, Peptide, or Protein,Hormone]
  1000   C1415831:ISLET AMYLOID POLYPEPTIDE [Gene or Genome]
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1305923:Polypeptide [Amino Acid, Peptide, or Protein]

Phrase: "(IAPP"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0063684:Islet Amyloid Polypeptide [Amino Acid, Peptide, or Protein,Hormone]
  1000   C1415831:ISLET AMYLOID POLYPEPTIDE [Gene or Genome]
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1305923:Polypeptide [Amino Acid, Peptide, or Protein]

Phrase: ")"

Phrase: "and"

Phrase: "insulin secretion."
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
  1000   C1256369:insulin secretion [Cell Function]
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C0036536:secretion [Biologic Function]
   861   C0036537:Secretion [Body Substance]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   777 E C3537244:Insulins [Pharmacologic Substance]
Processing 00000000.tx.255: In Molecular Biology of Diabetes. 

Phrase: "In Molecular Biology"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0026376:Molecular Biology [Biomedical Occupation or Discipline]
   861   C0005532:Biology [Biomedical Occupation or Discipline]
   861   C1521991:Molecular [Qualitative Concept]
   789 E C0205460:Biologic [Qualitative Concept]
   789 E C0567416:Molecule [Substance]
   789 E C2979985:BIOLOGIC [Biologically Active Substance,Pharmacologic Substance]

Phrase: "of Diabetes."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0011847:Diabetes [Disease or Syndrome]
  1000   C0011849:Diabetes [Disease or Syndrome]
Processing 00000000.tx.256: Draznin B, LeRoith D, Eds. 

Phrase: "Draznin B, LeRoith D,"

Phrase: "Eds."
Processing 00000000.tx.257: Totowa, NJ, Humana Press,1994 , p.381 398 Schwartz P: Senile cerebral, pancreatic insular and cardiac amyloidosis. 

Phrase: "Totowa,"

Phrase: "NJ,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0027971:NJ [Geographic Area]

Phrase: "Humana Press,"

Phrase: "1994 ,"

Phrase: "p.381 398 Schwartz P"

Phrase: ":"

Phrase: "Senile cerebral, pancreatic insular"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   825   C0022131:Pancreatic insula [Body Part, Organ, or Organ Component]
   741   C0021640:Insula [Body Part, Organ, or Organ Component]
   741   C1281019:Insula [Body Part, Organ, or Organ Component]

Phrase: "and"

Phrase: "cardiac amyloidosis."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0268407:Cardiac amyloidosis [Disease or Syndrome]
   861   C0002726:Amyloidosis [Disease or Syndrome]
Processing 00000000.tx.258: Trans N Y Acad Sci27 :393 413,1965[Medline] Petersen RC, Kokmen E, Tangalos E, Ivnik RJ, Kurland LT: Mayo Clinic Alzheimer disease patient registry. 

Phrase: "Trans N Y Acad Sci27"

Phrase: ":"

Phrase: "393 413,"

Phrase: "1965"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Petersen RC,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1419366:RC [Gene or Genome]

Phrase: "Kokmen E,"

Phrase: "Tangalos E,"

Phrase: "Ivnik RJ,"

Phrase: "Kurland LT"

Phrase: ":"

Phrase: "Mayo Clinic Alzheimer disease patient registry."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   839   C0920465:disease registry [Intellectual Product]
   827   C0920631:patient registry [Intellectual Product]
   799   C0034975:Registry [Intellectual Product]
Processing 00000000.tx.259: Aging2 :408 415,1990[Medline] Gearing M, Mirra SS, Hedreen JC, Sumi SM, Hansen LA, Heyman A: The Consortium to Establish a Registry for Alzheimer Disease (CERAD): Part X. 

Phrase: "Aging2"

Phrase: ":"

Phrase: "408 415,"

Phrase: "1990"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Gearing M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Mirra SS,"

Phrase: "Hedreen JC,"

Phrase: "Sumi SM,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0036154:SM [Geographic Area]

Phrase: "Hansen LA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0023031:La [Element, Ion, or Isotope]

Phrase: "Heyman"

Phrase: "A"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0001128:Acidic [Chemical]
   928 E C0202406:Acid [Laboratory Procedure]

Phrase: ":"

Phrase: "The Consortium to Establish a Registry for Alzheimer Disease (CERAD)"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   812   C0002395:Alzheimer's Disease [Disease or Syndrome]
   812   C1521724:Alzheimer's Disease [Pathologic Function]
   793   C0012634:Disease [Disease or Syndrome]
   793   C0034975:Registry [Intellectual Product]
   793   C0443211:establish [Qualitative Concept]
   793   C1513822:Consortium [Professional or Occupational Group]
   793   C1880171:Consortium [Professional or Occupational Group]
   737 E C1836721:MALS [Finding]
   737 E C3538764:MALS [Gene or Genome]
   737 E C3540595:MAL [Gene or Genome]

Phrase: ":"

Phrase: "Part X."
Processing 00000000.tx.260: Neuropathology confirmation of the clinical diagnosis of Alzheimer disease. 

Phrase: "Neuropathology confirmation of the clinical diagnosis of Alzheimer disease."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   764   C0521091:Confirmation of [Qualitative Concept]
           confirmation
   742   C0750484:Confirmation [Idea or Concept]
Processing 00000000.tx.261: Neurology45 :461 466,1995[Abstract] Betsholtz C, Christmansson L, Engstrom U, Rorsman F, Svensson V, Johnson KH, Westermark P: Sequence divergence in a specific region of islet amyloid polypeptide (IAPP) explains differences in islet amyloid formation between species. 

Phrase: "Neurology45"

Phrase: ":"

Phrase: "461 466,"

Phrase: "1995"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Betsholtz C,"

Phrase: "Christmansson L,"

Phrase: "Engstrom U,"

Phrase: "Rorsman F,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]

Phrase: "Svensson V,"

Phrase: "Johnson KH,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0006797:KH [Geographic Area]

Phrase: "Westermark P"

Phrase: ":"

Phrase: "Sequence divergence in a specific region of islet amyloid polypeptide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   739   C0443204:Divergence [Spatial Concept]

Phrase: "(IAPP"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0063684:Islet Amyloid Polypeptide [Amino Acid, Peptide, or Protein,Hormone]
  1000   C1415831:ISLET AMYLOID POLYPEPTIDE [Gene or Genome]
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1305923:Polypeptide [Amino Acid, Peptide, or Protein]

Phrase: ")"

Phrase: "explains"

Phrase: "differences in islet amyloid formation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   726   C1705241:*Difference [Quantitative Concept]
   726   C1705242:Difference [Qualitative Concept]

Phrase: "between species."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705920:Species [Conceptual Entity]
Processing 00000000.tx.262: FEBS Lett251 :261 264,1989[Medline] Westermark P, Engstrom U, Johnson KH, Westermark GT, Betsholtz C: Islet amyloid polypeptide: pinpointing amino acid residues linked to amyloid fibril formation. 

Phrase: "FEBS Lett251"

Phrase: ":"

Phrase: "261 264,"

Phrase: "1989"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Westermark P,"

Phrase: "Engstrom U,"

Phrase: "Johnson KH,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0006797:KH [Geographic Area]

Phrase: "Westermark GT,"

Phrase: "Betsholtz C"

Phrase: ":"

Phrase: "Islet amyloid polypeptide"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0063684:Islet Amyloid Polypeptide [Amino Acid, Peptide, or Protein,Hormone]
  1000   C1415831:ISLET AMYLOID POLYPEPTIDE [Gene or Genome]
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1305923:Polypeptide [Amino Acid, Peptide, or Protein]

Phrase: ":"

Phrase: "pinpointing"

Phrase: "amino acid residues"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   793   C1709915:Residue [Conceptual Entity]
   793   C1882936:RESIDUE [Phenomenon or Process]
   743 E C1609982:Residual [Qualitative Concept]
   734   C0002520:Amino acid [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   734   C2917660:Amino Acid [Pharmacologic Substance]

Phrase: "linked to amyloid fibril formation."
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   862   C3544412:amyloid fibril formation [Molecular Function]
   760   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0011560:Amyloid [Pathologic Function]
   760   C0220781:formation [Biologic Function]
   760   C0225328:Fibril [Cell Component]
   760   C0439634:formation [Spatial Concept]
   760   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C1522492:Formation [Functional Concept]
   760   C1948066:Fibril [Physical Object]
   726   C1517892:Link [Intellectual Product]
   726   C1704666:Link [Intellectual Product]
Processing 00000000.tx.263: Proc Natl Acad Sci U S A87 :5036 5040,1990[Abstract] Zhang S, Liu J, Saafi EL, Cooper GJ: Induction of apoptosis by human amylin in RINm5F islet beta-cells is associated with enhanced expression of p53 and p21WAF1/CIP1. 

Phrase: "Proc Natl Acad Sci U S A87"

Phrase: ":"

Phrase: "5036 5040,"

Phrase: "1990"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Zhang S,"

Phrase: "Liu J,"

Phrase: "Saafi EL,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1416870:EL [Gene or Genome]
   861   C1823249:EL [Gene or Genome]

Phrase: "Cooper GJ"

Phrase: ":"

Phrase: "Induction of apoptosis"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C3266896:Induction of Apoptosis [Cell Function]
           Apoptosis Induction
   790   C0205263:Induction [Functional Concept]
   790   C0857127:induction [Therapeutic or Preventive Procedure]

Phrase: "by human amylin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0063684:Amylin [Amino Acid, Peptide, or Protein,Hormone]
   861   C1415831:AMYLIN [Gene or Genome]

Phrase: "in RINm5F islet beta-cells"
Meta Candidates (Total=11; Excluded=4; Pruned=0; Remaining=7)
   875   C0022131:Islet Cells [Body Part, Organ, or Organ Component]
   858 E C1522529:Islet Cell [Cell]
   827   C0030281:Beta cell [Cell]
   812   C0007634:Cells [Cell]
   812   C0330390:Beta [Plant]
   812   C0439096:Beta [Intellectual Product]
   812   C2004068:Beta [Qualitative Concept]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]

Phrase: "is"

Phrase: "associated with enhanced expression of p53"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   790   C0332281:Associated with [Qualitative Concept]
           Associated
   753   C0079419:P53 [Gene or Genome]
   753   C0185117:Expression [Therapeutic or Preventive Procedure]
   753   C1705526:p53 [Gene or Genome]
   753   C2349975:Enhanced [Activity]
   719 E C0750490:Associate [Idea or Concept]
   719 E C1706221:Associate [Professional or Occupational Group]

Phrase: "and"

Phrase: "p21WAF1/CIP1."
Processing 00000000.tx.264: FEBS Lett455 :315 320,1999[Medline] Zhang S, Liu J, MacGibbon G, Dragunow M, Cooper GJ: Increased expression and activation of c-Jun contributes to human amylin-induced apoptosis in pancreatic islet beta-cells. 

Phrase: "FEBS Lett455"

Phrase: ":"

Phrase: "315 320,"

Phrase: "1999"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Zhang S,"

Phrase: "Liu J,"

Phrase: "MacGibbon G,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "Dragunow M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Cooper GJ"

Phrase: ":"

Phrase: "Increased expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "activation of c-Jun"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1879547:Activation [Activity]

Phrase: "contributes to human amylin-induced apoptosis"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   753   C0063684:Amylin [Amino Acid, Peptide, or Protein,Hormone]
   753   C0086418:Human [Human]
   753   C0162638:Apoptosis [Cell Function]
   753   C0205263:Induced [Functional Concept]
   753   C1415831:AMYLIN [Gene or Genome]
   753   C1880177:Contribute [Activity]

Phrase: "in pancreatic islet beta-cells."
Meta Candidates (Total=13; Excluded=4; Pruned=0; Remaining=9)
   923   C0030281:Pancreatic beta Cells [Cell]
           Beta cell
   906   C0734999:Pancreatic islet cell [Cell]
   875   C0022131:Islet Cells [Body Part, Organ, or Organ Component]
   858 E C1522529:Islet Cell [Cell]
   812   C0007634:Cells [Cell]
   812   C0330390:Beta [Plant]
   812   C0439096:Beta [Intellectual Product]
   812   C2004068:Beta [Qualitative Concept]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.265: J Mol Biol324 :271 285,2002[Medline] Bai JZ, Saafi EL, Shang S, Cooper GJ: Role of Ca2+ in apoptosis evoked by human amylin in pancreatic islet beta-cells. 

Phrase: "J Mol Biol324"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C2346604:J/mol [Quantitative Concept]

Phrase: ":"

Phrase: "271 285,"

Phrase: "2002"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Bai JZ,"

Phrase: "Saafi EL,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1416870:EL [Gene or Genome]
   861   C1823249:EL [Gene or Genome]

Phrase: "Shang S,"

Phrase: "Cooper GJ"

Phrase: ":"

Phrase: "Role of Ca2+"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0035820:Role [Social Behavior]
   790   C1705810:Role [Conceptual Entity]

Phrase: "in apoptosis"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0162638:Apoptosis [Cell Function]
   928 E C1516044:Apoptotic [Qualitative Concept]

Phrase: "evoked by human amylin"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0063684:Amylin [Amino Acid, Peptide, or Protein,Hormone]
   770   C0086418:Human [Human]
   770   C1415831:AMYLIN [Gene or Genome]
   770   C1444748:Evoked [Qualitative Concept]

Phrase: "in pancreatic islet beta-cells."
Meta Candidates (Total=13; Excluded=4; Pruned=0; Remaining=9)
   923   C0030281:Pancreatic beta Cells [Cell]
           Beta cell
   906   C0734999:Pancreatic islet cell [Cell]
   875   C0022131:Islet Cells [Body Part, Organ, or Organ Component]
   858 E C1522529:Islet Cell [Cell]
   812   C0007634:Cells [Cell]
   812   C0330390:Beta [Plant]
   812   C0439096:Beta [Intellectual Product]
   812   C2004068:Beta [Qualitative Concept]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.266: Biochem J343 :53 61,1999[Medline] Tucker HM, Rydel RE, Wright S, Estus S: Human amylin induces "apoptotic" pattern of gene expression concomitant with cortical neuronal apoptosis. 

Phrase: "Biochem J343"

Phrase: ":"

Phrase: "53 61,"

Phrase: "1999"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Tucker HM,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0262500:hm [Health Care Activity]
   861   C1512358:HM [Geographic Area]
   861   C3538713:HM [Idea or Concept]

Phrase: "Rydel RE,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2986904:RE [Idea or Concept]

Phrase: "Wright S,"

Phrase: "Estus S"

Phrase: ":"

Phrase: "Human amylin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0063684:Amylin [Amino Acid, Peptide, or Protein,Hormone]
   861   C1415831:AMYLIN [Gene or Genome]

Phrase: "induces"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: """apoptotic"" pattern of gene expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0449774:Pattern [Spatial Concept]

Phrase: "concomitant with cortical neuronal apoptosis."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0521115:Concomitant [Temporal Concept]
Processing 00000000.tx.267: J Neurochem71 :506 516,1998[Medline] Laczko I, Holly S, Konya Z, Soos K, Varga J, Hollosi M, Penke B: Conformational mapping of amyloid peptides from the putative neurotoxic 2535 region. 

Phrase: "J Neurochem71"

Phrase: ":"

Phrase: "506 516,"

Phrase: "1998"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Laczko I,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Holly S,"

Phrase: "Konya Z,"

Phrase: "Soos K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Varga J,"

Phrase: "Hollosi M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Penke"

Phrase: "B"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1527178:Basic [Functional Concept]
   928 E C0920750:basicity [Quantitative Concept]

Phrase: ":"

Phrase: "Conformational mapping of amyloid peptides"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   781   C0030944:Peptide Mapping [Laboratory Procedure]
   760   C1283195:Mapping [Activity]

Phrase: "from the putative neurotoxic 2535 region."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   812   C0017446:Region [Geographic Area]
   812   C0205147:Region [Spatial Concept]
   741 E C0205276:Regional [Spatial Concept]
   741 E C1947913:Regional [Spatial Concept]
Processing 00000000.tx.268: Biochem Biophys Res Commun205 :120 126,1994[Medline] Kayed R, Head E, Thompson JL, McIntire TM, Milton SC, Glabe CG: Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis. 

Phrase: "Biochem Biophys Res Commun205"

Phrase: ":"

Phrase: "120 126,"

Phrase: "1994"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Kayed R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Head E,"

Phrase: "Thompson JL,"

Phrase: "McIntire TM,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0145779:TM [Amino Acid, Peptide, or Protein,Receptor]
   861   C3540468:TM [Gene or Genome]

Phrase: "Milton SC,"

Phrase: "Glabe CG"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0054868:CG [Amino Acid, Peptide, or Protein,Enzyme]
   861   C3540479:CG [Gene or Genome]

Phrase: ":"

Phrase: "Common structure of soluble amyloid oligomers"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0678594:Structure [Spatial Concept]

Phrase: "implies"

Phrase: "common mechanism of pathogenesis."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0441712:Mechanism [Functional Concept]
   770   C1706376:Mechanism [Manufactured Object]
Processing 00000000.tx.269: Science300 :486 489,2003[Abstract/Free FullText] Blake MJ, Edelsman R, Feulner GJ, Nortone DD, Holbrook NJ: Stress-induced heat shock protein 70 expression in adrenal cortex: an adrenocorticotropic hormone-sensitive, age-dependent response. 

Phrase: "Science300"

Phrase: ":"

Phrase: "486 489,"

Phrase: "2003"

Phrase: "[Abstract/Free FullText"

Phrase: "] Blake MJ,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439254:MJ [Medical Device]

Phrase: "Edelsman R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Feulner GJ,"

Phrase: "Nortone DD,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3538867:DD [Gene or Genome]

Phrase: "Holbrook NJ"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0027971:NJ [Geographic Area]

Phrase: ":"

Phrase: "Stress-induced heat shock protein 70 expression in adrenal cortex"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   757   C1171362:expression protein [Genetic Function]
   739   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: ":"

Phrase: "an adrenocorticotropic hormone-sensitive, age-dependent response."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   799   C0871261:Response [Organism Attribute]
   799   C1704632:Response [Finding]
   799   C1706817:Response [Intellectual Product]
   799   C2911692:Response [Mental Process]
Processing 00000000.tx.270: Proc Natl Acad Sci U S A88 :9873 9877,1991[Abstract] Finch CE, Cohen DM: Aging, metabolism, and Alzheimer disease: review and hypothesis. 

Phrase: "Proc Natl Acad Sci U S A88"

Phrase: ":"

Phrase: "9873 9877,"

Phrase: "1991"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Finch CE,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2827664:CE [Idea or Concept]

Phrase: "Cohen DM"

Phrase: ":"

Phrase: "Aging,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001811:Ageing [Organism Function]

Phrase: "metabolism,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0025519:Metabolism [Organism Function]
  1000   C0025520:metabolism [Functional Concept]

Phrase: "and"

Phrase: "Alzheimer disease"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: ":"

Phrase: "review"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0282443:Review [Intellectual Product]
  1000   C1552617:Review [Idea or Concept]

Phrase: "and"

Phrase: "hypothesis."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1512571:Hypothesis [Idea or Concept]
Processing 00000000.tx.271: Exp Neurol143 :82 102,1997[Medline] Yan SD, Stern D, Schmidt AM: Whats the rage? 

Phrase: "Exp Neurol143"

Phrase: ":"

Phrase: "82 102,"

Phrase: "1997"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Yan SD,"

Phrase: "Stern D,"

Phrase: "Schmidt"

Phrase: "AM"

Phrase: ":"

Phrase: "Whats"

Phrase: "the rage?"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0034634:Rage [Mental Process]
  1000   C3539760:RAGE [Gene or Genome]
Processing 00000000.tx.272: The receptor for advanced glycation and end products (RAGE) and the dark side of glucose. 

Phrase: "The receptor for advanced glycation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "and"

Phrase: "end products"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   861   C0444930:End [Spatial Concept]
   861   C1514468:Products [Entity]
   861   C2746065:End [Temporal Concept]
   827 E C1704444:Product [Quantitative Concept]
   805 E C0205088:Terminal [Temporal Concept]
   805 E C1705314:Terminal [Manufactured Object]
   805 E C1705315:Terminal [Spatial Concept]

Phrase: "(RAGE)"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0034634:Rage [Mental Process]
  1000   C3539760:RAGE [Gene or Genome]

Phrase: "and"

Phrase: "the dark side of glucose."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0441987:Side [Spatial Concept]
Processing 00000000.tx.273: Eur J Clin Invest27 :179 181,1997[Medline] Sasaki N, Toki S, Chowei H, Saito T, Nakao N, Hayashi Y, Takeuchi M, Makita Z: Immunohistochemical distribution of the receptor for advanced glycation end products in neurons and astrocytes in Alzheimer disease. 

Phrase: "Eur J Clin Invest27"

Phrase: ":"

Phrase: "179 181,"

Phrase: "1997"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Sasaki N,"

Phrase: "Toki S,"

Phrase: "Chowei H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Saito T,"

Phrase: "Nakao N,"

Phrase: "Hayashi Y,"

Phrase: "Takeuchi M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Makita Z"

Phrase: ":"

Phrase: "Immunohistochemical distribution of the receptor"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0520511:distribution [Idea or Concept]
   760   C1704711:Distribution [Functional Concept]

Phrase: "for advanced glycation end products"
Meta Candidates (Total=11; Excluded=5; Pruned=0; Remaining=6)
  1000   C0162574:Glycation End Products, Advanced [Biologically Active Substance,Organic Chemical]
   812   C0205179:Advanced [Qualitative Concept]
   812   C0444930:End [Spatial Concept]
   812   C0598528:glycation [Phenomenon or Process]
   812   C1514468:Products [Entity]
   812   C2746065:End [Temporal Concept]
   779 E C0725066:Advance [Medical Device]
   779 E C1704444:Product [Quantitative Concept]
   756 E C0205088:Terminal [Temporal Concept]
   756 E C1705314:Terminal [Manufactured Object]
   756 E C1705315:Terminal [Spatial Concept]

Phrase: "in neurons"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0027882:Neurons [Cell]
   916 E C0521390:Neuronal [Immunologic Factor]

Phrase: "and"

Phrase: "astrocytes in Alzheimer disease."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0004112:Astrocytes [Cell]
Processing 00000000.tx.274: Brain Res888 :256 262,2001[Medline] Heitner J, Dickson D: Diabetics do not have increased Alzheimer-type pathology with age-matched control subjects: a retrospective postmortem immunocytochemical and histofluorescent study. 

Phrase: "Brain Res888"

Phrase: ":"

Phrase: "256 262,"

Phrase: "2001"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Heitner J,"

Phrase: "Dickson D"

Phrase: ":"

Phrase: "Diabetics"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0241863:diabetics [Finding]

Phrase: "do"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "have"

Phrase: "increased Alzheimer-type pathology with age-matched control subjects"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   742   C0030664:Pathology [Biomedical Occupation or Discipline]
   742   C0205469:pathology [Functional Concept]
   742   C0677042:pathology [Pathologic Function]

Phrase: ":"

Phrase: "a retrospective postmortem"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0004398:postmortem [Diagnostic Procedure]
   861   C0580205:Postmortem [Temporal Concept]
   861   C0848632:post mortem [Finding]

Phrase: "immunocytochemical"

Phrase: "and"

Phrase: "histofluorescent study."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0557651:Study [Manufactured Object]
   861   C2603343:Study [Research Activity]
Processing 00000000.tx.275: Neurology49 :1306 1311,1997[Abstract] Curb JD, Rodriguez BL, Abbott RD, Petrovitch H, Ross GW, Masaki KH, Foley D, Blanchette PL, Harris T, Chen R, White LR: Longitudinal association of vascular and Alzheimer dementias, diabetes, and glucose tolerance. 

Phrase: "Neurology49"

Phrase: ":"

Phrase: "1306 1311,"

Phrase: "1997"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Curb JD,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1549972:JD [Intellectual Product]

Phrase: "Rodriguez BL,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0006413:BL [Neoplastic Process]
   861   C1552663:BL [Idea or Concept]
   861   C2827109:BL [Geographic Area]

Phrase: "Abbott RD,"

Phrase: "Petrovitch H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Ross GW,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0018387:GW [Geographic Area]

Phrase: "Masaki KH,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0006797:KH [Geographic Area]

Phrase: "Foley D,"

Phrase: "Blanchette PL,"

Phrase: "Harris T,"

Phrase: "Chen R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "White LR"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0023617:LR [Geographic Area]
   861   C2986899:LR [Idea or Concept]

Phrase: ":"

Phrase: "Longitudinal association of vascular"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0004083:Association [Mental Process]
   770   C0439849:Association [Qualitative Concept]
   770   C0596306:Association [Phenomenon or Process]
   770   C0699792:association [Social Behavior]

Phrase: "and"

Phrase: "Alzheimer dementias,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   966   C0002395:Alzheimer's Dementia [Disease or Syndrome]
   861   C0497327:Dementias [Mental or Behavioral Dysfunction]
   827 E C0011265:dementia [Mental or Behavioral Dysfunction]
   755 E C0860630:dement [Mental or Behavioral Dysfunction]

Phrase: "diabetes,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0011847:Diabetes [Disease or Syndrome]
  1000   C0011849:Diabetes [Disease or Syndrome]

Phrase: "and"

Phrase: "glucose tolerance."
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
  1000   C0178665:Glucose tolerance [Physiologic Function]
   861   C0013220:Tolerance [Finding]
   861   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   861   C0020963:Tolerance [Pathologic Function]
   861   C0220929:tolerance [Mental Process]
   861   C0231197:Tolerance [Physiologic Function]
   861   C1704410:Tolerance [Qualitative Concept]
   805 E C0680282:toleration [Social Behavior]
   789 E C0231198:Tolerant [Functional Concept]
Processing 00000000.tx.276: Neurology52 :971 975,1999[Abstract/Free FullText] MacKight C, Rockwood K, Awalt E, McDowell I: Diabetes mellitus and the risk of dementia, Alzheimer disease and vascular cognitive impairment in the Canadian study of health and aging. 

Phrase: "Neurology52"

Phrase: ":"

Phrase: "971 975,"

Phrase: "1999"

Phrase: "[Abstract/Free FullText"

Phrase: "] MacKight C,"

Phrase: "Rockwood K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Awalt E,"

Phrase: "McDowell I"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: ":"

Phrase: "Diabetes mellitus"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0011849:Diabetes Mellitus [Disease or Syndrome]
           Diabetes
   861   C0011847:Diabetes [Disease or Syndrome]

Phrase: "and"

Phrase: "the risk of dementia,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0035647:Risk [Qualitative Concept]

Phrase: "Alzheimer disease"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "and"

Phrase: "vascular cognitive impairment in the Canadian"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0338656:Cognitive impairment [Mental or Behavioral Dysfunction]
   753   C0684336:Impairment [Pathologic Function]

Phrase: "study of health"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0018684:Health [Idea or Concept]
   790   C0557651:Study [Manufactured Object]
   790   C2603343:Study [Research Activity]

Phrase: "and"

Phrase: "aging."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001811:Ageing [Organism Function]
Processing 00000000.tx.277: Dement Geriatr Cogn Disord14 :77 83,2002[Medline] Isomaa B, Almgren P, Tuomi T, Forsn B, Lahti K, Nissn M, Taskinen M-R, Groop L: Cardiovascular morbidity and mortality associated with the metabolic syndrome. 

Phrase: "Dement Geriatr Cogn Disord14"

Phrase: ":"

Phrase: "77 83,"

Phrase: "2002"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Isomaa B, Almgren P,"

Phrase: "Tuomi T,"

Phrase: "Forsn B, Lahti K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   812   C1708601:K' [Quantitative Concept]

Phrase: "Nissn M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Taskinen"

Phrase: "M-"

Phrase: "R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Groop L"

Phrase: ":"

Phrase: "Cardiovascular morbidity"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1301700:Cardiovascular morbidity [Disease or Syndrome]
   861   C0026538:Morbidity [Quantitative Concept]
   861   C0220880:morbidity [Intellectual Product]

Phrase: "and"

Phrase: "mortality"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0026565:Mortality [Quantitative Concept]
  1000   C0026566:mortality [Quantitative Concept]

Phrase: "associated with the metabolic syndrome."
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   806   C0332281:Associated with [Qualitative Concept]
           Associated
   806   C0524620:Metabolic syndrome [Disease or Syndrome]
   760   C0039082:Syndrome [Disease or Syndrome]
   760   C0311400:Metabolic [Functional Concept]
   760   C1524026:Metabolic [Cell Function]
   760   C2707259:Metabolic [Clinical Attribute]
   726 E C0750490:Associate [Idea or Concept]
   726 E C1706221:Associate [Professional or Occupational Group]
Processing 00000000.tx.278: Diabetes Care24 :683 689,2001[Abstract/Free FullText] Sasaki N, Fukatsu R, Tsuzuki K, Hayashi Y, Yoshida T, Fujii N, Koike T, Wakayama I, Yanagihara R, Garruto R, Amano N, Makita Z: Advanced glycation end products in Alzheimer disease and other neurodegenerative diseases. 

Phrase: "Diabetes Care24"

Phrase: ":"

Phrase: "683 689,"

Phrase: "2001"

Phrase: "[Abstract/Free FullText"

Phrase: "] Sasaki N,"

Phrase: "Fukatsu R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Tsuzuki K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Hayashi Y,"

Phrase: "Yoshida T,"

Phrase: "Fujii N,"

Phrase: "Koike T,"

Phrase: "Wakayama I,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Yanagihara R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Garruto R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Amano N,"

Phrase: "Makita Z"

Phrase: ":"

Phrase: "Advanced glycation end products in Alzheimer disease"
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
   853   C0162574:Glycation End Products, Advanced [Biologically Active Substance,Organic Chemical]
   774   C0679246:advanced disease [Finding]
   748   C0205179:Advanced [Qualitative Concept]
   748   C0444930:End [Spatial Concept]
   748   C0598528:glycation [Phenomenon or Process]
   748   C1514468:Products [Entity]
   748   C2746065:End [Temporal Concept]
   746   C0679247:Terminal Disease [Disease or Syndrome]
   714 E C0725066:Advance [Medical Device]
   714 E C1704444:Product [Quantitative Concept]

Phrase: "and"

Phrase: "other neurodegenerative diseases."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0524851:Neurodegenerative Diseases [Disease or Syndrome]
   861   C0012634:Diseases [Disease or Syndrome]
   789 E C1836721:MALS [Finding]
   789 E C3538764:MALS [Gene or Genome]
   789 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.279: Am J Pathol153 :1149 1155,1998[Abstract/Free FullText] Mast H, Thompson JL, Lee SH, Mohr JP, Sacco RL: Hypertension and diabetes mellitus as determinants of multiple lacunar infarcts. 

Phrase: "Am"

Phrase: "J Pathol153"

Phrase: ":"

Phrase: "1149 1155,"

Phrase: "1998"

Phrase: "[Abstract/Free FullText"

Phrase: "] Mast H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Thompson JL,"

Phrase: "Lee SH,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0038108:SH [Geographic Area]

Phrase: "Mohr JP,"

Phrase: "Sacco RL"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1419337:RL [Gene or Genome]
   861   C3539667:RL [Gene or Genome]

Phrase: ":"

Phrase: "Hypertension"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0020538:Hypertension [Disease or Syndrome]
  1000   C1963138:Hypertension [Finding]

Phrase: "and"

Phrase: "diabetes mellitus as determinants of multiple lacunar infarcts."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0011849:Diabetes Mellitus [Disease or Syndrome]
           Diabetes
   744   C0011847:Diabetes [Disease or Syndrome]
Processing 00000000.tx.280: Stroke26 :30 33,1995[Abstract/Free FullText] Tatemichi TK, Desmond DW, Paik M, Figueroa M, Gropen TI, Stern Y, Sano M, Remien R, Williams JB, Mohr JP, et al.: 

Phrase: "Stroke26"

Phrase: ":"

Phrase: "30 33,"

Phrase: "1995"

Phrase: "[Abstract/Free FullText"

Phrase: "] Tatemichi TK,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0220928:TK [Geographic Area]

Phrase: "Desmond DW,"

Phrase: "Paik M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Figueroa M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Gropen TI,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0040302:Ti [Element, Ion, or Isotope]
   861   C1553045:Ti [Quantitative Concept]
   861   C1704756:TI [Idea or Concept]

Phrase: "Stern Y,"

Phrase: "Sano M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Remien R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Williams JB,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1550751:JB [Temporal Concept]

Phrase: "Mohr JP,"

Phrase: "et al."

Phrase: ":"
Processing 00000000.tx.281: Clinical determinants of dementia related to stroke. 

Phrase: "Clinical determinants of dementia"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   737   C1521761:Determinant [Functional Concept]

Phrase: "related"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0439849:Related [Qualitative Concept]
  1000   C0445223:Related [Finding]
   966 E C0163712:Relate [Organic Chemical]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "stroke."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0038454:Stroke [Disease or Syndrome]
Processing 00000000.tx.282: Ann Neurol33 :568 575,1993[Medline] Desmond DW, Tatemichi TK, Paik M, Stern Y: Risk factors for cerebrovascular disease as correlates of cognitive function in a stroke-free cohort. 

Phrase: "Ann Neurol33"

Phrase: ":"

Phrase: "568 575,"

Phrase: "1993"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Desmond DW,"

Phrase: "Tatemichi TK,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0220928:TK [Geographic Area]

Phrase: "Paik M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Stern Y"

Phrase: ":"

Phrase: "Risk factors for cerebrovascular disease"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   835   C0850664:disease factors risk [Finding]
   806   C0035648:risk factors [Quantitative Concept]
   806   C1553898:risk factors [Idea or Concept]
   797   C0679238:disease factors [Functional Concept]
   797   C1281905:disease risk [Finding]
   760   C0035647:Risk [Qualitative Concept]
   726   C1521761:Factor [Functional Concept]
   726   C2827422:Factor [Conceptual Entity]

Phrase: "as correlates"

Phrase: "of cognitive function"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
  1000   C0392335:cognitive function [Mental Process]
   861   C0031843:function [Physiologic Function]
   861   C0542341:Function [Functional Concept]
   861   C0700205:FUNCTION [Classification]
   861   C1516691:Cognitive [Functional Concept]
   861   C1705273:Function [Intellectual Product]
   789 E C0205245:Functional [Functional Concept]
   789 E C2700217:Functional [Conceptual Entity]

Phrase: "in a stroke-free cohort."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0599755:Cohort [Population Group]
Processing 00000000.tx.283: Arch Neurol50 :162 166,1993[Abstract] McCall AL: The impact of diabetes on the NCS. 

Phrase: "Arch Neurol50"

Phrase: ":"

Phrase: "162 166,"

Phrase: "1993"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] McCall AL"

Phrase: ":"

Phrase: "The impact of diabetes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1825598:IMPACT [Gene or Genome]

Phrase: "on the NCS."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0027597:NCS [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
Processing 00000000.tx.284: Diabetes41 :557 570,1992[Abstract] Biessels GJ, Kappelle AC, Bravenboer B, Erkelens DW, Gibsen WH: Cerebral function in diabetes mellitus. 

Phrase: "Diabetes41"

Phrase: ":"

Phrase: "557 570,"

Phrase: "1992"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Biessels GJ,"

Phrase: "Kappelle AC,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1412573:AC [Gene or Genome]
   861   C2350443:AC [Amino Acid, Peptide, or Protein,Enzyme]
   861   C3539770:AC [Gene or Genome]

Phrase: "Bravenboer B, Erkelens DW,"

Phrase: "Gibsen WH"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2349143:Wh [Quantitative Concept]

Phrase: ":"

Phrase: "Cerebral function in diabetes mellitus."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   806   C0234386:Cerebral function [Organ or Tissue Function]
   760   C0031843:function [Physiologic Function]
   760   C0542341:Function [Functional Concept]
   760   C0700205:FUNCTION [Classification]
   760   C1705273:Function [Intellectual Product]
Processing 00000000.tx.285: Diabetologia37 :643 650,1994[Medline] Langen SJ, Deary IJ, Hepburn DA, Frier BM: Cumulative cognitive impairment following recurrent severe hypoglycaemia in adult patients with insulin-treated diabetes mellitus. 

Phrase: "Diabetologia37"

Phrase: ":"

Phrase: "643 650,"

Phrase: "1994"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Langen SJ,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1515101:SJ [Geographic Area]
   861   C2986905:SJ [Idea or Concept]

Phrase: "Deary IJ,"

Phrase: "Hepburn DA,"

Phrase: "Frier BM"

Phrase: ":"

Phrase: "Cumulative cognitive impairment"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0338656:Cognitive impairment [Mental or Behavioral Dysfunction]
   827   C0684336:Impairment [Pathologic Function]

Phrase: "following"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332282:Following [Temporal Concept]
   966 E C0332283:follow [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "recurrent severe hypoglycaemia in adult patients"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   833   C0342316:Recurrent severe hypoglycaemia [Pathologic Function]
   753   C0020615:Hypoglycaemia [Disease or Syndrome]
   753   C0205082:Severe [Qualitative Concept]

Phrase: "with insulin-treated diabetes mellitus."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0011849:Diabetes Mellitus [Disease or Syndrome]
           Diabetes
   812   C0011847:Diabetes [Disease or Syndrome]
Processing 00000000.tx.286: Diabetologia34 :337 344,1991[Medline] Ott A, Stolk RP, van Harskamp F, Pols H, Hofman A, Breteler M: Diabetes mellitus and the risk of dementia: the Rotterdam study. 

Phrase: "Diabetologia34"

Phrase: ":"

Phrase: "337 344,"

Phrase: "1991"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Ott A, Stolk RP,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C1538326:RP [Gene or Genome]
   812   C3541325:RP [Idea or Concept]

Phrase: "van Harskamp F,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   827   C0439133:(f) [Intellectual Product]
   827   C1553038:[f] [Quantitative Concept]

Phrase: "Pols H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Hofman A, Breteler M"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   812   C0441923:M+ [Intellectual Product]

Phrase: ":"

Phrase: "Diabetes mellitus"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0011849:Diabetes Mellitus [Disease or Syndrome]
           Diabetes
   861   C0011847:Diabetes [Disease or Syndrome]

Phrase: "and"

Phrase: "the risk of dementia"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0035647:Risk [Qualitative Concept]

Phrase: ":"

Phrase: "the Rotterdam study."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0557651:Study [Manufactured Object]
   861   C2603343:Study [Research Activity]
Processing 00000000.tx.287: Neurology53 :1937 1942,1999[Abstract/Free FullText] Leibson CL, Rocca WA, Hanson VA, Cha R, Kokmen E, OBrien PC, Palumbo PJ: The risk of dementia among persons with diabetes mellitus: a population based cohort study. 

Phrase: "Neurology53"

Phrase: ":"

Phrase: "1937 1942,"

Phrase: "1999"

Phrase: "[Abstract/Free FullText"

Phrase: "] Leibson CL,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0596019:Cl - [Element, Ion, or Isotope]

Phrase: "Rocca WA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0043038:WA [Geographic Area]

Phrase: "Hanson VA,"

Phrase: "Cha R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Kokmen E,"

Phrase: "OBrien PC,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3540812:PC [Gene or Genome]

Phrase: "Palumbo PJ"

Phrase: ":"

Phrase: "The risk of dementia"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0035647:Risk [Qualitative Concept]

Phrase: "among persons"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0027361:Persons [Population Group]
   966 E C2347489:Person [Group]
   916 E C1519021:Personal [Organism Attribute]

Phrase: "with diabetes mellitus"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0011849:Diabetes Mellitus [Disease or Syndrome]
           Diabetes
   861   C0011847:Diabetes [Disease or Syndrome]

Phrase: ":"

Phrase: "a population based cohort study."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   923   C1709599:Population Based Study [Research Activity]
   902   C0681876:Population Study [Research Activity]
   861   C0009247:Cohort Study [Quantitative Concept]
   812   C0557651:Study [Manufactured Object]
   812   C0599755:Cohort [Population Group]
   812   C2603343:Study [Research Activity]
Processing 00000000.tx.288: Am J Epidemiol145 :301 308,1997[Abstract] Luchsinger JA, Tang M-X, Yaakov S, Shea S, Mayeux R: Diabetes mellitus and risk of Alzheimer disease and dementia with stroke in a multiethnic cohort. 

Phrase: "Am"

Phrase: "J Epidemiol145"

Phrase: ":"

Phrase: "301 308,"

Phrase: "1997"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Luchsinger JA,"

Phrase: "Tang"

Phrase: "M-"

Phrase: "X,"

Phrase: "Yaakov S,"

Phrase: "Shea S,"

Phrase: "Mayeux R"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: ":"

Phrase: "Diabetes mellitus"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0011849:Diabetes Mellitus [Disease or Syndrome]
           Diabetes
   861   C0011847:Diabetes [Disease or Syndrome]

Phrase: "and"

Phrase: "risk of Alzheimer disease"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   819   C1281905:disease risk [Finding]
   770   C0035647:Risk [Qualitative Concept]

Phrase: "and"

Phrase: "dementia with stroke"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0011265:dementia [Mental or Behavioral Dysfunction]
   790   C0497327:Dementia [Mental or Behavioral Dysfunction]

Phrase: "in a multiethnic cohort."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0599755:Cohort [Population Group]
Processing 00000000.tx.289: Am J Epidemiol154 :635 641,2001[Abstract/Free FullText] Bucht G, Adolfsson R, Lithner F, Winblad B: Changes in blood glucose and insulin secretion in patients with senile dementia of Alzheimer type. 

Phrase: "Am"

Phrase: "J Epidemiol154"

Phrase: ":"

Phrase: "635 641,"

Phrase: "2001"

Phrase: "[Abstract/Free FullText"

Phrase: "] Bucht G,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "Adolfsson R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Lithner F,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]

Phrase: "Winblad"

Phrase: "B"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1527178:Basic [Functional Concept]
   928 E C0920750:basicity [Quantitative Concept]

Phrase: ":"

Phrase: "Changes in blood glucose"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C0392747:changes [Functional Concept]
   770   C0443172:changes [Quantitative Concept]
   737 E C1705241:Change [Quantitative Concept]

Phrase: "and"

Phrase: "insulin secretion in patients"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   833   C1256369:insulin secretion [Cell Function]
   770   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   770   C0036536:secretion [Biologic Function]
   770   C0036537:Secretion [Body Substance]
   770   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   770   C1579433:Insulin [Pharmacologic Substance]
   715 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "with senile dementia"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
  1000   C0002395:Dementia, Senile [Disease or Syndrome]
  1000   C0011268:Senile dementia [Mental or Behavioral Dysfunction]
   861   C0011265:dementia [Mental or Behavioral Dysfunction]
   861   C0392079:Senile [Finding]
   861   C0497327:Dementia [Mental or Behavioral Dysfunction]
   805 E C0231337:Old age [Finding]
   805 E C1999167:Old age [Population Group]
   761 E C0860630:dement [Mental or Behavioral Dysfunction]

Phrase: "of Alzheimer type."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0332307:Type [Qualitative Concept]
   861   C1547052:*Type [Quantitative Concept]
Processing 00000000.tx.290: Acta Med Scand213 :387 392,1983[Medline] Wolf-Klein GP, Silversone FA, Brod MS, Levy A, Foley CJ, Termotto V, Breuer J: Are Alzheimer patients healthier? 

Phrase: "Acta Med Scand213"

Phrase: ":"

Phrase: "387 392,"

Phrase: "1983"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Wolf-Klein GP,"

Phrase: "Silversone FA,"

Phrase: "Brod MS,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039676:MS [Amino Acid, Peptide, or Protein,Enzyme]
   861   C2349943:Ms. [Conceptual Entity]
   861   C3539704:MS [Gene or Genome]

Phrase: "Levy A, Foley CJ,"

Phrase: "Termotto V,"

Phrase: "Breuer J"

Phrase: ":"

Phrase: "Are"

Phrase: "Alzheimer patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0030705:Patients [Patient or Disabled Group]

Phrase: "healthier?"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   916   C0018684:Health [Idea or Concept]
   916   C0031206:healthiness [Finding]
Processing 00000000.tx.291: J Am Geriatr Soc36 :219 224,1988[Medline] Ferini-Strambi L, Smirne S, Garanchini P, Pinto P, Franceschi M: Clinical and epidemiological aspects of Alzheimer disease with presenile onset: a case control study. 

Phrase: "J"

Phrase: "Am"

Phrase: "Geriatr Soc36"

Phrase: ":"

Phrase: "219 224,"

Phrase: "1988"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Ferini-Strambi L,"

Phrase: "Smirne S,"

Phrase: "Garanchini P,"

Phrase: "Pinto P,"

Phrase: "Franceschi M"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: ":"

Phrase: "Clinical"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205210:Clinical [Qualitative Concept]

Phrase: "and"

Phrase: "epidemiological aspects of Alzheimer disease"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   726   C1547011:Aspect [Quantitative Concept]
   726   C1879746:Aspect [Qualitative Concept]

Phrase: "with presenile onset"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0332162:Onset [Qualitative Concept]

Phrase: ":"

Phrase: "a case control study."
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
  1000   C0007328:Case-Control Study [Research Activity]
   913   C0085973:Case Study [Intellectual Product]
   901   C0872128:case control [Health Care Activity]
   827   C0243148:control [Qualitative Concept]
   827   C0557651:Study [Manufactured Object]
   827   C0868928:Case [Functional Concept]
   827   C1550141:Control [Substance]
   827   C1706255:CASE [Medical Device]
   827   C1706256:Case [Conceptual Entity]
   827   C1882979:Control [Conceptual Entity]
   827   C2587213:Control [Functional Concept]
   827   C2603343:Study [Research Activity]
   827   C3274648:Control [Qualitative Concept]
Processing 00000000.tx.292: Neuroepidemiology9 :39 49,1990[Medline] Landin K, Blennow K, Wallin A, Gottfries C-G: Low blood pressure and blood glucose levels in Alzheimer disease: evidence for a hypometabolic disorder? 

Phrase: "Neuroepidemiology9"

Phrase: ":"

Phrase: "39 49,"

Phrase: "1990"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Landin K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Blennow K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Wallin A, Gottfries C-G"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0439267:g% [Quantitative Concept]

Phrase: ":"

Phrase: "Low blood pressure"
Meta Candidates (Total=20; Excluded=7; Pruned=0; Remaining=13)
  1000   C0020649:Blood Pressure, Low [Finding]
   901   C0005823:Blood Pressure [Organism Function]
   901   C1271104:Blood Pressure [Finding]
   901   C1272641:Blood pressure [Finding]
   827   C0005767:Blood [Tissue]
   827   C0005768:blood [Body Substance]
   827   C0033095:Pressure [Phenomenon or Process]
   827   C0205251:low [Qualitative Concept]
   827   C0229664:Blood [Body Substance]
   827   C0460139:Pressure [Finding]
   827   C1299352:Low [Qualitative Concept]
   827   C1306345:Pressure [Functional Concept]
   827   C1550472:low [Idea or Concept]
   755 E C0333275:Bloody [Qualitative Concept]
   743 E C0005847:Blood Vessel [Body Part, Organ, or Organ Component]
   743 E C0392895:Bloods [Population Group]
   743 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   743 E C1511228:VESSEL, BLOOD [Tissue]
   727 E C1558950:VASCULAR [Finding]
   727 E C1801960:Vascular [Qualitative Concept]

Phrase: "and"

Phrase: "blood glucose levels in Alzheimer disease"
Meta Candidates (Total=15; Excluded=5; Pruned=0; Remaining=10)
   833   C0428554:blood glucose levels [Laboratory or Test Result]
   790   C0005802:Blood Glucose [Carbohydrate]
   790   C0428548:glucose levels [Laboratory or Test Result]
   783   C0018939:Blood disease NOS [Disease or Syndrome]
   783   C1533163:Blood disease [Disease or Syndrome]
   756 E C0337438:glucose level [Laboratory Procedure]
   753   C0005767:Blood [Tissue]
   753   C0005768:blood [Body Substance]
   753   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   753   C0229664:Blood [Body Substance]
   753   C0441889:Levels [Qualitative Concept]
   742 E C0042373:blood vessel disease [Disease or Syndrome]
   719 E C0456079:Level [Classification]
   719 E C1547707:Level [Geographic Area]
   719 E C2946261:Level [Pharmacologic Substance]

Phrase: ":"

Phrase: "evidence for a hypometabolic disorder?"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0332120:Evidence [Functional Concept]
Processing 00000000.tx.293: J Intern Med233 :357 363,1993[Medline] Mortel KF, Wood S, Pavol MA, Meyer JS, Rexer JL: Analysis of familial and individual risk factors among patients with ischemic vascular dementia and Alzheimer disease. 

Phrase: "J Intern Med233"

Phrase: ":"

Phrase: "357 363,"

Phrase: "1993"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Mortel KF,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1427198:KF [Gene or Genome]

Phrase: "Wood S,"

Phrase: "Pavol MA,"

Phrase: "Meyer JS,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1552154:Js [Body Part, Organ, or Organ Component]

Phrase: "Rexer JL"

Phrase: ":"

Phrase: "Analysis of familial"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0002778:Analysis [Laboratory Procedure]
   790   C0936012:Analysis [Research Activity]
   790   C1524024:analysis [Functional Concept]

Phrase: "and"

Phrase: "individual risk factors among patients"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   862   C0815141:individual risk factors [Clinical Attribute]
   806   C0035648:risk factors [Quantitative Concept]
   806   C1553898:risk factors [Idea or Concept]
   760   C0035647:Risk [Qualitative Concept]
   726   C1521761:Factor [Functional Concept]
   726   C2827422:Factor [Conceptual Entity]

Phrase: "with ischemic vascular dementia"
Meta Candidates (Total=15; Excluded=8; Pruned=0; Remaining=7)
   901   C0011269:Dementia, Vascular [Disease or Syndrome]
   827   C0005847:vascular [Body Part, Organ, or Organ Component]
   827   C0011265:dementia [Mental or Behavioral Dysfunction]
   827   C0475224:Ischaemic [Functional Concept]
   827   C0497327:Dementia [Mental or Behavioral Dysfunction]
   827   C1558950:VASCULAR [Finding]
   827   C1801960:Vascular [Qualitative Concept]
   771 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   771 E C1511228:VESSEL, BLOOD [Tissue]
   727 E C0005767:Blood [Tissue]
   727 E C0005768:blood [Body Substance]
   727 E C0229664:Blood [Body Substance]
   727 E C0392895:Bloods [Population Group]
   727 E C0860630:dement [Mental or Behavioral Dysfunction]
   711 E C0333275:Bloody [Qualitative Concept]

Phrase: "and"

Phrase: "Alzheimer disease."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.294: Angiology44 :599 605,1993[Medline] Neilson KA, Nolan JH, Berchtold NC, Sandman CA, Mulnard RA, Cotman CW: Apolipoprotein-E genotyping of diabetic dementia patients: is diabetes rare in Alzheimer disease? 

Phrase: "Angiology44"

Phrase: ":"

Phrase: "599 605,"

Phrase: "1993"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Neilson KA,"

Phrase: "Nolan JH,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0268060:JH [Disease or Syndrome]
   861   C1415529:JH [Gene or Genome]

Phrase: "Berchtold NC,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0027964:NC [Geographic Area]
   861   C0028407:NC [Geographic Area]
   861   C0067895:NC [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "Sandman CA,"

Phrase: "Mulnard RA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3538806:Ra [Spatial Concept]

Phrase: "Cotman CW"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0454665:CW [Geographic Area]

Phrase: ":"

Phrase: "Apolipoprotein-E genotyping of diabetic dementia patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1285573:Genotyping [Laboratory Procedure]

Phrase: ":"

Phrase: "is"

Phrase: "diabetes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0011847:Diabetes [Disease or Syndrome]
  1000   C0011849:Diabetes [Disease or Syndrome]

Phrase: "rare in Alzheimer disease?"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   819   C0678236:Rare Disease [Disease or Syndrome]
   770   C0521114:Rare [Temporal Concept]
   770   C0522498:Rare [Qualitative Concept]
   770   C1514917:RARE [Gene or Genome]
Processing 00000000.tx.295: J Am Geriatr Soc44 :1 8,1996[Medline] Heyman A, Wilkinson WE, Stafford JA, Helms MJ, Sigmon AH, Weinberg T: Alzheimer disease: a study of epidemiological aspects. 

Phrase: "J"

Phrase: "Am"

Phrase: "Geriatr Soc44"

Phrase: ":"

Phrase: "1 8,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: "1996"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Heyman A, Wilkinson"

Phrase: "WE,"

Phrase: "Stafford JA,"

Phrase: "Helms MJ,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439254:MJ [Medical Device]

Phrase: "Sigmon AH,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1836672:AH [Disease or Syndrome]

Phrase: "Weinberg T"

Phrase: ":"

Phrase: "Alzheimer disease"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: ":"

Phrase: "a study of epidemiological aspects."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   838   C0699910:Study of epidemiology [Health Care Activity]
   797   C0002783:Epidemiological Study [Research Activity]
   760   C0557651:Study [Manufactured Object]
   760   C2603343:Study [Research Activity]
Processing 00000000.tx.296: Ann Neurol15 :335 341,1984[Medline] Broe GA, Henderson AS, Creasey H, McCusker E, Korten AE, Jorm AF, Longley W, Anthony JC: A case controlled study of Alzheimer disease in Australia. 

Phrase: "Ann Neurol15"

Phrase: ":"

Phrase: "335 341,"

Phrase: "1984"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Broe GA,"

Phrase: "Henderson AS,"

Phrase: "Creasey H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "McCusker E,"

Phrase: "Korten AE,"

Phrase: "Jorm AF,"

Phrase: "Longley W,"

Phrase: "Anthony JC"

Phrase: ":"

Phrase: "A case controlled study of Alzheimer disease"
Meta Candidates (Total=16; Excluded=5; Pruned=0; Remaining=11)
   802   C0007328:Case-Control Study [Research Activity]
   778   C0681867:Controlled Study [Research Activity]
   774   C0085973:Case Study [Intellectual Product]
   774   C2911690:Disease Controlled [Finding]
   762   C0872128:case control [Health Care Activity]
   757 E C0920467:control disease [Therapeutic or Preventive Procedure]
   748   C0557651:Study [Manufactured Object]
   748   C0868928:Case [Functional Concept]
   748   C1706255:CASE [Medical Device]
   748   C1706256:Case [Conceptual Entity]
   748   C2587213:Controlled [Functional Concept]
   748   C2603343:Study [Research Activity]
   714 E C0243148:control [Qualitative Concept]
   714 E C1550141:Control [Substance]
   714 E C1882979:Control [Conceptual Entity]
   714 E C3274648:Control [Qualitative Concept]

Phrase: "in Australia."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0004340:Australia [Geographic Area]
   928 E C0238711:AUSTRALIAN [Finding]
Processing 00000000.tx.297: Neurology40 :1698 1707,1990[Abstract] Kokmen E, Beard CM, Chandra V, Offord KP, Schoenberg BS, Ballard DJ: Clinical risk factors for Alzheimer disease: a population based case-control study. 

Phrase: "Neurology40"

Phrase: ":"

Phrase: "1698 1707,"

Phrase: "1990"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Kokmen E,"

Phrase: "Beard CM,"

Phrase: "Chandra V,"

Phrase: "Offord KP,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0022772:KP [Geographic Area]
   861   C1881334:kp [Quantitative Concept]

Phrase: "Schoenberg BS,"

Phrase: "Ballard DJ"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0012836:DJ [Geographic Area]

Phrase: ":"

Phrase: "Clinical risk factors for Alzheimer disease"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   814   C0850664:disease factors risk [Finding]
   790   C0035648:risk factors [Quantitative Concept]
   790   C1553898:risk factors [Idea or Concept]
   783   C0679238:disease factors [Functional Concept]
   783   C1281905:disease risk [Finding]
   753   C0035647:Risk [Qualitative Concept]
   719   C1521761:Factor [Functional Concept]
   719   C2827422:Factor [Conceptual Entity]

Phrase: ":"

Phrase: "a population based case-control study."
Meta Candidates (Total=17; Excluded=0; Pruned=0; Remaining=17)
   911   C1709599:Population Based Study [Research Activity]
   897   C0681876:Population Study [Research Activity]
   888   C0007328:based case study [Research Activity]
           Case-Control Study
   875   C0032662:Population Control [Occupation or Discipline]
   853   C0085973:Case Study [Intellectual Product]
   840   C0872128:case control [Health Care Activity]
   804   C0243148:control [Qualitative Concept]
   804   C0557651:Study [Manufactured Object]
   804   C0868928:Case [Functional Concept]
   804   C1550141:Control [Substance]
   804   C1706255:CASE [Medical Device]
   804   C1706256:Case [Conceptual Entity]
   804   C1882979:Control [Conceptual Entity]
   804   C2587213:Control [Functional Concept]
   804   C2603343:Study [Research Activity]
   804   C3274648:Control [Qualitative Concept]
Processing 00000000.tx.298: Neurology41 :1393 1397,1991[Abstract] Thorpe J, Widman LP, Wallin A, Beiswanger J, Blumenthal HT: Comorbidity of other chronic age-dependent diseases in dementia. 

Phrase: "Neurology41"

Phrase: ":"

Phrase: "1393 1397,"

Phrase: "1991"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Thorpe J,"

Phrase: "Widman LP,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0037943:LP [Diagnostic Procedure,Therapeutic or Preventive Procedure]
   861   C0228341:LP [Body Part, Organ, or Organ Component]
   861   C2239920:LP [Gene or Genome]

Phrase: "Wallin A, Beiswanger J,"

Phrase: "Blumenthal HT"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0018510:HT [Geographic Area]
   861   C0677607:HT [Disease or Syndrome]

Phrase: ":"

Phrase: "Comorbidity of other chronic age-dependent diseases"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0009488:Comorbidity [Idea or Concept]

Phrase: "in dementia."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0011265:dementia [Mental or Behavioral Dysfunction]
  1000   C0497327:Dementia [Mental or Behavioral Dysfunction]
   900 E C0860630:dement [Mental or Behavioral Dysfunction]
Processing 00000000.tx.299: Aging Clin Exp Res6 :159 166,1994 Curb JD, Roderiquez BL, Petrovich H, Masaki KH, Burchfiel CM, Ross W, Chen R, Harris T, White LR: The relationship of diabetes and glucose tolerance to Alzheimer disease and vascular dementia (Abstract 488). 

Phrase: "Aging Clin Exp Res6"

Phrase: ":"

Phrase: "159 166,"

Phrase: "1994 Curb JD,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1549972:JD [Intellectual Product]

Phrase: "Roderiquez BL,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0006413:BL [Neoplastic Process]
   861   C1552663:BL [Idea or Concept]
   861   C2827109:BL [Geographic Area]

Phrase: "Petrovich H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Masaki KH,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0006797:KH [Geographic Area]

Phrase: "Burchfiel CM,"

Phrase: "Ross W,"

Phrase: "Chen R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Harris T,"

Phrase: "White LR"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0023617:LR [Geographic Area]
   861   C2986899:LR [Idea or Concept]

Phrase: ":"

Phrase: "The relationship of diabetes"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0439849:Relationship [Qualitative Concept]
   770   C1705630:Relationship [Idea or Concept]
   770   C1706279:Relationship [Idea or Concept]
   770   C3540605:Relationship [Intellectual Product]

Phrase: "and"

Phrase: "glucose tolerance to Alzheimer disease"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   806   C0178665:Glucose tolerance [Physiologic Function]
   760   C0013220:Tolerance [Finding]
   760   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   760   C0020963:Tolerance [Pathologic Function]
   760   C0220929:tolerance [Mental Process]
   760   C0231197:Tolerance [Physiologic Function]
   760   C1704410:Tolerance [Qualitative Concept]
   704 E C0680282:toleration [Social Behavior]

Phrase: "and"

Phrase: "vascular dementia"
Meta Candidates (Total=14; Excluded=8; Pruned=0; Remaining=6)
  1000   C0011269:Dementia, Vascular [Disease or Syndrome]
   861   C0005847:vascular [Body Part, Organ, or Organ Component]
   861   C0011265:dementia [Mental or Behavioral Dysfunction]
   861   C0497327:Dementia [Mental or Behavioral Dysfunction]
   861   C1558950:VASCULAR [Finding]
   861   C1801960:Vascular [Qualitative Concept]
   805 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   805 E C1511228:VESSEL, BLOOD [Tissue]
   761 E C0005767:Blood [Tissue]
   761 E C0005768:blood [Body Substance]
   761 E C0229664:Blood [Body Substance]
   761 E C0392895:Bloods [Population Group]
   761 E C0860630:dement [Mental or Behavioral Dysfunction]
   745 E C0333275:Bloody [Qualitative Concept]

Phrase: "(Abstract 488"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0000857:Abstract [Occupational Activity]
   861   C0600678:Abstract [Intellectual Product]
   861   C1552863:Abstract [Idea or Concept]

Phrase: ")."
Processing 00000000.tx.300: Neurobiol Aging17 (Suppl.) 

Phrase: "Neurobiol Aging17"

Phrase: "(Suppl."

Phrase: ")"
Processing 00000000.tx.301: :S122 ,1996 The expert committee on the diagnosis and classification of diabetes mellitus. 

Phrase: ":"

Phrase: "S122 ,"

Phrase: "1996"

Phrase: "The expert committee on the diagnosis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C2699414:Committee [Group]

Phrase: "and"

Phrase: "classification of diabetes mellitus."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0008902:Classification [Classification]
   770   C0008903:classification [Functional Concept]
   770   C0678229:classification [Occupational Activity]
Processing 00000000.tx.302: Diabetes Care20 :1183 1197,1997[Medline]

Phrase: "Diabetes Care20"

Phrase: ":"

Phrase: "1183 1197,"

Phrase: "1997"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

